<?xml version="1.0" encoding="UTF-8" standalone="no"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0" version="2.0"><channel><title><![CDATA[Plenary Session]]></title><description><![CDATA[Dr Prasad on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com <br/><br/><a href="https://www.drvinayprasad.com?utm_medium=podcast">www.drvinayprasad.com</a>]]></description><link>https://www.drvinayprasad.com/podcast</link><generator>Substack</generator><lastBuildDate>Sun, 22 Nov 2026 22:59:34 GMT</lastBuildDate><atom:link href="https://api.substack.com/feed/podcast/231792.rss" rel="self" type="application/rss+xml"/><author><![CDATA[Vinay Prasad]]></author><copyright><![CDATA[Vinay Prasad]]></copyright><language><![CDATA[en]]></language><webMaster><![CDATA[vinayprasadmdmph@substack.com]]></webMaster><itunes:new-feed-url>https://api.substack.com/feed/podcast/231792.rss</itunes:new-feed-url><itunes:author>Vinay Prasad, MD MPH</itunes:author><itunes:subtitle>A podcast on medicine, oncology, &amp; health policy.</itunes:subtitle><itunes:type>episodic</itunes:type><itunes:explicit>no</itunes:explicit><itunes:image href="https://i.imgur.com/eXCakHP.jpg"/><itunes:keywords>medicine,oncology,health,policy</itunes:keywords><itunes:summary>A podcast on medicine, oncology, &amp; health policy. &#13;
Host: Vinay Prasad, MD MPH from University of California, San Francisco.&#13;
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.</itunes:summary><itunes:category text="Science &amp; Medicine"><itunes:category text="Medicine"/></itunes:category><itunes:owner><itunes:email>plenarysessionpodcast@gmail.com</itunes:email><itunes:name>Vinay Prasad, MD MPH</itunes:name></itunes:owner><item><title><![CDATA[Moderna cancer therapeutic vaccine]]></title><description><![CDATA[<p>Thanks for alerting me</p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/moderna-cancer-therapeutic-vaccine</link><guid isPermaLink="false">substack:post:225996592</guid><pubDate>Sun, 22 Nov 2026 02:52:48 GMT</pubDate><enclosure length="12896685" type="audio/mpeg" url="https://api.substack.com/feed/podcast/225996592/f8e7679fbd05672d8924f23b898138a8.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/225996592/b436399aae618acbd16322813ccf9a44.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>806</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/225996592/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>Thanks for alerting me This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>Thanks for alerting me This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[New AML vax, MAHA, and Listener Questions]]></title><description><![CDATA[<p>Live episode from Youtube </p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/new-aml-vax-maha-and-listener-questions</link><guid isPermaLink="false">substack:post:225734689</guid><pubDate>Fri, 20 Nov 2026 01:17:46 GMT</pubDate><enclosure length="45309420" type="audio/mpeg" url="https://api.substack.com/feed/podcast/225734689/38c5562eaa7b7860cda44c195c702a97.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/225734689/949ab5b5adae75ca229e33e13c1169a5.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>2832</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/225734689/2a5d5876f1e626e57cff4558cba5f45b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>Live episode from Youtube This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>Live episode from Youtube This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Will cancer be cured in 10 years?]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/will-cancer-be-cured-in-10-years</link><guid isPermaLink="false">substack:post:225443727</guid><pubDate>Wed, 18 Nov 2026 10:39:26 GMT</pubDate><enclosure length="6832097" type="audio/mpeg" url="https://api.substack.com/feed/podcast/225443727/2993380c63f43909e824f7f7ddae5da3.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/225443727/b683b34b291cedd0cbc581a556272b6e.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>427</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/225443727/7916343b75569a91751f6cedb5c74180.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Cornell, Calley Means, and Lp (a)]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/cornell-calley-means-and-lp-a</link><guid isPermaLink="false">substack:post:224986110</guid><pubDate>Sun, 15 Nov 2026 10:26:30 GMT</pubDate><enclosure length="11337292" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224986110/9430fb90360cf3d3b08e91c4f711c747.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/224986110/a9d9867002945733db2b675b7b3edc57.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>566</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224986110/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Elizabeth Holmes/ AI researchers start smoking/ Moderna vax]]></title><description><![CDATA[Elizabeth Holmes/ AI researchers start smoking/ Moderna vax by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/elizabeth-holmes-ai-researchers-start-cdf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2425780587</guid><pubDate>Sun, 25 Oct 2026 21:08:16 GMT</pubDate><enclosure length="15007322" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525149/c3888727678fd4885ee0950d4d02ca55.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Elizabeth Holmes/ AI researchers start smoking/ M…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1250</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525149/1eb33e37c19ba139a6c12aa4c7f00b5b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Elizabeth Holmes/ AI researchers start smoking/ Moderna vax by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Pope has cancer; Phase 1 trials for AI; Can AI hack cancer trials__1]]></title><description><![CDATA[Pope has cancer; Phase 1 trials for AI; Can AI hack cancer trials__1 by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/pope-has-cancer-phase-1-trials-for-9b9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2420939952</guid><pubDate>Sat, 17 Oct 2026 14:51:21 GMT</pubDate><enclosure length="21470263" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525150/4b056b944f0736771c8ae4cec43d57f1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Pope has cancer; Phase 1 trials for AI; Can AI ha…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1341</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525150/64217270015286e905d57fdd72348c0d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Pope has cancer; Phase 1 trials for AI; Can AI hack cancer trials__1 by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[An interview with Dr. Vinay Prasad]]></title><description><![CDATA[ <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/an-interview-with-dr-vinay-prasad</link><guid isPermaLink="false">substack:post:219481914</guid><pubDate>Thu, 08 Oct 2026 20:28:02 GMT</pubDate><enclosure length="65875529" type="audio/mpeg" url="https://api.substack.com/feed/podcast/219481914/bba04de043aefb3623385ce26fe06fc1.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/219481914/722e71b699242e622718e0ff617c2503.vtt"/><itunes:author>Vinay Prasad MD MPH and Alex Berenson</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>4117</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/219481914/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Mulicancer early detection tests]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/mulicancer-early-detection-tests</link><guid isPermaLink="false">substack:post:217009117</guid><pubDate>Wed, 23 Sep 2026 08:06:53 GMT</pubDate><enclosure length="7523402" type="audio/mpeg" url="https://api.substack.com/feed/podcast/217009117/97d2f8463208c1556c1990b3c8f13011.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/217009117/a3c9b232386905c54738f6e1e652f851.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>470</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/217009117/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[How to think about confidence intervals and p values]]></title><description><![CDATA[<p>For prospective randomized studies when alpha is split…</p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/how-to-think-about-confidence-intervals</link><guid isPermaLink="false">substack:post:216761197</guid><pubDate>Mon, 21 Sep 2026 16:43:47 GMT</pubDate><enclosure length="6414974" type="audio/mpeg" url="https://api.substack.com/feed/podcast/216761197/1e8eb899e0a38cf71ae14d716aa1d99e.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/216761197/9e585f2172b558171469eff6b5c2e293.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>401</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/216761197/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>For prospective randomized studies when alpha is split… This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>For prospective randomized studies when alpha is split… This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.05 Measles in PA, Nature's editorial, and more]]></title><description><![CDATA[5.05 Measles in PA, Nature's editorial, and more by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/505-measles-in-pa-natures-editorial-213</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2395762956</guid><pubDate>Mon, 07 Sep 2026 01:48:13 GMT</pubDate><enclosure length="16457866" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525151/e2227eb7e063d1917927bea81a087cc5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>5.05 Measles in PA, Nature's editorial, and more …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1371</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525151/f5e9a2cc75f473bf49c5d0202a5a4bd8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>5.05 Measles in PA, Nature's editorial, and more by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[My interview for the Doctors Lounge]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/my-interview-for-the-doctors-lounge</link><guid isPermaLink="false">substack:post:213734708</guid><pubDate>Tue, 01 Sep 2026 16:53:37 GMT</pubDate><enclosure length="57299425" type="audio/mpeg" url="https://api.substack.com/feed/podcast/213734708/b26cb885f8a68b2d4083f343f2a8f5ee.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>3581</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/213734708/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards]]></title><description><![CDATA[5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/504-jason-arday-nathan-cofnas-and-609</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2389027227</guid><pubDate>Wed, 26 Aug 2026 22:13:58 GMT</pubDate><enclosure length="29279112" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525152/4c7ae7fd6521482a4b54f5e8ab16a86e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>5.04 Jason Arday, Nathan Cofnas and the Decline o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1828</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525152/bacb669abcf824bbc5a59c4cddb0f400.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Jason Arday, Nathan Cofnas, Cambridge, Ghent and NEJM Voices]]></title><description><![CDATA[<p>The thesis that universities have lost the plot seems to be repeatedly confirmed</p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/jason-arday-nathan-cofnas-cambridge</link><guid isPermaLink="false">substack:post:212345377</guid><pubDate>Sat, 22 Aug 2026 23:39:02 GMT</pubDate><enclosure length="25268277" type="audio/mpeg" url="https://api.substack.com/feed/podcast/212345377/92b703bf025dd37c9999996e67af29f9.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/212345377/27191d692232e048689a7604d1f03ac6.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>1579</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/212345377/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>The thesis that universities have lost the plot seems to be repeatedly confirmed This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>The thesis that universities have lost the plot seems to be repeatedly confirmed This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin]]></title><description><![CDATA[5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/503-5-red-flags-betting-markets-covid-8bf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2377667828</guid><pubDate>Fri, 07 Aug 2026 23:45:51 GMT</pubDate><enclosure length="18512437" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525153/03945333422f44944bbd860bf8a5a8c4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>5.03 - 5 red flags, Betting Markets, Covid Czar s…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1540</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525153/7560b72a03f6fe66d64f833befd9ef4f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Former Covid Czar says lab leak, and who is responsible for decisions politicians or scientist]]></title><description><![CDATA[<p>My latest</p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/former-covid-czar-says-lab-leak-and</link><guid isPermaLink="false">substack:post:209986401</guid><pubDate>Fri, 07 Aug 2026 01:33:01 GMT</pubDate><enclosure length="17355892" type="audio/mpeg" url="https://api.substack.com/feed/podcast/209986401/1b9509b78ee44f42a3af3a5c5db4dcad.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/209986401/9234d6a8cf0b04be45dc862001805f8c.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>1085</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/209986401/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>My latest This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>My latest This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony]]></title><description><![CDATA[Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/season-5-ep-2-anthony-faucis-diary-9e2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2374655309</guid><pubDate>Tue, 04 Aug 2026 03:03:44 GMT</pubDate><enclosure length="20428930" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525154/bf87183f4b7ca6d1dffe6bed0627a2a2.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Season 5 Ep 2 - Anthony Fauci's Diary and Congres…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1276</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525154/40ca96a2f606314346b19ece35d6bb48.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Anthony Fauci]]></title><description><![CDATA[<p>My video summary of recent events</p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/anthony-fauci</link><guid isPermaLink="false">substack:post:209553307</guid><pubDate>Sun, 02 Aug 2026 22:19:15 GMT</pubDate><enclosure length="19185717" type="audio/mpeg" url="https://api.substack.com/feed/podcast/209553307/d35c806c544c0935507252db27fb8aed.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/209553307/1a17b87eb95f23072a7b9c654dfa4154.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>1199</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/209553307/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>My video summary of recent events This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>My video summary of recent events This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Reboot - I am back with Audio podcasts]]></title><description><![CDATA[Reboot - I am back with Audio podcasts by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/reboot-i-am-back-with-audio-podcasts-fb0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2365506038</guid><pubDate>Tue, 21 Jul 2026 23:23:47 GMT</pubDate><enclosure length="37362957" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525155/29e2017edf454d12b279c2352252d59e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Reboot - I am back with Audio podcasts by Plenary…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3108</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525155/b22614a19cee0d92caa38a265bd827fa.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Reboot - I am back with Audio podcasts by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[How much fraud is there in academic medicine?]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/how-much-fraud-is-there-in-academic</link><guid isPermaLink="false">substack:post:206536705</guid><pubDate>Sat, 11 Jul 2026 11:53:08 GMT</pubDate><enclosure length="15606732" type="audio/mpeg" url="https://api.substack.com/feed/podcast/206536705/1a858122deefd5e9f85a580eaeaafc29.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/206536705/e34acee89a271cbb6c7743c9c70c0683.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>975</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/206536705/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Should you take an SSRI for 40+ years?]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/should-you-take-an-ssri-for-40-years</link><guid isPermaLink="false">substack:post:206239894</guid><pubDate>Thu, 09 Jul 2026 12:11:03 GMT</pubDate><enclosure length="1338860" type="audio/mpeg" url="https://api.substack.com/feed/podcast/206239894/87b258dbd3d34410214766c6fb9d365d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>84</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/206239894/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Longevity Episode 2 - Nutrition science]]></title><description><![CDATA[Longevity Episode 2 - Nutrition science by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/longevity-episode-2-nutrition-science-0b8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2324476559</guid><pubDate>Wed, 20 May 2026 20:44:57 GMT</pubDate><enclosure length="26589310" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525156/6c43b8a134052926c9fd997d4e0b95c5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Longevity Episode 2 - Nutrition science by Plenar…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2213</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525156/04994ac1380a7ac23068bde610a1bbe1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Longevity Episode 2 - Nutrition science by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Longevity Lecture series Introduction and Lecture 1]]></title><description><![CDATA[Longevity Lecture series Introduction and Lecture 1 by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/longevity-lecture-series-introduction-527</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2319473549</guid><pubDate>Tue, 12 May 2026 23:16:07 GMT</pubDate><enclosure length="28294229" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525157/1cb03cc9d89f21ba0dcfcef5ad977fe2.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Longevity Lecture series Introduction and Lecture…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1764</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525157/59f80b22d4ac695c21b2a9931dfb1b10.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Longevity Lecture series Introduction and Lecture 1 by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[CABINET - trial - Cabozantinib for NET]]></title><description><![CDATA[Back to basics as I break down a trial <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/cabinet-trial-cabozantinib-for-net-99e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2039165156</guid><pubDate>Thu, 20 Feb 2025 00:00:00 GMT</pubDate><enclosure length="13896731" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525158/f0687e702c97a4fe94291ce303f79d79.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Back to basics as I break down a trial</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1157</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525158/9f39840353fcc6170af97bac86ef822d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Back to basics as I break down a trial This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints]]></title><description><![CDATA[I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/elons-6-engineers-unelected-rfk-jr-7b1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2038294972</guid><pubDate>Wed, 19 Feb 2025 00:00:00 GMT</pubDate><enclosure length="21989022" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525161/9ff591ee82dcfeeee857ab21a6a0c493.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I'm talking about USAID and Elon's team of six en…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1374</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525161/ca45ed9caf11b6f4cb7be7ef9eae0fdb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Why the NIH is a broken funding system]]></title><description><![CDATA[I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/why-the-nih-is-a-broken-funding-system-f2a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2038290468</guid><pubDate>Wed, 19 Feb 2025 00:00:00 GMT</pubDate><enclosure length="30538325" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525162/34ba7440e3dc6e73293e40477aa4d43c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I discuss the recent reduction in indirect funds …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1909</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525162/b231d3b09eb38be966197b0e5d60f452.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom]]></title><description><![CDATA[I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/rfk-jr-takes-office-cdc-layoffs-varmus-151</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2038298800</guid><pubDate>Wed, 19 Feb 2025 00:00:00 GMT</pubDate><enclosure length="26551044" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525159/6ddcf7e5b73a2a8f8d444bea7168f30f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I discuss RFK Jr.'s confirmation as the US Secret…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1659</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525159/d09ef9100e9b7f4d44c9460dac2c006a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!]]></title><description><![CDATA[I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/cia-says-lab-leak-faucis-pardon-nihs-278</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2038286856</guid><pubDate>Wed, 19 Feb 2025 00:00:00 GMT</pubDate><enclosure length="37264578" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525163/a97a184e1536eb4a04a95ae2b8669bd0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I discuss the CIA admitting that COVID was a lab …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2329</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525163/2873b5dc27690634b2afdb34320f1066.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Trump is breaking media brains / NIH cuts indirect payments and scientists freak out]]></title><description><![CDATA[I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/trump-is-breaking-media-brains-nih-c39</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2038297112</guid><pubDate>Wed, 19 Feb 2025 00:00:00 GMT</pubDate><enclosure length="19653148" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525160/e603b1c23495bce747f19bf1499a21fa.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I discuss the intense media coverage of Trump and…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1638</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525160/8b1f707d98cddbbb31c3297e7c0390ea.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!]]></title><description><![CDATA[I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more! <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/trumps-big-health-care-changes-nih-a61</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2017359849</guid><pubDate>Sat, 01 Feb 2025 17:01:05 GMT</pubDate><enclosure length="28023938" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525164/6dc75b2bfe9ff47603be25bce077ab50.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I discuss Trump's big health care changes: NIH st…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1751</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525164/2f459b72bda03117fe0e4c369f8420fd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[The ENTIRE healthcare system is broken, not just health insurance companies]]></title><description><![CDATA[The entire healthcare system is broken, it's not just health insurance companies. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/the-entire-healthcare-system-is-broken-44d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2016896119</guid><pubDate>Mon, 27 Jan 2025 00:00:00 GMT</pubDate><enclosure length="18106166" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525165/75f39b6306aac898c4e024c7e4a56227.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>The entire healthcare system is broken, it's not …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1132</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525165/bd0acc597aae38700add930ec62d4055.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>The entire healthcare system is broken, it's not just health insurance companies. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits]]></title><description><![CDATA[Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/alcohol-is-it-healthy-everything-131</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/2016895711</guid><pubDate>Fri, 24 Jan 2025 02:45:27 GMT</pubDate><enclosure length="39796165" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525166/c7f82ff72f3decf66f015bf07a091b46.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Is alcohol healthy for you? I break down everythi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2487</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525166/d21d69174cf09d58662ed92578bc57df.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More]]></title><description><![CDATA[Our 2 hour critical appraisal and ASH review.  <br/>SO many guest stars <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/2-hour-ash-presentation-with-aaron-354</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1980877479</guid><pubDate>Wed, 11 Dec 2024 00:00:00 GMT</pubDate><enclosure length="85170673" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525167/349efe3b33759358ab3ba8aa119f4a3f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Our 2 hour critical appraisal and ASH review.  
S…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7096</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525167/76ee1641dc4e71209107bf863a03f824.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Our 2 hour critical appraisal and ASH review. SO many guest stars This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Systematic Reviews - An Introduction⧸ How to do them⧸ Search Strategies⧸ Common Errors]]></title><description><![CDATA[Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/systematic-reviews-an-introduction-6a6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1958662971</guid><pubDate>Wed, 13 Nov 2024 00:00:00 GMT</pubDate><enclosure length="35041989" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525168/5bd3a082d5779bdd1951b1b95d1f54cd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Lecture on systematic review, given by Vinay Pras…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2920</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525168/adf80b7eace7e17b3c0696bb67271b7b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Special post-ESMO 2024 edition !]]></title><description><![CDATA[Timothee Olivier and I discuss the top ESMO 2024 abstracts! <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/special-post-esmo-2024-edition-74c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1948660611</guid><pubDate>Sun, 03 Nov 2024 00:00:00 GMT</pubDate><enclosure length="29860668" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525169/96cb0d4a78f6ee4044addd30d4a50218.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee Olivier and I discuss the top ESMO 2024 …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1865</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525169/df840b1db87a70af74fa71ee80947ac4.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee Olivier and I discuss the top ESMO 2024 abstracts! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Artificial Intelligence in Medicine - My Keynote]]></title><description><![CDATA[AI in healthcare - my latest keynote address <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/artificial-intelligence-in-medicine-ba0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1944374351</guid><pubDate>Mon, 28 Oct 2024 00:00:00 GMT</pubDate><enclosure length="42528237" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525170/0bfa8112d452f2bd1208cebf83b2f464.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>AI in healthcare - my latest keynote address</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3543</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525170/6c4be2a094cc0aadbc5e8c0975be3a98.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>AI in healthcare - my latest keynote address This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Masking Mistakes - my panel discussion at the Emory Center for Ethics]]></title><description><![CDATA["Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics program. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/masking-mistakes-my-panel-discussion-9de</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1937071463</guid><pubDate>Wed, 16 Oct 2024 00:00:00 GMT</pubDate><enclosure length="92927524" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525171/a2889012c44a9d01daa65df6ac90d651.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>"Masking Mistakes: Lessons from the Science, Poli…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5808</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525171/bde5c587e0d76581dbdbe29d8f382a62.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics program. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[How We Can Do Better As A County Hospital]]></title><description><![CDATA[Screening/ Drug efficacy/ Sotorasib/ Adaura and more <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/how-we-can-do-better-as-a-county-2aa</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1907345384</guid><pubDate>Sat, 31 Aug 2024 00:16:10 GMT</pubDate><enclosure length="39920957" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525172/6b57e391f1e1f3cbd3a3e13279cc7347.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Screening/ Drug efficacy/ Sotorasib/ Adaura and m…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2495</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525172/afa2ebb894254901276b5136dbed5f5e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Screening/ Drug efficacy/ Sotorasib/ Adaura and more This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Driver mutation lung cancer - My lecture]]></title><description><![CDATA[My UCSF lecture on driver mutation lung cancer <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/driver-mutation-lung-cancer-my-lecture-f4b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1887725631</guid><pubDate>Fri, 02 Aug 2024 20:44:13 GMT</pubDate><enclosure length="26923639" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525173/1fa6a4e22301ab8affea317ba704e497.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>My UCSF lecture on driver mutation lung cancer</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2242</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525173/5aee53eec26c2993e7aa0d5cde6700f9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>My UCSF lecture on driver mutation lung cancer This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Post ASCO wrap up with Timothee Olivier]]></title><description><![CDATA[We break down the best studies from ASCO <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/post-asco-wrap-up-with-timothee-olivier-ab1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1855221669</guid><pubDate>Sun, 23 Jun 2024 17:16:41 GMT</pubDate><enclosure length="32853544" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525174/90366069b05ed406f470727935298f7a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We break down the best studies from ASCO</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2728</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525174/64610bc4b4425ee7d562ae0ee03f8ae5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We break down the best studies from ASCO This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Critical Appraisal - My 2 hour ASCO lecture - Day 2 version]]></title><description><![CDATA[Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/critical-appraisal-my-2-hour-asco-428</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1838948010</guid><pubDate>Wed, 05 Jun 2024 21:10:02 GMT</pubDate><enclosure length="82208629" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525175/9eba6a669a7abf31f94e1ebd241172cd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Critical Appraisal - My 2 hour ASCO lecture - Day…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6850</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525175/35e3cdf07e61192f0c23264182c7a40c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Asco Prequel - We talk about what to look for]]></title><description><![CDATA[What you need to know in advance of ASCO <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/asco-prequel-we-talk-about-what-to-c87</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1833288303</guid><pubDate>Thu, 30 May 2024 00:10:32 GMT</pubDate><enclosure length="21313626" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525176/4589f4d763975bc0598a6a8e2c06e94b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>What you need to know in advance of ASCO</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1775</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525176/6de602f0ddb57f9f10f5d9187d5a4675.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>What you need to know in advance of ASCO This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[A SM crossover - Cifu, Prasad, Mandrola]]></title><description><![CDATA[Should trials have carbon footprint as an endpoint? <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/a-sm-crossover-cifu-prasad-mandrola-174</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1831418892</guid><pubDate>Mon, 27 May 2024 16:30:01 GMT</pubDate><enclosure length="32676222" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525177/92fd3d0030871c7104e478e7da424a4a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Should trials have carbon footprint as an endpoin…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2722</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525177/12c729b95f2f26dc4b3e606134fc2df3.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Should trials have carbon footprint as an endpoint? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[When Medical Evidence Expires]]></title><description><![CDATA[<p>I talk about medical practices that expire, and probe failed pandemic policy</p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/when-medical-evidence-expires</link><guid isPermaLink="false">substack:post:144709904</guid><pubDate>Fri, 17 May 2024 01:50:57 GMT</pubDate><enclosure length="50602873" type="audio/mpeg" url="https://api.substack.com/feed/podcast/144709904/72e791d80818187bf5c614015030f951.mp3"/><podcast:transcript type="text/vtt" url="https://api.substack.com/feed/podcast/transcript/144709904/ed33d6655956276e3b9b5b43c5c6b4a7.vtt"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>3163</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/144709904/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>I talk about medical practices that expire, and probe failed pandemic policy This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>I talk about medical practices that expire, and probe failed pandemic policy This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai]]></title><description><![CDATA[My grand rounds; Beta blockers post MI<br/>Single center vs multicenter RCT<br/>Masks<br/>Boosters and more <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/when-evidence-expires-my-grand-rounds-ca6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1823740116</guid><pubDate>Fri, 17 May 2024 01:40:52 GMT</pubDate><enclosure length="37963738" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525178/cc67d6533854550102eb0ce1d69369da.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>My grand rounds; Beta blockers post MI
Single cen…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3163</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525178/b7354291a3474c0a8b1517d5c47cfc2a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>My grand rounds; Beta blockers post MI Single center vs multicenter RCT Masks Boosters and more This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Cifu, Mandrola, Prasad - SM crossover]]></title><description><![CDATA[I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/cifu-mandrola-prasad-sm-crossover-c78</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1819229577</guid><pubDate>Fri, 10 May 2024 22:01:53 GMT</pubDate><enclosure length="30134666" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525179/5913156ab2e0aecf4a917bf8f3abe4c6.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I crossover SM podcast; Harvard med students vide…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2511</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525179/379c72c3ad332f4087cb35913579aa5f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Patient advocates funded by Pharma]]></title><description><![CDATA[Patient advocates, Pharma funding, and is MRD a suitable endpoint <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/patient-advocates-funded-by-pharma-218</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1802452194</guid><pubDate>Wed, 17 Apr 2024 23:18:12 GMT</pubDate><enclosure length="18901465" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525180/ff03ee398c448f54b7fe11230b12377a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Patient advocates, Pharma funding, and is MRD a s…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1574</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525180/aeb11100c651fed442e987df2b41f9fa.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Patient advocates, Pharma funding, and is MRD a suitable endpoint This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[FDA makes MRD the basis for AA]]></title><description><![CDATA[5 reasons that is a bad idea <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/fda-makes-mrd-the-basis-for-aa-02e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1799588527</guid><pubDate>Fri, 12 Apr 2024 19:28:42 GMT</pubDate><enclosure length="6158103" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525181/737e9e4644dff6c40389bc056e3af4ad.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>5 reasons that is a bad idea</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>512</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525181/2ecbb9f4f4803c135fcb088376f56782.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>5 reasons that is a bad idea This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Beta Blockers After Heart Attacks Don't Work]]></title><description><![CDATA[Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction". <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/beta-blockers-after-heart-attacks-702</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1796483992</guid><pubDate>Tue, 09 Apr 2024 00:09:37 GMT</pubDate><enclosure length="14931234" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525182/f922ddaea2ba00962ccca70fbfa8b122.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Another flawed quality metric. Reviewing the NEJM…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>933</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525182/29b6881e898682ca8c333b73237c1702.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction". This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Blood based and Stool DNA colon cancer screening - Two NEJM papers]]></title><description><![CDATA[They are shitty <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/blood-based-and-stool-dna-colon-cancer-8c1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1786098462</guid><pubDate>Wed, 27 Mar 2024 23:10:16 GMT</pubDate><enclosure length="18803483" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525183/c4bebe2f80baf413854fa0a8dbe349c7.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>They are shitty</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1566</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525183/34c8942175ee733abbfc43d3cee3fcfd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>They are shitty This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Keynote 564 - a flawed study]]></title><description><![CDATA[Another flawed study Keynote 564. Pembro in adjuvant RCC <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/keynote-564-a-flawed-study-792</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1734506697</guid><pubDate>Thu, 01 Feb 2024 17:10:25 GMT</pubDate><enclosure length="12932837" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525184/8189f4e618dde0668f701979802e624c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Another flawed study Keynote 564. Pembro in adjuv…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1077</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525184/7974ef7ecc9fc18b6c117f3a88508f33.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Another flawed study Keynote 564. Pembro in adjuvant RCC This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial]]></title><description><![CDATA[What happens when doctors run unethical studies? <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/contact-01-cabo-atezo-in-prostate-906</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1728949119</guid><pubDate>Sat, 27 Jan 2024 02:49:03 GMT</pubDate><enclosure length="17852238" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525185/0798972dd5455eb3f29178aa8e64751e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>What happens when doctors run unethical studies?</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1486</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525185/f8b3c6b5601ae98244cadaf7739940d9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>What happens when doctors run unethical studies? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[If you feel sick this holiday season, should you take a COVID test?]]></title><description><![CDATA[<p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/if-you-feel-sick-this-holiday-season</link><guid isPermaLink="false">substack:post:140188793</guid><pubDate>Sat, 30 Dec 2023 01:44:23 GMT</pubDate><enclosure length="18514057" type="audio/mpeg" url="https://api.substack.com/feed/podcast/140188793/8052f5654b32cdc7e7dfedc68dae113f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>1157</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/140188793/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[CAR T causes MDS??? Manni, Goodman, Raj, Prasad]]></title><description><![CDATA[Does car T cause secondary AML?<br/><br/>We discuss <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/car-t-causes-mds-manni-goodman-raj-7bc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1702178517</guid><pubDate>Thu, 28 Dec 2023 18:32:58 GMT</pubDate><enclosure length="19780444" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525186/9c7a9fa28e8d49acff3fd79d2d957082.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Does car T cause secondary AML?

We discuss</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1647</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525186/c813837daa0278a019f156e875da0e26.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Does car T cause secondary AML? We discuss This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Timothee and Prasad talk 2023 cancer trials]]></title><description><![CDATA[We talk about 2023 cancer trials <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/timothee-and-prasad-talk-2023-cancer-85f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1698656826</guid><pubDate>Sun, 24 Dec 2023 17:58:00 GMT</pubDate><enclosure length="31785899" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525187/5c0501732186070db82d36df250e0198.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We talk about 2023 cancer trials</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2648</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525187/eec3450869ed1e4b654ee9fcdcc65cb2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We talk about 2023 cancer trials This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Aaron Goodman Prasad ASH UPDATES]]></title><description><![CDATA[Goodman and I discuss ash updates.<br/>My myeloma talk<br/><a href="https://www.youtube.com/watch?v=jAz84yCnfjQ" class="linkified" target="_blank">https://www.youtube.com/watch?v=jAz84yCnfjQ</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/aaron-goodman-prasad-ash-updates-494</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1695348267</guid><pubDate>Wed, 20 Dec 2023 18:31:56 GMT</pubDate><enclosure length="38048208" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525188/df82d92bd18f381df2f648a7e0c9d090.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Goodman and I discuss ash updates.
My myeloma tal…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3170</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525188/997d20db84212843461406f77c347e4f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Goodman and I discuss ash updates. My myeloma talk https://www.youtube.com/watch?v=jAz84yCnfjQ This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Mandrola and Prasad]]></title><description><![CDATA[Subscribe to Sensible Med Pod; This is x over<br/>Post partum depression, orbita 2 and physics vs medicine <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/mandrola-and-prasad-82e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1692870801</guid><pubDate>Sun, 17 Dec 2023 22:33:41 GMT</pubDate><enclosure length="35797515" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525189/bf6b58e1b946cc9962510239ec51fdcb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Subscribe to Sensible Med Pod; This is x over
Pos…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2982</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525189/eed38d16ed3cc73a17c782cd44980451.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Subscribe to Sensible Med Pod; This is x over Post partum depression, orbita 2 and physics vs medicine This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[COVID19 Policy: What the US Got Wrong]]></title><description><![CDATA[My Lecture in Curacao 4/4 <br/>Vaccines, Masks, Mandates, Lockdowns, School closure<br/>Other lectures to come <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/covid19-policy-what-the-us-got-wrong-850</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1674667479</guid><pubDate>Sun, 26 Nov 2023 01:22:00 GMT</pubDate><enclosure length="63080820" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525190/447c8a532f97ead25f8ba9ea38b2c8b3.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>My Lecture in Curacao 4/4 
Vaccines, Masks, Manda…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5256</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525190/2d06a09f81dc48b6189d3d3cc69f91bd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>My Lecture in Curacao 4/4 Vaccines, Masks, Mandates, Lockdowns, School closure Other lectures to come This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Lecture 1 of 4 Curacao - How to Keep Up with Literature]]></title><description><![CDATA[Entresto, Lung Transplants, How to Keep Up with Literature - Lecture to Trainees in Curacao <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/lecture-1-of-4-curacao-how-to-keep-66e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1673866362</guid><pubDate>Fri, 24 Nov 2023 22:09:54 GMT</pubDate><enclosure length="29913875" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525191/9ea31c62cebe9f32ec083b8bda010311.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Entresto, Lung Transplants, How to Keep Up with L…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2492</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525191/8ad068658fddcb553556d807510b27ab.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Entresto, Lung Transplants, How to Keep Up with Literature - Lecture to Trainees in Curacao This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Advice Pre-Med Students | Lecture at UC Berkeley]]></title><description><![CDATA[This is a lecture I gave on November 5, 2023, to pre-medicine undergraduate students at University of California Berkeley. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/advice-pre-med-students-lecture-at-243</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1662097554</guid><pubDate>Sat, 11 Nov 2023 01:43:10 GMT</pubDate><enclosure length="46395724" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525192/e6935cd0866d51dc7edcbcb250fb8c94.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is a lecture I gave on November 5, 2023, to …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2900</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525192/1f68e9f2910aa897a3abfd5e942a603e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is a lecture I gave on November 5, 2023, to pre-medicine undergraduate students at University of California Berkeley. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Radiation oncology in GI malignancy - Nina Sanford and Bill Hall]]></title><description><![CDATA[Radiation oncology in GI malignancy (endpoints and stratification) in the JCO <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/radiation-oncology-in-gi-malignancy-888</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1653604944</guid><pubDate>Tue, 31 Oct 2023 18:15:25 GMT</pubDate><enclosure length="16979559" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525193/8d0e181799e97a06b7218abf5ed115f7.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Radiation oncology in GI malignancy (endpoints an…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1414</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525193/44540a03ab832064631d56491cd27d36.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Radiation oncology in GI malignancy (endpoints and stratification) in the JCO This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Hawai Keynote - Coffee and colon cancer & Censoring & More]]></title><description><![CDATA[Prasad is back in Hawaii to give another keynote (good thing they cancelled Dallas not Honolulu).  I discuss coffee and colon cancer, and censoring, and Lu177 PSMA <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/hawai-keynote-coffee-and-colon-cancer-eb2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1646963730</guid><pubDate>Mon, 23 Oct 2023 01:25:52 GMT</pubDate><enclosure length="32835841" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525194/c17ad089f34d6764f946c02bd69b0f0b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Prasad is back in Hawaii to give another keynote …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2736</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525194/78fe2ac44b787d0de2320233577808a4.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Prasad is back in Hawaii to give another keynote (good thing they cancelled Dallas not Honolulu). I discuss coffee and colon cancer, and censoring, and Lu177 PSMA This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3]]></title><description><![CDATA[This is a lecture I gave on ethics and institutional review boards in Denmark in September 2023. It is the last of the three lectures I gave. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/ethics-how-irbs-can-do-better-my-3f4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1644738486</guid><pubDate>Thu, 19 Oct 2023 18:15:33 GMT</pubDate><enclosure length="41035711" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525195/6fef123ccc9a81bab68f4fac064170dc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is a lecture I gave on ethics and institutio…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2565</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525195/79d08ed926fa423970b6eda09abe9dca.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is a lecture I gave on ethics and institutional review boards in Denmark in September 2023. It is the last of the three lectures I gave. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover]]></title><description><![CDATA[Mandrola, Prasad and Cifu are back to discuss the latest drama <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/prasads-lecture-gets-cancelled-cifu-b0d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1642027410</guid><pubDate>Mon, 16 Oct 2023 15:01:41 GMT</pubDate><enclosure length="39554395" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525196/37fdad380664f25436678c189078a95a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Mandrola, Prasad and Cifu are back to discuss the…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3295</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525196/ead0c97baa3459b2e00198a2ae85963d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Mandrola, Prasad and Cifu are back to discuss the latest drama This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3]]></title><description><![CDATA[This is a lecture I gave on the state of immunotherapy in oncology at the Immunotherapy Symposium In Denmark in September 2023. It is the second of three lectures I gave. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/the-state-of-immunotherapy-in-oncology-a53</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1635554619</guid><pubDate>Mon, 09 Oct 2023 04:27:06 GMT</pubDate><enclosure length="44231009" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525197/65ebe6b290caa6badc434881da4c2d69.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is a lecture I gave on the state of immunoth…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2764</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525197/4e1dd7e70cf2a783f7cc8d447ad46b8f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is a lecture I gave on the state of immunotherapy in oncology at the Immunotherapy Symposium In Denmark in September 2023. It is the second of three lectures I gave. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3]]></title><description><![CDATA[The first of the three lectures I gave in Denmark in September 2023 was on the medical evidence behind decision-making by health technology assessment groups. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/do-we-have-good-evidence-for-new-783</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1631876913</guid><pubDate>Wed, 04 Oct 2023 01:56:12 GMT</pubDate><enclosure length="73099450" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525198/182930e960ac07c1ff08ccf3379c3a48.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>The first of the three lectures I gave in Denmark…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4569</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525198/a3b53638affa58f81d2808ce53f17072.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>The first of the three lectures I gave in Denmark in September 2023 was on the medical evidence behind decision-making by health technology assessment groups. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Great And Crazy Things We Do In Medicine]]></title><description><![CDATA[This is the live recording of a talk given on the great and crazy things we do in medicine, from cancer drugs to boosters and more. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/great-and-crazy-things-we-do-in-medicine-7fb</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1620465288</guid><pubDate>Wed, 20 Sep 2023 03:50:00 GMT</pubDate><enclosure length="110202941" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525199/1f36aa99dff885e9f505e0524ce3f565.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is the live recording of a talk given on the…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6888</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525199/ab3e931d10b686df19c6d9d4a3b83089.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is the live recording of a talk given on the great and crazy things we do in medicine, from cancer drugs to boosters and more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Fixing Cancer Medicine w/ Timothee Olivier]]></title><description><![CDATA[Timothee is back to discuss Malignant and Solutions <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/fixing-cancer-medicine-w-timothee-442</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1614601356</guid><pubDate>Tue, 12 Sep 2023 16:02:44 GMT</pubDate><enclosure length="30960492" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525200/f7b7138b678cfdef77999dfa275ebdec.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee is back to discuss Malignant and Solutio…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2579</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525200/f04adbf9c4d89280457a1c73093210ed.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee is back to discuss Malignant and Solutions This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Coumadin, ECMO, RCTs and more]]></title><description><![CDATA[A far reaching discussion btw Mandrola and Prasad on RCTs, Coumadin, ECMO and RCTs for covid shots <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/coumadin-ecmo-rcts-and-more-203</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1613158644</guid><pubDate>Mon, 11 Sep 2023 00:51:48 GMT</pubDate><enclosure length="35036508" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525201/e93e09c25c09e9d0d2c6ab325cf56453.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A far reaching discussion btw Mandrola and Prasad…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2919</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525201/b227fde8ee2d5235c69801de51657f41.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A far reaching discussion btw Mandrola and Prasad on RCTs, Coumadin, ECMO and RCTs for covid shots This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting]]></title><description><![CDATA[Simultaneously released on Sensible Medicine. Time to subscribe to Sensible Medicine substack and podcast. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/prasad-and-mandrola-discuss-recent-5a5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1599052251</guid><pubDate>Wed, 23 Aug 2023 01:35:58 GMT</pubDate><enclosure length="30771140" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525202/cd1348134aaf22c0d91326f810dd00d5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Simultaneously released on Sensible Medicine. Tim…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2564</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525202/59b223fefd42c54c268dd09b5f241990.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Simultaneously released on Sensible Medicine. Time to subscribe to Sensible Medicine substack and podcast. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover]]></title><description><![CDATA[Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/placebo-journal-errors-cancer-screening-5ef</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1561069210</guid><pubDate>Mon, 10 Jul 2023 16:50:53 GMT</pubDate><enclosure length="59909725" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525203/22d83b138983b4375404baaae1b2c6f2.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Placebo/ Journal Errors/ Cancer Screening w/ Mand…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4991</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525203/332d8e9ecd78ec005f3db14c35281a76.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Testosterone/ Should Scientists Debate/ Mike Joyner]]></title><description><![CDATA[A sensible medicine crossover episode<br/>Follow the sensible medicine podcast feed for more of these discussions <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/testosterone-should-scientists-debate-3f9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1551676555</guid><pubDate>Wed, 28 Jun 2023 00:50:38 GMT</pubDate><enclosure length="42718871" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525204/b20b2c3973022cfa3b36911de7219d4e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A sensible medicine crossover episode
Follow the …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3559</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525204/d02e080008ec67bff83d1fbd5fdd4006.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A sensible medicine crossover episode Follow the sensible medicine podcast feed for more of these discussions This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP]]></title><description><![CDATA[T. Olivier from Geneva is back.  A fan favorite guest.  We discuss 3 recent papers. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/post-protocol-therapy-qol-adjuvant-335</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1535633026</guid><pubDate>Sat, 10 Jun 2023 01:58:33 GMT</pubDate><enclosure length="29799398" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525205/bbb5a768e293f3aa0df5cbf77f5df74e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>T. Olivier from Geneva is back.  A fan favorite g…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2483</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525205/d12250b27c8fe96b33fb00025d257b4f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>T. Olivier from Geneva is back. A fan favorite guest. We discuss 3 recent papers. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL]]></title><description><![CDATA[Researchers were too busy counting dead bodies to give the control arm appropriate therapy when their cancer recurred. Disgusting conduct.<br/><br/>I break down ADAURA <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/adaura-os-results-the-trial-was-unethical-d22</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1534441906</guid><pubDate>Thu, 08 Jun 2023 20:24:35 GMT</pubDate><enclosure length="17378664" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525206/dd83c619a92874457e31743a0d242069.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Researchers were too busy counting dead bodies to…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1447</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525206/eda34831f0d019f3f14b7cb9337071f7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Researchers were too busy counting dead bodies to give the control arm appropriate therapy when their cancer recurred. Disgusting conduct. I break down ADAURA This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper]]></title><description><![CDATA[Mike Putman, Todd C. Lee, John Mandrola and I debate the recent JAMA paper on RCT Duplicate. This is a spirited round table discussion on the limitations of observational data.   If you are reading this, leave a comment as a review! <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/obs-studies-vs-rcts-trial-emulation-f67</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1516454149</guid><pubDate>Wed, 17 May 2023 23:26:47 GMT</pubDate><enclosure length="54088753" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525207/23bee5ff5f6bc9f299f4f9869d6e1f8a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Mike Putman, Todd C. Lee, John Mandrola and I deb…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4506</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525207/ea6cf037453c7b5890a7a17422b991d5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Mike Putman, Todd C. Lee, John Mandrola and I debate the recent JAMA paper on RCT Duplicate. This is a spirited round table discussion on the limitations of observational data. If you are reading this, leave a comment as a review! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Myeloma Roundtable - Manni M. Raj C. VP discuss controversies]]></title><description><![CDATA[Early treatment of myeloma, dual vs. single maintenance, and finally transplant or no transplant. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/myeloma-roundtable-manni-m-raj-c-62e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1513641349</guid><pubDate>Sat, 13 May 2023 20:45:19 GMT</pubDate><enclosure length="77696567" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525208/b571fc745e559777bd650bd11f934515.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Early treatment of myeloma, dual vs. single maint…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4855</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525208/668c580976c5a02e2e97103f5e2e3c2e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Early treatment of myeloma, dual vs. single maintenance, and finally transplant or no transplant. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Mammographic Screening : A complete review of the evidence]]></title><description><![CDATA[Why the USPSTF is wrong <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/mammographic-screening-a-complete-ea0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1511532907</guid><pubDate>Thu, 11 May 2023 03:23:32 GMT</pubDate><enclosure length="26705076" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525209/2a4b9f485eefe4405a7922ff8a38f48b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Why the USPSTF is wrong</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2225</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525209/0f5773775029ecfcfc99d4728665faa7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Why the USPSTF is wrong This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[The Crushing, Cruel Cost of Cancer Drugs - My Lecture]]></title><description><![CDATA[Cost of Cancer drugs - VP's lecture <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/the-crushing-cruel-cost-of-cancer-ca7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1503044392</guid><pubDate>Sat, 29 Apr 2023 23:53:27 GMT</pubDate><enclosure length="29417720" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525210/7512e9dbf866ca91a9527428d953be4b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Cost of Cancer drugs - VP's lecture</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1838</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525210/e16df9084202ae6c6cc1c5a6af4aec14.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Cost of Cancer drugs - VP's lecture This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky]]></title><description><![CDATA[I combine two latest tracks on interpreting medical studies, medical boards, 7 doses of vaccine, and finally Walensky. Stay tuned. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/sensible-med-crossover-cifu-mandrola-547</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1498998502</guid><pubDate>Mon, 24 Apr 2023 04:45:40 GMT</pubDate><enclosure length="60265886" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525211/66e9d4741423b0f1fa20847ac3a27598.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I combine two latest tracks on interpreting medic…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5020</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525211/62c3246cce6c2cf02832ef5b234fee89.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I combine two latest tracks on interpreting medical studies, medical boards, 7 doses of vaccine, and finally Walensky. Stay tuned. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad]]></title><description><![CDATA[We explore the fight btw NYTimes, Cochrane, and the last people keeping EBM alive <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/cochrane-mask-debates-jefferson-heneghan-809</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1492883227</guid><pubDate>Sat, 15 Apr 2023 00:50:34 GMT</pubDate><enclosure length="56087075" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525212/1bb3efbf30255663f2b86c9b4333e312.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We explore the fight btw NYTimes, Cochrane, and t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4673</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525212/f128d796c14478a491d6b995f6448514.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We explore the fight btw NYTimes, Cochrane, and the last people keeping EBM alive This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself]]></title><description><![CDATA[Zeb joins me for the 7th time to discuss all the key pandemic questions <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/zeb-jamrozik-vaccine-errors-sweden-9f9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1490450455</guid><pubDate>Wed, 12 Apr 2023 04:19:51 GMT</pubDate><enclosure length="52630185" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525213/693d6be5c85042863d2989d7dae9dd6c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Zeb joins me for the 7th time to discuss all the …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4385</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525213/81a70fdce27268b559cb59da3fb3589c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Zeb joins me for the 7th time to discuss all the key pandemic questions This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals]]></title><description><![CDATA[My lecture to Harvard regulatory science <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/harvard-mit-center-for-reg-science-76d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1485406189</guid><pubDate>Wed, 05 Apr 2023 03:52:24 GMT</pubDate><enclosure length="41511288" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525214/09d562967e4f8ba9a5c36ab6a6199996.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>My lecture to Harvard regulatory science</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3458</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525214/a5ea1572f44143999c09947a6e178eb8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>My lecture to Harvard regulatory science This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.47 - Real World Evidence - Keynote Lecture in Denmark]]></title><description><![CDATA[VP goes to Denmark to give the keynote at the Danish medical association conference <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/547-real-world-evidence-keynote-lecture-a66</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1477784683</guid><pubDate>Sun, 26 Mar 2023 08:25:03 GMT</pubDate><enclosure length="35200298" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525215/ad2e20a8738ee9df2e6e702199162102.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>VP goes to Denmark to give the keynote at the Dan…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2933</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525215/08ceeb859fddbe5392c634700890fb91.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>VP goes to Denmark to give the keynote at the Danish medical association conference This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.46 - What is Science: reflections on the field]]></title><description><![CDATA[What is science? <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/546-what-is-science-reflections-on-866</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1465638022</guid><pubDate>Fri, 10 Mar 2023 04:21:04 GMT</pubDate><enclosure length="21376078" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525216/9c2d8d5bf4fbff70e74b3894976d5ae8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>What is science?</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1781</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525216/ef733c28902c19b9b133425ba9285cbe.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>What is science? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care]]></title><description><![CDATA[Karmma  3 discussion; then Sensible Medicine on Long COVID, 4th year fellowships and more; Then my breakdown of FDA's NEJM Letter to the Editor <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/545-bar-karmma-karmma-3-idacel-vs-04c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1463125780</guid><pubDate>Tue, 07 Mar 2023 05:20:43 GMT</pubDate><enclosure length="80900242" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525217/6a5d27db6ab9043b4f3a56da4d197e61.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Karmma  3 discussion; then Sensible Medicine on L…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6739</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525217/dca3f2c5fba739d46a4a306eef447c34.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Karmma 3 discussion; then Sensible Medicine on Long COVID, 4th year fellowships and more; Then my breakdown of FDA's NEJM Letter to the Editor This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[More basics on randomized controlled trials - Part 2]]></title><description><![CDATA[I get into endpoints, surrogates, validation, blinding, crossover, and control arms. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/more-basics-on-randomized-controlled-001</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1460072068</guid><pubDate>Thu, 02 Mar 2023 22:07:20 GMT</pubDate><enclosure length="30744230" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525218/928deb25fe6f6303a7398b53323c4a37.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I get into endpoints, surrogates, validation, bli…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2561</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525218/beb73790bda0f09c4e05085cb31c465a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I get into endpoints, surrogates, validation, blinding, crossover, and control arms. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[RCT 101 And Papa Heme]]></title><description><![CDATA[I talk RCTs 101; KM Plots; Blinding: 2:1 randomization: Concealment and more.  Then Papa Heme Tells you How to Find your First Job <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/rct-101-and-papa-heme-619</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1457550943</guid><pubDate>Tue, 28 Feb 2023 01:40:22 GMT</pubDate><enclosure length="50728804" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525219/062f622a442350b27803251472be8ab8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I talk RCTs 101; KM Plots; Blinding: 2:1 randomiz…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4226</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525219/d6c5244fccd5630174110a738f7f2bbf.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I talk RCTs 101; KM Plots; Blinding: 2:1 randomization: Concealment and more. Then Papa Heme Tells you How to Find your First Job This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Tom Newman And VP Discuss Public Health]]></title><description><![CDATA[Dr. Tom Newman UCSF Emeritus Professor & Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/tom-newman-and-vp-discuss-public-a55</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1452690460</guid><pubDate>Wed, 22 Feb 2023 01:44:47 GMT</pubDate><enclosure length="40925279" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525220/aee09905679daaa4e8ddc66f203d5062.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Dr. Tom Newman UCSF Emeritus Professor &amp; Superb t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3409</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525220/aa02517e4622f57a3490d8d29efc5b03.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Dr. Tom Newman UCSF Emeritus Professor &amp; Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.41 - Michael Putman MCW debates me on recent policy Qs]]></title><description><![CDATA[Mike Putman, asst prof. EBM Rhematologist debates me on value of boosters, observational studies and more. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/541-michael-putman-mcw-debates-me-3ce</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1448694883</guid><pubDate>Thu, 16 Feb 2023 22:46:58 GMT</pubDate><enclosure length="48548183" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525221/79a25403ae49cb3295a6bcf1ce44e834.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Mike Putman, asst prof. EBM Rhematologist debates…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4045</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525221/cda8a0f3fa9a695f261539f0f2b19470.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Mike Putman, asst prof. EBM Rhematologist debates me on value of boosters, observational studies and more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Sensible Med Superbowl Plenary Session Crossover]]></title><description><![CDATA[A new podcast feed called Sensible Medicine is up; here is a sample of what we have to offer <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/sensible-med-superbowl-plenary-session-9f5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1445983414</guid><pubDate>Mon, 13 Feb 2023 16:15:17 GMT</pubDate><enclosure length="38677219" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525222/4694e481eab0198f2ef37b6062c94250.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A new podcast feed called Sensible Medicine is up…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3221</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525222/de1091768d9405c7231d65516ef80074.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A new podcast feed called Sensible Medicine is up; here is a sample of what we have to offer This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.39 - Sotorasib and Codebreak 200]]></title><description><![CDATA[I destroy the trial.  Bad control arm. Informative Censoring. No OS gain. Authors DOWNPOWERED TRIAL. Fishy PFS. Fishy HRQoL. This trial should be in trash can. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/539-sotorasib-and-codebreak-200-37b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1443702253</guid><pubDate>Fri, 10 Feb 2023 01:40:52 GMT</pubDate><enclosure length="32372368" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525223/674b26e2df72a2b38638115fba40df46.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I destroy the trial.  Bad control arm. Informativ…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2697</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525223/631a50b042da17c4ef64f2cd0331409d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I destroy the trial. Bad control arm. Informative Censoring. No OS gain. Authors DOWNPOWERED TRIAL. Fishy PFS. Fishy HRQoL. This trial should be in trash can. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise]]></title><description><![CDATA[I annotate an online case discussion;  Every decision is not based in evidence.  Madness <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/myeloma-twitter-just-makes-things-770</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1430040541</guid><pubDate>Sun, 22 Jan 2023 19:31:58 GMT</pubDate><enclosure length="30356186" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525224/29a3b0b3789ecc0d7703f9616e086c77.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I annotate an online case discussion;  Every deci…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2529</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525224/7ac3ec9afb3935ddfa31d11792da1e6c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I annotate an online case discussion; Every decision is not based in evidence. Madness This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.37 - Keynote Lecture on Physician Burnout]]></title><description><![CDATA[This lecture on Burnout will not be like any other you have heard <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/537-keynote-lecture-on-physician-a3d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1424917870</guid><pubDate>Sun, 15 Jan 2023 22:43:54 GMT</pubDate><enclosure length="28935736" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525225/d03c87cccbfdd652f0dffeb92cf8a875.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This lecture on Burnout will not be like any othe…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2411</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525225/312d117cd93ab799107f80499c5c6ef1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This lecture on Burnout will not be like any other you have heard This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.36 - ASH UPDATE #4 - GEM CESAR]]></title><description><![CDATA[I break down the GEM CESAR trial<br/>K, R, D, Pom, Dara, Dex, R, and Auto and all before you actually have cancer<br/>What a crazy trial! <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/536-ash-update-4-gem-cesar-620</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1412742958</guid><pubDate>Fri, 30 Dec 2022 02:30:20 GMT</pubDate><enclosure length="15892914" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525226/cd2dadaf03de90fcfeac5db2a07ea161.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I break down the GEM CESAR trial
K, R, D, Pom, Da…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1322</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525226/80926703120abddabc048f2de1126873.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I break down the GEM CESAR trial K, R, D, Pom, Dara, Dex, R, and Auto and all before you actually have cancer What a crazy trial! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.35 - ASH Update #3 - the Ascent Trial]]></title><description><![CDATA[This uncontrolled trial of Dara-KRD claims to be looking for cure; Unfortunately, the PI has not thought through what that would look like, and accordingly all the claims are incorrect. Moreover the primary endpt is negative.  Sad day for oncology <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/535-ash-update-3-the-ascent-trial-6e3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1412005750</guid><pubDate>Thu, 29 Dec 2022 00:21:53 GMT</pubDate><enclosure length="13869258" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525227/cacc62503a69563a30dd214c3dfa9749.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This uncontrolled trial of Dara-KRD claims to be …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1154</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525227/dce675cfd29af8e98724183d11fff218.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This uncontrolled trial of Dara-KRD claims to be looking for cure; Unfortunately, the PI has not thought through what that would look like, and accordingly all the claims are incorrect. Moreover the primary endpt is negative. Sad day for oncology This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed]]></title><description><![CDATA[Sample size games, primary endpoint, head to head trials in oncology<br/>Rate this podcast on itunes<br/>Coming next is Triangle trial <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/534-ash-update-2-alpine-zanibrutinib-556</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1409749579</guid><pubDate>Sat, 24 Dec 2022 23:55:43 GMT</pubDate><enclosure length="15599832" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525228/977bae4f077b5f55dfdcf86a8d2ffd95.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Sample size games, primary endpoint, head to head…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1297</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525228/c68a532e0fab7d5993030921b3e9aa37.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Sample size games, primary endpoint, head to head trials in oncology Rate this podcast on itunes Coming next is Triangle trial This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.33 USC Grand Rounds Hematology]]></title><description><![CDATA[Grand rounds on heme and heme malignancies given 12/16 at University of Southern California (some parts removed)<br/><br/>More ASH coming soon <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/533-usc-grand-rounds-hematology-543</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1409116390</guid><pubDate>Fri, 23 Dec 2022 21:30:13 GMT</pubDate><enclosure length="34560927" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525229/8076e10f600e93e031c631f4598f93d0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Grand rounds on heme and heme malignancies given …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2879</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525229/9d761437cc16397529544d805c3b3e3a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Grand rounds on heme and heme malignancies given 12/16 at University of Southern California (some parts removed) More ASH coming soon This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.32 - ASH Update #1 - Talquetamab NEJM]]></title><description><![CDATA[Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1?  VP says hell no. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/532-ash-update-1-talquetamab-nejm-522</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1400573332</guid><pubDate>Sun, 11 Dec 2022 19:39:33 GMT</pubDate><enclosure length="12825213" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525230/164c90b650e9a1d4a7f6049c4dc11edc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Is it acceptable to take someone with myeloma who…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1068</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525230/1e907315c589494086ccb9dcf86df85f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.31 - MUST LISTEN Grand Rounds - COVID19 Updates]]></title><description><![CDATA[In this lecture given December 7, 2022, I cover 5 things:<br/>Vaccines<br/>Masking<br/>Long COVID<br/>Schools/Immunity Debt<br/>Paxlovid <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/531-must-listen-grand-rounds-covid19-b8f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1398806005</guid><pubDate>Thu, 08 Dec 2022 18:59:34 GMT</pubDate><enclosure length="53017076" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525231/0677f43b33bf96335e7914b1e4bbfd5a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this lecture given December 7, 2022, I cover 5…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3314</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525231/4f97f4771ef3dd9fe83784247c6505c0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this lecture given December 7, 2022, I cover 5 things: Vaccines Masking Long COVID Schools/Immunity Debt Paxlovid This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.30 Rajkumar vs Goodman; Long COVID vs Long URI]]></title><description><![CDATA[Should we treat smoldering MM, a debate<br/>Long COVID vs Long URI<br/>Review the show; Say Hi at ASH22 <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/530-rajkumar-vs-goodman-long-covid-10e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1395555199</guid><pubDate>Sat, 03 Dec 2022 20:19:38 GMT</pubDate><enclosure length="29215764" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525232/0ed9d962a0edeb1a32ceaa5244599766.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Should we treat smoldering MM, a debate
Long COVI…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2433</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525232/af1923bbecd76ddc49dd200d2bb2dff5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Should we treat smoldering MM, a debate Long COVID vs Long URI Review the show; Say Hi at ASH22 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.29 Smart Start is a useless Lymphoma study]]></title><description><![CDATA[Smart Start is a useless lymphoma study; We have to stop putting our careers ahead of patients.  In the second part, I discuss the 'experts' featured on STAT.  Wowzers.<br/><br/>I will be at ask. Hit me up:<br/><a href="mailto:plenarysessionpodcast@gmail.com" class="linkified">plenarysessionpodcast@gmail.com</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/529-smart-start-is-a-useless-lymphoma-37e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1391173246</guid><pubDate>Sun, 27 Nov 2022 01:13:09 GMT</pubDate><enclosure length="35904164" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525233/19ebebbdc5fd5e2c665035a0c1d762b0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Smart Start is a useless lymphoma study; We have …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2990</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525233/27823a6cfc5806fd17b4231b34b3c8fd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Smart Start is a useless lymphoma study; We have to stop putting our careers ahead of patients. In the second part, I discuss the 'experts' featured on STAT. Wowzers. I will be at ask. Hit me up: plenarysessionpodcast@gmail.com This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.28 - Pandemic Amnesty or Accountability with Paul Fenyves]]></title><description><![CDATA[I am joined by Cornell Professor Paul Fenyves; a practicing internist Dr. Fenyves walks us through COVID19 policy.  We will be back soon with more cancer medicine. Including a devastating lymphoma one. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/528-pandemic-amnesty-or-accountability-e79</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1381352524</guid><pubDate>Sat, 12 Nov 2022 03:26:32 GMT</pubDate><enclosure length="27573716" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525234/d585edecd72caa0668fdadb689b1ed45.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I am joined by Cornell Professor Paul Fenyves; a …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2296</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525234/c5b42c69861d432fab87694061aeff1d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I am joined by Cornell Professor Paul Fenyves; a practicing internist Dr. Fenyves walks us through COVID19 policy. We will be back soon with more cancer medicine. Including a devastating lymphoma one. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.27 - Multiple Myeloma - Do Our Trials Help Patients?]]></title><description><![CDATA[I was invited to give this talk to a UK conference on Myeloma<br/>Please LEAVE A REVIEW of this podcast <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/527-multiple-myeloma-do-our-trials-35b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1379041588</guid><pubDate>Tue, 08 Nov 2022 21:24:32 GMT</pubDate><enclosure length="20442534" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525235/c5bd1b52348818dbb9e8eb8424d21160.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I was invited to give this talk to a UK conferenc…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1703</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525235/f64e5889bb789c3dc3fc976a8c062342.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I was invited to give this talk to a UK conference on Myeloma Please LEAVE A REVIEW of this podcast This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.26 - Hawaii Oncology Association Keynote Lecture]]></title><description><![CDATA[Lecture I gave this weekend in Hawaii to the Medical Oncology Association; One of the best audiences I've had <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/526-hawaii-oncology-association-keynote-5f8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1377581701</guid><pubDate>Sun, 06 Nov 2022 16:12:12 GMT</pubDate><enclosure length="31739836" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525236/05042841cbc77b9eabe166fa1b9902f4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Lecture I gave this weekend in Hawaii to the Medi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2644</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525236/db9c576302cfa37e819b3a5eb0a6a065.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Lecture I gave this weekend in Hawaii to the Medical Oncology Association; One of the best audiences I've had This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.25 - Neurosurgery Grand Rounds by Vinay Prasad]]></title><description><![CDATA[I give Grand Rounds to UCSF Neurosurgery on how to read and interpret Neurosurgery Studies<br/>(Video and slides coming soon to YouTube)<br/>Also I discuss Bob Califf's Promotion of Paxlovid <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/525-neurosurgery-grand-rounds-by-f8b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1375387501</guid><pubDate>Thu, 03 Nov 2022 04:36:19 GMT</pubDate><enclosure length="52099164" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525237/1849183b40b5114a83c4efa939e1cc61.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I give Grand Rounds to UCSF Neurosurgery on how t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4340</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525237/f16c970b4c3637cdf1ed51617de785c1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I give Grand Rounds to UCSF Neurosurgery on how to read and interpret Neurosurgery Studies (Video and slides coming soon to YouTube) Also I discuss Bob Califf's Promotion of Paxlovid This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.24 Vlad Kogan is back to discuss Kids Test Scores]]></title><description><![CDATA[Learning Loss is Devastating; Here are the data and what it means <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/524-vlad-kogan-is-back-to-discuss-757</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1374279937</guid><pubDate>Tue, 01 Nov 2022 14:25:14 GMT</pubDate><enclosure length="57459785" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525238/1f8301f053344fa0ed3b27ebc8cd6be5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Learning Loss is Devastating; Here are the data a…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4787</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525238/192ee02e696a0a797be4f33452241bf6.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Learning Loss is Devastating; Here are the data and what it means This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.24 - Gerald Hsu MD PhD UCSF Heme Onc Program Director]]></title><description><![CDATA[Learn about UCSF Hematology Oncology Program with Dr. Gerald Hsu, MD PhD Malignant Heme and Program Director <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/524-gerald-hsu-md-phd-ucsf-heme-onc-add</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1371584344</guid><pubDate>Fri, 28 Oct 2022 03:02:05 GMT</pubDate><enclosure length="49298515" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525239/fd848849c4a88f884590567a1d3e98c6.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Learn about UCSF Hematology Oncology Program with…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4107</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525239/4a8ec3febe9754d25ca63a3febaefd3b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Learn about UCSF Hematology Oncology Program with Dr. Gerald Hsu, MD PhD Malignant Heme and Program Director This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.23 - Subclinical Myocarditis]]></title><description><![CDATA[A new study from Switzerland confirms the rate of subclinical myocarditis <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/523-subclinical-myocarditis-9e1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1366368010</guid><pubDate>Wed, 19 Oct 2022 23:30:23 GMT</pubDate><enclosure length="9107596" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525240/409b71b6ffedb8b29ddb8f9f694ea374.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A new study from Switzerland confirms the rate of…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>758</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525240/6d72c8ccd1f471e905ce3446175125c1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A new study from Switzerland confirms the rate of subclinical myocarditis This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.23 - ID Ethicist joins me for a 6th discussion of COVID19 policy]]></title><description><![CDATA[LONG COVID, Vaccines, Paxlovid and More <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/523-id-ethicist-joins-me-for-a-6th-63d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1365525745</guid><pubDate>Tue, 18 Oct 2022 16:07:46 GMT</pubDate><enclosure length="64022875" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525241/9867ca3110f200db08a53bbb79aca6fc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>LONG COVID, Vaccines, Paxlovid and More</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5334</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525241/6e7e0e36873448c20cb80b5018bfde34.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>LONG COVID, Vaccines, Paxlovid and More This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.22 NordICC trial interview with PI Michael Bretthauer - Offer but don't Nudge]]></title><description><![CDATA[discuss NordICC with the trial PI<br/>Power calc specified 50% non-adherence<br/>ADR is on par with US studies from the time<br/>Colo quality good<br/>Perf rate lower than US!<br/>How does he counsel individuals & governments<br/>What he thinks of USPSTF <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/522-nordicc-trial-interview-with-82f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1363279936</guid><pubDate>Sat, 15 Oct 2022 00:59:25 GMT</pubDate><enclosure length="49466323" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525242/91bc9b78168ab59618307b2da50128d2.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>discuss NordICC with the trial PI
Power calc spec…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4121</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525242/b6b2a087ba55e453f35e942e6baea830.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>discuss NordICC with the trial PI Power calc specified 50% non-adherence ADR is on par with US studies from the time Colo quality good Perf rate lower than US! How does he counsel individuals &amp; governments What he thinks of USPSTF This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.21 Science Mag Editor Condemns Ladapo But Silent About Jha]]></title><description><![CDATA[A double standard to condemn data with limitations, based on political party, will destroy medicine.<br/><br/>We will back to oncology soon, but this is important <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/521-science-mag-editor-condemns-ladapo-597</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1362717313</guid><pubDate>Fri, 14 Oct 2022 03:19:40 GMT</pubDate><enclosure length="25188898" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525243/bca25e2354b8c7c28b7d01115244ec1b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A double standard to condemn data with limitation…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2098</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525243/fcd187dfcf346b50331175e0d236fc31.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A double standard to condemn data with limitations, based on political party, will destroy medicine. We will back to oncology soon, but this is important This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.20 The Great Colonoscopy Debate]]></title><description><![CDATA[Cifu, Mandrola and Prasad fight about colonoscopy <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/520-the-great-colonoscopy-debate-793</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1360778998</guid><pubDate>Tue, 11 Oct 2022 18:00:18 GMT</pubDate><enclosure length="44229805" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525244/1edee198560c0a491e72083eeb214beb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Cifu, Mandrola and Prasad fight about colonoscopy</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3685</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525244/b06668af813c236b885258a1fc510bd1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Cifu, Mandrola and Prasad fight about colonoscopy This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.19 - NEJM's first ever RCT of Colonoscopy-- Explained]]></title><description><![CDATA[I break down the history and data for the first ever randomized trial of colonoscopy, appearing in NEJM on Oct 9, 2022 <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/519-nejms-first-ever-rct-of-colonoscopy-489</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1359874237</guid><pubDate>Sun, 09 Oct 2022 22:23:11 GMT</pubDate><enclosure length="29668688" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525245/b8d90fd883071cbf5dedcec08f753a34.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I break down the history and data for the first e…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1853</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525245/16b9f2f662d833d2a25679535b8bf682.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I break down the history and data for the first ever randomized trial of colonoscopy, appearing in NEJM on Oct 9, 2022 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.18 Lecture to Heme Onc Fellows - POLO; Javelin 100 bladder]]></title><description><![CDATA[Polo Javelin 100 bladder Crossover Control arms How to read and keep up with the literature <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/518-lecture-to-heme-onc-fellows-polo-017</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1359259075</guid><pubDate>Sat, 08 Oct 2022 15:39:10 GMT</pubDate><enclosure length="33649159" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525246/4b7ad8178200d4b785171388bd1a70f8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Polo Javelin 100 bladder Crossover Control arms H…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2803</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525246/58d3704e588d6b2d0246410f3891e5a6.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Polo Javelin 100 bladder Crossover Control arms How to read and keep up with the literature This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.17 - The State Of Precision Oncology]]></title><description><![CDATA[Invited Lecture to Cancer Center Directors <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/517-the-state-of-precision-oncology-7fe</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1358362093</guid><pubDate>Fri, 07 Oct 2022 00:48:15 GMT</pubDate><enclosure length="10845404" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525247/11cca81a77e12ed9c3c1b4c3c30b3a71.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Invited Lecture to Cancer Center Directors</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>903</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525247/f7c1613fe5cd037af6341be2f3b67507.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Invited Lecture to Cancer Center Directors This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.16 - Aaron Goodman UCSD]]></title><description><![CDATA[I travel to UCSD to interview Dr. Goodman about myeloma, celebrity oncology culture, his career, education, patient care, choosing a specialty and more. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/516-aaron-goodman-ucsd-e2c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1353809695</guid><pubDate>Thu, 29 Sep 2022 19:54:51 GMT</pubDate><enclosure length="68005758" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525248/693559ffe413ef638f7ff279ad74ae87.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I travel to UCSD to interview Dr. Goodman about m…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5666</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525248/e3aac6e993d9a959fcc95824dcc20519.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I travel to UCSD to interview Dr. Goodman about myeloma, celebrity oncology culture, his career, education, patient care, choosing a specialty and more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.15 - How To Apply For And Get Your Perfect First Job]]></title><description><![CDATA[Based on listener questions, I discuss how to apply for and get your first job. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/515-how-to-apply-for-and-get-your-cd6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1348431556</guid><pubDate>Wed, 21 Sep 2022 21:40:55 GMT</pubDate><enclosure length="26081271" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525249/a174a381a7be6752165bdfca651713e8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Based on listener questions, I discuss how to app…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2173</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525249/d9bb6c0906099fbee98baa0895a8d8bd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Based on listener questions, I discuss how to apply for and get your first job. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Unspoken Rules of Oncology - Malignant BC Part 6]]></title><description><![CDATA[T.O. joins me for the missing episode. These are the unspoken rules of Oncology; We dive deeper into Malignant Book Club. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/unspoken-rules-of-oncology-malignant-3e2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1345931725</guid><pubDate>Sun, 18 Sep 2022 00:21:24 GMT</pubDate><enclosure length="45241155" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525250/7241c45c9d9bca0196be863a7e95c5bd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>T.O. joins me for the missing episode. These are …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3769</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525250/8240e0b091243ffa29f715661cf0e1e0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>T.O. joins me for the missing episode. These are the unspoken rules of Oncology; We dive deeper into Malignant Book Club. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Malignant Book Club - Episode 7 - famous trials]]></title><description><![CDATA[Timothee Olivier joins me for the 7th installment of our book-club<br/>We cover famous trials in oncology <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/malignant-book-club-episode-7-famous-590</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1340833063</guid><pubDate>Fri, 09 Sep 2022 16:28:05 GMT</pubDate><enclosure length="30058750" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525251/8596621b9e55e20a77d92b698aefde4c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee Olivier joins me for the 7th installment…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2504</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525251/de69014cafa29a3cbf5e2483da534653.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee Olivier joins me for the 7th installment of our book-club We cover famous trials in oncology This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.12 - Academics Vs Industry - A.Goodman S.Loghavi D.Steensma V.P.]]></title><description><![CDATA[How do careers vary between the academy and industry?  We have a panel of the best: Sanam Loghavi from MD Anderson, Aaron Goodman UCSD, and David Steensma Novartis (formerly Farber/ Mayo) and VP<br/><br/>#Real talk <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/512-academics-vs-industry-agoodman-abf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1336732021</guid><pubDate>Sat, 03 Sep 2022 01:35:44 GMT</pubDate><enclosure length="64742948" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525252/2d4e1a5ef6f5e299b6b3c638cffa76b9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>How do careers vary between the academy and indus…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5394</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525252/b5aeba2214feb0f32d69da74714de3ee.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>How do careers vary between the academy and industry? We have a panel of the best: Sanam Loghavi from MD Anderson, Aaron Goodman UCSD, and David Steensma Novartis (formerly Farber/ Mayo) and VP #Real talk This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.11 - Malignant Book Club - Part 5]]></title><description><![CDATA[Timothee Olivier joinrs me as we explore part 3 of the book<br/>Crossover, sample size, observational vs RCTs <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/511-malignant-book-club-part-5-fa5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1331476645</guid><pubDate>Fri, 26 Aug 2022 00:38:01 GMT</pubDate><enclosure length="37903344" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525253/6ad37c0eaf557b071d7f774fdefaee10.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee Olivier joinrs me as we explore part 3 o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3158</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525253/cdf04553918a5f1a8171254cba9914eb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee Olivier joinrs me as we explore part 3 of the book Crossover, sample size, observational vs RCTs This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.10 - Adam Cifu on clinical excellence]]></title><description><![CDATA[Adam Cifu is here to discuss clinical excellence and his new podcast <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/510-adam-cifu-on-clinical-excellence-be3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1330478449</guid><pubDate>Wed, 24 Aug 2022 15:57:14 GMT</pubDate><enclosure length="49023016" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525254/f520c3764bc9bb4d6cb3b3893f9b037e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Adam Cifu is here to discuss clinical excellence …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4084</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525254/8cddd4b07faf872bc21a5bab1a4caf74.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Adam Cifu is here to discuss clinical excellence and his new podcast This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.09 - Malignant Book Club Part 4]]></title><description><![CDATA[T.O. joins me to grill me on the rest of Financial Conflict of Interest and Precision Oncology.  We discuss the need for randomization, and when it can be omitted.  A must listen for Oncology Fans. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/509-malignant-book-club-part-4-b60</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1328445661</guid><pubDate>Mon, 22 Aug 2022 00:25:32 GMT</pubDate><enclosure length="43311142" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525255/d649bcb69e6a8fe8ab4133cf1167cecf.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>T.O. joins me to grill me on the rest of Financia…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3608</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525255/a0a0f5011039f4fffff13bef79bbfbef.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>T.O. joins me to grill me on the rest of Financial Conflict of Interest and Precision Oncology. We discuss the need for randomization, and when it can be omitted. A must listen for Oncology Fans. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.08 - LaceWing RCT Phase 3 Blood - Spin Cycle]]></title><description><![CDATA[VP discusses the LaceWing study in Blood. A Phase 3 RCT of GILT AZA vs AZA; Medical writers; confounding; table 1; balance; and so much more <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/508-lacewing-rct-phase-3-blood-spin-dbf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1326575572</guid><pubDate>Thu, 18 Aug 2022 16:44:28 GMT</pubDate><enclosure length="24192193" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525256/066738fabeaf3ae9465593f64b87251f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>VP discusses the LaceWing study in Blood. A Phase…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2015</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525256/b05e8a4ae4b45bee542712003fdb5639.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>VP discusses the LaceWing study in Blood. A Phase 3 RCT of GILT AZA vs AZA; Medical writers; confounding; table 1; balance; and so much more This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.07 - Plenary Session Alps Edition]]></title><description><![CDATA[Timothee Olivier joins me to discuss recent papers:<br/>IMPOWER10<br/>Checkmate 816<br/>Path CR/ EFS/ Surrogates<br/>Drug Dosing, cGCSF rules and more<br/>Bread and butter oncology <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/507-plenary-session-alps-edition-713</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1321366342</guid><pubDate>Wed, 10 Aug 2022 06:36:48 GMT</pubDate><enclosure length="42442914" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525257/149608c5f747b8383d38d43eba52bcac.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee Olivier joins me to discuss recent paper…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3536</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525257/2e5078907463493b658d613a86d9d9c9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee Olivier joins me to discuss recent papers: IMPOWER10 Checkmate 816 Path CR/ EFS/ Surrogates Drug Dosing, cGCSF rules and more Bread and butter oncology This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.06 - POLO trial now has OS results - OMG]]></title><description><![CDATA[The POLO trial, which we first broke on PS Season 1- is back with null OS results.  But the trial authors enter the spin cycle.  VP goes line by line. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/506-polo-trial-now-has-os-results-a2c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1308915622</guid><pubDate>Thu, 21 Jul 2022 01:03:49 GMT</pubDate><enclosure length="22098441" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525258/9403140d9c18a9c342f9bc14d4414abc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>The POLO trial, which we first broke on PS Season…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1840</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525258/4b018ef887b7a8166696b70407d526b1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>The POLO trial, which we first broke on PS Season 1- is back with null OS results. But the trial authors enter the spin cycle. VP goes line by line. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.05 - Citations, Metrics, Rankings in Oncology & Medicine]]></title><description><![CDATA[VP explains H index, total cites, papers, US News and World Report rankings and how evaluates researchers and doctors. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/505-citations-metrics-rankings-in-6e0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1307094058</guid><pubDate>Mon, 18 Jul 2022 05:38:19 GMT</pubDate><enclosure length="26385947" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525259/d73342c77717afdda9555494fb40c85a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>VP explains H index, total cites, papers, US News…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2198</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525259/f6f0a5f36bf006616db33ca11d5bcf71.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>VP explains H index, total cites, papers, US News and World Report rankings and how evaluates researchers and doctors. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.04 - Echelon 1 reports OS benefit - But does it add up?]]></title><description><![CDATA[VP addresses what to do you if you get an idea from listening to the show, and deconstructs ECHELON-1. Instead of listening we highly recommend you watch the video on YouTube with graphics.  This is worth the watch. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/504-echelon-1-reports-os-benefit-f05</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1305427600</guid><pubDate>Thu, 14 Jul 2022 23:54:59 GMT</pubDate><enclosure length="28240400" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525260/dc3794501729d4e3d8320a43c516f27d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>VP addresses what to do you if you get an idea fr…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2353</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525260/84dbd5af878fd5e734a1287bc4800136.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>VP addresses what to do you if you get an idea from listening to the show, and deconstructs ECHELON-1. Instead of listening we highly recommend you watch the video on YouTube with graphics. This is worth the watch. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?]]></title><description><![CDATA[How to think about when and how to do RCTs? What are the limitations to observational studies?  Smoking. Parachutes. Dostarlimab. Guarantee Time Bias.  Confounding. Multiple Hypothesis testing and more <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/503-vps-grand-rounds-lecture-evidence-cc5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1304282698</guid><pubDate>Wed, 13 Jul 2022 04:59:47 GMT</pubDate><enclosure length="36815400" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525261/0a2daa0f0a9191ac5566997d7b9af56b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>How to think about when and how to do RCTs? What …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3067</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525261/7a8ddc8d599d7c7ccd61b824869387b6.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>How to think about when and how to do RCTs? What are the limitations to observational studies? Smoking. Parachutes. Dostarlimab. Guarantee Time Bias. Confounding. Multiple Hypothesis testing and more This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers]]></title><description><![CDATA[I make the case why this podcast should be your go to for Med, Onc & Policy.  I describe my philosophy of Evidence, Empiricism, and show how this connects to many oncology studies.  I answer a bunch of Listener Questions <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/502-listener-questions-cancer-and-449</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1303005949</guid><pubDate>Mon, 11 Jul 2022 01:27:24 GMT</pubDate><enclosure length="33511802" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525262/f462c3831187a1e46cee08b876e32e5e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I make the case why this podcast should be your g…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2792</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525262/e7a46b86e82c478b78714ca042c61587.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I make the case why this podcast should be your go to for Med, Onc &amp; Policy. I describe my philosophy of Evidence, Empiricism, and show how this connects to many oncology studies. I answer a bunch of Listener Questions This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[5.01 - How To Read Randomized Trials In Cancer]]></title><description><![CDATA[How to read randomized trials in cancer medicine. Phase 2 vs 3, control arm, crossover, post protocol, censoring (the basics), and how law professors and medical professors are different and why it matters. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/501-how-to-read-randomized-trials-936</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1301577349</guid><pubDate>Thu, 07 Jul 2022 23:58:45 GMT</pubDate><enclosure length="27231077" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525263/b44c8bc6b121def05deb5042dca6563c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>How to read randomized trials in cancer medicine.…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2269</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525263/43ae3ece6f1710593a73996c40d6a739.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>How to read randomized trials in cancer medicine. Phase 2 vs 3, control arm, crossover, post protocol, censoring (the basics), and how law professors and medical professors are different and why it matters. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health]]></title><description><![CDATA[Lies and Exaggerations about Kids Vaccine<br/>I give examples, and show why they are lies <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/lies-and-exaggerations-about-kids-d64</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1292018893</guid><pubDate>Wed, 22 Jun 2022 05:31:10 GMT</pubDate><enclosure length="13691036" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525264/93c0a0c7c88959d7bcfaa60578142329.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Lies and Exaggerations about Kids Vaccine
I give …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1140</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525264/3f99db882123436d2e102276adf3bcb7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Lies and Exaggerations about Kids Vaccine I give examples, and show why they are lies This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer]]></title><description><![CDATA[What happens when you treat people with $168,000 a year medicine when most of them will never need treatment, and all of them don't need treatment now <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/enact-trial-enza-vs-active-surveillance-d9f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1290934708</guid><pubDate>Mon, 20 Jun 2022 14:19:40 GMT</pubDate><enclosure length="10748487" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525265/17e5343590126f6733cfde39fdf4c8d8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>What happens when you treat people with $168,000 …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>895</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525265/67e71ab06b9e81054a345e76ba542ac9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>What happens when you treat people with $168,000 a year medicine when most of them will never need treatment, and all of them don't need treatment now This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[Kids Vaccine For Under 5 years Old]]></title><description><![CDATA[I take a deep dive into the data for the mRNA vaccines for kids under 5 years olds <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/kids-vaccine-for-under-5-years-old-7c6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1290164770</guid><pubDate>Sat, 18 Jun 2022 22:56:55 GMT</pubDate><enclosure length="30664462" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525266/72dabb784238fbd97b89f8b7bede1ca5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I take a deep dive into the data for the mRNA vac…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2555</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525266/25d98fd7fa7c891aac63932638be8a38.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I take a deep dive into the data for the mRNA vaccines for kids under 5 years olds This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189]]></title><description><![CDATA[I sit down with H Jack West.  City of Hope. Thoracic Oncology and we have a long discussion about trials; staging; PDL1 thresholds; Driver mutations and post protocol care; ADAURA; Adjuvant; & More <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/h-jack-west-lung-cancer-podcasting-84c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1289703280</guid><pubDate>Sat, 18 Jun 2022 02:54:06 GMT</pubDate><enclosure length="55532885" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525267/8c67cde6b94a8dd296abf798a0178a92.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I sit down with H Jack West.  City of Hope. Thora…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4627</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525267/464d5736dab2906d9384d4cc348fb3a8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I sit down with H Jack West. City of Hope. Thoracic Oncology and we have a long discussion about trials; staging; PDL1 thresholds; Driver mutations and post protocol care; ADAURA; Adjuvant; &amp; More This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[QuANTUM - Quizartinib Front Line - Ethics of Global Trials]]></title><description><![CDATA[I discuss the timeline of Ratify and Quantum.  Was this an ethical trial?  Is it sufficient to say a trial is ethical because 50% of participants get something? <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/quantum-quizartinib-front-line-ethics-756</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1287951274</guid><pubDate>Wed, 15 Jun 2022 13:16:33 GMT</pubDate><enclosure length="30085795" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525268/b1afb986337fc980def035d727af39df.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I discuss the timeline of Ratify and Quantum.  Wa…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2506</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525268/2c32d47e4750ad8096f17d0329fcf488.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I discuss the timeline of Ratify and Quantum. Was this an ethical trial? Is it sufficient to say a trial is ethical because 50% of participants get something? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.67 Teclistimab for R/R Multiple Myeloma]]></title><description><![CDATA[The drug has a high response rate and lots of infections, is it active?  Yes; Efficacious? ????  I review ASCO2022 updates <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/467-teclistimab-for-rr-multiple-myeloma-0f5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1284543910</guid><pubDate>Thu, 09 Jun 2022 22:56:25 GMT</pubDate><enclosure length="27165308" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525269/a903c0cae62f7116e429298be81340eb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>The drug has a high response rate and lots of inf…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2263</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525269/fa8427faba6f952c3acbf9f995c740b5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??]]></title><description><![CDATA[Are the results from Luis Diaz as good as touted.  What trial should they do going forward?<br/>A 100% CR rate in Stage II and III rectal cancer?? <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/466-pd1-ab-for-msi-h-stage-ii-iii-beb</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1283565502</guid><pubDate>Wed, 08 Jun 2022 14:23:41 GMT</pubDate><enclosure length="17437113" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525270/ed33c6e2a96f8d9f5a5a3ea857a2bb66.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Are the results from Luis Diaz as good as touted.…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1452</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525270/cd449d7ec53526765959067b06ee153b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Are the results from Luis Diaz as good as touted. What trial should they do going forward? A 100% CR rate in Stage II and III rectal cancer?? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.65 DESTINY BREAST 04 - A complex trial to deconstruct]]></title><description><![CDATA[My take on the standing ovation for DESTINY Breast 04<br/>Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/465-destiny-breast-04-a-complex-trial-d86</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1282772626</guid><pubDate>Tue, 07 Jun 2022 14:25:07 GMT</pubDate><enclosure length="23221311" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525271/cfa1c7b84e247c34192a0d265eb21242.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>My take on the standing ovation for DESTINY Breas…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1934</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525271/b4b6abfa4c53bbebc737cf804e8ac431.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.64 - DETERMINATION - Should we still use transplant Myeloma?]]></title><description><![CDATA[I break down Richardson, et al. NEJM DETERMINATION<br/>Transplanters are determined to keep going, should they be?<br/><br/>Watch the videos b/c I have lots of great visuals<br/>My ASCO Coverage continues <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/464-determination-should-we-still-9c7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1282044919</guid><pubDate>Mon, 06 Jun 2022 14:52:57 GMT</pubDate><enclosure length="22968784" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525272/c98424ea4154c83456e4efbd98c7af7e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I break down Richardson, et al. NEJM DETERMINATIO…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1913</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525272/f887cc36faf91044cf619ad8cb474cc1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I break down Richardson, et al. NEJM DETERMINATION Transplanters are determined to keep going, should they be? Watch the videos b/c I have lots of great visuals My ASCO Coverage continues This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer]]></title><description><![CDATA[The second paper from #ASCO2022 #ASCO22 that I break down<br/>This is one of the most technical papers I breakdown on the channel<br/>CT DNA used to omit chemo in Stage II colon cancer<br/>Read the book Malignant if you learn from this<br/>Watch the YouTube Figures <a href="https://youtu.be/QxOBIi7I2BU" class="linkified" target="_blank">https://youtu.be/QxOBIi7I2BU</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/463-asco22-dynamic-can-ct-dna-allow-4e8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1281651451</guid><pubDate>Sun, 05 Jun 2022 23:14:58 GMT</pubDate><enclosure length="25569322" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525273/7fc52bff55622ab63ffd9390248b4cc3.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>The second paper from #ASCO2022 #ASCO22 that I br…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2130</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525273/657e55b5dda18d8f7ddd8929817fe125.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>The second paper from #ASCO2022 #ASCO22 that I break down This is one of the most technical papers I breakdown on the channel CT DNA used to omit chemo in Stage II colon cancer Read the book Malignant if you learn from this Watch the YouTube Figures https://youtu.be/QxOBIi7I2BU This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial]]></title><description><![CDATA[Continuous vs. Fixed, 3 vs 2, PFS is the primary endpoint<br/>No OS<br/>Bad crossover<br/>Lots to discuss here<br/>I will be covering all the major ASCO papers on @PlenarySession<br/>Subscribe to my substack <a href="https://vinayprasadmdmph.substack.com/" class="linkified" target="_blank">https://vinayprasadmdmph.substack.com/</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/462-shine-ibrutinib-br-vs-br-limitations-e00</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1281129748</guid><pubDate>Sat, 04 Jun 2022 19:33:26 GMT</pubDate><enclosure length="12992998" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525274/de6850fd6aa1f854948385e8d69274dc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Continuous vs. Fixed, 3 vs 2, PFS is the primary …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1082</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525274/a8d9c7ee6d77dcf0f360c278de53e032.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Continuous vs. Fixed, 3 vs 2, PFS is the primary endpoint No OS Bad crossover Lots to discuss here I will be covering all the major ASCO papers on @PlenarySession Subscribe to my substack https://vinayprasadmdmph.substack.com/ This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis]]></title><description><![CDATA[I am joined by Dr. Katie Sharff, infectious disease doc, to discuss two of her papers on myocarditis after COVID-19 vaccination.<br/><br/><a href="https://doi.org/10.1016/j.amjcard.2022.02.039" class="linkified" target="_blank">https://doi.org/10.1016/j.amjcard.2022.02.039</a><br/><a href="https://doi.org/10.1101/2021.12.21.21268209" class="linkified" target="_blank">https://doi.org/10.1101/2021.12.21.21268209</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/461-how-cdcs-vaccine-safety-missed-1c9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1275963910</guid><pubDate>Fri, 27 May 2022 00:43:24 GMT</pubDate><enclosure length="52672883" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525275/486c95924153bbeda610937c6adc5d43.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I am joined by Dr. Katie Sharff, infectious disea…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3277</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525275/fef2658d705fc655e805c594aa20f573.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I am joined by Dr. Katie Sharff, infectious disease doc, to discuss two of her papers on myocarditis after COVID-19 vaccination. https://doi.org/10.1016/j.amjcard.2022.02.039 https://doi.org/10.1101/2021.12.21.21268209 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods]]></title><description><![CDATA[I get back to my roots; I explain surrogate validation and a new JCO paper from the FDA authors on EFS and OS in AML. You won't want to miss it <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/460-new-jco-paper-aml-efs-cr-cri-f70</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1272741481</guid><pubDate>Sat, 21 May 2022 18:09:05 GMT</pubDate><enclosure length="24627685" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525276/36e49014f310cdae11440f444e2292a9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I get back to my roots; I explain surrogate valid…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2052</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525276/ce2bd172cd288ed1be2631139b685015.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I get back to my roots; I explain surrogate validation and a new JCO paper from the FDA authors on EFS and OS in AML. You won't want to miss it This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.59 - How to be a better reader of case control studies]]></title><description><![CDATA[In this episode I dissect a test negative case control trial; I talk about a famous pancreas cancer study and I revisit the failure of Myeloma trialists <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/459-how-to-be-a-better-reader-of-571</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1269767506</guid><pubDate>Tue, 17 May 2022 04:06:02 GMT</pubDate><enclosure length="13615363" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525277/82330bf12b0c963a8e942e461c1f07cf.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode I dissect a test negative case co…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1134</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525277/6b14715c7c9f66b67eeebb88f61f121e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode I dissect a test negative case control trial; I talk about a famous pancreas cancer study and I revisit the failure of Myeloma trialists This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.58 - Myeloma is a broken field - New BLOOD Paper!]]></title><description><![CDATA[I am joined by Manni Mohyuddin to talk about How I treat frontline transplant eligible myeloma.  Vinay Prasad makes the case the entire field of myeloma is corrupt and broken. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/458-myeloma-is-a-broken-field-new-8e0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1268382685</guid><pubDate>Sat, 14 May 2022 18:19:03 GMT</pubDate><enclosure length="45246412" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525278/70caba2c2e3abac882cc5862b8012937.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I am joined by Manni Mohyuddin to talk about How …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3770</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525278/f80c8767cb8ead160874a479020f960c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I am joined by Manni Mohyuddin to talk about How I treat frontline transplant eligible myeloma. Vinay Prasad makes the case the entire field of myeloma is corrupt and broken. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen]]></title><description><![CDATA[I join Dr. Bienen in person to discuss COVID19 and failures in public health <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/457-covid19-and-the-failures-of-public-b5f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1263470245</guid><pubDate>Fri, 06 May 2022 17:48:48 GMT</pubDate><enclosure length="58762901" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525279/b5cc975e650b1910483bea381ecf9d36.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I join Dr. Bienen in person to discuss COVID19 an…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4896</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525279/5b1299f53db7bf78cd4afde171a99707.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I join Dr. Bienen in person to discuss COVID19 and failures in public health This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.56 - Fifth Installment of the brilliant Zeb Jamrozik]]></title><description><![CDATA[ID ethicist, and brilliant COVID19 commenter <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/456-fifth-installment-of-the-brilliant-76f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1261846648</guid><pubDate>Wed, 04 May 2022 01:30:07 GMT</pubDate><enclosure length="60807043" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525280/d8f23972eb469acdadc9b8c331615cef.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>ID ethicist, and brilliant COVID19 commenter</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5066</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525280/a571b09287ddcbf10069488fb9f816c8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>ID ethicist, and brilliant COVID19 commenter This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.55 - Compilation Of Recent Covid Monologues]]></title><description><![CDATA[This is a compilation of the last week and half of monologues by VP on his Youtube Channel about COVID19 policy <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/455-compilation-of-recent-covid-monologues-bb7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1260252904</guid><pubDate>Sun, 01 May 2022 04:21:20 GMT</pubDate><enclosure length="52482517" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525281/8e16a946bf985764f9bced911f598ab8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is a compilation of the last week and half o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4370</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525281/235fb9b0b698c0778aa9dc4eb0a053b5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is a compilation of the last week and half of monologues by VP on his Youtube Channel about COVID19 policy This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist]]></title><description><![CDATA[I talk to UCSF Professor Eric Collison about his lab, grant writing, the physician scientist life, cancer, and a doctors duty. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/454-eric-collisson-professor-gi-oncologist-e0c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1259646772</guid><pubDate>Sat, 30 Apr 2022 01:35:02 GMT</pubDate><enclosure length="39252206" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525282/4f5b94ac4f414ea41a0c4a7a0aac1928.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I talk to UCSF Professor Eric Collison about his …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3270</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525282/fa015ba02a954b9d6f8bd57bacf5ee88.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I talk to UCSF Professor Eric Collison about his lab, grant writing, the physician scientist life, cancer, and a doctors duty. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.53 John Ioannidis lectures the VKPrasad Lab about COVID19]]></title><description><![CDATA[A brilliant talk by one of the most brilliant scientists alive;  JPAI lectures VKPrasad lab on all things COVID19; When does the pandemic end? What are the lessons? <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/453-john-ioannidis-lectures-the-vkprasad-807</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1258157842</guid><pubDate>Wed, 27 Apr 2022 19:02:35 GMT</pubDate><enclosure length="64024539" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525283/201924b22ddcfe5016c7d7b38ae1844c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A brilliant talk by one of the most brilliant sci…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5334</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525283/09878c608c7a7861f1ad32a9bad766b1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A brilliant talk by one of the most brilliant scientists alive; JPAI lectures VKPrasad lab on all things COVID19; When does the pandemic end? What are the lessons? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience]]></title><description><![CDATA[Listen in as I give an unscripted lecture to a general audience about COVID-19; What we got right and wrong these last 2+ years. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/452-vinay-prasad-gives-a-lecture-13e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1256098219</guid><pubDate>Sun, 24 Apr 2022 16:09:12 GMT</pubDate><enclosure length="30012868" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525284/53c1cadb059fb5a9498db61f8e8323d7.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Listen in as I give an unscripted lecture to a ge…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2500</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525284/ad753923ee8949c0cae1e634bfdbc5bd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Listen in as I give an unscripted lecture to a general audience about COVID-19; What we got right and wrong these last 2+ years. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine]]></title><description><![CDATA[Kristina Jenei becomes the 4th guest host and flips the tables on me, interviewing me about academic medicine and more... <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/451-vinay-prasad-is-interviewed-by-097</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1254750850</guid><pubDate>Fri, 22 Apr 2022 03:24:28 GMT</pubDate><enclosure length="57232876" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525285/be2cc45cab523bf2bf2275a1f0dcd19b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Kristina Jenei becomes the 4th guest host and fli…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4769</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525285/4e3a8dca77238981994873eb3ee83614.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Kristina Jenei becomes the 4th guest host and flips the tables on me, interviewing me about academic medicine and more... This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club]]></title><description><![CDATA[I perform an analysis of the AGILE trial that came out in NEJM today;  I find 6 huge problems.  Follow PS on twitter; and write to us to let us know what you think <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/450-ivosidenib-and-aza-vs-aza-the-f03</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1254102559</guid><pubDate>Thu, 21 Apr 2022 06:32:48 GMT</pubDate><enclosure length="14343216" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525286/ffdfb1cb50800c819e526cedaa1ec2b8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I perform an analysis of the AGILE trial that cam…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1193</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525286/53402c009b716b8f19515b5d2e5025dc.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I perform an analysis of the AGILE trial that came out in NEJM today; I find 6 huge problems. Follow PS on twitter; and write to us to let us know what you think This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.49 - Malignant Book Club Part 3 Audio]]></title><description><![CDATA[Timothee Olivier joins me for the 3rd of 9 parts of the Malignant book club - this covers all of Oncology <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/449-malignant-book-club-part-3-audio-bbc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1250517517</guid><pubDate>Fri, 15 Apr 2022 03:47:51 GMT</pubDate><enclosure length="31834084" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525287/449fa2f10a81d519c834492fd63c7e0a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee Olivier joins me for the 3rd of 9 parts …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2652</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525287/b33bdee2b733aa8c5e4606c3a65e700f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee Olivier joins me for the 3rd of 9 parts of the Malignant book club - this covers all of Oncology This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.48 - The Truth About RCTs In Cancer Medicine]]></title><description><![CDATA[Pragmatic vs Ideal, Surrogate vs. Hard Endpoints; Time it takes; Ethics; Control arms; Purpose; I cover it all here. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/448-the-truth-about-rcts-in-cancer-c24</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1246253695</guid><pubDate>Thu, 07 Apr 2022 21:13:36 GMT</pubDate><enclosure length="24957481" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525288/5ca83dccf6c249f806a03415f16e9ee8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Pragmatic vs Ideal, Surrogate vs. Hard Endpoints;…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2079</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525288/4b3d3b1041dd348311ec1603d18876e9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Pragmatic vs Ideal, Surrogate vs. Hard Endpoints; Time it takes; Ethics; Control arms; Purpose; I cover it all here. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[CDC's method underestimates Vaccine Induced Myocarditis]]></title><description><![CDATA[<p>On this audio podcast, I discuss limitations in the CDC’s method for counting myocarditis. Katie Sharff is the expert on this topic.</p><p><p>Vinay Prasad's Observations and Thoughts is a reader-supported publication. Become a free or paid subscriber for weekly updates.</p></p><p></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/cdcs-method-underestimates-vaccine</link><guid isPermaLink="false">substack:post:51626327</guid><pubDate>Tue, 05 Apr 2022 03:25:53 GMT</pubDate><enclosure length="33333333" type="audio/mpeg" url="https://api.substack.com/feed/podcast/51626327/474a26f23d26fc348940abc68d71d8b9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:explicit>No</itunes:explicit><itunes:duration>3277</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/51626327/75b956e80e2d507ca57f24efef6c3948.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:subtitle>On this audio podcast, I discuss limitations in the CDC’s method for counting myocarditis. Katie Sharff is the expert on this topic. Vinay Prasad's Observations and Thoughts is a reader-supported publication. Become a free or paid subscriber for weekly updates. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:subtitle><itunes:summary>On this audio podcast, I discuss limitations in the CDC’s method for counting myocarditis. Katie Sharff is the expert on this topic. Vinay Prasad's Observations and Thoughts is a reader-supported publication. Become a free or paid subscriber for weekly updates. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.47 Malignant Book Club w/ Dr. Olivier Part 2 of 9]]></title><description><![CDATA[In this book club we discuss Chapters 2 and 3 of Malignant, covering Surrogates and their role in Oncology <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/447-malignant-book-club-w-dr-olivier-010</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1236454087</guid><pubDate>Tue, 22 Mar 2022 00:24:02 GMT</pubDate><enclosure length="37314503" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525289/c4d2627849140d0599697d948da556d1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this book club we discuss Chapters 2 and 3 of …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3108</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525289/9c321f51a1a884753483e2f929a4fb10.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this book club we discuss Chapters 2 and 3 of Malignant, covering Surrogates and their role in Oncology This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.46 - Cancer Monologue and Lecture #5 from VP's Class on How to Appraise Medical Literature]]></title><description><![CDATA[This is a brief monologue with Dr. Timothee Olivier, and the audio from a class I taught on RCTs-- when are they needed in biomedicine <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/446-cancer-monologue-and-lecture-205</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1233592267</guid><pubDate>Wed, 16 Mar 2022 23:19:43 GMT</pubDate><enclosure length="36716062" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525290/8caaea238dbd362717e3fd4f660f2387.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is a brief monologue with Dr. Timothee Olivi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3059</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525290/487a5aea0f7ca47c1d6745320e2c98fe.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is a brief monologue with Dr. Timothee Olivier, and the audio from a class I taught on RCTs-- when are they needed in biomedicine This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.45 - Malignant Book Club w/ Dr. Olivier Part 1 of 9]]></title><description><![CDATA[Here is the first of a 9 part series on Malignant Book Club with Timothee Olivier from Switzerland<br/><br/>We cover cost of drugs, and intro to cancer drug policy <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/445-malignant-book-club-w-dr-olivier-6a7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1230786961</guid><pubDate>Sat, 12 Mar 2022 00:42:50 GMT</pubDate><enclosure length="45783804" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525291/534438f82788f190869e26ab09df34ce.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Here is the first of a 9 part series on Malignant…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3815</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525291/f676b37726636b85d5a11839be319b32.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Here is the first of a 9 part series on Malignant Book Club with Timothee Olivier from Switzerland We cover cost of drugs, and intro to cancer drug policy This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.44 - Cost Of Cancer Drugs - Basics In Cancer Drug Policy]]></title><description><![CDATA[I lecture on basics on cancer drug policy <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/444-cost-of-cancer-drugs-basics-in-480</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1226018959</guid><pubDate>Fri, 04 Mar 2022 01:02:25 GMT</pubDate><enclosure length="31500177" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525292/ec6ffcb9876c5c429068fbe4134c1fe4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I lecture on basics on cancer drug policy</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2624</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525292/4751a49444e6c1d802d789b2f8a00161.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I lecture on basics on cancer drug policy This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.43 - VKPrasad Lab Update Part 2 With Timothee Olivier]]></title><description><![CDATA[I am back with Timothee Olivier from Geneva Switzerland to discuss Part 2 of our laboratory work.  Can oncologists criticize RCTs?  We also announce our new series.  A 9 week Malignant Bookclub <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/443-vkprasad-lab-update-part-2-with-163</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1224152608</guid><pubDate>Tue, 01 Mar 2022 00:11:22 GMT</pubDate><enclosure length="48225846" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525293/0860ba0f4e226d752228121404c8468e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I am back with Timothee Olivier from Geneva Switz…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4018</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525293/37013a6b648e18a3f1d6e27dbf59e876.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I am back with Timothee Olivier from Geneva Switzerland to discuss Part 2 of our laboratory work. Can oncologists criticize RCTs? We also announce our new series. A 9 week Malignant Bookclub This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.42 - Timothee Olivier, Geneva in the first Installment of VKPrasad Lab updates]]></title><description><![CDATA[Timothee Olivier from Geneva Hospital Switzerland joins me for the first in a series of episodes on updates from VKPrasad laboratory, where we discuss cancer drugs & policy & evidence <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/442-timothee-olivier-geneva-in-the-15b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1221874477</guid><pubDate>Thu, 24 Feb 2022 20:18:31 GMT</pubDate><enclosure length="47549988" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525294/f360e6d429c51fcac1a9f7556611123b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Timothee Olivier from Geneva Hospital Switzerland…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3962</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525294/60b3c3c3eab4216393251a4a7a4e92fa.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Timothee Olivier from Geneva Hospital Switzerland joins me for the first in a series of episodes on updates from VKPrasad laboratory, where we discuss cancer drugs &amp; policy &amp; evidence This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.41 The Mask Debacle with Jacob Hale Russell]]></title><description><![CDATA[Jacob Hale Russell is back from Rutgers law to talk about his new piece in Tablet Magazine. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/441-the-mask-debacle-with-jacob-hale-6c5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1218556999</guid><pubDate>Sat, 19 Feb 2022 01:40:39 GMT</pubDate><enclosure length="48243782" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525295/9f43fda9580898d52114a3b612454b9b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Jacob Hale Russell is back from Rutgers law to ta…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4020</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525295/817f0e1a612ffd5895cc5d838c4a6a94.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Jacob Hale Russell is back from Rutgers law to talk about his new piece in Tablet Magazine. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.40 H Gilbert Welch - Melanoma Screening; Blood Based Cancer testing; Lung CA screening]]></title><description><![CDATA[A discussion about the excesses of testing with Gil Welch <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/440-h-gilbert-welch-melanoma-screening-384</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1205493463</guid><pubDate>Fri, 28 Jan 2022 15:47:24 GMT</pubDate><enclosure length="45664884" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525296/774b5c085e9d42ad8b75dd8cb0f20574.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>A discussion about the excesses of testing with G…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3805</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525296/8fef4954363586362316d1a0b0eaca6f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>A discussion about the excesses of testing with Gil Welch This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.39 Dr Zeb Jamrozik, ID ethicist, practicing doctor, great thinker]]></title><description><![CDATA[I am joined for my 4th conversation with Zeb. This is a far reaching conversation where we discuss mandates, vaccines, masking, and why evidence based medicine still has something to offer. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/439-dr-zeb-jamrozik-id-ethicist-practicing-e86</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1204376716</guid><pubDate>Thu, 27 Jan 2022 01:51:43 GMT</pubDate><enclosure length="66206394" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525297/eb009e0fb141d0abf40f562b3a5355f0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>I am joined for my 4th conversation with Zeb. Thi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5516</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525297/ade907c07d032e7dd9977219b30c042a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>I am joined for my 4th conversation with Zeb. This is a far reaching conversation where we discuss mandates, vaccines, masking, and why evidence based medicine still has something to offer. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.38 COVID-19: Boosters for Adults and Teens, Paul Offitt, Testing, Myocarditis, Campus Restrictions]]></title><description><![CDATA[We're back this week with a collection of monologues! We talk about a Paul Offitt quote, COVID boosters for adults and kids, COVID testing, whether this is a pandemic of the unvaccinated, myocarditis and pericarditis, college campus restrictions, and more!<br/><br/>STAT News Op-Ed: <a href="https://www.statnews.com/2021/12/23/at-a-time-when-the-u-s-needed-covid-19-dialogue-between-scientists-francis-collins-moved-to-shut-it-down/" class="linkified" target="_blank">https://www.statnews.com/2021/12/23/at-a-time-when-the-u-s-needed-covid-19-dialogue-between-scientists-francis-collins-moved-to-shut-it-down/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/438-covid-19-boosters-for-adults-ec2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1200623998</guid><pubDate>Fri, 21 Jan 2022 03:05:35 GMT</pubDate><enclosure length="126551464" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525298/c5019fef5ecad58e34deb74c953967cb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're back this week with a collection of monolog…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7909</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525298/3970b8abcb8298d18a6be6f08eb6cc80.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're back this week with a collection of monologues! We talk about a Paul Offitt quote, COVID boosters for adults and kids, COVID testing, whether this is a pandemic of the unvaccinated, myocarditis and pericarditis, college campus restrictions, and more! STAT News Op-Ed: https://www.statnews.com/2021/12/23/at-a-time-when-the-u-s-needed-covid-19-dialogue-between-scientists-francis-collins-moved-to-shut-it-down/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.37 MEMOIR & The Emperor Has No Clothes (a Critique of Cancer Care) with Dr. Christopher Booth]]></title><description><![CDATA[Today we have a short discussion for you of the MEMOIR study, published in The Lancet Oncology: "Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study". We also have a special treat for you: a lecture Dr. Chris Booth of Queen's University, Kingston, Ontario, Canada recently gave titled "The Emperor Has No Clothes", a critique of the current state of cancer care.<br/><br/>MEMOIR: <a href="http://doi.org/10.1016/S1470-2045(21)00546-5" class="linkified" target="_blank">doi.org/10.1016/S1470-2045(21)00546-5</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/437-memoir-and-the-emperor-has-no-b21</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1191705736</guid><pubDate>Thu, 06 Jan 2022 22:22:51 GMT</pubDate><enclosure length="54647438" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525299/d1678d32274b5a60ccdfd97de8b4a7bb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have a short discussion for you of the M…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3415</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525299/73ef8bf202b7710fec60538be118ed1a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have a short discussion for you of the MEMOIR study, published in The Lancet Oncology: "Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study". We also have a special treat for you: a lecture Dr. Chris Booth of Queen's University, Kingston, Ontario, Canada recently gave titled "The Emperor Has No Clothes", a critique of the current state of cancer care. MEMOIR: doi.org/10.1016/S1470-2045(21)00546-5 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.36 Where Are We Now with COVID-19? with Dr. John Ioannidis]]></title><description><![CDATA[Today we have an in-depth, in-person interview with Dr. John Ioannidis of Stanford University. We ask him: where are we now with COVID-19?<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/436-where-are-we-now-with-covid-19-522</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1188172183</guid><pubDate>Tue, 04 Jan 2022 20:00:02 GMT</pubDate><enclosure length="102718595" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525300/629f75c17e22a2ebf4ab1dcf795bed06.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have an in-depth, in-person interview wi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6420</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525300/e65c677ab2c6f96c00a24021273f3773.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have an in-depth, in-person interview with Dr. John Ioannidis of Stanford University. We ask him: where are we now with COVID-19? Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.35 Omicron, Travel Bans, Masks, Vaccine Mandates with Dr. Zeb Jamrozik]]></title><description><![CDATA[Dr. Zeb Jamrozik, an infectious disease bioethicist at the Monash Bioethics Centre and the University of Oxford, is back again! We discuss Omicron, travel bans, masks, vaccine mandates, and more.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/435-omicron-travel-bans-masks-vaccine-fda</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1188168004</guid><pubDate>Fri, 31 Dec 2021 22:19:00 GMT</pubDate><enclosure length="85711419" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525301/cfd8c758c6ab9e0f183226af2bb9dec5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Dr. Zeb Jamrozik, an infectious disease bioethici…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5357</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525301/a918096382987e5b3849bd6c2edfcd63.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Dr. Zeb Jamrozik, an infectious disease bioethicist at the Monash Bioethics Centre and the University of Oxford, is back again! We discuss Omicron, travel bans, masks, vaccine mandates, and more. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.34 ASH Lymphoma Updates: POLARIX, ZUMA 7, BELINDA w/ Papa Heme and DRG]]></title><description><![CDATA[David Russler-Germain and Papa Heme join VP to discuss the hottest ASH lymphoma papers:  POLARIX and 2 CAR-T trials (ZUMA-7 & BELINDA)<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/434-ash-lymphoma-updates-polarix-467</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1184379397</guid><pubDate>Fri, 24 Dec 2021 16:54:22 GMT</pubDate><enclosure length="54349994" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525302/6c14ed6d561ec5a83f4e5d1b62551766.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>David Russler-Germain and Papa Heme join VP to di…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4529</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525302/29788be729e209861dc508ea7c9f5784.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>David Russler-Germain and Papa Heme join VP to discuss the hottest ASH lymphoma papers: POLARIX and 2 CAR-T trials (ZUMA-7 &amp; BELINDA) Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.33 Melanoma: Tebentafusp, Stage Migration, Adjuvant Therapy, Training with Dr. Adil Daud]]></title><description><![CDATA[We have an in-person interview for you today! We sit down with Dr. Adil Daud of UCSF to talk all things melanoma. We cover Tebentafusp, nodal dissection, the Will Rogers phenomenon and the effect of stage migration on clinical trials as imaging advances, adjuvant vs I/O, academic training vs apprenticeship for budding oncologists, and more!<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/433-melanoma-tebentafusp-stage-migration-a09</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1182413278</guid><pubDate>Wed, 22 Dec 2021 04:05:38 GMT</pubDate><enclosure length="62103831" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525303/428e2d047853c766e8469bb671c48614.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have an in-person interview for you today! We …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3881</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525303/fe8c83e589f42ddb74849c4f2fdc8d80.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have an in-person interview for you today! We sit down with Dr. Adil Daud of UCSF to talk all things melanoma. We cover Tebentafusp, nodal dissection, the Will Rogers phenomenon and the effect of stage migration on clinical trials as imaging advances, adjuvant vs I/O, academic training vs apprenticeship for budding oncologists, and more! Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.32 Oral Azacitidine for AML and Nelarabine for T-ALL with Dr. Bernard Marini]]></title><description><![CDATA[We're back with a hematology/oncology heavy episode! We talk about oral azacitidine for acute myeloid leukemia (AML) and nelarabine for T-cell acute lymphoblastic leukemia (T-ALL) with Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology and Associate Professor at University of Michigan Medicine.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/432-oral-azacitidine-for-aml-and-ce0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1171032001</guid><pubDate>Fri, 03 Dec 2021 03:47:53 GMT</pubDate><enclosure length="62720321" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525304/77d36b70f423472185acc1470ce34d68.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're back with a hematology/oncology heavy episo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3920</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525304/474c01f1cd7e9962b2e2b7cadd912d3a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're back with a hematology/oncology heavy episode! We talk about oral azacitidine for acute myeloid leukemia (AML) and nelarabine for T-cell acute lymphoblastic leukemia (T-ALL) with Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology and Associate Professor at University of Michigan Medicine. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.31 Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma with Dr. William Hall]]></title><description><![CDATA[Today we interview Dr. Bill Hall, Associate Professor of Radiation Oncology and Surgery at Medical College of Wisconsin, on his new paper out now in the Journal of Clinical Oncology titled "Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma".<br/><br/>Neoadjuvant: <a href="http://doi.org/10.1200/JCO.21.01220" class="linkified" target="_blank">doi.org/10.1200/JCO.21.01220</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/431-neoadjuvant-radiation-therapy-68e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1165731049</guid><pubDate>Wed, 24 Nov 2021 20:00:19 GMT</pubDate><enclosure length="52636219" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525305/a26c4fe02dff1b3e3d7fc5dae2c12284.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Bill Hall, Associate Profe…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3290</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525305/fc15870de0ccede7b4e755d3a023428f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Bill Hall, Associate Professor of Radiation Oncology and Surgery at Medical College of Wisconsin, on his new paper out now in the Journal of Clinical Oncology titled "Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma". Neoadjuvant: doi.org/10.1200/JCO.21.01220 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.30 COVID in Children and the US FDA Vaccine Advisory Committee with Dr. Cody Meissner]]></title><description><![CDATA[Today we interview Dr. Cody Meissner, Chief of the Division of Pediatric Infectious Disease and Professor of Pediatrics at Tufts University School of Medicine. Dr. Meissner is also a member of the US FDA Vaccine Advisory Committee. We talk about the affect of school closures on the health of children, the evidence base for COVID vaccine mandates in children, and the nuance surrounding all of it. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/430-covid-in-children-and-the-us-7b0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1164425125</guid><pubDate>Mon, 22 Nov 2021 04:26:14 GMT</pubDate><enclosure length="66402541" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525306/fa7b72985344b03d63e3dd56ce49500d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Cody Meissner, Chief of th…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4150</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525306/a019eae25f6668b9e3c495ad1e308d96.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Cody Meissner, Chief of the Division of Pediatric Infectious Disease and Professor of Pediatrics at Tufts University School of Medicine. Dr. Meissner is also a member of the US FDA Vaccine Advisory Committee. We talk about the affect of school closures on the health of children, the evidence base for COVID vaccine mandates in children, and the nuance surrounding all of it. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.29 Scientific and Ethical Failures of COVID-19 with Dr. Zeb Jamrozik]]></title><description><![CDATA[Dr. Zeb Jamrozik, an infectious disease bioethicist at the Monash Bioethics Centre and the University of Oxford, is back by popular demand! We talk about the failures, both scientific and ethical, of the COVID-19 pandemic.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/429-scientific-and-ethical-failures-7cc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1157814829</guid><pubDate>Thu, 11 Nov 2021 01:23:28 GMT</pubDate><enclosure length="70433339" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525307/c21083320ca4b8ec983b1e087676f451.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Dr. Zeb Jamrozik, an infectious disease bioethici…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4402</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525307/3581db0d5497d6810b7c4d9f09576a2a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Dr. Zeb Jamrozik, an infectious disease bioethicist at the Monash Bioethics Centre and the University of Oxford, is back by popular demand! We talk about the failures, both scientific and ethical, of the COVID-19 pandemic. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.28 Calling Out Unethical Clinical Trials, Melflufen, and Academic Oncology with Dr. Aaron Goodman]]></title><description><![CDATA[We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to talk about calling out an unethical clinical trial, Melflufen, and academic oncology.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/428-calling-out-unethical-clinical-30d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1154808238</guid><pubDate>Sat, 06 Nov 2021 04:48:09 GMT</pubDate><enclosure length="53562417" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525308/01553ee5184b0d5e5c619d0a65a058bd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're joined today by Dr. Aaron Goodman, a hemato…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3348</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525308/5f18502535347a9f3b9e076b9ca22c30.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to talk about calling out an unethical clinical trial, Melflufen, and academic oncology. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.27 Economics and Medicine with the Host of Freakonomics, M.D., Dr. Anupam Bapu Jena]]></title><description><![CDATA[We're joined by Dr. Bapu Jena of Harvard Medical School to talk about his show, Freakonomics, M.D., and his career at the intersection of economics and medicine.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/427-economics-and-medicine-with-the-165</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1150449670</guid><pubDate>Fri, 29 Oct 2021 21:01:58 GMT</pubDate><enclosure length="77108146" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525309/7d0c894a67af01bd8927c5abfba5aab4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're joined by Dr. Bapu Jena of Harvard Medical …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4819</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525309/67a49c1c2f69f865190396230a1e51d0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're joined by Dr. Bapu Jena of Harvard Medical School to talk about his show, Freakonomics, M.D., and his career at the intersection of economics and medicine. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.26 Recent Kidney Cancer Trials, Unethical Cancer Clinical Trial, & CASSIOPEIA]]></title><description><![CDATA[We have three topics for you today: We talk about our recent paper on the use of second-line immunotherapy in kidney cancer, the controversy over whether a cancer clinical trial was unethical, and the results of the randomized clinical trial CASSIOPEIA. <br/><br/>Kidney Cancer: <a href="http://doi.org/10.1001/jamanetworkopen.2021.24728" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2021.24728</a><br/>CASSIOPEIA <a href="http://doi.org/10.1016/S1470-2045(21)00428-9" class="linkified" target="_blank">doi.org/10.1016/S1470-2045(21)00428-9</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/426-recent-kidney-cancer-trials-unethical-7d5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1149315589</guid><pubDate>Thu, 28 Oct 2021 04:06:19 GMT</pubDate><enclosure length="33285544" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525310/468c8c54cd4cd238327b5a190abe80d1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have three topics for you today: We talk about…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2080</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525310/1927d1dce6fbe1486c36f274b0544eea.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have three topics for you today: We talk about our recent paper on the use of second-line immunotherapy in kidney cancer, the controversy over whether a cancer clinical trial was unethical, and the results of the randomized clinical trial CASSIOPEIA. Kidney Cancer: doi.org/10.1001/jamanetworkopen.2021.24728 CASSIOPEIA doi.org/10.1016/S1470-2045(21)00428-9 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.25 A Critique of COVID-19 Health Policy with Infectious Disease Ethicist Dr. Zeb Jamrozik]]></title><description><![CDATA[Today we have an interview with Dr. Zeb Jamrozik, an infectious disease bioethicist at the Monash Bioethics Centre and the University of Oxford. We talk about COVID-19 health policy and where we went wrong, speaking specifically from the values framework of health, fairness, and freedom.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/425-a-critique-of-covid-19-health-e66</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1144690693</guid><pubDate>Wed, 20 Oct 2021 00:58:53 GMT</pubDate><enclosure length="70184235" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525311/73cbfbffa8592d333f25ff2d7dad36b9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have an interview with Dr. Zeb Jamrozik,…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4386</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525311/7d6a0bfac0b9164ef3d87e33b2bc694b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have an interview with Dr. Zeb Jamrozik, an infectious disease bioethicist at the Monash Bioethics Centre and the University of Oxford. We talk about COVID-19 health policy and where we went wrong, speaking specifically from the values framework of health, fairness, and freedom. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.24 COVID-19: Moderna booster, Myocarditis, Progressivism, Social Media, Masks, Tests, J&J booster]]></title><description><![CDATA[We have a summary of our thoughts for you on recent news about COVID. We discuss the prospect of FDA authorization of a Moderna booster, 8 lessons for health policy in times of crisis, updates on myocarditis data from Israel and Europe, how our experiences with COVID warn us of the possible end to democracy, how progressivism is dead, why social media should not censor views, the CDC's new masking studies,  the slogan "follow the science", weekly testing of vaccinated college students who don't have symptoms, the survival of science after COVID, and the question of requiring a booster to follow the Johnson & Johnson vaccine.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/424-covid-19-moderna-booster-myocarditis-54a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1142675905</guid><pubDate>Sat, 16 Oct 2021 03:31:05 GMT</pubDate><enclosure length="102331147" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525312/9c89f7378433df461706ef2392ef8e00.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a summary of our thoughts for you on rece…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6396</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525312/9782bd8464c0725cd30fdadeb3316c5d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a summary of our thoughts for you on recent news about COVID. We discuss the prospect of FDA authorization of a Moderna booster, 8 lessons for health policy in times of crisis, updates on myocarditis data from Israel and Europe, how our experiences with COVID warn us of the possible end to democracy, how progressivism is dead, why social media should not censor views, the CDC's new masking studies, the slogan "follow the science", weekly testing of vaccinated college students who don't have symptoms, the survival of science after COVID, and the question of requiring a booster to follow the Johnson &amp; Johnson vaccine. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.23 Access to Cancer Medicines, Standard of Care in Oncology, and the Oncology Value Paradigm]]></title><description><![CDATA[On today's episode we're joined by a number of special guests: Dr. Christopher Booth and Dr. Adam Fundytus of Queen's University in Kingston, Ontario, Dr. Manju Sengar of the Tata Memorial Centre, and Dr. Aaron Goodman of the University of California at San Diego. We talk about their new papers: "Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey", "Practicing on the edge of oncology: when standard of care feels uncomfortable", and "Has the Current Oncology Value Paradigm Forgotten Patients’ Time? Too Little of a Good Thing".<br/><br/>Cancer Medicines: <a href="http://doi.org/10.1016/S1470-2045(21)00463-0" class="linkified" target="_blank">doi.org/10.1016/S1470-2045(21)00463-0</a><br/>Edge of Oncology: <a href="http://doi.org/10.1038/s41571-021-00550-9" class="linkified" target="_blank">doi.org/10.1038/s41571-021-00550-9</a><br/>Value Paradigm: <a href="http://doi.org/10.1001/jamaoncol.2021.3600" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2021.3600</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/423-access-to-cancer-medicines-standard-369</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1142069626</guid><pubDate>Fri, 15 Oct 2021 03:23:13 GMT</pubDate><enclosure length="84618873" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525313/74a980e4dd89e2f4eb684e503811dbc5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we're joined by a number of sp…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5289</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525313/df7f14a88e06ffb4a4c16733e53973f1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we're joined by a number of special guests: Dr. Christopher Booth and Dr. Adam Fundytus of Queen's University in Kingston, Ontario, Dr. Manju Sengar of the Tata Memorial Centre, and Dr. Aaron Goodman of the University of California at San Diego. We talk about their new papers: "Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey", "Practicing on the edge of oncology: when standard of care feels uncomfortable", and "Has the Current Oncology Value Paradigm Forgotten Patients’ Time? Too Little of a Good Thing". Cancer Medicines: doi.org/10.1016/S1470-2045(21)00463-0 Edge of Oncology: doi.org/10.1038/s41571-021-00550-9 Value Paradigm: doi.org/10.1001/jamaoncol.2021.3600 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.22 Honoring Dr. Elilhu Estey and His Decades-Long Oncology Career]]></title><description><![CDATA[On today's episode, in honor of him and in recognition of his passing, we have an old interview with Dr. Elihu Estey of the University of Washington on his 40 years of experience as an oncologist, the "Renaissance" of drugs for leukemia, and advice for trainees on how to approach career goals. This interview originally aired as episode 1.49. He will be missed. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/422-honoring-dr-elilhu-estey-and-2ae</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1140255658</guid><pubDate>Tue, 12 Oct 2021 05:24:04 GMT</pubDate><enclosure length="75343941" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525314/e9abaac1ea537d90a8acd8fa47651f82.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, in honor of him and in recogn…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4709</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525314/a5de2011db976a5392ea515410a73a27.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, in honor of him and in recognition of his passing, we have an old interview with Dr. Elihu Estey of the University of Washington on his 40 years of experience as an oncologist, the "Renaissance" of drugs for leukemia, and advice for trainees on how to approach career goals. This interview originally aired as episode 1.49. He will be missed. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.21 Cognitive Errors in Medical Decision-Making with Dr. Daniel Morgan & COVID-19 Policy]]></title><description><![CDATA[This week we take a break from #zercovid to give you another episode that's a deep dive into COVID-19. We start with an interview with epidemiologist and infectious disease expert Dr. Daniel Morgan of the University of Maryland School of Medicine; we talk about cognitive errors in medical decision-making and how it relates to COVID-19 health policy. After that, we have a series of thoughts for you on COVID vaccine mandates for schools, President Biden's vaccine plan, the FDA's vote on boosters, John Ioannidis' new paper on vaccinating students, the Pfizer results for vaccines in kids 5-11, and accepting that COVID is here to stay.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/421-cognitive-errors-in-medical-decision-995</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1129418497</guid><pubDate>Wed, 22 Sep 2021 23:00:04 GMT</pubDate><enclosure length="85722453" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525315/49de3f3445315374d91920c4761dc105.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we take a break from #zercovid to give …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5358</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525315/8cc4bd4b06c1df7bb0d0fc4eda9f3264.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we take a break from #zercovid to give you another episode that's a deep dive into COVID-19. We start with an interview with epidemiologist and infectious disease expert Dr. Daniel Morgan of the University of Maryland School of Medicine; we talk about cognitive errors in medical decision-making and how it relates to COVID-19 health policy. After that, we have a series of thoughts for you on COVID vaccine mandates for schools, President Biden's vaccine plan, the FDA's vote on boosters, John Ioannidis' new paper on vaccinating students, the Pfizer results for vaccines in kids 5-11, and accepting that COVID is here to stay. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.20 Vaccinating Kids and College Students, Boosters, Outdoor Masking, Bangladesh RCT, & more!]]></title><description><![CDATA[Today we take a brief break from our #zerocovid mantra to offer you our thoughts on current events. We cover a variety of topics, including: medical doctors in academia, cancelling conferences even for the vaccinated, masking 2-year-olds, equipoise, the CDC Georgia study, myocarditis, booster shots, outdoor masking at Duke, no more zero COVID in Australia, the Bangladesh cluster RCT on masks and its implications for kids in the USA, the resignation of two senior FDA officials, LA schools mandating vaccines, vaccinating college students, and more.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/420-vaccinating-kids-and-college-ff1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1124255149</guid><pubDate>Tue, 14 Sep 2021 04:11:18 GMT</pubDate><enclosure length="67380566" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525316/a73f7cb963770db28cb294776e48cf87.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we take a brief break from our #zerocovid m…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4211</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525316/385bca7d71e25a19dc08451d09d650ec.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we take a brief break from our #zerocovid mantra to offer you our thoughts on current events. We cover a variety of topics, including: medical doctors in academia, cancelling conferences even for the vaccinated, masking 2-year-olds, equipoise, the CDC Georgia study, myocarditis, booster shots, outdoor masking at Duke, no more zero COVID in Australia, the Bangladesh cluster RCT on masks and its implications for kids in the USA, the resignation of two senior FDA officials, LA schools mandating vaccines, vaccinating college students, and more. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.19 Censoring: Not on Facebook, but in Kaplan-Meier Curves]]></title><description><![CDATA[Today's episode is a lecture our host, Dr. Vinay Prasad of University of California San Francisco, gave recently on censoring patients in Kaplan-Meier plots.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/419-censoring-not-on-facebook-but-abc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1120805230</guid><pubDate>Wed, 08 Sep 2021 04:18:13 GMT</pubDate><enclosure length="29343355" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525317/06617781e13581b4164c5a51913613f0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today's episode is a lecture our host, Dr. Vinay …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1834</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525317/931cfed01a430607cf9030670cece6c2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today's episode is a lecture our host, Dr. Vinay Prasad of University of California San Francisco, gave recently on censoring patients in Kaplan-Meier plots. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.18 Dementia Interventions, Skills for Epidemiologists, & Aducanumab with Dr. Maria Glymour]]></title><description><![CDATA[Today we're joined by social epidemiologist, Dr. Maria Glymour of UCSF. We talk about her work in studying public health interventions for dementia and how her experience in academia has led to her conviction in the necessity of rigorous, quantitative technical skills training for epidemiology PhD students. We touch on how to have a good idea, her advice for PhD applicants, and working in a soft money (grants) vs hard money environment. Finally, we discuss her idea for a stepped-wedge trial approach to evaluate the new Alzheimer's drug, aducanumab. <br/><br/>Aducanumab: <a href="https://sites.bu.edu/melodem/files/2021/07/Pragmatic-Study-Designs-to-Accelerate-Aducanumab-Evidence_Glymour.pdf" class="linkified" target="_blank">https://sites.bu.edu/melodem/files/2021/07/Pragmatic-Study-Designs-to-Accelerate-Aducanumab-Evidence_Glymour.pdf</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/418-dementia-interventions-skills-7ea</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1116666118</guid><pubDate>Wed, 01 Sep 2021 02:10:38 GMT</pubDate><enclosure length="75251153" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525318/fef17b20be224405d8595a2d76bfeebb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we're joined by social epidemiologist, Dr. …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4703</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525318/de277d57156476bebb1393cd9abf2c6a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we're joined by social epidemiologist, Dr. Maria Glymour of UCSF. We talk about her work in studying public health interventions for dementia and how her experience in academia has led to her conviction in the necessity of rigorous, quantitative technical skills training for epidemiology PhD students. We touch on how to have a good idea, her advice for PhD applicants, and working in a soft money (grants) vs hard money environment. Finally, we discuss her idea for a stepped-wedge trial approach to evaluate the new Alzheimer's drug, aducanumab. Aducanumab: https://sites.bu.edu/melodem/files/2021/07/Pragmatic-Study-Designs-to-Accelerate-Aducanumab-Evidence_Glymour.pdf Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin]]></title><description><![CDATA[We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting FDA approval of cancer drugs. The second is with Dr. Ghulam Rehman "Manni" Mohyuddin of the University of Utah on a variety of myeloma studies, including LIGHTHOUSE, OCEANS, and HORIZON.<br/><br/>Feasibility of RCTs: <a href="http://doi.org/10.1093/jncics/pkab061" class="linkified" target="_blank">doi.org/10.1093/jncics/pkab061</a><br/>RR of Alternative Treatments: <a href="http://doi.org/10.1002/ijc.33231" class="linkified" target="_blank">doi.org/10.1002/ijc.33231</a><br/>Study Time Reduction: <a href="http://doi.org/10.1001/jamainternmed.2018.8351" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2018.8351</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/417-rcts-for-cancer-drug-approval-50f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1113809212</guid><pubDate>Fri, 27 Aug 2021 04:42:47 GMT</pubDate><enclosure length="56667852" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525319/4607f1371371d01452b86800d3ac4a8a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have two oncology conversations for you today.…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3542</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525319/b16e5d559c813bf790c7a8d4dbc888c5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting FDA approval of cancer drugs. The second is with Dr. Ghulam Rehman "Manni" Mohyuddin of the University of Utah on a variety of myeloma studies, including LIGHTHOUSE, OCEANS, and HORIZON. Feasibility of RCTs: doi.org/10.1093/jncics/pkab061 RR of Alternative Treatments: doi.org/10.1002/ijc.33231 Study Time Reduction: doi.org/10.1001/jamainternmed.2018.8351 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.16 Treating Lymphoma, Histiocytic Disorders, Learning by Teaching, & More! with Dr. Bita Fakhri]]></title><description><![CDATA[Today we interview Dr. Bita Fakhri of UCSF on the current research behind treatments for lymphoma. We touch on CAR-T, ABVD, DA-EPOCH-R, and more. We also talk about histiocytic disorders, Dr. Fakhri's career in academia, and learning through teaching.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/416-treating-lymphoma-histiocytic-dd2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1110362128</guid><pubDate>Sat, 21 Aug 2021 20:07:38 GMT</pubDate><enclosure length="62409357" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525320/006a9b9f18b8c6222428fa4991bef0f5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Bita Fakhri of UCSF on the…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3901</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525320/bcbae9dc3622868edb8f337ef677a165.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Bita Fakhri of UCSF on the current research behind treatments for lymphoma. We touch on CAR-T, ABVD, DA-EPOCH-R, and more. We also talk about histiocytic disorders, Dr. Fakhri's career in academia, and learning through teaching. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.15 #AllCOVID-19: the Tough Questions About Policies Concerning the Delta Variant of COVID-19]]></title><description><![CDATA[Today we're compiling all our recent monologues on COVID-19. That's right -- we're taking a break from #zerocovid to give you an episode that's #allcovid! We cover a whole range of news and opinions covering the Delta variant. We give an evidence-based-medicine doctor's take on the question: Are RCTs necessary in the age of COVID19? We also talk about how the American Academy of Pediatrics (AAP) lost the narrative. We detail how America failed kids because the AAP, CDC, & the teachers unions all hate Trump more than they love kids. We cover vaccine boosters: are they justified? Is there enough evidence? We detail how to run a randomized controlled trial of a policy intervention. And, finally, we confront the New York Times opinion article "Actually, Wearing a Mask Can Help Your Child Learn". We confront the tough questions: Do children really need to see faces? Why do we even have faces?<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/415-allcovid-19-the-tough-questions-4ef</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1108540267</guid><pubDate>Thu, 19 Aug 2021 03:04:11 GMT</pubDate><enclosure length="40589380" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525321/ba794987e95d45c199abd3ae67785ff6.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we're compiling all our recent monologues o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2537</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525321/a4db720af5af30667c13ce96f42d9f03.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we're compiling all our recent monologues on COVID-19. That's right -- we're taking a break from #zerocovid to give you an episode that's #allcovid! We cover a whole range of news and opinions covering the Delta variant. We give an evidence-based-medicine doctor's take on the question: Are RCTs necessary in the age of COVID19? We also talk about how the American Academy of Pediatrics (AAP) lost the narrative. We detail how America failed kids because the AAP, CDC, &amp; the teachers unions all hate Trump more than they love kids. We cover vaccine boosters: are they justified? Is there enough evidence? We detail how to run a randomized controlled trial of a policy intervention. And, finally, we confront the New York Times opinion article "Actually, Wearing a Mask Can Help Your Child Learn". We confront the tough questions: Do children really need to see faces? Why do we even have faces? Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.14 Evolution of GI Cancer Therapy, Editing JCO, Advice for Clinical Trialists with Dr. Alan Venook]]></title><description><![CDATA[Today we interview Dr. Alan Venook of UCSF, a renowned expert in clinical trial design and gastrointestinal malignancies. We talk about the evolution of the treatment for colorectal cancer over the last few decades, starting with 5FU. We also discuss his time working as an editor for the Journal of Clinical Oncology and we talk about his advice for budding clinical trialists. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/414-evolution-of-gi-cancer-therapy-851</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1104243946</guid><pubDate>Wed, 11 Aug 2021 19:40:55 GMT</pubDate><enclosure length="65661079" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525322/ad63f39d13432776624ca54b54a780c5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Alan Venook of UCSF, a ren…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4104</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525322/ebb6dc9fb6c8355bc5b5b89cfb34eb30.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Alan Venook of UCSF, a renowned expert in clinical trial design and gastrointestinal malignancies. We talk about the evolution of the treatment for colorectal cancer over the last few decades, starting with 5FU. We also discuss his time working as an editor for the Journal of Clinical Oncology and we talk about his advice for budding clinical trialists.  Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.13 Lessons from Publishing 300 Peer-Reviewed Papers & What Telemedicine Will Do to Cancer Care]]></title><description><![CDATA[We have two short thinkpieces for you. The first is on the lessons that can be learned, or have been learned along the way, from publishing 300 peer-reviewed papers in medical/scientific journals. The second is on the recent publication with Jenny Gill out now in the International Journal of Cancer, titled "After COVID-19, telemedicine may be used in addition to usual care and not in lieu of: Implications for health systems".<br/><br/>Telemedicine: <a href="http://doi.org/10.1002/ijc.33752" class="linkified" target="_blank">doi.org/10.1002/ijc.33752</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/413-lessons-from-publishing-300-peer-e08</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1101541267</guid><pubDate>Fri, 06 Aug 2021 21:46:42 GMT</pubDate><enclosure length="14270490" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525323/860ade6fe66bd1f09c61edd5236f2f23.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have two short thinkpieces for you. The first …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>892</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525323/c4bc4c870185f708ef0affe21c3ea735.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have two short thinkpieces for you. The first is on the lessons that can be learned, or have been learned along the way, from publishing 300 peer-reviewed papers in medical/scientific journals. The second is on the recent publication with Jenny Gill out now in the International Journal of Cancer, titled "After COVID-19, telemedicine may be used in addition to usual care and not in lieu of: Implications for health systems". Telemedicine: doi.org/10.1002/ijc.33752 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier]]></title><description><![CDATA[Today we interview Dr. Josee-Lyne Ethier of Queen's University in Kingston, Ontario, Canada on her new paper "Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer", out now in JAMA Oncology. We talk about the real-world survival outcomes for pertuzumab and T-DM1, comparing these outcomes to the results of pivotal clinical trials CLEOPATRA and EMILIA. <br/><br/>Practice Patterns and Outcomes: <a href="http://doi.org/10.1001/jamaoncol.2021.2140" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2021.2140</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/412-real-world-survival-outcomes-f24</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1099603714</guid><pubDate>Tue, 03 Aug 2021 22:42:38 GMT</pubDate><enclosure length="34414031" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525324/681dcb5a56431b43eb911d0a1046e021.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Josee-Lyne Ethier of Queen…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2151</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525324/3fea45f77ea85c3b7ef1fc7d5b4220ed.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Josee-Lyne Ethier of Queen's University in Kingston, Ontario, Canada on her new paper "Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer", out now in JAMA Oncology. We talk about the real-world survival outcomes for pertuzumab and T-DM1, comparing these outcomes to the results of pivotal clinical trials CLEOPATRA and EMILIA. Practice Patterns and Outcomes: doi.org/10.1001/jamaoncol.2021.2140 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain]]></title><description><![CDATA[Today's episode is a compilation of a few short monologues. We provide an oncologist's evidence-based medicine perspective on four papers: CheckMate 274, adjuvant nivolumab in urothelial cancer; PARADIGM-HF/Entresto; the POLO trial, olaparib in pancreas cancer; and the paper "An algorithmic approach to reducing unexplained pain disparities in underserved populations".<br/><br/>CheckMate 274: <a href="http://doi.org/10.1056/NEJMoa2034442" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2034442</a><br/>PARADIGM-HF: <a href="http://doi.org/10.1056/nejmoa1409077" class="linkified" target="_blank">doi.org/10.1056/nejmoa1409077</a><br/>POLO: <a href="http://doi.org/10.1056/NEJMoa1903387" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903387</a><br/>Knee pain: <a href="http://doi.org/10.1038/s41591-020-01192-7" class="linkified" target="_blank">doi.org/10.1038/s41591-020-01192-7</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/411-checkmate-274-paradigm-hfernesto-84a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1097398177</guid><pubDate>Sat, 31 Jul 2021 01:53:36 GMT</pubDate><enclosure length="52139262" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525325/bf76bf4a50ed07f6d5aa86df1267c99c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today's episode is a compilation of a few short m…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3259</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525325/7dba92d78d9e83bc796dfe83004ba675.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today's episode is a compilation of a few short monologues. We provide an oncologist's evidence-based medicine perspective on four papers: CheckMate 274, adjuvant nivolumab in urothelial cancer; PARADIGM-HF/Entresto; the POLO trial, olaparib in pancreas cancer; and the paper "An algorithmic approach to reducing unexplained pain disparities in underserved populations". CheckMate 274: doi.org/10.1056/NEJMoa2034442 PARADIGM-HF: doi.org/10.1056/nejmoa1409077 POLO: doi.org/10.1056/NEJMoa1903387 Knee pain: doi.org/10.1038/s41591-020-01192-7 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien]]></title><description><![CDATA[Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial, which pitted first-line nivolumab plus chemotherapy against chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma.<br/><br/>CheckMate 649: <a href="http://doi.org/10.1016/S0140-6736(21)00797-2" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(21)00797-2</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/410-a-deep-dive-into-checkmate-649-078</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1095377119</guid><pubDate>Wed, 28 Jul 2021 02:00:59 GMT</pubDate><enclosure length="56619784" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525326/cc145f6382188436e4649161f256943d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down (in person!) with Dr. Jeff Bien…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3539</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525326/5e70ae43987b8e5fdd741138a08a98c9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial, which pitted first-line nivolumab plus chemotherapy against chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma. CheckMate 649: doi.org/10.1016/S0140-6736(21)00797-2 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma]]></title><description><![CDATA[Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients".<br/><br/>Fecal transplant: <a href="http://doi.org/10.1126/science.abb5920" class="linkified" target="_blank">doi.org/10.1126/science.abb5920</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/409-problems-with-the-vision-trial-ad0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1092952834</guid><pubDate>Fri, 23 Jul 2021 19:18:42 GMT</pubDate><enclosure length="25580463" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525327/acd40afaa4e82cffaac983210cbcb6a9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have two short monologues for you on rec…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1599</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525327/e36ad33ae565b78cf30f88de31a50e21.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients". Fecal transplant: doi.org/10.1126/science.abb5920 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021]]></title><description><![CDATA[In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval"<br/><br/>ODAC Votes: <a href="http://doi.org/10.1001/jamaoncol.2021.3046" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2021.3046</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/408-implications-for-the-fate-of-424</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1088975539</guid><pubDate>Fri, 16 Jul 2021 23:20:50 GMT</pubDate><enclosure length="11058472" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525328/991b418666b3106c428c97c3e76d5f63.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In today's quick episode, we talk about our new p…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>691</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525328/77962367c303e60c39ba11fafb5fbddb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval" ODAC Votes: doi.org/10.1001/jamaoncol.2021.3046 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad]]></title><description><![CDATA[We have a reverse episode for you today! Emma Greenstreet, a second-year medical student at UCSF, interviews our usual host, Dr. Vinay Prasad on why and how he chose hematology/oncology as a specialty, engaging with criticism, mentorship, medical student rotations, choosing a research project, and urging doctors in academia to aim higher. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/407-questions-from-a-medical-student-167</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1084798549</guid><pubDate>Fri, 09 Jul 2021 22:19:51 GMT</pubDate><enclosure length="47064819" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525329/27e57a5a989b38af27640bc2e2c10f72.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a reverse episode for you today! Emma Gre…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2942</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525329/cf53d5b0fea4e9c5468d2aafd55a146b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a reverse episode for you today! Emma Greenstreet, a second-year medical student at UCSF, interviews our usual host, Dr. Vinay Prasad on why and how he chose hematology/oncology as a specialty, engaging with criticism, mentorship, medical student rotations, choosing a research project, and urging doctors in academia to aim higher. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee]]></title><description><![CDATA[We sat down in person with Dr. Rahul Banerjee, a BMT/CAR-T fellow at UCSF, to talk about all manner of topics including CAR-T, randomized trials in oncology (and, specifically, Dr. Banerjee's two recent papers out now), social media, treating Multiple Myeloma, and how people make career decisions. <br/><br/>What Oncologists Can Learn From COVID-19: <a href="http://doi.org/10.1038/s41571-020-00448-y" class="linkified" target="_blank">doi.org/10.1038/s41571-020-00448-y</a><br/>Are Observational, Real-World Studies Suitable: <a href="http://doi.org/10.1001/jamanetworkopen.2020.12119" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2020.12119</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/406-car-t-oncology-rcts-social-media-b15</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1084053544</guid><pubDate>Thu, 08 Jul 2021 18:54:09 GMT</pubDate><enclosure length="88049479" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525330/df44861f6c55e60c654394303a590dc4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We sat down in person with Dr. Rahul Banerjee, a …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5503</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525330/eb69d09b928d084c64dec2aef10237e0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We sat down in person with Dr. Rahul Banerjee, a BMT/CAR-T fellow at UCSF, to talk about all manner of topics including CAR-T, randomized trials in oncology (and, specifically, Dr. Banerjee's two recent papers out now), social media, treating Multiple Myeloma, and how people make career decisions. What Oncologists Can Learn From COVID-19: doi.org/10.1038/s41571-020-00448-y Are Observational, Real-World Studies Suitable: doi.org/10.1001/jamanetworkopen.2020.12119 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari]]></title><description><![CDATA[Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/405-exodus-from-academia-and-the-79d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1082865277</guid><pubDate>Wed, 07 Jul 2021 02:03:13 GMT</pubDate><enclosure length="51139503" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525331/51daf8604bc373a4b9d6e2588d3c968f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we are joined by Dr. Ameet Sarpatwari of Ha…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3196</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525331/265ea04bf8086b7fb65e5a103a8980d8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs]]></title><description><![CDATA[Today we have a short monologue for you on just a few topics: a treatment algorithm for follicular lymphoma and our host Dr. Prasad's new paper out now in the European Journal of Clinical Investigation: "Reliable, cheap, fast and few: What is the best study for assessing medical practices? Randomized controlled trials or synthetic control arms?"<br/><br/>RCTs or Synthetic Control Arms?: <a href="http://doi.org/10.1111/eci.13580" class="linkified" target="_blank">doi.org/10.1111/eci.13580</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/404-treatment-algorithm-for-follicular-b70</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1076142880</guid><pubDate>Sat, 26 Jun 2021 00:14:41 GMT</pubDate><enclosure length="29359650" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525332/ae11d3b7cebac1c1dad233cecaa4c700.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have a short monologue for you on just a…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1835</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525332/69ad3394a9b3dc350d0533da8d780f07.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have a short monologue for you on just a few topics: a treatment algorithm for follicular lymphoma and our host Dr. Prasad's new paper out now in the European Journal of Clinical Investigation: "Reliable, cheap, fast and few: What is the best study for assessing medical practices? Randomized controlled trials or synthetic control arms?" RCTs or Synthetic Control Arms?: doi.org/10.1111/eci.13580 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.03 Multiple Myeloma, Productivity Metrics, and Field Changes in Oncology with Dr. Nina Shah]]></title><description><![CDATA[Today we're back with another real-life (non-virtual!) interview. We're joined by Dr. Nina Shah of UCSF to discuss her career and her work in mutiple myeloma as well as the complexities of advancing your career -- dealing with productivity metrics like the h-index or the Kardashian index, switching institutions, balancing work with your home life, adapting to the changing field of oncology, and more. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/403-multiple-myeloma-productivity-78b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1071338164</guid><pubDate>Fri, 18 Jun 2021 15:36:52 GMT</pubDate><enclosure length="66656656" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525333/dd97e2b9fd99a12dd682304478a9d583.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we're back with another real-life (non-virt…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4166</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525333/21b3a13509b958e84cd3e2221a6d08a5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we're back with another real-life (non-virtual!) interview. We're joined by Dr. Nina Shah of UCSF to discuss her career and her work in mutiple myeloma as well as the complexities of advancing your career -- dealing with productivity metrics like the h-index or the Kardashian index, switching institutions, balancing work with your home life, adapting to the changing field of oncology, and more. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.02 The History of Breast Cancer Research and Treatment with Dr. George Sledge]]></title><description><![CDATA[Today we sit down with Dr. George Sledge of the Stanford University Medical Center to hear the story of his career and to discuss the history of breast cancer research and treatment.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/402-the-history-of-breast-cancer-c2b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1068549949</guid><pubDate>Tue, 15 Jun 2021 02:28:58 GMT</pubDate><enclosure length="99472303" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525334/70816a268a8aa251b1e97144bd7c87be.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. George Sledge of the S…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6217</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525334/422e28ed9936f310886b690be4a6d65a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. George Sledge of the Stanford University Medical Center to hear the story of his career and to discuss the history of breast cancer research and treatment. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[4.01 Highlights from the 2021 ASCO Annual Meeting]]></title><description><![CDATA[Today we're launching season 4 of Plenary Session! This season we're returning to our love of monologues. On today's episode we talk about highlights from the recent annual meeting of the American Society of Clinical Oncology. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/401-highlights-from-the-2021-asco-8bf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1066823395</guid><pubDate>Fri, 11 Jun 2021 22:44:01 GMT</pubDate><enclosure length="47970955" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525335/b6d045d2e435e0082ba6660737d7ce41.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we're launching season 4 of Plenary Session…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2998</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525335/745832c80f9ab5740db28d3133bb0c67.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we're launching season 4 of Plenary Session! This season we're returning to our love of monologues. On today's episode we talk about highlights from the recent annual meeting of the American Society of Clinical Oncology. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.90 Redesigning Health Care, Overuse, Burnout, and COVID-19 Groupthink with Dr. Marty Makary]]></title><description><![CDATA[On today's episode, we interview Dr. Marty Makary of Johns Hopkins School of Medicine and Bloomberg School of Public Health on how he chose his path in medicine, how health care as it is in the United States needs to change, and how groupthink dominated COVID-19 health policy. We discuss a variety of topics from his research on overuse, the prevalence of burnout in healthcare professionals, silos in medicine, to patients' lawsuits against hospitals. We touch on his two books, the latter of which has a new edition coming out next month that addresses COVID-19: Unaccountable: What Hospitals Won't Tell You and How Transparency Can Revolutionize Health Care, and "The Price We Pay: What Broke American Health Care--and How to Fix It".<br/><br/>Unaccountable: <a href="https://www.bloomsbury.com/us/unaccountable-9781608198368/" class="linkified" target="_blank">https://www.bloomsbury.com/us/unaccountable-9781608198368/</a><br/>The Price We Pay: <a href="https://www.bloomsbury.com/us/the-price-we-pay-9781635575910/" class="linkified" target="_blank">https://www.bloomsbury.com/us/the-price-we-pay-9781635575910/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/390-redesigning-health-care-overuse-028</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1055651080</guid><pubDate>Fri, 04 Jun 2021 19:00:01 GMT</pubDate><enclosure length="73001277" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525336/e1cfc5af8033e5f73467d5dce22ea1c3.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, we interview Dr. Marty Makary…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4563</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525336/e65fc3072b899c8dfc8338ad04dd05e4.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, we interview Dr. Marty Makary of Johns Hopkins School of Medicine and Bloomberg School of Public Health on how he chose his path in medicine, how health care as it is in the United States needs to change, and how groupthink dominated COVID-19 health policy. We discuss a variety of topics from his research on overuse, the prevalence of burnout in healthcare professionals, silos in medicine, to patients' lawsuits against hospitals. We touch on his two books, the latter of which has a new edition coming out next month that addresses COVID-19: Unaccountable: What Hospitals Won't Tell You and How Transparency Can Revolutionize Health Care, and "The Price We Pay: What Broke American Health Care--and How to Fix It". Unaccountable: https://www.bloomsbury.com/us/unaccountable-9781608198368/ The Price We Pay: https://www.bloomsbury.com/us/the-price-we-pay-9781635575910/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.89 How to Think About COVID-19 Policy with Rare Events and Declining Probabilities]]></title><description><![CDATA[Today we have a brief monologue for you on how to think about COVID-19 policy in the context of rare event and declining probabilities. We also touch on what to expect from season 4 of this podcast, as season 3 comes to an end. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/389-how-to-think-about-covid-19-policy-588</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1055759479</guid><pubDate>Thu, 03 Jun 2021 19:00:01 GMT</pubDate><enclosure length="26847716" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525337/eacd2d505cee94d3b680848d7acee067.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have a brief monologue for you on how to…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1678</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525337/de904af0cfd7c3033ebd5636a9b66499.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have a brief monologue for you on how to think about COVID-19 policy in the context of rare event and declining probabilities. We also touch on what to expect from season 4 of this podcast, as season 3 comes to an end. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.88 Behind the Scenes for the One-Year Anniversary of Malignant with Dr. Vinay Prasad]]></title><description><![CDATA[Today's episode is hosted by guest Logan Powell, an incoming medical student at the Texas A&M College of Medicine and creator of this podcast's show notes. He reverse interviews our usual host, Dr. Vinay Prasad, in honor of the one-year anniversary release of Dr. Prasad's book "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer". They explore a few behind-the-scenes stories.<br/><br/>Show notes: <a href="http://www.plenarysessionpodcast.com" class="linkified" target="_blank">www.plenarysessionpodcast.com</a><br/><br/>Listen to Malignant with a free 30-day trial of Audible: <a href="http://www.audible.com/pd/B08864KFHW/?so…ACX0_195112_rh_us" class="linkified" target="_blank">www.audible.com/pd/B08864KFHW/?so…ACX0_195112_rh_us</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/388-behind-the-scenes-for-the-one-fbc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1055531041</guid><pubDate>Wed, 02 Jun 2021 19:00:01 GMT</pubDate><enclosure length="74890034" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525338/556282df2f6a9669c17d04215c4d3c9d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today's episode is hosted by guest Logan Powell, …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4681</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525338/cada19d6899e3c180a3f1a76d18625cf.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today's episode is hosted by guest Logan Powell, an incoming medical student at the Texas A&amp;M College of Medicine and creator of this podcast's show notes. He reverse interviews our usual host, Dr. Vinay Prasad, in honor of the one-year anniversary release of Dr. Prasad's book "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer". They explore a few behind-the-scenes stories. Show notes: www.plenarysessionpodcast.com Listen to Malignant with a free 30-day trial of Audible: www.audible.com/pd/B08864KFHW/?so…ACX0_195112_rh_us Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.87 Round Table on Multiple Myeloma Initial Therapy, High Risk, and Maintenance]]></title><description><![CDATA[Today we try something new. We're joined by five esteemed multiple myeloma experts for a back-and-forth round table discussion on the disease, including initial therapy, high risk, and maintenance. Our guests are Dr. Raj Chakraborty of Columbia University, Dr. Sam Rubinstein of the University of North Carolina Chapel Hill, Dr. Manni Mohyuddin of the University of Utah, Dr. Ben Derman of the University of Chicago, and Dr. Kevin Knopf of Highland Hospital. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/387-round-table-on-multiple-myeloma-6cf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1055419309</guid><pubDate>Mon, 31 May 2021 19:00:03 GMT</pubDate><enclosure length="61329347" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525339/4d8904ffc68b949e791531643ed2b4ef.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we try something new. We're joined by five …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3833</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525339/e0e8fb9fd3babf4b9dbc867203cb34d6.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we try something new. We're joined by five esteemed multiple myeloma experts for a back-and-forth round table discussion on the disease, including initial therapy, high risk, and maintenance. Our guests are Dr. Raj Chakraborty of Columbia University, Dr. Sam Rubinstein of the University of North Carolina Chapel Hill, Dr. Manni Mohyuddin of the University of Utah, Dr. Ben Derman of the University of Chicago, and Dr. Kevin Knopf of Highland Hospital. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.86 Lenvatinib plus Pembrolizumab or Everolimus for Advanced RCC with Dr. Karine Tawagi]]></title><description><![CDATA[Today we bring back our popular Journal Club with a Fellow segment. We're joined by Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the CLEAR trial: "Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma" as published in the New England Journal of Medicine. <br/><br/>CLEAR: <a href="http://doi.org/10.1056/NEJMoa2035716" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2035716</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/386-lenvatinib-plus-pembrolizumab-20d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1055374339</guid><pubDate>Fri, 28 May 2021 19:00:03 GMT</pubDate><enclosure length="33299751" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525340/35b4e7d33f90409dd43ca40e26df2265.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we bring back our popular Journal Club with…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2081</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525340/c6144d672b0548668db08a069ba0d13b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we bring back our popular Journal Club with a Fellow segment. We're joined by Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the CLEAR trial: "Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma" as published in the New England Journal of Medicine. CLEAR: doi.org/10.1056/NEJMoa2035716 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.85 Med-Psych, Palliative Care, and Respect for Autonomy and Dignity with Dr. Joshua Briscoe]]></title><description><![CDATA[Our guest today is Dr. Joshua Briscoe of Duke University. We discuss Med-Psych (a joint internal medicine and psychiatry residency) and how it and palliative care connect to the human side to medicine: providing the care for quality of life and dignity that patients actually need, from comfortable bedding to physician-assisted suicide.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/385-med-psych-palliative-care-and-708</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1054909291</guid><pubDate>Thu, 27 May 2021 19:00:03 GMT</pubDate><enclosure length="44753922" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525341/21bfdfd789b84cac0ac99dfc3603349f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Our guest today is Dr. Joshua Briscoe of Duke Uni…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2797</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525341/bb883ae8c6fd4e0339ca95a3e84a365c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Our guest today is Dr. Joshua Briscoe of Duke University. We discuss Med-Psych (a joint internal medicine and psychiatry residency) and how it and palliative care connect to the human side to medicine: providing the care for quality of life and dignity that patients actually need, from comfortable bedding to physician-assisted suicide. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman]]></title><description><![CDATA[We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to discuss diffuse large B-cell lymphoma (DLBCL). We talk about bad cancer drugs and bad Twitter users.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/384-dlbcl-bad-cancer-drugs-and-bad-87c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1054847695</guid><pubDate>Wed, 26 May 2021 19:00:00 GMT</pubDate><enclosure length="68671218" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525343/31493479f096d0ca83bffa879247ccd0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're joined today by Dr. Aaron Goodman, a hemato…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4292</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525343/e3ab8973015617fdc97782f67d099916.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to discuss diffuse large B-cell lymphoma (DLBCL). We talk about bad cancer drugs and bad Twitter users. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.83 MetaResearch, Reproducibility, Expertise, & Early Career Researchers with Dr. Ioana Cristea]]></title><description><![CDATA[Today we sit down with Dr. Ioana Cristea of the University of Pavia, Italy and the Meta-Research Innovation Center at Stanford to discuss meta-research, reproducibility, and expertise. We also talk about our shared experiences as "early career researchers" (ECRs), also known as Early Stage Investigators, a term coined by the National Institutes of Health to describe researchers who earned their last research degree less than 10 years ago.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/383-metaresearch-reproducibility-b90</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1054835332</guid><pubDate>Tue, 25 May 2021 19:00:00 GMT</pubDate><enclosure length="74388064" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525344/3c557aabae3589e0d41069ebe0afd838.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Ioana Cristea of the U…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4649</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525344/184e976faf3c99ac7614bdaeb4718679.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Ioana Cristea of the University of Pavia, Italy and the Meta-Research Innovation Center at Stanford to discuss meta-research, reproducibility, and expertise. We also talk about our shared experiences as "early career researchers" (ECRs), also known as Early Stage Investigators, a term coined by the National Institutes of Health to describe researchers who earned their last research degree less than 10 years ago. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.82 Classical Hematology Chat on CVT and VITT with Drs. Sven Olson and Joseph Shatzel]]></title><description><![CDATA[Today we host a Classical Hematology Chat on thrombosis associated with COVID-19 vaccines. We're joined by Drs. Sven Olson and Joseph Shatzel of Oregon Health & Science University as we talk about cerebral venous thrombosis (CVT) and vaccine-induced immune thrombotic thrombocytopenia (VITT).<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/382-classical-hematology-chat-on-c6d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1053196318</guid><pubDate>Mon, 24 May 2021 19:00:00 GMT</pubDate><enclosure length="44491444" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525345/3c279fcfbb7ab375a3e1706a16707c24.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we host a Classical Hematology Chat on thro…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2781</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525345/2481c51ad1be65407e44973089fc6414.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we host a Classical Hematology Chat on thrombosis associated with COVID-19 vaccines. We're joined by Drs. Sven Olson and Joseph Shatzel of Oregon Health &amp; Science University as we talk about cerebral venous thrombosis (CVT) and vaccine-induced immune thrombotic thrombocytopenia (VITT). Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.81 Impact of COVID-19 on Sociology, Politics, and Democracy with Genève Campbell]]></title><description><![CDATA[Today we are joined by Genève Campbell, scholar of democracy and government, as we discuss sociology and politics in the context of COVID-19.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/381-impact-of-covid-19-on-sociology-b8b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1052518057</guid><pubDate>Fri, 21 May 2021 19:00:20 GMT</pubDate><enclosure length="73887767" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525346/8163789cd174d3d7bcc53675651a7a04.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we are joined by Genève Campbell, scholar o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4618</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525346/6195067dcd4c323f1ea555972ca203eb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we are joined by Genève Campbell, scholar of democracy and government, as we discuss sociology and politics in the context of COVID-19. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.80 ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) with Drs. Bishal Gyawali and Nathan Cherny]]></title><description><![CDATA[Today we sit down with Dr. Bishal Gyawali of Queen's University in Kingston, Ontario, Canada and with Dr. Nathan Cherny of Shaare Zedek Medical Center in Jerusalem, Israel to talk about the European Society of Medical Oncology (ESMO) and the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS), which aims to improve cancer therapy decision-making. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/380-esmo-magnitude-of-clinical-benefit-352</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1051867018</guid><pubDate>Thu, 20 May 2021 19:00:10 GMT</pubDate><enclosure length="52236227" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525347/d32a75ed6258f4a499712903f4d71682.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Bishal Gyawali of Quee…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3265</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525347/ef074ebc0db7469253ef2102175b2d34.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Bishal Gyawali of Queen's University in Kingston, Ontario, Canada and with Dr. Nathan Cherny of Shaare Zedek Medical Center in Jerusalem, Israel to talk about the European Society of Medical Oncology (ESMO) and the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS), which aims to improve cancer therapy decision-making. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.79 Sweden's Stance on COVID-19, Hydroxychloroquine, Schools, & Mask Data with Dr. Cathrine Axfors]]></title><description><![CDATA[On today's episode, we sit down with Dr. Cathrine Axfors of the Meta-Research Innovation Center at Stanford (METRICS) to discuss how Sweden responded to COVID-19 and the nation's attention to what policies would be sustainable. We also touch on her paper "Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials" as well as school closures, data to support mask policies, and more!<br/><br/>Hydroxychloroquine: <a href="http://doi.org/10.1038/s41467-021-22446-z" class="linkified" target="_blank">doi.org/10.1038/s41467-021-22446-z</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/379-swedens-stance-on-covid-19-hydroxychloroquin-ea1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1050591466</guid><pubDate>Wed, 19 May 2021 19:00:00 GMT</pubDate><enclosure length="66366591" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525348/340a345fbe28bb2059062ce934bade1f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, we sit down with Dr. Cathrine…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4148</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525348/5db900f29ba687725d2c287aa6f5fca5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, we sit down with Dr. Cathrine Axfors of the Meta-Research Innovation Center at Stanford (METRICS) to discuss how Sweden responded to COVID-19 and the nation's attention to what policies would be sustainable. We also touch on her paper "Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials" as well as school closures, data to support mask policies, and more! Hydroxychloroquine: doi.org/10.1038/s41467-021-22446-z Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.78 Astronomy, Being a Scientist, and the Culture of the Academy with Dr. Avi Loeb]]></title><description><![CDATA[Today we talk with Dr. Avi Loeb of the Harvard-Smithsonian Center for Astrophysics about astronomy and the culture of the academy, as well as diving into topics discussed in his new book Extraterrestrial: The First Sign of Intelligent Life Beyond Earth.<br/><br/>Extraterrestrial: <a href="https://www.hmhbooks.com/shop/books/Extraterrestrial/9780358274551" class="linkified" target="_blank">https://www.hmhbooks.com/shop/books/Extraterrestrial/9780358274551</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/378-astronomy-being-a-scientist-and-86d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1050552148</guid><pubDate>Tue, 18 May 2021 19:00:16 GMT</pubDate><enclosure length="58278245" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525349/bd805882f854f7131c5df39f467124ce.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we talk with Dr. Avi Loeb of the Harvard-Sm…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3642</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525349/1c4de8f6d7249d311b1a15a85e17c7d8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we talk with Dr. Avi Loeb of the Harvard-Smithsonian Center for Astrophysics about astronomy and the culture of the academy, as well as diving into topics discussed in his new book Extraterrestrial: The First Sign of Intelligent Life Beyond Earth. Extraterrestrial: https://www.hmhbooks.com/shop/books/Extraterrestrial/9780358274551 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe]]></title><description><![CDATA[Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases.<br/><br/>Race Reporting: <a href="http://doi.org/10.1038/s41391-021-00361-0" class="linkified" target="_blank">doi.org/10.1038/s41391-021-00361-0</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/377-reporting-of-race-in-us-fda-registration-c56</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1048463575</guid><pubDate>Mon, 17 May 2021 19:00:06 GMT</pubDate><enclosure length="24874111" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525376/593935b4ea233b4c9c865ffba2cea2d0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we talk with Dr. Mark Lythgoe, a Clinical R…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1555</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525376/43a71c59fda2e6df45a0a3cd7bd6e166.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases. Race Reporting: doi.org/10.1038/s41391-021-00361-0 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.76 COVID-19 Transmission in Schools with Dr. Christopher Whaley and Dr. Neeraj Sood]]></title><description><![CDATA[On today's episode, we invite Dr. Chris Whaley of RAND and Dr. Neeraj Sood of the USC Price School of Public Policy to discuss their new paper titled "Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission", out now in the National Bureau of Economic Research.<br/><br/>Back to School: <a href="http://doi.org/10.3386/w28645" class="linkified" target="_blank">doi.org/10.3386/w28645</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/376-covid-19-transmission-in-schools-eb8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1048456936</guid><pubDate>Fri, 14 May 2021 19:00:26 GMT</pubDate><enclosure length="41536054" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525377/aebbf29fbcc6c373eb872a09e522c0a5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, we invite Dr. Chris Whaley of…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2596</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525377/bbc781aed651c92a15ca9415a867f571.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, we invite Dr. Chris Whaley of RAND and Dr. Neeraj Sood of the USC Price School of Public Policy to discuss their new paper titled "Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission", out now in the National Bureau of Economic Research. Back to School: doi.org/10.3386/w28645 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.75 All Things COVID-19 with Infectious Disease Professor Dr. Paul Edward Sax]]></title><description><![CDATA[Today our guest is Dr. Paul Edward Sax, Clinical Director of the Infectious Disease Clinic and Professor of Medicine at Harvard Medical School. We talk about all things COVID-19.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/375-all-things-covid-19-with-infectious-851</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1048449007</guid><pubDate>Fri, 14 May 2021 01:23:04 GMT</pubDate><enclosure length="79820698" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525378/eca13c6038fca606673bbb68a0262dcd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today our guest is Dr. Paul Edward Sax, Clinical …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4989</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525378/e1694ef4e3ba90878fc8f9a39724ccef.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today our guest is Dr. Paul Edward Sax, Clinical Director of the Infectious Disease Clinic and Professor of Medicine at Harvard Medical School. We talk about all things COVID-19. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.74 Artificial Intelligence in Dermatology with Dr. Roxana Daneshjou]]></title><description><![CDATA[On today's episode, we interview Dr. Roxana Daneshjou, a clinical scholar in dermatology and postdoctoral research fellow at Stanford University. We talk about artificial intelligence in dermatology and beyond.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/374-artificial-intelligence-in-dermatology-5aa</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1047953965</guid><pubDate>Thu, 13 May 2021 05:00:04 GMT</pubDate><enclosure length="41588299" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525379/6d143e3e84de14b71da72870ee8052e7.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, we interview Dr. Roxana Danes…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2599</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525379/c53c1309d4be6d0766a4463079f14023.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, we interview Dr. Roxana Daneshjou, a clinical scholar in dermatology and postdoctoral research fellow at Stanford University. We talk about artificial intelligence in dermatology and beyond. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.73 CheckMate 577: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer]]></title><description><![CDATA[On today's episode, we have a short monologue for you on the recent CheckMate 577 study that was recently published in the New England Journal of Medicine. The title of the paper is "Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer".<br/><br/>CheckMate 577: <a href="http://doi.org/10.1056/NEJMoa2032125" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2032125</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/373-checkmate-577-adjuvant-nivolumab-584</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1047262546</guid><pubDate>Wed, 12 May 2021 02:16:02 GMT</pubDate><enclosure length="15010693" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525380/764397f33f1d8daaa0bef22ce4abb568.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, we have a short monologue for…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>938</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525380/7e6c4a4669b1f0f61e7a37a479a4ee46.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, we have a short monologue for you on the recent CheckMate 577 study that was recently published in the New England Journal of Medicine. The title of the paper is "Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer". CheckMate 577: doi.org/10.1056/NEJMoa2032125 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.72 Industry Payments to US Physicians for Cancer Therapeutics with Dr. Daniel Meyers]]></title><description><![CDATA[Today we're joined by Dr. Daniel Meyers of the University of Calgary who's here to discuss his new paper out now in the Journal of Cancer Policy. It's titled "Industry payments to US physicians for cancer therapeutics: An analysis of the 2016–2018 open payments datasets".<br/><br/>Industry payments: <a href="http://doi.org/10.1016/j.jcpo.2021.100283" class="linkified" target="_blank">doi.org/10.1016/j.jcpo.2021.100283</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/372-industry-payments-to-us-physicians-7cc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1046571016</guid><pubDate>Tue, 11 May 2021 01:02:05 GMT</pubDate><enclosure length="46536936" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525381/704dd6b70d99761bec382401378386d5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we're joined by Dr. Daniel Meyers of the Un…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2909</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525381/1515a2db4d9e7edcc3841e068b1552df.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we're joined by Dr. Daniel Meyers of the University of Calgary who's here to discuss his new paper out now in the Journal of Cancer Policy. It's titled "Industry payments to US physicians for cancer therapeutics: An analysis of the 2016–2018 open payments datasets". Industry payments: doi.org/10.1016/j.jcpo.2021.100283 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.71 How Research Influences Policy with Dr. Kirsten Bibbins-Domingo]]></title><description><![CDATA[Today we sit down with Dr. Kirsten Bibbins-Domingo, Chair of the Department of Epidemiology and Biostatistics and the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. We talk about mentorship throughout a career, the unique value of epidemiology and biostatistics, finding passion in your work, disparities in healthcare during the COVID-19 pandemic, and more.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/371-how-research-influences-policy-6e8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1043234866</guid><pubDate>Wed, 05 May 2021 17:24:46 GMT</pubDate><enclosure length="87230696" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525382/c3dbb1a79b34551634c99e2d5495bc26.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Kirsten Bibbins-Doming…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5452</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525382/1012f4ca0fc35e5db77fb4c069eb53fc.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Kirsten Bibbins-Domingo, Chair of the Department of Epidemiology and Biostatistics and the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. We talk about mentorship throughout a career, the unique value of epidemiology and biostatistics, finding passion in your work, disparities in healthcare during the COVID-19 pandemic, and more. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.70 The Motivation We Need to Reach the End of the COVID-19 Pandemic with Dr. Monica Gandhi]]></title><description><![CDATA[Today we sit down with Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH. We talk about ending COVID-19 pandemic restrictions, vaccination boosters, and more. She gives us the motivation we all need right now.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/370-the-motivation-we-need-to-reach-908</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1039554955</guid><pubDate>Fri, 30 Apr 2021 19:00:22 GMT</pubDate><enclosure length="29774685" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525383/b1737ecc11f02dbbda81599ad5b9515c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Monica Gandhi, Associa…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1861</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525383/a63f16739daeebfbec8a162c0abaf82d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH. We talk about ending COVID-19 pandemic restrictions, vaccination boosters, and more. She gives us the motivation we all need right now. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.69 Reporting of Postprotocol Therapies in Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin]]></title><description><![CDATA[Today we talk with Dr. Manni Mohyuddin of Kansas University Medical Center on his new paper out now in JAMA Network Open titled "Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review".<br/><br/>Postprotocol Therapies: <a href="http://doi.org/10.1001/jamanetworkopen.2021.8084" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2021.8084</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/369-reporting-of-postprotocol-therapies-dc1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1038860137</guid><pubDate>Thu, 29 Apr 2021 19:00:12 GMT</pubDate><enclosure length="38214535" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525384/a7f552b1f283f3c9ec02373a8c6f14f8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we talk with Dr. Manni Mohyuddin of Kansas …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2388</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525384/501629d20d5978aa42268f3f4f3756c8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we talk with Dr. Manni Mohyuddin of Kansas University Medical Center on his new paper out now in JAMA Network Open titled "Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review". Postprotocol Therapies: doi.org/10.1001/jamanetworkopen.2021.8084 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.68 A Career in Academic Medicine & Challenges of 2021 with Former Harvard Dean, Dr. Jeffrey Flier]]></title><description><![CDATA[On today's episode, we interview Dr. Jeffrey Flier, an esteemed endocrinologist and physician researcher who was Dean of the Faculty of Medicine at Harvard University for nine years (2007-2016). We talk about his career in academic medicine as well as the challenges of 2021. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/368-a-career-in-academic-medicine-53c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1038857071</guid><pubDate>Thu, 29 Apr 2021 04:50:25 GMT</pubDate><enclosure length="67903847" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525385/c283322a63a13edc9dadec04ea097816.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode, we interview Dr. Jeffrey Flie…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4244</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525385/85abc2cd32ef93acfe0caa56414395b2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode, we interview Dr. Jeffrey Flier, an esteemed endocrinologist and physician researcher who was Dean of the Faculty of Medicine at Harvard University for nine years (2007-2016). We talk about his career in academic medicine as well as the challenges of 2021. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.67 Thoughts on PhD Programs and Idecabtagene Vicleucel with Dr. David Russler-Germain]]></title><description><![CDATA[Today we bring back popular guest Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, to discuss his thoughts on PhD programs (in response to a listener question) as well as his take on Idecabtagene vicleucel for multiple myeloma.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/367-thoughts-on-phd-programs-and-2af</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1035356113</guid><pubDate>Fri, 23 Apr 2021 16:02:45 GMT</pubDate><enclosure length="59937127" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525386/64a31ed0eed0d1a8b179ca1cda214c3a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we bring back popular guest Dr. David Russl…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3746</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525386/ee1bfba88b6b4c28aa3f563ebe2e01be.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we bring back popular guest Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, to discuss his thoughts on PhD programs (in response to a listener question) as well as his take on Idecabtagene vicleucel for multiple myeloma. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.66 COVID-19 Policies and Progressing Past Disagreement with Dr. Martin Kulldorff]]></title><description><![CDATA[Today we talk with Dr. Martin Kulldorff, a Professor of Medicine at Harvard Medical School and Brigham and Women's Hospital, about COVID-19 health policy and about disagreement.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/366-covid-19-policies-and-progressing-a5d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1026200611</guid><pubDate>Fri, 16 Apr 2021 12:00:06 GMT</pubDate><enclosure length="63120304" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525387/29abe9433b60a484ac01822ac5f00750.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we talk with Dr. Martin Kulldorff, a Profes…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3945</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525387/bdc90de389eb91032b274bc56d460d18.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we talk with Dr. Martin Kulldorff, a Professor of Medicine at Harvard Medical School and Brigham and Women's Hospital, about COVID-19 health policy and about disagreement. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.65 Banning Books, Social Media, & Medical Education with Dr. Adam Cifu]]></title><description><![CDATA[Today we bring back popular guest Dr. Adam Cifu, a Professor of Medicine at the University of Chicago, to talk about the idea of banning books. the power of social media, and the current state of medical education.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/365-banning-books-social-media-and-4ab</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1026085693</guid><pubDate>Wed, 14 Apr 2021 12:00:06 GMT</pubDate><enclosure length="59706832" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525388/df26ea1316c07177fe03e78885a74a62.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we bring back popular guest Dr. Adam Cifu, …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3732</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525388/0e35a1715794addb55be0b7b2228029d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we bring back popular guest Dr. Adam Cifu, a Professor of Medicine at the University of Chicago, to talk about the idea of banning books. the power of social media, and the current state of medical education. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.64 A Legal and Philosophical View on COVID-19 with Samantha Godwin]]></title><description><![CDATA[Today we are joined by Samantha Godwin, a Resident Fellow for the Information Society Project at Yale Law School, to discuss COVID-19 health policy from a legal and philosophical perspective.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/364-a-legal-and-philosophical-view-720</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1026077704</guid><pubDate>Mon, 12 Apr 2021 12:00:16 GMT</pubDate><enclosure length="55058708" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525389/61816eb78f9675627b9a523aca16f87f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we are joined by Samantha Godwin, a Residen…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3441</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525389/ffb30ce52017a09f5792fbe794b5ec49.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we are joined by Samantha Godwin, a Resident Fellow for the Information Society Project at Yale Law School, to discuss COVID-19 health policy from a legal and philosophical perspective. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.63 The Medical Scientist Training Program with Dr. David Russler-Germain]]></title><description><![CDATA[Today we talk again with Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, this time on the Medical Scientist Training Program (MSTP).<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/363-the-medical-scientist-training-349</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1024782052</guid><pubDate>Thu, 08 Apr 2021 17:06:13 GMT</pubDate><enclosure length="59703488" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525390/d2c167a15810bd12f2abf56e28c78b8b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we talk again with Dr. David Russler-Germai…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3731</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525390/a1c225c08bc74ef4fc39ad415a39e2f0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we talk again with Dr. David Russler-Germain, a Hematology/Oncology Fellow at the Washington University School of Medicine in St. Louis, this time on the Medical Scientist Training Program (MSTP). Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.62 COVID-19 Transmission, Vaccines, & Olaparib with Dr. Tom Beer]]></title><description><![CDATA[Today we interview Dr. Tom Beer, the Deputy Director of the Oregon Health & Science University Knight Cancer Institute, about COVID-19 transmission, policy, and vaccines. We also talk about olaparib.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/362-covid-19-transmission-vaccines-6fc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1024771258</guid><pubDate>Thu, 08 Apr 2021 01:15:18 GMT</pubDate><enclosure length="33805901" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525391/e27207af0b5d08169fdcfc93caaab353.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Tom Beer, the Deputy Direc…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2113</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525391/bfbdfa845f189f3f82cff5ddfb3b4e65.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Tom Beer, the Deputy Director of the Oregon Health &amp; Science University Knight Cancer Institute, about COVID-19 transmission, policy, and vaccines. We also talk about olaparib. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.61 The Neuroscience and Psychology of Recreational Drug Use in Adults with Dr. Carl Hart]]></title><description><![CDATA[Today we are joined by guest Dr. Carl Hart, a behavioral neuroscientist and Professor of Psychology at Columbia University. We discuss his research, his philosophies, and his new book "Drug Use for Grown-Ups." <br/><br/>Drug Use for Grown-Ups: <a href="https://www.penguinrandomhouse.com/books/534657/drug-use-for-grown-ups-by-dr-carl-l-hart/" class="linkified" target="_blank">https://www.penguinrandomhouse.com/books/534657/drug-use-for-grown-ups-by-dr-carl-l-hart/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/361-the-neuroscience-and-psychology-dc7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1023013909</guid><pubDate>Tue, 06 Apr 2021 02:32:23 GMT</pubDate><enclosure length="43822711" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525392/6c75618daebf8b4036d4b6bca831b73e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we are joined by guest Dr. Carl Hart, a beh…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2739</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525392/a24a597fbaf09ea8230983062b5ce7ff.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we are joined by guest Dr. Carl Hart, a behavioral neuroscientist and Professor of Psychology at Columbia University. We discuss his research, his philosophies, and his new book "Drug Use for Grown-Ups." Drug Use for Grown-Ups: https://www.penguinrandomhouse.com/books/534657/drug-use-for-grown-ups-by-dr-carl-l-hart/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.60 Drugs for Acute Lymphoblastic Leukemia with Dr. Bernard Marini]]></title><description><![CDATA[Today we bring back popular guest Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology at University of Michigan Medicine, to discuss treatment of Acute Lymphoblastic Leukemia (ALL).<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/360-drugs-for-acute-lymphoblastic-16c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1019472562</guid><pubDate>Wed, 31 Mar 2021 00:57:48 GMT</pubDate><enclosure length="78970153" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525393/bf31082146a275e327a411ca75b0ef45.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we bring back popular guest Dr. Bernie Mari…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4936</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525393/cada066927aee7dd847f414c59dcff89.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we bring back popular guest Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology at University of Michigan Medicine, to discuss treatment of Acute Lymphoblastic Leukemia (ALL). Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.59 Genetic Alterations Linked to SARS-CoV-2 Acquisition and Bad Outcomes with Dr. Nathan Pearson]]></title><description><![CDATA[Today we are joined by genomicist Dr. Nathan Pearson, founder of Root (<a href="http://rootdeep.com" class="linkified" target="_blank">rootdeep.com</a>), to discuss which genetic alterations in the host predispose to SARS-CoV-2 acquisition and bad outcomes.<br/><br/>Gift of Life: <a href="http://www.giftoflife.org/page/content/covid19faq" class="linkified" target="_blank">www.giftoflife.org/page/content/covid19faq</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/359-genetic-alterations-linked-to-f0a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1018812334</guid><pubDate>Tue, 30 Mar 2021 01:28:58 GMT</pubDate><enclosure length="26802577" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525394/1d1909e670744b1a740b43207f52b626.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we are joined by genomicist Dr. Nathan Pear…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1675</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525394/29e2671797d71538a3a4947623bec639.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we are joined by genomicist Dr. Nathan Pearson, founder of Root (rootdeep.com), to discuss which genetic alterations in the host predispose to SARS-CoV-2 acquisition and bad outcomes. Gift of Life: www.giftoflife.org/page/content/covid19faq Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.58 Expertise and Disinformation with Jacob Hale Russell]]></title><description><![CDATA[Today we bring back popular guest Jacob Hale Russell, an Associate Professor of Law at Rutgers Law School, for a discussion on expertise, disinformation, and intellectual disagreement. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/358-expertise-and-disinformation-810</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1017035977</guid><pubDate>Fri, 26 Mar 2021 22:11:46 GMT</pubDate><enclosure length="70677424" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525395/37c68e3c264d4daf105752b39827ae55.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we bring back popular guest Jacob Hale Russ…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4417</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525395/828c78c74ce3b530e0eeb19de97f4453.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we bring back popular guest Jacob Hale Russell, an Associate Professor of Law at Rutgers Law School, for a discussion on expertise, disinformation, and intellectual disagreement. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.57 Career Paths and Evolution of the Oncology Randomized Clinical Trial with Dr. Christopher Booth]]></title><description><![CDATA[On today's episode we talk with popular guest Dr. Chris Booth of Queen's University in Kingston, Ontario, Canada about mapping out a career path after medical school and about his new paper out now in JAMA Oncology titled "Evolution of the Randomized Clinical Trial in the Era of Precision Oncology".<br/><br/>The Oncology RCT: <a href="http://doi.org/10.1001/jamaoncol.2021.0379" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2021.0379</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/357-career-paths-and-evolution-of-1ae</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1016549131</guid><pubDate>Fri, 26 Mar 2021 03:34:51 GMT</pubDate><enclosure length="60963635" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525396/343f904c289c7b6f5fa6f44f40d11eb4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we talk with popular guest Dr.…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3810</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525396/14ed2e7786bb56b6fb675bf00cd5050f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we talk with popular guest Dr. Chris Booth of Queen's University in Kingston, Ontario, Canada about mapping out a career path after medical school and about his new paper out now in JAMA Oncology titled "Evolution of the Randomized Clinical Trial in the Era of Precision Oncology". The Oncology RCT: doi.org/10.1001/jamaoncol.2021.0379 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.56 Quality of Control Groups in RCTs of Multiple Myeloma with Dr. Ghulam Rehman Mohyuddin]]></title><description><![CDATA[Today we interview Dr. Ghulam Rehman Mohyuddin of Kansas University Medical Center on his new paper out now in The Lancet Haematology titled "Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review".<br/><br/>Control Groups: <a href="http://doi.org/10.1016/S2352-3026(21)00024-7" class="linkified" target="_blank">doi.org/10.1016/S2352-3026(21)00024-7</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/356-quality-of-control-groups-in-bb0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1015793464</guid><pubDate>Thu, 25 Mar 2021 00:45:32 GMT</pubDate><enclosure length="30448853" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525397/a4d3106b0991d26790c61ff4fcc9fa12.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Ghulam Rehman Mohyuddin of…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1903</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525397/81516447a90cc04825a9ba6394ab7ca2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Ghulam Rehman Mohyuddin of Kansas University Medical Center on his new paper out now in The Lancet Haematology titled "Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review". Control Groups: doi.org/10.1016/S2352-3026(21)00024-7 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.55 Equity in Vaccine Distribution, Cancel Culture, and Zero COVID-19 with Dr. Matthew Smith]]></title><description><![CDATA[Today we sit down with Dr. Matthew Smith, an associate professor in the Northeastern University Department of Philosophy and Religion, to discuss the morality and philosophical backbone behind COVID-19 vaccine distribution and how we should define equity; cancel culture and its historical longevity; and the impossibility (at least in the USA) of Zero COVID-19.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/355-equity-in-vaccine-distribution-5a7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1015237489</guid><pubDate>Wed, 24 Mar 2021 04:21:43 GMT</pubDate><enclosure length="78292223" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525398/4d04c6eef1e34873d0761ba3c54c38dc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Matthew Smith, an asso…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4893</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525398/ea4f6b8197585935772cb308e27ce137.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Matthew Smith, an associate professor in the Northeastern University Department of Philosophy and Religion, to discuss the morality and philosophical backbone behind COVID-19 vaccine distribution and how we should define equity; cancel culture and its historical longevity; and the impossibility (at least in the USA) of Zero COVID-19. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.54 The Passing of Dr. José Baselga]]></title><description><![CDATA[For today's episode we have a short monologue in remembrance of famed cancer researcher Dr. José Baselga.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/354-the-passing-of-dr-jose-baselga-977</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1014219325</guid><pubDate>Tue, 23 Mar 2021 02:58:46 GMT</pubDate><enclosure length="15154891" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525399/e984da943cb679adeaab108a2e523e9e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>For today's episode we have a short monologue in …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>947</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525399/8ca07c53d1992068230a4b53ee3dae85.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>For today's episode we have a short monologue in remembrance of famed cancer researcher Dr. José Baselga. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.53 Updates on COVID-19 and Looking Back Over the Last Year with Dr. Aaron Richterman]]></title><description><![CDATA[Today we interview Dr. Aaron Richterman, an infectious disease specialist at Penn Medicine. We talk about updates on all things COVID-19 and we look back at how treatments, risk assessment, and behavior have changed. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/353-updates-on-covid-19-and-looking-30d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1010844469</guid><pubDate>Fri, 19 Mar 2021 00:53:36 GMT</pubDate><enclosure length="78645398" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525400/4b3711a0b50afc53aa2d9df7001cd15c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Aaron Richterman, an infec…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4915</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525400/b54c1d6358ad525fabb92e99a8ff99d4.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Aaron Richterman, an infectious disease specialist at Penn Medicine. We talk about updates on all things COVID-19 and we look back at how treatments, risk assessment, and behavior have changed. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.52 Medicine, Leadership, SARS-CoV-2, and Social Media with Dr. Bob Wachter]]></title><description><![CDATA[Today we interview Dr. Bob Wachter, the Chair of the Department of Medicine at University of California San Francisco. We talk about a wide range of topics including medicine, leadership, SARS-CoV-2, and social media. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/352-medicine-leadership-sars-cov-c53</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1005787792</guid><pubDate>Sun, 14 Mar 2021 13:00:18 GMT</pubDate><enclosure length="71071142" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525401/430db8f87e99df8bf695ecb9194b614a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Bob Wachter, the Chair of …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4442</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525401/30c3be712862332f132cccbff2fcfe12.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Bob Wachter, the Chair of the Department of Medicine at University of California San Francisco. We talk about a wide range of topics including medicine, leadership, SARS-CoV-2, and social media. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.51 COVID-19 Modeling with Youyang Gu]]></title><description><![CDATA[On today's episode we interview Youyang Gu, an independent data scientist who created some of the most models of the COVID-19 pandemic. He talks us through how he made the projections. His work is available on his website: <a href="https://covid19-projections.com/" class="linkified" target="_blank">https://covid19-projections.com/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/351-covid-19-modeling-with-youyang-7cb</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1005759535</guid><pubDate>Fri, 12 Mar 2021 22:57:48 GMT</pubDate><enclosure length="53493451" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525402/e054320a05b01aa0c2f63cfa0fca5270.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we interview Youyang Gu, an in…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3343</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525402/65cd15f337a80fcd91f5ac7870a8779d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we interview Youyang Gu, an independent data scientist who created some of the most models of the COVID-19 pandemic. He talks us through how he made the projections. His work is available on his website: https://covid19-projections.com/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.50 Evildoer Marty Makary [SHORT]]]></title><description><![CDATA[On today's SHORT episode, we talk about censorship, Facebook, Twitter, and the "evildoer" Dr. Marty Makary.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/350-evildoer-marty-makary-short-ce3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1005108775</guid><pubDate>Thu, 11 Mar 2021 23:24:40 GMT</pubDate><enclosure length="10798502" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525403/4e0e11dbc7c69320c681e9852e0fd63e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's SHORT episode, we talk about censorshi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>675</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525403/48e2a596f3e8b12d0d2c51e3e2a765f2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's SHORT episode, we talk about censorship, Facebook, Twitter, and the "evildoer" Dr. Marty Makary. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.49 The Role of Government in Public Health and in COVID-19 Policy with Dr. Robert Freudenthal]]></title><description><![CDATA[Today we interview Dr. Robert Freudenthal, a psychiatrist in training at Barnet Enfield and Haringey Mental Health Trust in London, UK. We talk abut the power of the state and its role in public health policy. We focus specifically on how governments worldwide have responded to the COVID-19 pandemic, from extreme lockdowns to harm reduction advisories. We discuss how policy can be medical overreach as well as how it interplays with the criminal justice system and racial and class inequities. Finally, we discuss censorship and the need for trust and honesty in messaging. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/349-the-role-of-government-in-public-3b9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/1003623499</guid><pubDate>Wed, 10 Mar 2021 01:56:35 GMT</pubDate><enclosure length="60503880" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525404/93506d020b673fb97bc33a6580104d59.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Robert Freudenthal, a psyc…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3781</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525404/c2ff73407ae3981ae457732d711189fc.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Robert Freudenthal, a psychiatrist in training at Barnet Enfield and Haringey Mental Health Trust in London, UK. We talk abut the power of the state and its role in public health policy. We focus specifically on how governments worldwide have responded to the COVID-19 pandemic, from extreme lockdowns to harm reduction advisories. We discuss how policy can be medical overreach as well as how it interplays with the criminal justice system and racial and class inequities. Finally, we discuss censorship and the need for trust and honesty in messaging. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris]]></title><description><![CDATA[Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase".<br/><br/>Response Rates: <a href="http://doi.org/10.1001/jamaoncol.2020.7684" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2020.7684</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/348-the-predictive-value-of-high-257</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/999552010</guid><pubDate>Sat, 06 Mar 2021 01:14:09 GMT</pubDate><enclosure length="59035589" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525405/f353f95d4a9b773560159e779a9b38c5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Luc Morris of Memorial Slo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3690</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525405/a19fcc4289f9b637be3cd4682e14930e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase". Response Rates: doi.org/10.1001/jamaoncol.2020.7684 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.47 COVID-19 Vaccine Results, Messaging on a Patient Level, & Schools with Dr. Monica Gandhi]]></title><description><![CDATA[Today we interview Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH, on COVID-19 interventions. We talk about results from the vaccine studies and how vaccination is perceived by the public. We talk about her new paper out now in The Lancet Infectious Disease on the importance of non-pharmaceutical interventions (masking, social distancing, ventilation, hand-washing) in controlling COVID-19. We also talk about the stark difference between messaging created from the point of view of an epidemiologist vs the public health messaging that frontline health care workers deliver directly to patients. We end the interview by talking about schools and the need to re-open them.<br/><br/>Importance of non-pharmaceutical interventions: <a href="http://doi.org/10.1016/S1473-3099(20)30982-8" class="linkified" target="_blank">doi.org/10.1016/S1473-3099(20)30982-8</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/347-covid-19-vaccine-results-messaging-41c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/997551424</guid><pubDate>Wed, 03 Mar 2021 01:37:13 GMT</pubDate><enclosure length="54410453" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525406/66fb4c211b3dc135017e5105fc163480.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Monica Gandhi, Associate D…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3401</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525406/df873d647ce1988a25cfaa98cb15a3dd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH, on COVID-19 interventions. We talk about results from the vaccine studies and how vaccination is perceived by the public. We talk about her new paper out now in The Lancet Infectious Disease on the importance of non-pharmaceutical interventions (masking, social distancing, ventilation, hand-washing) in controlling COVID-19. We also talk about the stark difference between messaging created from the point of view of an epidemiologist vs the public health messaging that frontline health care workers deliver directly to patients. We end the interview by talking about schools and the need to re-open them. Importance of non-pharmaceutical interventions: doi.org/10.1016/S1473-3099(20)30982-8 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.46 COVID-19 Risk, Cases, and Transmission in K-12 Schools with Dr. Tracy Høeg]]></title><description><![CDATA[Today we interview Dr. Tracy Høeg on her new paper and her ongoing research into COVID-19 transmission in K-12 schools in Wisconsin, USA. Dr. Høeg is an epidemiologist and an interventional sports and medicine spine specialist at Northern California Orthopaedic Associates. Her paper is titled "COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020" and is published in the CDC's Morbidity and Mortality Weekly Report.<br/><br/>Cases in K-12 Schools: <a href="http://doi.org/10.15585/mmwr.mm7004e3" class="linkified" target="_blank">doi.org/10.15585/mmwr.mm7004e3</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/346-covid-19-risk-cases-and-transmission-6e4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/994233469</guid><pubDate>Sat, 27 Feb 2021 05:19:23 GMT</pubDate><enclosure length="44705862" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525407/8acda8a32a37e034ccc66c7d2e087841.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Dr. Tracy Høeg on her new pape…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2794</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525407/e134622018b57f71b8b7dc475935741b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Dr. Tracy Høeg on her new paper and her ongoing research into COVID-19 transmission in K-12 schools in Wisconsin, USA. Dr. Høeg is an epidemiologist and an interventional sports and medicine spine specialist at Northern California Orthopaedic Associates. Her paper is titled "COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020" and is published in the CDC's Morbidity and Mortality Weekly Report. Cases in K-12 Schools: doi.org/10.15585/mmwr.mm7004e3 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.45 USMLE Steps, Residency Match, & M.D. vs D.O. with Dr. Bryan Carmody]]></title><description><![CDATA[On today's episode we interview Dr. Bryan Carmody, commonly known as the Sheriff of Sodium. He's a pediatric nephrologist at Children's Hospital of the King's Daughters in Virginia. We talk with him about the USMLE Steps (Step 1, Step 2, and Step 2 CS), their usefulness, their origins, and how to reform them. We also break down and discuss the inner workings of residency matching and the M.D. and D.O. designations. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/345-usmle-steps-residency-match-and-672</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/992352160</guid><pubDate>Wed, 24 Feb 2021 21:31:59 GMT</pubDate><enclosure length="84756383" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525408/69c9b892245c47ac6fc8b6e40f07b230.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we interview Dr. Bryan Carmody…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5297</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525408/3796d47719198e4d6573d52d52fc462a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we interview Dr. Bryan Carmody, commonly known as the Sheriff of Sodium. He's a pediatric nephrologist at Children's Hospital of the King's Daughters in Virginia. We talk with him about the USMLE Steps (Step 1, Step 2, and Step 2 CS), their usefulness, their origins, and how to reform them. We also break down and discuss the inner workings of residency matching and the M.D. and D.O. designations. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.44 The Role of Philosophy, COVID-19 Policy, and COVID-19 Exceptionalism with Dr. Alex John London]]></title><description><![CDATA[Today we sit down with Dr. Alex John London, the Clara L. West Professor of Ethics and Philosophy and Director of the Center for Ethics and Policy at Carnegie Mellon University, to discuss the role of philosophy, COVID-19 exceptionalism, and various aspects of COVID-19 health policy including masking, vaccination, and schools.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/344-the-role-of-philosophy-covid-f67</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/987728074</guid><pubDate>Wed, 17 Feb 2021 23:54:35 GMT</pubDate><enclosure length="74875827" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525409/80bcf5ae611cbdfb4196701eac20c6d0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Alex John London, the …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4680</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525409/811072e1b0ae617e440f89f0bd6f4fe0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Alex John London, the Clara L. West Professor of Ethics and Philosophy and Director of the Center for Ethics and Policy at Carnegie Mellon University, to discuss the role of philosophy, COVID-19 exceptionalism, and various aspects of COVID-19 health policy including masking, vaccination, and schools. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.43 Reviewing the Beat AML Master Trial]]></title><description><![CDATA[On today’s episode we review the findings of the Beat AML study as published in Nature Medicine in an article titled “Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial”. <br/><br/>Beat AML: <a href="http://doi.org/10.1038/s41591-020-1089-8" class="linkified" target="_blank">doi.org/10.1038/s41591-020-1089-8</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/343-reviewing-the-beat-aml-master-880</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/986206105</guid><pubDate>Mon, 15 Feb 2021 19:04:39 GMT</pubDate><enclosure length="25674090" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525410/96be445b449608829b576e41091eb089.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today’s episode we review the findings of the …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1605</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525410/fb4c4c22be9476b22b16e3e1c6a39b38.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today’s episode we review the findings of the Beat AML study as published in Nature Medicine in an article titled “Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial”. Beat AML: doi.org/10.1038/s41591-020-1089-8 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.42 Overdiagnosis and Cutaneous Melanoma Diagnoses with Dr. Adewole Adamson and Dr. Benjamin Mazer]]></title><description><![CDATA[For today's episode, we sit down with Drs. Ade Adamson of the University of Texas at Austin Dell Medical School and Ben Mazer of Johns Hopkins Hospital to discuss their new paper out now in the New England Journal of Medicine titled "The Rapid Rise in Cutaneous Melanoma Diagnoses". It's one of the best papers you'll read all year.<br/><br/>Melanoma Diagnoses: <a href="http://doi.org/10.1056/NEJMsb2019760" class="linkified" target="_blank">doi.org/10.1056/NEJMsb2019760</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/342-overdiagnosis-and-cutaneous-melanoma-4d9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/982484050</guid><pubDate>Wed, 10 Feb 2021 00:59:39 GMT</pubDate><enclosure length="63578809" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525411/45ba989ef81ca7a5c1cbd1fa3ff149c9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>For today's episode, we sit down with Drs. Ade Ad…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3974</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525411/7231601eeaf8469bb9ca5ebe52c6d0a5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>For today's episode, we sit down with Drs. Ade Adamson of the University of Texas at Austin Dell Medical School and Ben Mazer of Johns Hopkins Hospital to discuss their new paper out now in the New England Journal of Medicine titled "The Rapid Rise in Cutaneous Melanoma Diagnoses". It's one of the best papers you'll read all year. Melanoma Diagnoses: doi.org/10.1056/NEJMsb2019760 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.41 Building a Meta-Research Career and Constructing COVID-19 Health Policy with Dr. John Ioannidis]]></title><description><![CDATA[For today's special episode, we sat down with Dr. John Ioannidis of Stanford University for an outdoor in-person interview. We take a deep dive into his work from 2000 all the way up to present day: his career from 2000 to 2010, his move to Stanford, and his work on COVID-19. We take a deep dive into his work on COVID-19: IFR, shielding ratio, the question of whether lockdown works, opening schools, and what public health policy should be.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/341-building-a-meta-research-career-e32</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/980949256</guid><pubDate>Sun, 07 Feb 2021 18:13:58 GMT</pubDate><enclosure length="114350401" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525412/c131f30b2ea9e706e9aff2575d608247.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>For today's special episode, we sat down with Dr.…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7147</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525412/145c82bf3cd363fa7c83370e9ce097bf.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>For today's special episode, we sat down with Dr. John Ioannidis of Stanford University for an outdoor in-person interview. We take a deep dive into his work from 2000 all the way up to present day: his career from 2000 to 2010, his move to Stanford, and his work on COVID-19. We take a deep dive into his work on COVID-19: IFR, shielding ratio, the question of whether lockdown works, opening schools, and what public health policy should be. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.40 COVID-19 Vaccines, Origin of SARS-CoV-2, and Pandemic Mitigation with Prof Francois Balloux]]></title><description><![CDATA[On today's episode we're joined by geneticist Dr. Francois Balloux, the Director of the University College London Genetics Institute and professor of computational systems biology, on pandemic mitigation, SARS-CoV-2 variants, how news and social media amplify fear over fact, opening schools, lethality and risk, the origin of SARS-CoV-2, COVID-19 vaccine efficacy and vaccine escape, and more!<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/340-covid-19-vaccines-origin-of-sars-c5d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/979867237</guid><pubDate>Fri, 05 Feb 2021 19:42:22 GMT</pubDate><enclosure length="54707207" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525413/27da9a3ed0affc57d432c290ee807e63.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we're joined by geneticist Dr.…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3419</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525413/f03855ba8d55c4a9b6e6ea351c62eb01.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we're joined by geneticist Dr. Francois Balloux, the Director of the University College London Genetics Institute and professor of computational systems biology, on pandemic mitigation, SARS-CoV-2 variants, how news and social media amplify fear over fact, opening schools, lethality and risk, the origin of SARS-CoV-2, COVID-19 vaccine efficacy and vaccine escape, and more! Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.39 Public Health Messaging on COVID-19 with Drs. Julia Marcus and Stefan Baral]]></title><description><![CDATA[On today's episode we feature an in-depth interview with Dr. Julia Marcus (Associate Professor at Harvard Medical School) and Dr. Stefan Baral (Associate Professor at Johns Hopkins Bloomberg School of Public Health), two infectious disease epidemiologists, on public health messaging around COVID-19 -- what we're getting right and where we're going terribly wrong.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/339-public-health-messaging-on-covid-f27</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/978704188</guid><pubDate>Thu, 04 Feb 2021 03:20:52 GMT</pubDate><enclosure length="65796918" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525414/30b4da3aa0322cd5b914fc159ab33a20.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we feature an in-depth intervi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4112</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525414/dba213a9560f60ec8c3b4bfc3af3c6aa.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we feature an in-depth interview with Dr. Julia Marcus (Associate Professor at Harvard Medical School) and Dr. Stefan Baral (Associate Professor at Johns Hopkins Bloomberg School of Public Health), two infectious disease epidemiologists, on public health messaging around COVID-19 -- what we're getting right and where we're going terribly wrong. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.38 Oncology During COVID-19 & RCTs from Low- vs High-Income Countries with Dr. Christopher Booth]]></title><description><![CDATA[On today's episode we sit down with Dr. Chris Booth of Queen's University in Kingston, Ontario, Canada to discuss his new paper out now in JAMA Oncology titled "An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries". We also talk about how COVID-19 has affected oncology research. We touch, too, on the topic of evaluating how you spend your time and prioritizing your research.<br/><br/>Contemporary Oncology RCTs: <a href="http://doi.org/10.1001/jamaoncol.2020.7478" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2020.7478</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/338-oncology-during-covid-19-and-376</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/975314335</guid><pubDate>Fri, 29 Jan 2021 19:18:25 GMT</pubDate><enclosure length="53809430" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525415/6e94e6eb3412b9cc5c9a6d76e07d6ffc.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we sit down with Dr. Chris Boo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3363</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525415/0558f984e4f4a1dcd5d2aed9c1598314.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we sit down with Dr. Chris Booth of Queen's University in Kingston, Ontario, Canada to discuss his new paper out now in JAMA Oncology titled "An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries". We also talk about how COVID-19 has affected oncology research. We touch, too, on the topic of evaluating how you spend your time and prioritizing your research. Contemporary Oncology RCTs: doi.org/10.1001/jamaoncol.2020.7478 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.37 Skepticism, COVID-19, and Debating Science in the Era of Trade-Offs with Jacob Hale Russell]]></title><description><![CDATA[On today's episode we are joined by Jacob Hale Russell, an Associate Professor of Law at Rutgers Law School. We discuss his forthcoming book on skepticism, elites, and expertise, as well as his article out now on StatNews about the myth of COVID-19 denial. We talk about anti-intellectualism and how science ought to be debated in the era of trade-offs and COVID-19.<br/><br/>Straw Man of Pandemic Denial: <a href="http://www.statnews.com/2020/12/23/put-straw-man-pandemic-denial-out-of-its-misery/comment-page-1/" class="linkified" target="_blank">www.statnews.com/2020/12/23/put-straw-man-pandemic-denial-out-of-its-misery/comment-page-1/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/337-skepticism-covid-19-and-debating-9a3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/973494271</guid><pubDate>Wed, 27 Jan 2021 01:12:12 GMT</pubDate><enclosure length="89339722" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525416/eaea067933219e74f82e918f03fbcd42.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we are joined by Jacob Hale Ru…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5584</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525416/09703d9bb49b93aea6d67deb234d6cce.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we are joined by Jacob Hale Russell, an Associate Professor of Law at Rutgers Law School. We discuss his forthcoming book on skepticism, elites, and expertise, as well as his article out now on StatNews about the myth of COVID-19 denial. We talk about anti-intellectualism and how science ought to be debated in the era of trade-offs and COVID-19. Straw Man of Pandemic Denial: www.statnews.com/2020/12/23/put-straw-man-pandemic-denial-out-of-its-misery/comment-page-1/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.36 Sustainable Ex-Vivo Seafood with Dr. Arye Elfenbein]]></title><description><![CDATA[On today's episode we sit down with Dr. Arye Elfenbein, a cardiologist and "doctorpreneur " to interview him on the bio-tech company he recently co-founded: Wildtype. Wildtype manufactures ex-vivo fish meat for human consumption in fulfillment of their mission to create the cleanest, most sustainable seafood.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/336-sustainable-ex-vivo-seafood-with-4ec</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/970296226</guid><pubDate>Fri, 22 Jan 2021 01:42:05 GMT</pubDate><enclosure length="45008045" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525417/c3aed545675aa21b531ed15288f74c2a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we sit down with Dr. Arye Elfe…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2813</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525417/35876cd13d81cd0a9490b87b63155afb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we sit down with Dr. Arye Elfenbein, a cardiologist and "doctorpreneur " to interview him on the bio-tech company he recently co-founded: Wildtype. Wildtype manufactures ex-vivo fish meat for human consumption in fulfillment of their mission to create the cleanest, most sustainable seafood. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.35 The Secrets of Vermont in Taming the COVID-19 Pandemic with Anne Sosin]]></title><description><![CDATA[Today we interview Anne Sosin of Dartmouth College on public health policy in Vermont and how the state has uniquely tamed the COVID-19 pandemic.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/335-the-secrets-of-vermont-in-taming-753</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/969036184</guid><pubDate>Wed, 20 Jan 2021 04:04:21 GMT</pubDate><enclosure length="34597936" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525418/aa6e9ed1607269778c6428673d0716f9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we interview Anne Sosin of Dartmouth Colleg…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2162</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525418/cba0cdc5a766638532ca26821862ced9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we interview Anne Sosin of Dartmouth College on public health policy in Vermont and how the state has uniquely tamed the COVID-19 pandemic. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.34 COVID-19 From a Philosopher's Point of View with Dr. Matthew Smith]]></title><description><![CDATA[Today we sit down with Dr. Matthew Smith, an associate professor in the Northeastern University Department of Philosophy and Religion, for a far-ranging discussion on COVID-19 from a philosopher's point of view.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/334-covid-19-from-a-philosophers-8f2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/965930008</guid><pubDate>Fri, 15 Jan 2021 02:47:26 GMT</pubDate><enclosure length="65222223" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525420/3ff7c32cfcc928f45221dbc799ead544.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we sit down with Dr. Matthew Smith, an asso…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4076</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525420/ab7e6188cbb76db1cc875e59c3731a57.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we sit down with Dr. Matthew Smith, an associate professor in the Northeastern University Department of Philosophy and Religion, for a far-ranging discussion on COVID-19 from a philosopher's point of view. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.33 Hematologic Malignancies and Transplantation with Dr. Aaron Goodman]]></title><description><![CDATA[Today we are joined by Dr. Aaron Goodman, an Assistant Clinical Professor at the University of California San Diego, who talks with us about hematologic malignancies, transplantation, and our new paper out now in Blood titled "Persistent Challenges with Treating Multiple Myeloma Early".<br/><br/>Persistent Challenges: <a href="http://doi.org/10.1182/blood.2020009752" class="linkified" target="_blank">doi.org/10.1182/blood.2020009752</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/333-hematologic-malignancies-and-7d8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/963918316</guid><pubDate>Tue, 12 Jan 2021 02:21:14 GMT</pubDate><enclosure length="45884088" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525421/c9a13fc11e73bf36c66c1681b9031c3a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we are joined by Dr. Aaron Goodman, an Assi…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2868</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525421/35d4d0686b9a69ea0064a06468397a04.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we are joined by Dr. Aaron Goodman, an Assistant Clinical Professor at the University of California San Diego, who talks with us about hematologic malignancies, transplantation, and our new paper out now in Blood titled "Persistent Challenges with Treating Multiple Myeloma Early". Persistent Challenges: doi.org/10.1182/blood.2020009752 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.32 Publishing Original Thought in Medical Journals with Dr. Stephen Bradley]]></title><description><![CDATA[Today we talk with Dr. Stephen Bradley, a General Practitioner and Clinical Research Fellow at the University of Leeds, on publishing in medical journals -- peer review, editorial practices, anti-intellectualism, and more!<br/><br/>Notes on Nationalism: <a href="http://www.orwellfoundation.com/the-orwell-foundation/orwell/essays-and-other-works/notes-on-nationalism/" class="linkified" target="_blank">www.orwellfoundation.com/the-orwell-foundation/orwell/essays-and-other-works/notes-on-nationalism/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/332-publishing-original-thought-in-597</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/962111353</guid><pubDate>Fri, 08 Jan 2021 23:56:31 GMT</pubDate><enclosure length="50078726" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525422/d964034bb4d1772a6b9520fd2b689927.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we talk with Dr. Stephen Bradley, a General…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3130</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525422/29fc406c6e6977e411389a84d0df22b5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we talk with Dr. Stephen Bradley, a General Practitioner and Clinical Research Fellow at the University of Leeds, on publishing in medical journals -- peer review, editorial practices, anti-intellectualism, and more! Notes on Nationalism: www.orwellfoundation.com/the-orwell-foundation/orwell/essays-and-other-works/notes-on-nationalism/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.31 Random Thoughts on Visiting Hospital Patients During COVID-19 and Norman Wang's Lawsuit]]></title><description><![CDATA[Today we have for you an episode of random thoughts. We talk over the ramifications of the strict COVID-19 policy that prevents people from visiting their dying loved ones in the hospital. We also talk more about Norman Wang and his surrounding controversy given the recent lawsuit the Center for Individual Rights has filed against the University of Pittsburgh on his behalf.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/331-random-thoughts-on-visiting-hospital-5f8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/960144901</guid><pubDate>Wed, 06 Jan 2021 02:10:03 GMT</pubDate><enclosure length="39105208" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525423/beebd3253035e8de1776a0ead1b1b505.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we have for you an episode of random though…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2444</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525423/f4a9a74c191bcfd2ec89a824482da46c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we have for you an episode of random thoughts. We talk over the ramifications of the strict COVID-19 policy that prevents people from visiting their dying loved ones in the hospital. We also talk more about Norman Wang and his surrounding controversy given the recent lawsuit the Center for Individual Rights has filed against the University of Pittsburgh on his behalf. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.30 Benefit and Risk of SpaceOAR with Dr. William Hall]]></title><description><![CDATA[On today's episode we interview Dr. Bill Hall, Associate Professor of Radiation Oncology and Surgery at Medical College of Wisconsin, on our new paper out now in The Lancet Oncology titled "Considering benefit and risk before routinely recommending SpaceOAR".<br/><br/>SpaceOAR: <a href="http://doi.org/10.1016/S1470-2045(20)30639-2" class="linkified" target="_blank">doi.org/10.1016/S1470-2045(20)30639-2</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/330-benefit-and-risk-of-spaceoar-844</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/959559412</guid><pubDate>Tue, 05 Jan 2021 04:43:41 GMT</pubDate><enclosure length="39646883" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525424/7dd37950eec0f20d69c9aa878c3e246b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we interview Dr. Bill Hall, As…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2478</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525424/0ca8324b9ee420b4d35e8cab4065618e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we interview Dr. Bill Hall, Associate Professor of Radiation Oncology and Surgery at Medical College of Wisconsin, on our new paper out now in The Lancet Oncology titled "Considering benefit and risk before routinely recommending SpaceOAR". SpaceOAR: doi.org/10.1016/S1470-2045(20)30639-2 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.29 Censorship in Medicine with Jonathan Darrow]]></title><description><![CDATA[On today's episode we discuss censorship in medicine in all its forms with legal expert Jonathan Darrow, an Assistant Professor at Harvard Medical School.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/329-censorship-in-medicine-with-jonathan-71a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/956884876</guid><pubDate>Thu, 31 Dec 2020 02:21:03 GMT</pubDate><enclosure length="59052311" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525425/54bb9cb89f19c9bae4b880b0fdefdb43.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we discuss censorship in medic…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3691</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525425/fb8e4d0f4652e99533c2a4b13c207088.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we discuss censorship in medicine in all its forms with legal expert Jonathan Darrow, an Assistant Professor at Harvard Medical School. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.28 Exploring the History of Medicine with Dr. Adam Rodman, host of Bedside Rounds]]></title><description><![CDATA[On today's episode we talk podcasting and the history of medicine with Dr. Adam Rodman, the creator and host of the wildly popular podcast Bedside Rounds, and a hospitalist at the Beth Israel Deaconess Medical Center.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/328-exploring-the-history-of-medicine-22b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/951815800</guid><pubDate>Mon, 21 Dec 2020 18:30:20 GMT</pubDate><enclosure length="70671158" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525426/01fb0449c5846b70e697d26aa24f6d13.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we talk podcasting and the his…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4417</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525426/d2fda8cef213011dd00114938d71cc4e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we talk podcasting and the history of medicine with Dr. Adam Rodman, the creator and host of the wildly popular podcast Bedside Rounds, and a hospitalist at the Beth Israel Deaconess Medical Center. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.27 All Recent Acute Myeloid Leukemia Drugs with Dr. Bernard Marini]]></title><description><![CDATA[On today's episode we discuss all the new drugs for acute myeloid leukemia with Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology at University of Michigan Medicine.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/327-all-recent-acute-myeloid-leukemia-4ca</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/949061353</guid><pubDate>Wed, 16 Dec 2020 23:38:59 GMT</pubDate><enclosure length="54691743" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525427/c5193606b71fd268d870850885ff7967.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On today's episode we discuss all the new drugs f…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3418</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525427/52e7ed5f62e42fe45efb0c05b55eb43b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On today's episode we discuss all the new drugs for acute myeloid leukemia with Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology at University of Michigan Medicine. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.26 The Importance of Debate and Dialogue with Dr. Saurabh Jha]]></title><description><![CDATA[Today's episode is an interview with Dr. Saurabh Jha, an Associate Professor of Radiology at the Hospital of the University of Pennsylvania, on the importance of debate and dialogue both historically and in today's modern context.<br/><br/>This is the second episode in our experiment in breaking our content up into bite-sized, single-topic episodes. What do you think? Do you prefer a shorter, single-focus episode, or do you prefer our old format?<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/326-the-importance-of-debate-and-d43</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/947714968</guid><pubDate>Tue, 15 Dec 2020 03:59:27 GMT</pubDate><enclosure length="55591609" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525428/75d91fe2a20990af6cf9b796e396f862.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today's episode is an interview with Dr. Saurabh …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3474</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525428/c6ca4f039184df50ffb2cb460a6156e5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today's episode is an interview with Dr. Saurabh Jha, an Associate Professor of Radiology at the Hospital of the University of Pennsylvania, on the importance of debate and dialogue both historically and in today's modern context. This is the second episode in our experiment in breaking our content up into bite-sized, single-topic episodes. What do you think? Do you prefer a shorter, single-focus episode, or do you prefer our old format? Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.25 Public Health Policy on the Risk of COVID-19 in Children with Dr. Alasdair Munro]]></title><description><![CDATA[Now that we are nine months into the COVID-19 pandemic in the United States, we invite Dr. Alasdair Munro, a pediatrics infectious disease expert, back on to the show to discuss recent developments in public health policy concerning the spread of COVID-19, the risk of it, and children. We also talk about the rigorously policed echo chamber of Twitter, specifically #medtwitter, and finding an audience for controversial opinions.<br/>This week is also the start of an experiment in breaking our content up into bite-sized, single-topic episodes. What do you think? Do you prefer a shorter, single-focus episode, or do you prefer our old format?<br/><br/>Evidence summary of pediatric COVID-19: <a href="https://dontforgetthebubbles.com/evidence-summary-paediatric-covid-19-literature/" class="linkified" target="_blank">https://dontforgetthebubbles.com/evidence-summary-paediatric-covid-19-literature/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/325-public-health-policy-on-the-risk-ff0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/945967978</guid><pubDate>Sat, 12 Dec 2020 02:18:47 GMT</pubDate><enclosure length="52148879" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525429/8fe844d9333a440f640d6424d73551c0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Now that we are nine months into the COVID-19 pan…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3259</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525429/a20d5b5c019442bff3784014b885cc76.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Now that we are nine months into the COVID-19 pandemic in the United States, we invite Dr. Alasdair Munro, a pediatrics infectious disease expert, back on to the show to discuss recent developments in public health policy concerning the spread of COVID-19, the risk of it, and children. We also talk about the rigorously policed echo chamber of Twitter, specifically #medtwitter, and finding an audience for controversial opinions. This week is also the start of an experiment in breaking our content up into bite-sized, single-topic episodes. What do you think? Do you prefer a shorter, single-focus episode, or do you prefer our old format? Evidence summary of pediatric COVID-19: https://dontforgetthebubbles.com/evidence-summary-paediatric-covid-19-literature/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.24 KEYNOTE-177 & Mathematic Models for Fighting COVID-19 with Dr. Wesley Pegden]]></title><description><![CDATA[This week we return to our roots of oncology and dissect the recent results from KEYNOTE-177. We also have an in-depth interview with mathematician Dr. Wes Pegden of Carnegie Mellon University on a mathematical approach to the COVID-19 pandemic.<br/><br/>KEYNOTE-177: <a href="http://doi.org/0.1056/NEJMoa2017699" class="linkified" target="_blank">doi.org/0.1056/NEJMoa2017699</a><br/>COVID-19 Mathematical Model: <a href="https://math.cmu.edu/~wes/covid.html" class="linkified" target="_blank">https://math.cmu.edu/~wes/covid.html</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/324-keynote-177-and-mathematic-models-ef9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/941623645</guid><pubDate>Fri, 04 Dec 2020 23:04:47 GMT</pubDate><enclosure length="73328961" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525430/b39f535c240a5d41563d7602a6c2277b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we return to our roots of oncology and …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4583</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525430/e6d37cf0e31ef3f1a375486935bc31bb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we return to our roots of oncology and dissect the recent results from KEYNOTE-177. We also have an in-depth interview with mathematician Dr. Wes Pegden of Carnegie Mellon University on a mathematical approach to the COVID-19 pandemic. KEYNOTE-177: doi.org/0.1056/NEJMoa2017699 COVID-19 Mathematical Model: https://math.cmu.edu/~wes/covid.html Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.23 Capturing Your Audience with Dr. Zubin "ZDoggMD" Damania & JAVELIN 100 with Dr. Karine Tawagi]]></title><description><![CDATA[We have a short and sweet episode for you this week -- no monologue, just two deep-dives with two stellar guests. Our first interview is with Dr. Zubin Damania (known as ZDoggMD) and we cover everything from making original music to the artistry of professional oratory to the pain of electronic health records. Our second interview is a return to our popular segment Journal Club with a Fellow: We invite on Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the JAVELIN 100 study.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/323-capturing-your-audience-with-308</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/936258811</guid><pubDate>Thu, 26 Nov 2020 05:00:48 GMT</pubDate><enclosure length="67628415" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525431/32a6fb343dba81a1dcc3a78d8729b22b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a short and sweet episode for you this we…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4227</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525431/d7b9a3f6de3a852412263c8e0c0eb513.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a short and sweet episode for you this week -- no monologue, just two deep-dives with two stellar guests. Our first interview is with Dr. Zubin Damania (known as ZDoggMD) and we cover everything from making original music to the artistry of professional oratory to the pain of electronic health records. Our second interview is a return to our popular segment Journal Club with a Fellow: We invite on Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the JAVELIN 100 study. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.22 New Podcast, Opening Schools with Dr. Vladimir Kogan, Virtual Learning with Dr. Carycruz Bueno]]></title><description><![CDATA[Our first guests this week are Drs. Adam Cifu and Scott Stern and are on to discuss their new podcast Symptom to Diagnosis -- based on their book of the same name -- about clinical reasoning. Next we bring back political scientist Dr. Vlad Kogan (from episode 3.13) to discuss the need to re-open schools in the context of rising COVID-19 cases and a changing political landscape. Finally we interview Dr. Carycruz Bueno on her critical research into the harms of fully virtual schooling.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/322-new-podcast-opening-schools-with-877</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/933209284</guid><pubDate>Sat, 21 Nov 2020 01:09:57 GMT</pubDate><enclosure length="178629597" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525432/a612924054688f18598e06983881a24b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Our first guests this week are Drs. Adam Cifu and…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>11164</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525432/5badf947a8b03eaa93c130a7763845b0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Our first guests this week are Drs. Adam Cifu and Scott Stern and are on to discuss their new podcast Symptom to Diagnosis -- based on their book of the same name -- about clinical reasoning. Next we bring back political scientist Dr. Vlad Kogan (from episode 3.13) to discuss the need to re-open schools in the context of rising COVID-19 cases and a changing political landscape. Finally we interview Dr. Carycruz Bueno on her critical research into the harms of fully virtual schooling. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.21 Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola]]></title><description><![CDATA[First up this week we interview constitutional law scholar Leah Litman, an Assistant Professor of Law at the University of Michigan, on Dr. Norman Wang and the intricacies of the laws on affirmative action. Next, we talk with Dr. Patrick DeMartino, a pediatric hematology/oncology fellow at Oregon Health & Science University, on his new paper out now in JAMA Internal Medicine: "Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018". Finally, we sit down with Dr. John Mandrola for an in-depth discussion on the intersection of medicine, politics, and advocacy. <br/><br/>Cost Implications: <a href="http://doi.org/10.1001/jamainternmed.2020.5921" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2020.5921</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/321-affirmative-action-with-leah-582</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/928911187</guid><pubDate>Fri, 13 Nov 2020 23:36:01 GMT</pubDate><enclosure length="177060579" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525433/645195d67bf85ffe3764df5ef0012630.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>First up this week we interview constitutional la…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>11066</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525433/174aab1172d42cf33b04aa59eb9f44a2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>First up this week we interview constitutional law scholar Leah Litman, an Assistant Professor of Law at the University of Michigan, on Dr. Norman Wang and the intricacies of the laws on affirmative action. Next, we talk with Dr. Patrick DeMartino, a pediatric hematology/oncology fellow at Oregon Health &amp; Science University, on his new paper out now in JAMA Internal Medicine: "Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018". Finally, we sit down with Dr. John Mandrola for an in-depth discussion on the intersection of medicine, politics, and advocacy. Cost Implications: doi.org/10.1001/jamainternmed.2020.5921 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.20 Public Health Messaging, COVID-19 in the U.S. Northeast, Journal Club with a Fellow]]></title><description><![CDATA[We have a multitude of interviews for you this week. We start by interviewing Dr. Julia Marcus of the Harvard Medical School and Harvard Pilgrim Health Care Institute on messaging around public health interventions during the COVID-19 pandemic. We continue talking about COVID-19 with Anne Sosin and Dr. Elizabeth Carpenter-Song, both of Dartmouth College. They join us on the podcast to discuss how the Northeast region of the United States has uniquely handled COVID-19. Finally, we bring back the Journal Club with a Fellow segment and interview Dr. David Russler-Germain of Washington University School of Medicine in St. Louis on a new paper out now in The Lancet on CAR T-cell therapy in DLBCL: TRANSCEND NHL 001.<br/><br/>TRANSCEND NHL 001: <a href="http://doi.org/10.1016/S0140-6736(20)31366-0" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(20)31366-0</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/320-public-health-messaging-covid-fbb</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/924838261</guid><pubDate>Sat, 07 Nov 2020 05:59:12 GMT</pubDate><enclosure length="175593542" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525434/3519c85cca7856bb180ceec83e0569e3.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a multitude of interviews for you this we…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>10975</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525434/54589901f3e74235c03c6c88cadefb96.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a multitude of interviews for you this week. We start by interviewing Dr. Julia Marcus of the Harvard Medical School and Harvard Pilgrim Health Care Institute on messaging around public health interventions during the COVID-19 pandemic. We continue talking about COVID-19 with Anne Sosin and Dr. Elizabeth Carpenter-Song, both of Dartmouth College. They join us on the podcast to discuss how the Northeast region of the United States has uniquely handled COVID-19. Finally, we bring back the Journal Club with a Fellow segment and interview Dr. David Russler-Germain of Washington University School of Medicine in St. Louis on a new paper out now in The Lancet on CAR T-cell therapy in DLBCL: TRANSCEND NHL 001. TRANSCEND NHL 001: doi.org/10.1016/S0140-6736(20)31366-0 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.19 COVID-19 and the AIDS Pandemics with Dr. Monica Gandhi & Classical Hematology Chat]]></title><description><![CDATA[We talk this week with Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH. Speaking from decades of experience treating HIV/AIDS patients, she gives us her take on the public health policies enacted in response to the COVID-19 pandemic. We then conclude this week's episode with a Classical Hematology Chat with Dr. Sven Olson of Oregon Health & Science University. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/319-covid-19-and-the-aids-pandemics-aeb</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/920669341</guid><pubDate>Fri, 30 Oct 2020 23:55:33 GMT</pubDate><enclosure length="98114775" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525435/d739037f9f5eebf97a4362242253bc85.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We talk this week with Dr. Monica Gandhi, Associa…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6132</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525435/8fb9cce07880f1e8c93c9474ed0f01bd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We talk this week with Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH. Speaking from decades of experience treating HIV/AIDS patients, she gives us her take on the public health policies enacted in response to the COVID-19 pandemic. We then conclude this week's episode with a Classical Hematology Chat with Dr. Sven Olson of Oregon Health &amp; Science University. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.18 Social Media and News with Dr. Benjamin Mazer & Caplacizumab for TTP with Dr. Tem Bendapudi]]></title><description><![CDATA[This week we have two fantastic interviews for you: The first is with Dr. Ben Mazer on the interplay between social media and news; the second is with Dr. Tem Bendapudi on whether Caplacizumab should be the standard of care for thrombotic thrombocytopenic purpura (TTP).<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/318-social-media-and-news-with-dr-461</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/916767676</guid><pubDate>Fri, 23 Oct 2020 21:18:12 GMT</pubDate><enclosure length="125506984" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525436/8524b88945e8cc037eb7dddbaea7c8e8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we have two fantastic interviews for yo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7844</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525436/3c7515105c025cbab787e708251e442f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we have two fantastic interviews for you: The first is with Dr. Ben Mazer on the interplay between social media and news; the second is with Dr. Tem Bendapudi on whether Caplacizumab should be the standard of care for thrombotic thrombocytopenic purpura (TTP). Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.17 COVID-19 and Schools in Norway with Dr. Atle Fretheim & Cancer Biology with Dr. Anthony Letai]]></title><description><![CDATA[This week we sit down virtually with Dr. Atle Fretheim, Research Director of the Norwegian Institute of Public Health, to talk about how Norway has responded to the COVID-19 crisis - specifically, how they've handled it when it comes to public schools. We also have an interview with Dr. Anthony "Tony" Letai of the Dana Farber Cancer Center on cancer biology. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/317-covid-19-and-schools-in-norway-b6e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/911943640</guid><pubDate>Fri, 16 Oct 2020 23:21:00 GMT</pubDate><enclosure length="149390426" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525437/a7e159f687852a59e2f40337f6749de1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we sit down virtually with Dr. Atle Fre…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9337</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525437/9b58835c8d93582aa316fa6b16862312.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we sit down virtually with Dr. Atle Fretheim, Research Director of the Norwegian Institute of Public Health, to talk about how Norway has responded to the COVID-19 crisis - specifically, how they've handled it when it comes to public schools. We also have an interview with Dr. Anthony "Tony" Letai of the Dana Farber Cancer Center on cancer biology. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.16 Non-Drug Interventions with Dr. Margaret McCartney & Cancer Biology with Dr. Jason Sheltzer]]></title><description><![CDATA[We start this week's episode off with a monologue covering a few current events, notably the recent editorial on the COVID-19 pandemic in the USA published by the New England Journal of Medicine titled "Dying in a Leadership Vacuum". From there we interview Dr. Margaret McCartney on her recent opinion piece in the BMJ titled "We need better evidence on non-drug interventions for covid-19"; we talk about masks, schools, the need for randomized trials, and more. Finally, we interview Dr. Jason Sheltzer on his recent papers on cancer biology and the implications of his findings on clinical medicine.<br/><br/>NEJM editorial: <a href="http://doi.org/10.1056/NEJMe2029812" class="linkified" target="_blank">doi.org/10.1056/NEJMe2029812</a><br/>Non-Drug Interventions: <a href="https://blogs.bmj.com/bmj/2020/08/28/margaret-mccartney-we-need-better-evidence-on-non-drug-interventions-for-covid-19/" class="linkified" target="_blank">https://blogs.bmj.com/bmj/2020/08/28/margaret-mccartney-we-need-better-evidence-on-non-drug-interventions-for-covid-19/</a><br/>Dr. Sheltzer's research: <a href="https://www.sheltzerlab.org/research" class="linkified" target="_blank">https://www.sheltzerlab.org/research</a><br/>You can reach Dr. Sheltzer at sheltzer at cshl dot edu.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/316-non-drug-interventions-with-dr-687</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/907973908</guid><pubDate>Fri, 09 Oct 2020 22:28:25 GMT</pubDate><enclosure length="137863529" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525438/eaa896c499a251a59e166b601fb56241.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode off with a monologue…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>8616</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525438/150978a0639529f0d24b7beda9b06145.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode off with a monologue covering a few current events, notably the recent editorial on the COVID-19 pandemic in the USA published by the New England Journal of Medicine titled "Dying in a Leadership Vacuum". From there we interview Dr. Margaret McCartney on her recent opinion piece in the BMJ titled "We need better evidence on non-drug interventions for covid-19"; we talk about masks, schools, the need for randomized trials, and more. Finally, we interview Dr. Jason Sheltzer on his recent papers on cancer biology and the implications of his findings on clinical medicine. NEJM editorial: doi.org/10.1056/NEJMe2029812 Non-Drug Interventions: https://blogs.bmj.com/bmj/2020/08/28/margaret-mccartney-we-need-better-evidence-on-non-drug-interventions-for-covid-19/ Dr. Sheltzer's research: https://www.sheltzerlab.org/research You can reach Dr. Sheltzer at sheltzer at cshl dot edu. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.15 COVID-19 in Children with Dr. Alasdair Munro & Pandemic Public Health with Dr. Stefan Baral]]></title><description><![CDATA[We start this week's episode by interviewing Dr. Alasdair Munro, a pediatrics infectious disease expert, on the risk of spread of COVID-19 in children and through schools. We end with an interview with Dr. Stefan Baral, a field epidemiologist studying COVID-19, on the nature of public health during a global pandemic. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/315-covid-19-in-children-with-dr-ffc</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/905662324</guid><pubDate>Tue, 06 Oct 2020 15:45:45 GMT</pubDate><enclosure length="114176946" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525439/46025b571ccbdc0f69f52c636e5413d5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode by interviewing Dr. …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7136</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525439/d4ff92aafea696cf9a0c7f2a56242eef.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode by interviewing Dr. Alasdair Munro, a pediatrics infectious disease expert, on the risk of spread of COVID-19 in children and through schools. We end with an interview with Dr. Stefan Baral, a field epidemiologist studying COVID-19, on the nature of public health during a global pandemic. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival]]></title><description><![CDATA[This week we have a two-hour-long, far-ranging interview with Dr. John Ioannidis of Stanford University on, broadly, meta-research and COVID-19 - including his recent controversies. We end the episode with an interview with Dr. Mary-Elizabeth Percival of the University of Washington on her new paper out now in Haematologica: "Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility". <br/><br/>High-Grade Myeloid Neoplasms: <a href="http://doi.org/10.3324/haematol.2020.254938" class="linkified" target="_blank">doi.org/10.3324/haematol.2020.254938</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/314-covid-19-with-dr-john-ioannidis-3d2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/903751621</guid><pubDate>Sat, 03 Oct 2020 01:45:54 GMT</pubDate><enclosure length="154371663" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525441/13155b044c95c5d2bf643bb647a5e64e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we have a two-hour-long, far-ranging in…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9648</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525441/da0554bceb1e9e034411c9c529693dc9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we have a two-hour-long, far-ranging interview with Dr. John Ioannidis of Stanford University on, broadly, meta-research and COVID-19 - including his recent controversies. We end the episode with an interview with Dr. Mary-Elizabeth Percival of the University of Washington on her new paper out now in Haematologica: "Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility". High-Grade Myeloid Neoplasms: doi.org/10.3324/haematol.2020.254938 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.13 COVID-19 and Schools, COVID-19 and Scott Atlas, and COVID-19 Policy]]></title><description><![CDATA[This week's episode is all about COVID-19. We discuss general COVID-19 health policy and how spread of SARS-CoV-2 has been managed and should be managed; we discuss whether or not schools should be re-opened; and we discuss Dr. Scott Atlas's views. Our special guests are political scientist Dr. Vladimir Kogan, epidemiologist Dr. Daniel Morgan, and health economist Dr. Jay Bhattacharya.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/313-covid-19-and-schools-covid-19-ef1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/899135857</guid><pubDate>Fri, 25 Sep 2020 00:17:40 GMT</pubDate><enclosure length="157548991" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525442/3b56d86288c255d2733b12ae0ed83f90.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's episode is all about COVID-19. We dis…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9847</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525442/69e560caf2be3084da0c6a47bf77c5dd.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's episode is all about COVID-19. We discuss general COVID-19 health policy and how spread of SARS-CoV-2 has been managed and should be managed; we discuss whether or not schools should be re-opened; and we discuss Dr. Scott Atlas's views. Our special guests are political scientist Dr. Vladimir Kogan, epidemiologist Dr. Daniel Morgan, and health economist Dr. Jay Bhattacharya. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.12 TMPRSS2, Cancer Imaging with Drs. Becker and Woo, Clinical Epidemiology with Dr. Thomas Newman]]></title><description><![CDATA[We start this week's episode by critically examining the new paper titled "Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2)" and asking, is it racist? After that, we discuss advances in prostate cancer imaging with two imaging specialists from Memorial Sloan Kettering Cancer Center, Drs. Anton Becker and Sungmin Woo. Finally, we have a far-reaching interview with Dr. Thomas Newman of University of California San Francisco on clinical epidemiology and his new book Evidence-Based Diagnosis: An Introduction to Clinical Epidemiology.<br/><br/>TMPRSS2 and COVID-19: <a href="http://doi.org/10.1001/jama.2020.17386" class="linkified" target="_blank">doi.org/10.1001/jama.2020.17386</a><br/>PSMA PET-CT: <a href="http://doi.org/10.1016/S0140-6736(20)30314-7" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(20)30314-7</a><br/>Evidence-Based Diagnosis: <a href="https://www.cambridge.org/core/books/evidencebased-diagnosis/2807345CA679EC723697ED9C6D98A1AA" class="linkified" target="_blank">https://www.cambridge.org/core/books/evidencebased-diagnosis/2807345CA679EC723697ED9C6D98A1AA</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/312-tmprss2-cancer-imaging-with-drs-9ec</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/896007982</guid><pubDate>Sat, 19 Sep 2020 15:10:29 GMT</pubDate><enclosure length="149469004" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525443/4d5eff6205c6b3f75d157e469ddf041f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode by critically examin…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9342</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525443/93779a0dae1d716820385149f8c9d605.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode by critically examining the new paper titled "Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2)" and asking, is it racist? After that, we discuss advances in prostate cancer imaging with two imaging specialists from Memorial Sloan Kettering Cancer Center, Drs. Anton Becker and Sungmin Woo. Finally, we have a far-reaching interview with Dr. Thomas Newman of University of California San Francisco on clinical epidemiology and his new book Evidence-Based Diagnosis: An Introduction to Clinical Epidemiology. TMPRSS2 and COVID-19: doi.org/10.1001/jama.2020.17386 PSMA PET-CT: doi.org/10.1016/S0140-6736(20)30314-7 Evidence-Based Diagnosis: https://www.cambridge.org/core/books/evidencebased-diagnosis/2807345CA679EC723697ED9C6D98A1AA Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.11 Experts, Lockdown, Affirmative Action, & COVID-19 and Hearts with Professor Darrel Francis]]></title><description><![CDATA[This week's monologue touches on the credibility of expert speakers, evaluating the COVID-19 lockdown as health policy, and the anti-affirmative action white paper written by Dr. Norman Wang and its controversy. In the second half of the episode we interview Professor Darrel Francis of Imperial College London on COVID-19 cardiology and Vascepa.<br/><br/>Anti-Affirmative Action: <a href="http://doi.org/10.1161/JAHA.120.015959" class="linkified" target="_blank">doi.org/10.1161/JAHA.120.015959</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/311-experts-lockdown-affirmative-418</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/891904525</guid><pubDate>Sat, 12 Sep 2020 03:46:18 GMT</pubDate><enclosure length="115915241" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525444/421140d910d30bb049894fa382c038fa.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's monologue touches on the credibility …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7245</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525444/732fba7ce7f637a370a7f7632f921083.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's monologue touches on the credibility of expert speakers, evaluating the COVID-19 lockdown as health policy, and the anti-affirmative action white paper written by Dr. Norman Wang and its controversy. In the second half of the episode we interview Professor Darrel Francis of Imperial College London on COVID-19 cardiology and Vascepa. Anti-Affirmative Action: doi.org/10.1161/JAHA.120.015959 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.10 Colon Cancer Screening, Vascepa Patent with Jonathan Darrow, PREVENTT with Dr. Toby Richards]]></title><description><![CDATA[We have a number of topics for you this week! Among them, we cover the issue of colon cancer screening, especially in the light of Chadwick Boseman's recent passing. We interview Jonathan Darrow, an Assistant Professor at Harvard Medical School and faculty at Brigham and Women's Hospital, on patent litigation and the recent patent appeal for Vascepa. Finally, we interview Dr. Toby Richards, Professor of Surgery, on running clinical trials and, specifically, the results of his recent trial PREVENTT, out now in The Lancet. <br/><br/>PREVENTT: <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31539-7/fulltext" class="linkified" target="_blank">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31539-7/fulltext</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/310-colon-cancer-screening-vascepa-143</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/888283189</guid><pubDate>Sat, 05 Sep 2020 16:07:03 GMT</pubDate><enclosure length="117550715" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525445/21986747756850114c54c104aa24ba5d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a number of topics for you this week! Amo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7347</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525445/b0385894bd0dfbd7f69a491edb4d028a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a number of topics for you this week! Among them, we cover the issue of colon cancer screening, especially in the light of Chadwick Boseman's recent passing. We interview Jonathan Darrow, an Assistant Professor at Harvard Medical School and faculty at Brigham and Women's Hospital, on patent litigation and the recent patent appeal for Vascepa. Finally, we interview Dr. Toby Richards, Professor of Surgery, on running clinical trials and, specifically, the results of his recent trial PREVENTT, out now in The Lancet. PREVENTT: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31539-7/fulltext Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.09 COVID-19 Risk, Financial Toxicity, & HALT-IT for Journal Club with Fellow Dr. Justine Ryu]]></title><description><![CDATA[We start this week's episode by revisiting our discussion from last week on the PNAS study on racial concordance and birthing mortality. We continue our theme of critical appraisal by then tearing apart the recent paper published in BMJ titled "Two metres or one: what is the evidence for physical distancing in covid-19?" and its inability to support its colorful figures. We end the monologue with a few thoughts on academics who somehow author one paper a week. Finally, we turn to the last two segments of the show: the first is a discussion with Dr. Bishal Gyawali on his new paper out now in The Lancet Haematology titled "A survey in Nepalese patients with acute leukaemia: a starting point for defining financial toxicity of cancer care in low-income and middle-income countries" and the second is Journal Club with a Fellow, where we interview Dr. Justine Ryu on a paper published in The Lancet titled "Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial".<br/><br/>Racial Concordance: <a href="http://doi.org/10.1073/pnas.1913405117" class="linkified" target="_blank">doi.org/10.1073/pnas.1913405117</a><br/>COVID-19 Risk: <a href="http://doi.org/10.1136/bmj.m3223" class="linkified" target="_blank">doi.org/10.1136/bmj.m3223</a><br/>Financial Toxicity: <a href="http://doi.org/10.1016/S2352-3026(20)30258-1" class="linkified" target="_blank">doi.org/10.1016/S2352-3026(20)30258-1</a><br/>HALT-IT: <a href="http://doi.org/10.1016/S0140-6736(20)30848-5" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(20)30848-5</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/309-covid-19-risk-financial-toxicity-fde</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/883843285</guid><pubDate>Sat, 29 Aug 2020 00:53:59 GMT</pubDate><enclosure length="80726836" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525446/b77e684c167b9300094f840fa34942f2.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode by revisiting our di…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5045</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525446/265f3488f2ed5ed08e38f216bc14ad08.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode by revisiting our discussion from last week on the PNAS study on racial concordance and birthing mortality. We continue our theme of critical appraisal by then tearing apart the recent paper published in BMJ titled "Two metres or one: what is the evidence for physical distancing in covid-19?" and its inability to support its colorful figures. We end the monologue with a few thoughts on academics who somehow author one paper a week. Finally, we turn to the last two segments of the show: the first is a discussion with Dr. Bishal Gyawali on his new paper out now in The Lancet Haematology titled "A survey in Nepalese patients with acute leukaemia: a starting point for defining financial toxicity of cancer care in low-income and middle-income countries" and the second is Journal Club with a Fellow, where we interview Dr. Justine Ryu on a paper published in The Lancet titled "Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial". Racial Concordance: doi.org/10.1073/pnas.1913405117 COVID-19 Risk: doi.org/10.1136/bmj.m3223 Financial Toxicity: doi.org/10.1016/S2352-3026(20)30258-1 HALT-IT: doi.org/10.1016/S0140-6736(20)30848-5 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.08 Racial Concordance in Birthing Mortality & HERO for Journal Club with Fellow Dr. Michael Burns]]></title><description><![CDATA[This week we take a deep dive into two recently published studies, their surrounding controversy, and the broader implications. The first study was published in the journal Proceedings of the National Academy of Sciences of the USA and is titled "Physician–patient racial concordance and disparities in birthing mortality for newborns". The second was published in the New England Journal of Medicine and is titled "Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer", commonly known as the HERO trial. We discuss the HERO trial with Dr. Michael Burns of Northwestern as part of our new segment, Journal Club with a Fellow.<br/><br/>Racial Concordance: <a href="http://doi.org/10.1073/pnas.1913405117" class="linkified" target="_blank">doi.org/10.1073/pnas.1913405117</a><br/>HERO: <a href="http://doi.org/10.1056/NEJMoa2004325" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2004325</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/308-racial-concordance-in-birthing-ac7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/879972478</guid><pubDate>Sat, 22 Aug 2020 03:01:13 GMT</pubDate><enclosure length="89430836" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525447/4442692fca5cd0d0cdde214b2c1e3894.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we take a deep dive into two recently p…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5589</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525447/ace15bc7ed3866be007a270314d5a9a5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we take a deep dive into two recently published studies, their surrounding controversy, and the broader implications. The first study was published in the journal Proceedings of the National Academy of Sciences of the USA and is titled "Physician–patient racial concordance and disparities in birthing mortality for newborns". The second was published in the New England Journal of Medicine and is titled "Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer", commonly known as the HERO trial. We discuss the HERO trial with Dr. Michael Burns of Northwestern as part of our new segment, Journal Club with a Fellow. Racial Concordance: doi.org/10.1073/pnas.1913405117 HERO: doi.org/10.1056/NEJMoa2004325 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.07 Lung Cancer Omics and Mortality, PPIs and COVID-19, & RECIST with Dr. Elizabeth Eisenhauer]]></title><description><![CDATA[We have a lot in store for you this week! We start off by evaluating two recently published studies: "Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer" (published in the Journal of Clinical Oncology: Oncology Practice) and "The Effect of Advances in Lung-Cancer Treatment on Population Mortality" (published in the New England Journal of Medicine). We talk a bit about tracking down the validity of a reference. We sit down with Dr. Branden Tarlow to discuss his thoughts on PPIs and COVID-19 acquisition. Finally, we conclude the episode by interviewing Dr. Elizabeth Eisenhauer of Queen's University in Kingston, Ontario, Canada on her career in cancer medicine.<br/><br/>Omics-Based Strategies: <a href="http://doi.org/10.1200/OP.20.00117" class="linkified" target="_blank">doi.org/10.1200/OP.20.00117</a><br/>Population Mortality: <a href="http://doi.org/10.1056/NEJMoa1916623" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1916623</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/307-lung-cancer-omics-and-mortality-54f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/876054343</guid><pubDate>Sat, 15 Aug 2020 00:53:28 GMT</pubDate><enclosure length="155578728" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525448/6c795df53a52ec507e5dfd00a31e6cc9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a lot in store for you this week! We star…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9724</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525448/42e53d4a5df0ef18fd0bcf45dd2be70d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a lot in store for you this week! We start off by evaluating two recently published studies: "Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer" (published in the Journal of Clinical Oncology: Oncology Practice) and "The Effect of Advances in Lung-Cancer Treatment on Population Mortality" (published in the New England Journal of Medicine). We talk a bit about tracking down the validity of a reference. We sit down with Dr. Branden Tarlow to discuss his thoughts on PPIs and COVID-19 acquisition. Finally, we conclude the episode by interviewing Dr. Elizabeth Eisenhauer of Queen's University in Kingston, Ontario, Canada on her career in cancer medicine. Omics-Based Strategies: doi.org/10.1200/OP.20.00117 Population Mortality: doi.org/10.1056/NEJMoa1916623 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.06 COVID-19 Vaccine Access, ADAURA, QOTW, & Journal Club with Fellow Dr. Karine Tawagi]]></title><description><![CDATA[We start this week's episode by discussing access to investigational COVID-19 vaccines and recapping the problems with the ADAURA study. We transition from there to a Question of the Week with medical student Audrey Tran of Oregon Health & Science University. Finally, we introduce a new segment - Journal Club with a Fellow. In this inaugural segment we invite Dr. Karine Tawagi of the Oschner Clinic in Louisiana to the podcast to talk about IMbrave150. <br/><br/>IMbrave150: <a href="http://doi.org/10.1056/NEJMoa1915745" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1915745</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/306-covid-19-vaccine-access-adaura-67a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/872107600</guid><pubDate>Fri, 07 Aug 2020 22:31:54 GMT</pubDate><enclosure length="111030131" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525449/2ee909daffb4f0380b24ff7a89ccee96.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode by discussing access…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6939</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525449/6f78a688794b78ede8781b3d5ebeb2ed.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode by discussing access to investigational COVID-19 vaccines and recapping the problems with the ADAURA study. We transition from there to a Question of the Week with medical student Audrey Tran of Oregon Health &amp; Science University. Finally, we introduce a new segment - Journal Club with a Fellow. In this inaugural segment we invite Dr. Karine Tawagi of the Oschner Clinic in Louisiana to the podcast to talk about IMbrave150. IMbrave150: doi.org/10.1056/NEJMoa1915745 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.05 LIVE! A Midsummer Night's Stream]]></title><description><![CDATA[This is the recording of a LIVE episode of Plenary Session in which Dr. Sue S Yom interviewed our host, Dr. Vinay Prasad, on how he built his career and how he conceptualizes his work. There's also a surprise guest near the end! Thank you to Dr. Kaleigh Doke, Dr. Brian Kavanagh, and the Virtual Visiting Professor Network for hosting this special episode. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/305-live-a-midsummer-nights-stream-65d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/867456016</guid><pubDate>Thu, 30 Jul 2020 22:41:56 GMT</pubDate><enclosure length="73129172" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525450/65e91c5d56ecd4b1ce161ce0d67daedb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is the recording of a LIVE episode of Plenar…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4571</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525450/a8cc9b4be610979c44f3edf4003bf6e7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is the recording of a LIVE episode of Plenary Session in which Dr. Sue S Yom interviewed our host, Dr. Vinay Prasad, on how he built his career and how he conceptualizes his work. There's also a surprise guest near the end! Thank you to Dr. Kaleigh Doke, Dr. Brian Kavanagh, and the Virtual Visiting Professor Network for hosting this special episode. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.04 Listener Questions & MedTwitter and Risk-Benefit Profile of Ramucirumab with Dr. Bishal Gyawali]]></title><description><![CDATA[This week we respond to several questions sent in by listeners and then we interview Dr. Bishal Gyawali of Queen's University in Kingston, Ontario, Canada on MedTwitter, other recent events, and his recently published paper titled "Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials".<br/><br/>Ramucirumab: <a href="http://doi.org/10.1016/j.eclinm.2020.100458" class="linkified" target="_blank">doi.org/10.1016/j.eclinm.2020.100458</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/304-listener-questions-and-medtwitter-0e6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/864058387</guid><pubDate>Fri, 24 Jul 2020 21:36:36 GMT</pubDate><enclosure length="88107575" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525451/07bf932258ee27ed674ba4f2dffef53f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we respond to several questions sent in…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5507</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525451/9264427708ab2c157a115752129c8061.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we respond to several questions sent in by listeners and then we interview Dr. Bishal Gyawali of Queen's University in Kingston, Ontario, Canada on MedTwitter, other recent events, and his recently published paper titled "Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials". Ramucirumab: doi.org/10.1016/j.eclinm.2020.100458 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.03 The National Lung Matrix Trial & the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg]]></title><description><![CDATA[This week we discuss two major papers: The first was just recently released in Nature and it's titled "The National Lung Matrix Trial of personalized therapy in lung cancer". The second is a few years old, but exemplifies the importance of trial design. We discuss the second paper, titled "A Randomized Trial of Intensive versus Standard Blood-Pressure Control" and published in the New England Journal of Medicine with Dr. Mark Friedberg, a health policies and performance measurement researcher.<br/><br/>National Lung Matrix Trial: <a href="http://doi.org/10.1038/s41586-020-2481-8" class="linkified" target="_blank">doi.org/10.1038/s41586-020-2481-8</a><br/>SPRINT: <a href="http://doi.org/10.1056/NEJMoa1511939" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1511939</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/303-the-national-lung-matrix-trial-692</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/860058319</guid><pubDate>Sat, 18 Jul 2020 01:08:58 GMT</pubDate><enclosure length="66697198" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525452/43d7ad97e19050cceb23ef33cb60410e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss two major papers: The first …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4169</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525452/8ce8b76ddfc89a4e4937d3c29d60171e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss two major papers: The first was just recently released in Nature and it's titled "The National Lung Matrix Trial of personalized therapy in lung cancer". The second is a few years old, but exemplifies the importance of trial design. We discuss the second paper, titled "A Randomized Trial of Intensive versus Standard Blood-Pressure Control" and published in the New England Journal of Medicine with Dr. Mark Friedberg, a health policies and performance measurement researcher. National Lung Matrix Trial: doi.org/10.1038/s41586-020-2481-8 SPRINT: doi.org/10.1056/NEJMoa1511939 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.02 BONUS! National Clinician Scholars Program with Dr. Hilary Seligman]]></title><description><![CDATA[This week's BONUS episode is a discussion of the National Clinician Scholars Program with Dr. Hilary Seligman, the head of the program at University of California, San Francisco. The deadline for the application for the 2021-2023 cohort is July 15, 2020 (very soon!), though there may be some leniency due to the pandemic.<br/><br/>National Clinician Scholars Program: <a href="https://nationalcsp.org/" class="linkified" target="_blank">https://nationalcsp.org/</a><br/>UCSF National Clinician Scholars Program: <a href="https://nationalscholars.ucsf.edu/" class="linkified" target="_blank">https://nationalscholars.ucsf.edu/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/302-bonus-national-clinician-scholars-b37</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/857458891</guid><pubDate>Mon, 13 Jul 2020 23:57:55 GMT</pubDate><enclosure length="33059425" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525453/f36ddbed316190871c85c899ea0966e3.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's BONUS episode is a discussion of the …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2066</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525453/1ebab8ecb83994d2c1ecc7ddcd148877.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's BONUS episode is a discussion of the National Clinician Scholars Program with Dr. Hilary Seligman, the head of the program at University of California, San Francisco. The deadline for the application for the 2021-2023 cohort is July 15, 2020 (very soon!), though there may be some leniency due to the pandemic. National Clinician Scholars Program: https://nationalcsp.org/ UCSF National Clinician Scholars Program: https://nationalscholars.ucsf.edu/ Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[3.01 Risk of COVID-19 Among Users of PPIs, Time to Treatment Initiation, & Dr. Lynora Saxinger]]></title><description><![CDATA[This week we discuss recent research (and the accompanying Twitter thread) on the risk of COVID-19 among users of proton pump inhibitors (PPIs). We also hold a philosophical discussion on the research surrounding time to treatment initiation (TTI) in cancer medicine. We end the episode with an interview with Dr. Lynora Saxinger of the University of Alberta, Edmonton, a specialist in Infectious Diseases.<br/><br/>PPIs and risk of COVID-19: <a href="https://twitter.com/BrennanSpiegel/status/1280527527325265920" class="linkified" target="_blank">https://twitter.com/BrennanSpiegel/status/1280527527325265920</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/301-risk-of-covid-19-among-users-5d1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/855900358</guid><pubDate>Sat, 11 Jul 2020 00:40:58 GMT</pubDate><enclosure length="97673825" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525454/39a6865f992f125b434a1dcc185fa6e4.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss recent research (and the acc…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6105</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525454/1953da5d4ebd9f8982867d7a48bf483b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss recent research (and the accompanying Twitter thread) on the risk of COVID-19 among users of proton pump inhibitors (PPIs). We also hold a philosophical discussion on the research surrounding time to treatment initiation (TTI) in cancer medicine. We end the episode with an interview with Dr. Lynora Saxinger of the University of Alberta, Edmonton, a specialist in Infectious Diseases. PPIs and risk of COVID-19: https://twitter.com/BrennanSpiegel/status/1280527527325265920 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.60 BONUS! Cancer Meta-Research 101: The Lay of the Land of Cancer Research]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given on June 18, 2020 as part of Stanford's METRICS International Forum. METRICS stands for Meta-Research Innovation Center at Stanford University. This lecture is geared towards a broad audience and aims to provide a general sense of current cancer research. The lecture is titled "Cancer Meta-Research 101". <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/260-bonus-cancer-meta-research-101-c13</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/853420039</guid><pubDate>Tue, 07 Jul 2020 02:01:40 GMT</pubDate><enclosure length="50456558" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525455/7e4bdb11f3834b7f8975bf956e5d99e1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3154</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525455/48155732a622444e2c74d0e9e29d4801.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given on June 18, 2020 as part of Stanford's METRICS International Forum. METRICS stands for Meta-Research Innovation Center at Stanford University. This lecture is geared towards a broad audience and aims to provide a general sense of current cancer research. The lecture is titled "Cancer Meta-Research 101". Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.59 The Best Doctor, Selinexor, & Annotation Services for NGS with Drs. Katsoulakis and Kelley]]></title><description><![CDATA[This week we respond to some listener feedback from Dr. Christopher Booth and use it to talk about how to be the best hematologist-oncologist. We also discuss the SADAL study on Selinexor for patients with relapsed refractory diffuse large B-cell lymphoma, as published in The Lancet Haematology.<br/>Finally, we interview Drs. Eva Katsoulakis and Michael Kelley on their recent paper out in the Journal of Clinical Oncology: Precision Oncology, titled "Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program".<br/><br/>Selinexor: <a href="http://doi.org/10.1016/S2352-3026(20)30120-4" class="linkified" target="_blank">doi.org/10.1016/S2352-3026(20)30120-4</a><br/>Annotation Services: <a href="http://doi.org/10.1200/PO.19.00118" class="linkified" target="_blank">doi.org/10.1200/PO.19.00118</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a><br/><br/>Check out our YouTube channel: <a href="https://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" class="linkified" target="_blank">https://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/259-the-best-doctor-selinexor-and-cb0</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/851718469</guid><pubDate>Fri, 03 Jul 2020 20:46:44 GMT</pubDate><enclosure length="72454168" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525456/288781943b841a52a20a1136cc29733e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we respond to some listener feedback fr…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4528</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525456/9ccb33b158c0e092b01aea23f71a583d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we respond to some listener feedback from Dr. Christopher Booth and use it to talk about how to be the best hematologist-oncologist. We also discuss the SADAL study on Selinexor for patients with relapsed refractory diffuse large B-cell lymphoma, as published in The Lancet Haematology. Finally, we interview Drs. Eva Katsoulakis and Michael Kelley on their recent paper out in the Journal of Clinical Oncology: Precision Oncology, titled "Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program". Selinexor: doi.org/10.1016/S2352-3026(20)30120-4 Annotation Services: doi.org/10.1200/PO.19.00118 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: https://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.58 RECOVERY & Twitter, Academic Debate, and Transitioning Your Career with Dr. Andrae Vandross]]></title><description><![CDATA[This week we briefly cover updates on the RECOVERY trial before segueing into an interview with Dr. Andrae Vandross on Twitter (specifically #medtwitter), academic discussions, and changing your career to find your calling. <br/><br/>RECOVERY: <a href="http://www.recoverytrial.net/" class="linkified" target="_blank">www.recoverytrial.net/</a><br/><br/>Malignant audiobook: <a href="http://www.audible.com/pd/B08864KFHW/?so…ACX0_195112_rh_us" class="linkified" target="_blank">www.audible.com/pd/B08864KFHW/?so…ACX0_195112_rh_us</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/258-recovery-and-twitter-academic-ee4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/847660666</guid><pubDate>Sat, 27 Jun 2020 02:33:40 GMT</pubDate><enclosure length="77816584" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525457/852976ed3d26c2552e1c934a8d825358.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we briefly cover updates on the RECOVER…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4864</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525457/d38dfdeaa7735a372f52f299d4753744.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we briefly cover updates on the RECOVERY trial before segueing into an interview with Dr. Andrae Vandross on Twitter (specifically #medtwitter), academic discussions, and changing your career to find your calling. RECOVERY: www.recoverytrial.net/ Malignant audiobook: www.audible.com/pd/B08864KFHW/?so…ACX0_195112_rh_us Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.57 RECOVERY, Clinical Trials in the US, EFS, Writing, Dr. Raj Chetty, & Dr. Ian Tannock]]></title><description><![CDATA[This week's episode is jam-packed with topics! We talk about the RECOVERY trial, the U.S. clinical trial infrastructure, event-free survival (EFS) and cost of care in acute myeloid leukemia, how long it takes to write papers in academic medicine, threats to public health officials, and the application to medicine of Dr. Raj Chetty's work in economics. Finally, we interview this week's special guest, Dr. Ian Tannock, on docetaxel, prostrate cancer, clinical trial appraisal, and his career in medicine.<br/><br/>RECOVERY: <a href="https://www.recoverytrial.net/" class="linkified" target="_blank">https://www.recoverytrial.net/</a><br/>EFS in AML: <a href="http://doi.org/10.1182/bloodadvances.2019001150" class="linkified" target="_blank">doi.org/10.1182/bloodadvances.2019001150</a><br/><br/>Malignant audiobook: <a href="https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us" class="linkified" target="_blank">https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/257-recovery-clinical-trials-in-the-e6b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/843365929</guid><pubDate>Fri, 19 Jun 2020 22:17:48 GMT</pubDate><enclosure length="129304140" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525458/8f26e4ff2ab1f59b1e812aa877ff142f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's episode is jam-packed with topics! We…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>8081</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525458/3ef1d5ca2b51b400b33a743d673f3b74.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's episode is jam-packed with topics! We talk about the RECOVERY trial, the U.S. clinical trial infrastructure, event-free survival (EFS) and cost of care in acute myeloid leukemia, how long it takes to write papers in academic medicine, threats to public health officials, and the application to medicine of Dr. Raj Chetty's work in economics. Finally, we interview this week's special guest, Dr. Ian Tannock, on docetaxel, prostrate cancer, clinical trial appraisal, and his career in medicine. RECOVERY: https://www.recoverytrial.net/ EFS in AML: doi.org/10.1182/bloodadvances.2019001150 Malignant audiobook: https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&amp;ref=acx_bty_BK_ACX0_195112_rh_us Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.56 HER2CLIMB & Misinformation and Disinformation with Dr. Cailin O'Connor]]></title><description><![CDATA[This week we tackle the topic of tucatinib in HER2-positive breast cancer with brain metastases. We also interview Dr. Cailin O'Connor of the University of California Irvine on her research on misinformation and disinformation. We discuss her recent article in the Boston Review, titled "Hydroxychloroquine and the Political Polarization of Science", as well as her extensive body of work.<br/><br/>HER2CLIMB: <a href="http://doi.org/10.1200/JCO.20.00775" class="linkified" target="_blank">doi.org/10.1200/JCO.20.00775</a><br/>Hydroxychloroquine: <a href="http://bostonreview.net/science-nature-politics/cailin-oconnor-james-owen-weatherall-hydroxychloroquine-and-political" class="linkified" target="_blank">http://bostonreview.net/science-nature-politics/cailin-oconnor-james-owen-weatherall-hydroxychloroquine-and-political</a><br/>The Dynamics of Retraction in Epistemic Networks: <a href="http://philsci-archive.pitt.edu/17088/" class="linkified" target="_blank">http://philsci-archive.pitt.edu/17088/</a><br/>How Misinformation Spreads: <a href="https://www.scientificamerican.com/article/how-misinformation-spreads-and-why-we-trust-it/" class="linkified" target="_blank">https://www.scientificamerican.com/article/how-misinformation-spreads-and-why-we-trust-it/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/256-her2climb-and-misinformation-79c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/839004202</guid><pubDate>Fri, 12 Jun 2020 16:40:19 GMT</pubDate><enclosure length="59907033" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525459/32a786204f2cb7a377ed9c1197a2d36a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we tackle the topic of tucatinib in HER…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3744</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525459/e86693f578dcb0f7ef05ba0a74f3bbe3.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we tackle the topic of tucatinib in HER2-positive breast cancer with brain metastases. We also interview Dr. Cailin O'Connor of the University of California Irvine on her research on misinformation and disinformation. We discuss her recent article in the Boston Review, titled "Hydroxychloroquine and the Political Polarization of Science", as well as her extensive body of work. HER2CLIMB: doi.org/10.1200/JCO.20.00775 Hydroxychloroquine: http://bostonreview.net/science-nature-politics/cailin-oconnor-james-owen-weatherall-hydroxychloroquine-and-political The Dynamics of Retraction in Epistemic Networks: http://philsci-archive.pitt.edu/17088/ How Misinformation Spreads: https://www.scientificamerican.com/article/how-misinformation-spreads-and-why-we-trust-it/ Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.55 Hydroxychloroquine for COVID-19, ASCO, QOTW, Private Equity in Medicine with Dr. Jane Zhu]]></title><description><![CDATA[We start this week's episode by covering some recent research: After thoroughly critiquing the recent randomized trial of hydroxychloroquine for postexposure prophylaxis for COVID-19, we then discuss the five abstracts selected for plenary sessions at the recent virtual meeting of the American Society of Clinical Oncology. We transition from there to a Question from a Medical Student with Audrey Tran of Oregon Health & Science University on the recent decision to make the USMLE Step 1 exam pass/fail. Finally, we end with an interview with Dr. Jane Zhu, also of OHSU, on her current research and her new paper published in JAMA titled, "Private Equity Acquisitions of Physician Medical Groups Across Specialties, 2013-2016". Dr. Zhu first guest-starred on Plenary Session in episode 1.31.<br/><br/>Hydroxychloroquine: <a href="http://doi.org/10.1056/NEJMoa2016638" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2016638</a><br/>JAVELIN: <a href="https://meetinglibrary.asco.org/record/186872/abstract" class="linkified" target="_blank">https://meetinglibrary.asco.org/record/186872/abstract</a><br/>ECOG-ACRIN: <a href="https://meetinglibrary.asco.org/record/186884/abstract" class="linkified" target="_blank">https://meetinglibrary.asco.org/record/186884/abstract</a><br/>ENDURANCE: <a href="https://meetinglibrary.asco.org/record/186906/abstract" class="linkified" target="_blank">https://meetinglibrary.asco.org/record/186906/abstract</a><br/>KEYNOTE-177: <a href="https://meetinglibrary.asco.org/record/186928/abstract" class="linkified" target="_blank">https://meetinglibrary.asco.org/record/186928/abstract</a><br/>ADAURA: <a href="https://meetinglibrary.asco.org/record/191929/abstract" class="linkified" target="_blank">https://meetinglibrary.asco.org/record/191929/abstract</a><br/>Private Equity Acquisitions: <a href="http://doi.org/10.1001/jama.2019.21844" class="linkified" target="_blank">doi.org/10.1001/jama.2019.21844</a><br/><br/>Listen to the audiobook of Malignant with a free 30-day trial from Audible! <a href="https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us" class="linkified" target="_blank">https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/255-hydroxychloroquine-for-covid-1b4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/834391324</guid><pubDate>Fri, 05 Jun 2020 02:28:08 GMT</pubDate><enclosure length="121490392" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525460/c789cdd7d14c1bf9d607d56ff720559d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode by covering some rec…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7593</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525460/5cd94a5aca56fce436e714a9a8418867.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode by covering some recent research: After thoroughly critiquing the recent randomized trial of hydroxychloroquine for postexposure prophylaxis for COVID-19, we then discuss the five abstracts selected for plenary sessions at the recent virtual meeting of the American Society of Clinical Oncology. We transition from there to a Question from a Medical Student with Audrey Tran of Oregon Health &amp; Science University on the recent decision to make the USMLE Step 1 exam pass/fail. Finally, we end with an interview with Dr. Jane Zhu, also of OHSU, on her current research and her new paper published in JAMA titled, "Private Equity Acquisitions of Physician Medical Groups Across Specialties, 2013-2016". Dr. Zhu first guest-starred on Plenary Session in episode 1.31. Hydroxychloroquine: doi.org/10.1056/NEJMoa2016638 JAVELIN: https://meetinglibrary.asco.org/record/186872/abstract ECOG-ACRIN: https://meetinglibrary.asco.org/record/186884/abstract ENDURANCE: https://meetinglibrary.asco.org/record/186906/abstract KEYNOTE-177: https://meetinglibrary.asco.org/record/186928/abstract ADAURA: https://meetinglibrary.asco.org/record/191929/abstract Private Equity Acquisitions: doi.org/10.1001/jama.2019.21844 Listen to the audiobook of Malignant with a free 30-day trial from Audible! https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&amp;ref=acx_bty_BK_ACX0_195112_rh_us Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.54 Classical Hematology Chat on Thrombosis in COVID-19 & Drugs for COVID-19 with Dr. Walid Gellad]]></title><description><![CDATA[This week we talk all things COVID-19! We start with an in-depth Classical Hematology Chat with Dr. Sven Olson and Dr. Joseph Shatzel of Oregon Health & Science University on thrombosis and anticoagulation in COVID-19, touching on a number of recent studies. We then turn to a conversation with Dr. Walid Gellad of the University of Pittsburgh on new pharmaceutical treatments for COVID-19.<br/><br/>Tang et al. paper: <a href="http://doi.org/10.1111/jth.14768" class="linkified" target="_blank">doi.org/10.1111/jth.14768</a><br/>Prospective autopsy study: <a href="http://doi.org/10.7326/M20-2566" class="linkified" target="_blank">doi.org/10.7326/M20-2566</a><br/>COVID-19 compared to H1N1: <a href="http://doi.org/10.1056/NEJMoa2015432" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2015432</a><br/>Hypercoagulability of COVID-19: <a href="http://doi.org/10.1111/jth.14850" class="linkified" target="_blank">doi.org/10.1111/jth.14850</a><br/>JACC letter: <a href="http://doi.org/10.1016/j.jacc.2020.05.001" class="linkified" target="_blank">doi.org/10.1016/j.jacc.2020.05.001</a><br/>JACC podcast: <a href="https://podcasts.apple.com/us/podcast/association-treatment-dose-anticoagulation-in-hospital/id932118437?i=1000474262300" class="linkified" target="_blank">https://podcasts.apple.com/us/podcast/association-treatment-dose-anticoagulation-in-hospital/id932118437?i=1000474262300</a><br/>Venous Thromboembolism in COVID-19: <a href="http://doi.org/10.1111/jth.14888" class="linkified" target="_blank">doi.org/10.1111/jth.14888</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/254-classical-hematology-chat-on-fb2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/831426829</guid><pubDate>Sun, 31 May 2020 03:31:11 GMT</pubDate><enclosure length="122243973" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525461/4a3ca231c1ed956d0c646135a845ebaa.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we talk all things COVID-19! We start w…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7640</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525461/d054886ac51ba02bdcc95f127d41175f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we talk all things COVID-19! We start with an in-depth Classical Hematology Chat with Dr. Sven Olson and Dr. Joseph Shatzel of Oregon Health &amp; Science University on thrombosis and anticoagulation in COVID-19, touching on a number of recent studies. We then turn to a conversation with Dr. Walid Gellad of the University of Pittsburgh on new pharmaceutical treatments for COVID-19. Tang et al. paper: doi.org/10.1111/jth.14768 Prospective autopsy study: doi.org/10.7326/M20-2566 COVID-19 compared to H1N1: doi.org/10.1056/NEJMoa2015432 Hypercoagulability of COVID-19: doi.org/10.1111/jth.14850 JACC letter: doi.org/10.1016/j.jacc.2020.05.001 JACC podcast: https://podcasts.apple.com/us/podcast/association-treatment-dose-anticoagulation-in-hospital/id932118437?i=1000474262300 Venous Thromboembolism in COVID-19: doi.org/10.1111/jth.14888 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.53 Why Agreeing 65% with Someone is Important & COVID-19 Health Policy with Dr. Daniel Morgan]]></title><description><![CDATA[This week we discuss why being open-minded enough to agree partially with someone - instead of taking an all-or-nothing approach to a discourse - is important. We also sit down with epidemiologist Dr. Daniel Morgan of the University of Maryland School of Medicine to critique the public health policy concerning COVID-19 transmission.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/253-why-agreeing-65-with-someone-6f4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/826220332</guid><pubDate>Sat, 23 May 2020 02:11:07 GMT</pubDate><enclosure length="61945001" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525462/80651685bcf0a65c75cc9177b17e510d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss why being open-minded enough…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3872</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525462/4c5415c25b0361fb43547f8658f94c20.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss why being open-minded enough to agree partially with someone - instead of taking an all-or-nothing approach to a discourse - is important. We also sit down with epidemiologist Dr. Daniel Morgan of the University of Maryland School of Medicine to critique the public health policy concerning COVID-19 transmission. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.52 Malignant Audiobook, PROfound trial, & Literature and Medicine with Dr. Adam Cifu]]></title><description><![CDATA[This week we have an announcement -- the audiobook of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer", written and narrated by our host Vinay Prasad, is available now on Amazon, iTunes, and Audible!<br/>We also have an in-depth journal club for you on the findings of the PROfound trial as published in a new paper out in the New England Journal of Medicine titled "Olaparib for Metastatic Castration-Resistant Prostate Cancer". <br/>Finally, we end the episode with an interview with Dr. Adam Cifu of the University of Chicago on literature, medicine, maintaining a feeling of normalcy and self during COVID-19, and more! <br/><br/>Listen to Malignant with a free 30-day trial of Audible: <a href="https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us" class="linkified" target="_blank">https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us</a><br/><br/>PROfound: <a href="http://doi.org/10.1056/NEJMoa1911440" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1911440</a><br/>Crossover: <a href="http://doi.org/10.1093/annonc/mdy116" class="linkified" target="_blank">doi.org/10.1093/annonc/mdy116</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/252-malignant-audiobook-profound-3ae</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/821442376</guid><pubDate>Sat, 16 May 2020 00:42:45 GMT</pubDate><enclosure length="99461854" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525463/4491ef19f459552ec2cae11836896721.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we have an announcement -- the audioboo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6216</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525463/83ce08a96328a806ddd0c97d5bd0a4dc.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we have an announcement -- the audiobook of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer", written and narrated by our host Vinay Prasad, is available now on Amazon, iTunes, and Audible! We also have an in-depth journal club for you on the findings of the PROfound trial as published in a new paper out in the New England Journal of Medicine titled "Olaparib for Metastatic Castration-Resistant Prostate Cancer". Finally, we end the episode with an interview with Dr. Adam Cifu of the University of Chicago on literature, medicine, maintaining a feeling of normalcy and self during COVID-19, and more! Listen to Malignant with a free 30-day trial of Audible: https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&amp;ref=acx_bty_BK_ACX0_195112_rh_us PROfound: doi.org/10.1056/NEJMoa1911440 Crossover: doi.org/10.1093/annonc/mdy116 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.51 BONUS! Clinical Trials Part 3]]></title><description><![CDATA[This BONUS lecture was a talk given to the Hematology/Oncology fellows at Oregon Health & Science University. It's part three of a three-part series on clinical trials. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/251-bonus-clinical-trials-part-3-784</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/819672139</guid><pubDate>Wed, 13 May 2020 16:06:55 GMT</pubDate><enclosure length="58533618" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525464/fb1594af8d3c8eed19686e8232f79cad.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS lecture was a talk given to the Hemato…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3658</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525464/a5f726db11d5adb1d05b846400c59868.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS lecture was a talk given to the Hematology/Oncology fellows at Oregon Health &amp; Science University. It's part three of a three-part series on clinical trials. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.50 Neil Ferguson, Ending Lockdown, & Updates on COVID-19 Management with Dr. Benjamin Singer]]></title><description><![CDATA[This week's topic is all things COVID-19 -- we discuss the viral scandal of British epidemiologist Neil Ferguson's actions and how it reflects (or doesn't) on his work, we talk about the nuances of how to end lockdowns, and we bring back Dr. Benjamin Singer, a pulmonary and critical care physician at Northwestern University, to address updates in the ICU management of COVID-19. <br/><br/>Invisible Pandemic: <a href="http://doi.org/10.1016/S0140-6736(20)31035-7" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(20)31035-7</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/250-neil-ferguson-ending-lockdown-69a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/815841079</guid><pubDate>Thu, 07 May 2020 22:14:36 GMT</pubDate><enclosure length="64006794" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525465/4f80d705a0e63c818fe04b2ffb06258f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's topic is all things COVID-19 -- we di…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4000</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525465/39c914cc6524ce965000cc7c27a47071.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's topic is all things COVID-19 -- we discuss the viral scandal of British epidemiologist Neil Ferguson's actions and how it reflects (or doesn't) on his work, we talk about the nuances of how to end lockdowns, and we bring back Dr. Benjamin Singer, a pulmonary and critical care physician at Northwestern University, to address updates in the ICU management of COVID-19. Invisible Pandemic: doi.org/10.1016/S0140-6736(20)31035-7 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.49 COVID-19 Contrarians, Remdesivir, & Book Club on "Malignant" with OHSU HemOnc Fellows]]></title><description><![CDATA[This week we begin with a monologue on the recent controversy surrounding Dr. John Ioannidis's published opinions on the COVID-19 pandemic. We end with a group discussion with Oregon Health & Science University's Hematology/Oncology fellows on our host's, Vinay Prasad's, new book "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer."<br/><br/>Expressing different views on COVID-19: <a href="https://www.statnews.com/2020/04/27/hear-scientists-different-views-covid-19-dont-attack-them/" class="linkified" target="_blank">https://www.statnews.com/2020/04/27/hear-scientists-different-views-covid-19-dont-attack-them/</a><br/>Malignant: <a href="http://www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/249-covid-19-contrarians-remdesivir-b2b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/811746604</guid><pubDate>Sat, 02 May 2020 01:44:40 GMT</pubDate><enclosure length="82649445" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525466/a419354b51e93f6174b892dbd385801e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we begin with a monologue on the recent…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5166</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525466/eea92f948580c40c62f004a17e1ceed1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we begin with a monologue on the recent controversy surrounding Dr. John Ioannidis's published opinions on the COVID-19 pandemic. We end with a group discussion with Oregon Health &amp; Science University's Hematology/Oncology fellows on our host's, Vinay Prasad's, new book "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer." Expressing different views on COVID-19: https://www.statnews.com/2020/04/27/hear-scientists-different-views-covid-19-dont-attack-them/ Malignant: www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.48 BONUS! Introduction to Malignant: How Bad Policy and Bad Evidence Harm People with Cancer]]></title><description><![CDATA[This week we have a BONUS episode for you! As a teaser to the forthcoming audiobook of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer" by Dr. Vinay Prasad (our host), Audrey Tran and Ian Straehley have set the introduction of the book to music they composed and arranged themselves. <br/><br/>You can buy the print version of Malignant from Amazon: <a href="https://www.amazon.com/Malignant-Policy-Evidence-People-Cancer-dp-1421437635/dp/1421437635/" class="linkified" target="_blank">https://www.amazon.com/Malignant-Policy-Evidence-People-Cancer-dp-1421437635/dp/1421437635/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/248-bonus-introduction-to-malignant-368</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/806523580</guid><pubDate>Sat, 25 Apr 2020 00:36:26 GMT</pubDate><enclosure length="19709392" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525467/10364f9328c2f4c63a17681fff79c1ec.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we have a BONUS episode for you! As a t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1232</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525467/847e7bc2a83ae14a2c8b584f032ed92a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we have a BONUS episode for you! As a teaser to the forthcoming audiobook of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer" by Dr. Vinay Prasad (our host), Audrey Tran and Ian Straehley have set the introduction of the book to music they composed and arranged themselves. You can buy the print version of Malignant from Amazon: https://www.amazon.com/Malignant-Policy-Evidence-People-Cancer-dp-1421437635/dp/1421437635/ Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari]]></title><description><![CDATA[This week we start with an in-depth monologue on various new developments surrounding COVID-19, specifically the new study in NEJM on the compassionate use of remdesivir as well as the CDC's advice for the general public to wear cloth masks. We end with an interview with Dr. Ameet Sarpatwari of Harvard Medical School on how to create a more effective pharmaceutical system, the CREATES Act of 2019, developing fair and equitable drugs to treat COVID-19, and how to create a just system that balances the need for innovation with the need for access. Dr. Ameet Sarpatwari is the Assistant Director of PORTAL.<br/><br/>Compassionate Use of Remdesivir: <a href="http://doi.org/10.1056/NEJMoa2007016" class="linkified" target="_blank">doi.org/10.1056/NEJMoa2007016</a><br/>U.S. Gene Therapy Trials: <a href="http://doi.org/10.1001/jama.2019.22214" class="linkified" target="_blank">doi.org/10.1001/jama.2019.22214</a><br/>NIH Fair Pricing Condition: <a href="http://doi.org/10.7326/M19-2576" class="linkified" target="_blank">doi.org/10.7326/M19-2576</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/247-remdesivir-cloth-masks-and-incentives-111</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/800431477</guid><pubDate>Thu, 16 Apr 2020 23:22:49 GMT</pubDate><enclosure length="73367410" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525468/857fdfc2a05de2966a34932757c6f8ab.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we start with an in-depth monologue on …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4585</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525468/dd83dfb6d72598ce7cc5af4c0b034447.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we start with an in-depth monologue on various new developments surrounding COVID-19, specifically the new study in NEJM on the compassionate use of remdesivir as well as the CDC's advice for the general public to wear cloth masks. We end with an interview with Dr. Ameet Sarpatwari of Harvard Medical School on how to create a more effective pharmaceutical system, the CREATES Act of 2019, developing fair and equitable drugs to treat COVID-19, and how to create a just system that balances the need for innovation with the need for access. Dr. Ameet Sarpatwari is the Assistant Director of PORTAL. Compassionate Use of Remdesivir: doi.org/10.1056/NEJMoa2007016 U.S. Gene Therapy Trials: doi.org/10.1001/jama.2019.22214 NIH Fair Pricing Condition: doi.org/10.7326/M19-2576 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.46 Psychology Unearthed by COVID-19 Precautions & Polygenic Risk Score with Dr. Venk Murthy]]></title><description><![CDATA[This week we have a far-reaching monologue on COVID-19 and how people are reacting to the public health recommendations concerning COVID-19 (such as cancelling conferences and school, maintaining 6+ feet of distance, wearing cloth masks). We end with an insightful interview with Dr. Venk Murthy on polygenic risk score and, at the end, a bit about how the world of science is failing to combat hype.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/246-psychology-unearthed-by-covid-e5d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/795756106</guid><pubDate>Sat, 11 Apr 2020 00:47:53 GMT</pubDate><enclosure length="88981947" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525469/e53fc8b3aa40e8c762aa790d5b3b064c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we have a far-reaching monologue on COV…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5561</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525469/cc3dbdc4295ecef1d8970f351fb350b5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we have a far-reaching monologue on COVID-19 and how people are reacting to the public health recommendations concerning COVID-19 (such as cancelling conferences and school, maintaining 6+ feet of distance, wearing cloth masks). We end with an insightful interview with Dr. Venk Murthy on polygenic risk score and, at the end, a bit about how the world of science is failing to combat hype. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.45 Viral Spread of SARS-CoV-2, Rationing Resources, "Evidence Fiasco", & Classical Hematology Chat]]></title><description><![CDATA[This week we discuss several recent articles on the novel coronavirus (SARS-CoV-2) and COVID-19, specifically Dr. Siddhartha Mukherjee's article on the history and science of humanity's history with viruses, Dr. Ezekiel Emanuel's essay on how to fairly allocate dwindling medical resources during this global pandemic, and Dr. John Ioannidis's article on the "evidence fiasco" that has been our response to COVID-19. We end the episode with a Classical Hematology Chat with Drs. Sven Olson and Joseph Shatzel.<br/><br/>Dr. Mukherjee's article: <a href="https://www.newyorker.com/magazine/2020/04/06/how-does-the-coronavirus-behave-inside-a-patient" class="linkified" target="_blank">https://www.newyorker.com/magazine/2020/04/06/how-does-the-coronavirus-behave-inside-a-patient</a><br/>Allocation of Medical Resources: <a href="http://doi.org/10.1056/NEJMsb2005114" class="linkified" target="_blank">doi.org/10.1056/NEJMsb2005114</a><br/>Dr. Ioannidis's article: <a href="https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/" class="linkified" target="_blank">https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/245-viral-spread-of-sars-cov-2-rationing-fc5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/788739658</guid><pubDate>Wed, 01 Apr 2020 22:57:23 GMT</pubDate><enclosure length="83351201" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525470/a1094a6d5edd5127aea08b3331cc013e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss several recent articles on t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5209</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525470/9771c8ec1b5aadbf858c8bea647362b2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss several recent articles on the novel coronavirus (SARS-CoV-2) and COVID-19, specifically Dr. Siddhartha Mukherjee's article on the history and science of humanity's history with viruses, Dr. Ezekiel Emanuel's essay on how to fairly allocate dwindling medical resources during this global pandemic, and Dr. John Ioannidis's article on the "evidence fiasco" that has been our response to COVID-19. We end the episode with a Classical Hematology Chat with Drs. Sven Olson and Joseph Shatzel. Dr. Mukherjee's article: https://www.newyorker.com/magazine/2020/04/06/how-does-the-coronavirus-behave-inside-a-patient Allocation of Medical Resources: doi.org/10.1056/NEJMsb2005114 Dr. Ioannidis's article: https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/ Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.44 ICU Management of COVID-19 with Dr. Benjamin Singer]]></title><description><![CDATA[This week we discuss management of COVID-19 in the intensive care unit with Dr. Benjamin Singer, a pulmonary and critical care physician at Northwestern University. We discuss medications, PPE, ventilators, and more!<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/244-icu-management-of-covid-19-with-a71</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/783347938</guid><pubDate>Wed, 25 Mar 2020 23:26:24 GMT</pubDate><enclosure length="36444060" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525471/4bb2c91c56fb64ab687be720e221e47f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss management of COVID-19 in th…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2278</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525471/38b1780a0a5e715e73987fc0135d11ce.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss management of COVID-19 in the intensive care unit with Dr. Benjamin Singer, a pulmonary and critical care physician at Northwestern University. We discuss medications, PPE, ventilators, and more! Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.43 BONUS! Novel Coronavirus and the COVID-19 Response in Oregon with Dr. John Townes]]></title><description><![CDATA[This bonus episode is an interview from March 16, 2020 with Dr. John Townes, the Interim Head for the Division of Infectious Disease and the Medical Director for Infection Prevention and Control here at Oregon Health & Science University. We talk about the novel coronavirus and how healthcare professionals are responding to the COVID-19 pandemic, with a focus on Oregon. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/243-bonus-novel-coronavirus-and-the-f38</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/778479271</guid><pubDate>Wed, 18 Mar 2020 19:32:09 GMT</pubDate><enclosure length="40319377" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525472/de9edc906189d31ce28ad452f9c8bb36.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This bonus episode is an interview from March 16,…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2520</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525472/003fd6d893739b4576174988e50b0bf9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This bonus episode is an interview from March 16, 2020 with Dr. John Townes, the Interim Head for the Division of Infectious Disease and the Medical Director for Infection Prevention and Control here at Oregon Health &amp; Science University. We talk about the novel coronavirus and how healthcare professionals are responding to the COVID-19 pandemic, with a focus on Oregon. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.42 Quality-of-Life Measurement in Oncology, KnowYourTumor, & Question of the Week]]></title><description><![CDATA[This week we discuss two recent papers -- one we praise, one we condemn -- and then we turn to a question of the week with medical student Audrey Tran on self-improvement and "refining conviction". The first paper is titled "Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical Trials" and the second is titled "Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial".<br/><br/>Quality of Life Measurement: <a href="http://doi.org/10.1001/jamanetworkopen.2020.0363" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2020.0363</a><br/>KnowYourTumor: <a href="http://doi.org/10.1016/S1470-2045(20)30074-7" class="linkified" target="_blank">doi.org/10.1016/S1470-2045(20)30074-7</a><br/><br/>Vinay's new book, Malignant: <a href="http://www.amazon.com/Malignant-Policy-…cer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-…cer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/242-quality-of-life-measurement-in-200</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/777364474</guid><pubDate>Tue, 17 Mar 2020 00:33:15 GMT</pubDate><enclosure length="65695351" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525473/a1f35d87fe48120ed11b81d3a85cef8d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss two recent papers -- one we …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4106</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525473/50234ea1b3cddd851f055e4992f0f534.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss two recent papers -- one we praise, one we condemn -- and then we turn to a question of the week with medical student Audrey Tran on self-improvement and "refining conviction". The first paper is titled "Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical Trials" and the second is titled "Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial". Quality of Life Measurement: doi.org/10.1001/jamanetworkopen.2020.0363 KnowYourTumor: doi.org/10.1016/S1470-2045(20)30074-7 Vinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.41 BONUS! Clinical Trials Part 2: Crossover and Control Arms]]></title><description><![CDATA[This BONUS lecture was a talk given to the Hematology/Oncology fellows here at Oregon Health & Science University. It's part two of a three-part series on clinical trials. This talk is on clinical trial design, specifically crossover and control arms.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/241-bonus-clinical-trials-part-2-940</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/774430315</guid><pubDate>Wed, 11 Mar 2020 16:13:11 GMT</pubDate><enclosure length="49604340" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525474/d5420c380b3abf97edbb741df8bf52c5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS lecture was a talk given to the Hemato…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3100</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525474/fbfed898aacd89e0ed2839eece131ccb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS lecture was a talk given to the Hematology/Oncology fellows here at Oregon Health &amp; Science University. It's part two of a three-part series on clinical trials. This talk is on clinical trial design, specifically crossover and control arms. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr]]></title><description><![CDATA[This week we revisit BEACON! The authors of the BEACON study have responded to the Letter to the Editor our host Dr. Vinay Prasad submitted to the New England Journal of Medicine, and we share our thoughts on what they said. We then turn to the FDA's recent approval of neratinib in combination with capecitabine for HER2-positive breast cancer, based on the phase III NALA trial. Finally, we interview Dr. David Carr, a Molecular Pathology Fellow at UC San Diego, on his work in general and, specifically, next-generation sequencing.<br/><br/>BEACON Letters to the Editor: <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1908075#article_letters" class="linkified" target="_blank">www.nejm.org/doi/full/10.1056/NEJMoa1908075#article_letters</a><br/>NALA: <a href="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neratinib-metastatic-her2-positive-breast-cancer" class="linkified" target="_blank">https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neratinib-metastatic-her2-positive-breast-cancer</a><br/><br/>Vinay's new book, Malignant: <a href="http://www.amazon.com/Malignant-Policy-…cer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-…cer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/240-beacon-part-2-nala-and-molecular-1b5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/771371500</guid><pubDate>Thu, 05 Mar 2020 20:40:21 GMT</pubDate><enclosure length="66426362" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525475/4a2f185e8f5b97f91b41e8271dc34cd7.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we revisit BEACON! The authors of the B…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4152</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525475/a9442dde655ed785ffcbc90de8bb0fd7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we revisit BEACON! The authors of the BEACON study have responded to the Letter to the Editor our host Dr. Vinay Prasad submitted to the New England Journal of Medicine, and we share our thoughts on what they said. We then turn to the FDA's recent approval of neratinib in combination with capecitabine for HER2-positive breast cancer, based on the phase III NALA trial. Finally, we interview Dr. David Carr, a Molecular Pathology Fellow at UC San Diego, on his work in general and, specifically, next-generation sequencing. BEACON Letters to the Editor: www.nejm.org/doi/full/10.1056/NEJMoa1908075#article_letters NALA: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neratinib-metastatic-her2-positive-breast-cancer Vinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner]]></title><description><![CDATA[Our guest this week is Dr. Michael Hengartner of the Zurich University of Applied Sciences. We interview him on his work studying the long-term consequences and effectiveness of newer-generation antidepressants - specifically focusing on selective serotonin reuptake inhibitors (SSRIs).<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/239-effectiveness-of-newer-generation-286</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/767697226</guid><pubDate>Thu, 27 Feb 2020 23:44:49 GMT</pubDate><enclosure length="40968471" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525476/0c7d2c88e781a79fd1e1001f6dbf4faa.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Our guest this week is Dr. Michael Hengartner of …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2560</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525476/cb8153ea6367a7fca17838026267207f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Our guest this week is Dr. Michael Hengartner of the Zurich University of Applied Sciences. We interview him on his work studying the long-term consequences and effectiveness of newer-generation antidepressants - specifically focusing on selective serotonin reuptake inhibitors (SSRIs). Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali]]></title><description><![CDATA[We start this episode by diving deep into KEYNOTE-048, the randomized, open-label, phase 3 study of pembrolizumab alone or with chemotherapy v.s. cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC). We transition from there to a continued discussion on careerism in academia and how the motivation behind publishing papers should always stem from the drive to disseminate information, not from the drive to advance your own career. We end the episode with an interview with Dr. Bishal Gyawali of Queen's University in Kingston, Canada on his recent paper out in Nature Cancer on global oncology. Specifically, Dr. Gyawali addresses the need for conducting cancer clinical trials in low- and middle-income countries.<br/><br/>KEYNOTE-048: <a href="http://doi.org/10.1016/S0140-6736(19)32591-7" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(19)32591-7</a><br/>Opportunities for Cancer Clinical Trials in LMIC: <a href="http://doi.org/10.1038/s43018-020-0030-x" class="linkified" target="_blank">doi.org/10.1038/s43018-020-0030-x</a><br/><br/>Vinay's new book, Malignant: <a href="http://www.amazon.com/Malignant-Policy-…cer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-…cer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/238-keynote-048-academic-currency-cf3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/762944083</guid><pubDate>Wed, 19 Feb 2020 16:22:16 GMT</pubDate><enclosure length="49742688" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525477/79b3cede4ec67d79fa17a72d0a9e3cdd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this episode by diving deep into KEYNOTE…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3109</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525477/6a9675e77fc1f9e10132c63c663d7b97.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this episode by diving deep into KEYNOTE-048, the randomized, open-label, phase 3 study of pembrolizumab alone or with chemotherapy v.s. cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC). We transition from there to a continued discussion on careerism in academia and how the motivation behind publishing papers should always stem from the drive to disseminate information, not from the drive to advance your own career. We end the episode with an interview with Dr. Bishal Gyawali of Queen's University in Kingston, Canada on his recent paper out in Nature Cancer on global oncology. Specifically, Dr. Gyawali addresses the need for conducting cancer clinical trials in low- and middle-income countries. KEYNOTE-048: doi.org/10.1016/S0140-6736(19)32591-7 Opportunities for Cancer Clinical Trials in LMIC: doi.org/10.1038/s43018-020-0030-x Vinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.37 Careerism, Presenting Abstracts, Twitter and the K-Index, & Classical Hematology Chat]]></title><description><![CDATA[We have a full slate for you this week! We discuss careerism in medicine, presenting abstracts at conferences, #MedTwitter, and Dr. Califf's opinions on the K-Index. We conclude the episode with our first-ever Classical Hematology Chat, featuring our host Dr. Vinay Prasad, Dr. Sven Olson, and Dr. Joseph Shatzel. The chat is on sickle cell disease. <br/><br/>"A Perspective on the K-Index": <a href="http://doi.org/10.1016/j.jaccas.2020.01.003" class="linkified" target="_blank">doi.org/10.1016/j.jaccas.2020.01.003</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/237-careerism-presenting-abstracts-707</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/760839475</guid><pubDate>Fri, 14 Feb 2020 23:11:17 GMT</pubDate><enclosure length="67024464" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525478/f31b09cc2e6b36e17730a3ac9300cd03.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a full slate for you this week! We discus…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4189</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525478/d78bcde709bec67af7887ca238d1e68c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a full slate for you this week! We discuss careerism in medicine, presenting abstracts at conferences, #MedTwitter, and Dr. Califf's opinions on the K-Index. We conclude the episode with our first-ever Classical Hematology Chat, featuring our host Dr. Vinay Prasad, Dr. Sven Olson, and Dr. Joseph Shatzel. The chat is on sickle cell disease. "A Perspective on the K-Index": doi.org/10.1016/j.jaccas.2020.01.003 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.36 Thought Leaders, NELSON, & Reliance on P Values in Cancer Trials with Dr. Sam Rubinstein]]></title><description><![CDATA[This week we discuss the concept of "thought leaders" and we examine the conclusions about volume CT screening for lung cancer from the NELSON trial. We end with an interview with Dr. Sam Rubinstein, a hematology/oncology fellow at Vanderbilt University Medical Center, on his new paper published in JAMA Network Open titled "Indication of Measures of Uncertainty for Statistical Significance in Abstracts of Published Oncology Trials: A Systematic Review and Meta-analysis".<br/><br/>NELSON: <a href="http://doi.org/10.1056/NEJMoa1911793" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1911793</a><br/>Measures of Uncertainty: <a href="http://doi.org/10.1001/jamanetworkopen.2019.17530" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2019.17530</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/236-thought-leaders-nelson-and-reliance-5d1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/756912613</guid><pubDate>Fri, 07 Feb 2020 23:09:21 GMT</pubDate><enclosure length="56825842" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525479/c2e2192b8050e80377fce6bb78708821.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss the concept of "thought lead…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3552</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525479/b42e30dc71cb7338758a59833d47bcc2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss the concept of "thought leaders" and we examine the conclusions about volume CT screening for lung cancer from the NELSON trial. We end with an interview with Dr. Sam Rubinstein, a hematology/oncology fellow at Vanderbilt University Medical Center, on his new paper published in JAMA Network Open titled "Indication of Measures of Uncertainty for Statistical Significance in Abstracts of Published Oncology Trials: A Systematic Review and Meta-analysis". NELSON: doi.org/10.1056/NEJMoa1911793 Measures of Uncertainty: doi.org/10.1001/jamanetworkopen.2019.17530 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.35 BONUS! How to Keep Up with the New Information in Medicine]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given to medical students titled "How to Keep Up with the New Information in Medicine." It's a primer on the steps healthcare professionals need to take in order to keep abreast of the latest medical findings.<br/><br/>Vinay's new book, Malignant: <a href="http://www.amazon.com/Malignant-Policy-…cer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-…cer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/235-bonus-how-to-keep-up-with-the-d23</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/752903752</guid><pubDate>Fri, 31 Jan 2020 20:07:28 GMT</pubDate><enclosure length="57886204" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525480/6518f6fbde0905e489b4115fa149d545.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3618</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525480/e3320d6c1c33c2f1be4e31a27649eb6f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given to medical students titled "How to Keep Up with the New Information in Medicine." It's a primer on the steps healthcare professionals need to take in order to keep abreast of the latest medical findings. Vinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.34 Red Light, Pola for DLBCL, Hem/Onc Question of the Week, & TAILORx with Dr. Ali Khaki]]></title><description><![CDATA[We have a variety of topics for you this week! We tackle red light therapy, polatuzumab olatuzumab vedotin in relapsed or refractory diffuse large b-cell lymphoma; we have a hematology/oncology question of the week from Dr. Emerson Chen of OHSU; and we sit down with Dr. Ali Khaki of the Fred Hutchinson Cancer Research Center to discuss his recent paper critiquing TAILORx.<br/><br/>Pola for DLBCL: <a href="http://doi.org/10.1200/JCO.19.00172" class="linkified" target="_blank">doi.org/10.1200/JCO.19.00172</a><br/>Financial COI on Twitter: <a href="http://doi.org/10.1001/jamainternmed.2016.8467" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2016.8467</a><br/>Ignoring Valuable Data: <a href="http://doi.org/10.6004/jnccn.2019.7363" class="linkified" target="_blank">doi.org/10.6004/jnccn.2019.7363</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/234-red-light-pola-for-dlbcl-hemonc-eef</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/748948300</guid><pubDate>Fri, 24 Jan 2020 21:51:52 GMT</pubDate><enclosure length="88496280" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525481/e4ea9446406c1e6c3d349ae5d5d66daf.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have a variety of topics for you this week! We…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5531</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525481/40d48914f4b47da398a9a1ddc9435245.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have a variety of topics for you this week! We tackle red light therapy, polatuzumab olatuzumab vedotin in relapsed or refractory diffuse large b-cell lymphoma; we have a hematology/oncology question of the week from Dr. Emerson Chen of OHSU; and we sit down with Dr. Ali Khaki of the Fred Hutchinson Cancer Research Center to discuss his recent paper critiquing TAILORx. Pola for DLBCL: doi.org/10.1200/JCO.19.00172 Financial COI on Twitter: doi.org/10.1001/jamainternmed.2016.8467 Ignoring Valuable Data: doi.org/10.6004/jnccn.2019.7363 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.33 Olaparib and POLO & the Classical Fallacies of Cancer Screening with Dr. H Gilbert Welch]]></title><description><![CDATA[This week we're treating you to a recording of the Grand Rounds lecture on overdiagnosis and cancer screening that Dr. H Gilbert Welch gave at Oregon Health & Science University on October 30, 2019. Before the lecture, we take a moment to reiterate with renewed vigor our distaste for the POLO trial (first discussed in episode 1.64).<br/><br/>POLO: <a href="http://doi.org/10.1056/NEJMoa1903387" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903387</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/233-olaparib-and-polo-and-the-classical-8ee</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/744089692</guid><pubDate>Wed, 15 Jan 2020 23:10:20 GMT</pubDate><enclosure length="70935725" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525482/140cf47de5e1d8a641b748ea2675246a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we're treating you to a recording of th…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4433</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525482/a5a80f42eb4143b01ba7329ce2bb284c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we're treating you to a recording of the Grand Rounds lecture on overdiagnosis and cancer screening that Dr. H Gilbert Welch gave at Oregon Health &amp; Science University on October 30, 2019. Before the lecture, we take a moment to reiterate with renewed vigor our distaste for the POLO trial (first discussed in episode 1.64). POLO: doi.org/10.1056/NEJMoa1903387 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.32 BONUS! Clinical Trials Part 1: Thinking Better About Cancer Medicine]]></title><description><![CDATA[This BONUS lecture was a talk given to the Hematology/Oncology fellows here at Oregon Health & Science University. It's part one of a three-part series on clinical trials, titled "Thinking Better About Cancer Medicine".<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/232-bonus-clinical-trials-part-1-5f4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/741545470</guid><pubDate>Fri, 10 Jan 2020 23:00:13 GMT</pubDate><enclosure length="51044630" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525483/821d7836e88683ad08d83d8fc21ec45b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS lecture was a talk given to the Hemato…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3190</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525483/6d5610a09121fe1acdeb7de842ece0d7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS lecture was a talk given to the Hematology/Oncology fellows here at Oregon Health &amp; Science University. It's part one of a three-part series on clinical trials, titled "Thinking Better About Cancer Medicine". Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.31 Listener Questions, Responsibility of Reviewers, & Duration of Response with Dr. Bishal Gyawali]]></title><description><![CDATA[This week we answer a few questions: the first is from Patreon backer, Harry Hong, on Kaplan-Meier curves. The second is from a student at Mount Sinai Medical School who reached out with some ethical questions they had after the ASH annual meeting on the obligations and responsibilities of peer reviewers. Finally, we end the episode with an interview with Dr. Bishal Gyawali of Queens University in Kingston, Ontario, Canada on his new paper out today in the Journal of the National Comprehensive Cancer Network titled "Response Rates and Durations of Response for Biomarker-Based Cancer Drugs in Nonrandomized Versus Randomized Trials". <br/><br/>Durations of Response: <a href="http://doi.org/10.6004/jnccn.2019.7345" class="linkified" target="_blank">doi.org/10.6004/jnccn.2019.7345</a><br/><br/>Vinay's new book, Malignant: <a href="http://www.amazon.com/Malignant-Policy-…cer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-…cer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/231-listener-questions-responsibility-483</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/739924798</guid><pubDate>Tue, 07 Jan 2020 23:51:54 GMT</pubDate><enclosure length="38552666" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525484/0e9b1d2ecd1400a148817b952f5fc27e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we answer a few questions: the first is…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2410</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525484/ea43083af685b302c54958c22433d247.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we answer a few questions: the first is from Patreon backer, Harry Hong, on Kaplan-Meier curves. The second is from a student at Mount Sinai Medical School who reached out with some ethical questions they had after the ASH annual meeting on the obligations and responsibilities of peer reviewers. Finally, we end the episode with an interview with Dr. Bishal Gyawali of Queens University in Kingston, Ontario, Canada on his new paper out today in the Journal of the National Comprehensive Cancer Network titled "Response Rates and Durations of Response for Biomarker-Based Cancer Drugs in Nonrandomized Versus Randomized Trials". Durations of Response: doi.org/10.6004/jnccn.2019.7345 Vinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.30 Questions from a Medical Student & Epidemiology with Dr. Ellie Murray]]></title><description><![CDATA[This week we return to our discussion of going after soft targets vs hard targets, but this time with a focus on how it applies to building a burgeoning career in medicine, in our segment Questions from a Medical Student with Audrey Tran. We end this week's episode with a far-reaching interview with Dr. Ellie Murray (most people know her as Epi Ellie on Twitter and as the co-host of the podcast Casual Inference) on all things epidemiology.<br/><br/>Check out Dr. Murray's excellent podcast here: <a href="https://casualinfer.libsyn.com/" class="linkified" target="_blank">https://casualinfer.libsyn.com/</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/230-questions-from-a-medical-student-b58</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/738056356</guid><pubDate>Fri, 03 Jan 2020 23:18:57 GMT</pubDate><enclosure length="103594220" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525485/d8f12dd65cf5d5c283cd0b865b5cd750.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we return to our discussion of going af…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6475</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525485/282a75a93ad0785a79f6a86b51cb03b2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we return to our discussion of going after soft targets vs hard targets, but this time with a focus on how it applies to building a burgeoning career in medicine, in our segment Questions from a Medical Student with Audrey Tran. We end this week's episode with a far-reaching interview with Dr. Ellie Murray (most people know her as Epi Ellie on Twitter and as the co-host of the podcast Casual Inference) on all things epidemiology. Check out Dr. Murray's excellent podcast here: https://casualinfer.libsyn.com/ Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.29 Time from Diagnosis to Treatment in AML and Real-World Data with Dr. Sherrie Aspinall]]></title><description><![CDATA[This week we wonder incredulously how this abstract from ASH titled "Time from diagnosis to treatment does not affect outcome in intensively treated patients with newly diagnosed acute myeloid leukemia" was selected as one of the top abstracts from the conference. In the second half of the episode we interview Dr. Sherrie Aspinall of the Veterans Administration on how to use real-world data. Her new paper is titled "Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration".<br/><br/>Time from diagnosis to treatment in AML: <a href="https://ashpublications.org/blood/article-lookup/doi/10.1182/blood-2019-123717" class="linkified" target="_blank">https://ashpublications.org/blood/article-lookup/doi/10.1182/blood-2019-123717</a><br/>Targeted therapies for advanced RCC: <a href="http://doi.org/10.1002/cam4.2531" class="linkified" target="_blank">doi.org/10.1002/cam4.2531</a><br/><br/>Vinay's new book, Malignant: <a href="http://www.amazon.com/Malignant-Policy-…cer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-…cer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/229-time-from-diagnosis-to-treatment-28b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/734624425</guid><pubDate>Fri, 27 Dec 2019 17:56:31 GMT</pubDate><enclosure length="66281751" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525486/d26290ffbf5dc8e125d55cd927007564.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we wonder incredulously how this abstra…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4143</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525486/d1dc7813ecb32d0f673f0d21b8be29d2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we wonder incredulously how this abstract from ASH titled "Time from diagnosis to treatment does not affect outcome in intensively treated patients with newly diagnosed acute myeloid leukemia" was selected as one of the top abstracts from the conference. In the second half of the episode we interview Dr. Sherrie Aspinall of the Veterans Administration on how to use real-world data. Her new paper is titled "Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration". Time from diagnosis to treatment in AML: https://ashpublications.org/blood/article-lookup/doi/10.1182/blood-2019-123717 Targeted therapies for advanced RCC: doi.org/10.1002/cam4.2531 Vinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.28 Trastuzumab in Later Lines of Therapy for HER2+ Breast Cancer, Kaplan-Meier Curves, & Patreon]]></title><description><![CDATA[We're back in Plenary Session HQ! We have multiple topics for you this week. We cover the use of trastuzumab in later lines of therapy for HER2+ metastatic breast cancer, we take a listener question on Kaplan-Meier curves, and we talk a little about Patreon.<br/><br/>Malignant: <a href="http://www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635" class="linkified" target="_blank">www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/228-trastuzumab-in-later-lines-of-2ef</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/731547739</guid><pubDate>Fri, 20 Dec 2019 18:54:02 GMT</pubDate><enclosure length="61328099" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525487/481cff1f99036cd91cbe933bd0e79df6.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're back in Plenary Session HQ! We have multipl…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3833</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525487/0b71cba8319c1c2647162fcb9c39b6df.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're back in Plenary Session HQ! We have multiple topics for you this week. We cover the use of trastuzumab in later lines of therapy for HER2+ metastatic breast cancer, we take a listener question on Kaplan-Meier curves, and we talk a little about Patreon. Malignant: www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.27 BONUS! Use of Bone-Modifying Agents Among Medicare Beneficiaries with MM with Dr. Arjun Gupta]]></title><description><![CDATA[This BONUS episode is an interview with Dr. Arjun Gupta, a second-year hem/onc fellow at Johns Hopkins University, on his new paper out TODAY in JAMA Oncology titled ''Use of Bone-modifying Agents among Medicare Beneficiaries with Multiple Myeloma''. <br/><br/>Use of bone-modifying agents: <a href="http://doi.org/10.1001/jamaoncol.2019.5426" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2019.5426</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/227-bonus-use-of-bone-modifying-agents-856</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/717000826</guid><pubDate>Thu, 12 Dec 2019 17:31:02 GMT</pubDate><enclosure length="25035031" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525488/bba134dc1b5ab3624b5ac40e910fca60.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is an interview with Dr. Arjun…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1565</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525488/d2c70f67125ed1635e9eb8ada6f7fc31.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is an interview with Dr. Arjun Gupta, a second-year hem/onc fellow at Johns Hopkins University, on his new paper out TODAY in JAMA Oncology titled ''Use of Bone-modifying Agents among Medicare Beneficiaries with Multiple Myeloma''. Use of bone-modifying agents: doi.org/10.1001/jamaoncol.2019.5426 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.26 Questions of the Week: Hematology/Oncology, USMLE Step 2 CK, & a bonus Hematology/Oncology]]></title><description><![CDATA[This is the last week of pre-recorded episodes -- we'll be back next week with a fresh, hard-hitting monologue. In the meantime, we have three questions of the week for you. Two are inspired by the hematology/oncology boards and are presented by Dr. Sven Olson. Between the two, we have one from Ian Straehely that's inspired by the USMLE Step 2 CK. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/226-questions-of-the-week-hematologyoncology-a67</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/716079478</guid><pubDate>Mon, 09 Dec 2019 19:39:13 GMT</pubDate><enclosure length="38655067" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525489/03261fd512032a2893484b2225613a09.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This is the last week of pre-recorded episodes --…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2416</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525489/7cec2b131aba7779c1c0f326d96c0ff2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This is the last week of pre-recorded episodes -- we'll be back next week with a fresh, hard-hitting monologue. In the meantime, we have three questions of the week for you. Two are inspired by the hematology/oncology boards and are presented by Dr. Sven Olson. Between the two, we have one from Ian Straehely that's inspired by the USMLE Step 2 CK. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.25 Questions of the Week: Hematology/Oncology, the USMLE Step 2 CK, & One From a Med Student]]></title><description><![CDATA[Our host is still out of town, but don't worry -- we have some questions of the week to tide you over. The first is inspired by the hematology/oncology boards, presented by Dr. Sven Olson; the second is inspired by the USMLE Step 2 CK, presented by Ian Straehley; and the third is from Audrey Tran, inspired by her experiences as a med student.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/225-questions-of-the-week-hematologyoncology-9f1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/716055070</guid><pubDate>Mon, 02 Dec 2019 19:02:06 GMT</pubDate><enclosure length="45554737" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525490/f5841fa6340acd8e9b300eef128a520f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Our host is still out of town, but don't worry --…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2847</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525490/53096b976dd9e1d882e3ca0b20a96688.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Our host is still out of town, but don't worry -- we have some questions of the week to tide you over. The first is inspired by the hematology/oncology boards, presented by Dr. Sven Olson; the second is inspired by the USMLE Step 2 CK, presented by Ian Straehley; and the third is from Audrey Tran, inspired by her experiences as a med student. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.24 Questions of the Week: the USMLE Step 2 CK, Hematology/Oncology, & One From a Med Student]]></title><description><![CDATA[This week our host is still in Australia, but we have some questions of the week saved for you! The first is inspired by the USMLE Step 2 CK, presented by Ian Straehley; the second is inspired by the hematology/oncology boards, presented by Dr. Sven Olson; and the third is from Audrey Tran, inspired by her experiences as a med student.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/224-questions-of-the-week-the-usmle-40e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/716023225</guid><pubDate>Tue, 26 Nov 2019 14:59:08 GMT</pubDate><enclosure length="36331632" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525491/0f18bb3bfb8b256d44e3ae5f34b8ca86.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week our host is still in Australia, but we …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2271</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525491/0d016466d0a18587ec7454af5ac0cef5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week our host is still in Australia, but we have some questions of the week saved for you! The first is inspired by the USMLE Step 2 CK, presented by Ian Straehley; the second is inspired by the hematology/oncology boards, presented by Dr. Sven Olson; and the third is from Audrey Tran, inspired by her experiences as a med student. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.23 Question of the Week & Ethics and Inefficiencies of Clinical Trials with Dr. Jonathan Kimmelman]]></title><description><![CDATA[First up this week is Question of the Week inspired by the Hematology/Oncology boards, with Dr. Sven Olson. No monologue on current trials this week because our host is still in Australia, so we conclude the episode with an interview with Dr. Jonathan Kimmelman of McGill University on his extensive work in research ethics, studying the most important issue in cancer medicine today: the risk-benefit of clinical trials and how best to spare patients from the burdens of creating a new drug. <br/><br/>Review of Sunitinib: <a href="http://doi.org/10.1093/jnci/djv292" class="linkified" target="_blank">doi.org/10.1093/jnci/djv292</a><br/>Benefit, Burden, and Impact: <a href="http://doi.org/10.1177/1740774519873883" class="linkified" target="_blank">doi.org/10.1177/1740774519873883</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/223-question-of-the-week-and-ethics-e15</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/715134880</guid><pubDate>Wed, 20 Nov 2019 18:21:59 GMT</pubDate><enclosure length="56045094" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525492/5826b6daf22315615aa0f0e1f53dfff1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>First up this week is Question of the Week inspir…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3503</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525492/247195e044efc8acee251e38e506c4a7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>First up this week is Question of the Week inspired by the Hematology/Oncology boards, with Dr. Sven Olson. No monologue on current trials this week because our host is still in Australia, so we conclude the episode with an interview with Dr. Jonathan Kimmelman of McGill University on his extensive work in research ethics, studying the most important issue in cancer medicine today: the risk-benefit of clinical trials and how best to spare patients from the burdens of creating a new drug. Review of Sunitinib: doi.org/10.1093/jnci/djv292 Benefit, Burden, and Impact: doi.org/10.1177/1740774519873883 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.22 Question of the Week & EMR, Talking to Patients, and Being a Doctor with Dr. Robert Hirschtick]]></title><description><![CDATA[This week we have a question of the week from Ian Straehley, inspired by the USMLE Step 2 CK, as well as an interview with Dr. Robert Hirschtick of Northwestern University on what it means to be a doctor, how you should think as a physician, and his many popular pieces published in journals like JAMA. <br/><br/>"Copy-and-Paste": <a href="http://doi.org/10.1001/jama.295.20.2335" class="linkified" target="_blank">doi.org/10.1001/jama.295.20.2335</a><br/>"Extremities": <a href="http://doi.org/10.1001/jama.300.10.1125" class="linkified" target="_blank">doi.org/10.1001/jama.300.10.1125</a><br/>"The Quick Physical Exam": <a href="http://doi.org/10.1001/jama.2016.8182" class="linkified" target="_blank">doi.org/10.1001/jama.2016.8182</a><br/>Robiewon on YouTube: <a href="http://www.youtube.com/channel/UC2Ki7Zbo2VCGQAYinsJhU3w" class="linkified" target="_blank">www.youtube.com/channel/UC2Ki7Zbo2VCGQAYinsJhU3w</a><br/>"You Did Not Teach Me What You Thought You Did": <a href="http://doi.org/10.1001/jama.2019.15849" class="linkified" target="_blank">doi.org/10.1001/jama.2019.15849</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/222-question-of-the-week-and-emr-5a7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/712998082</guid><pubDate>Fri, 15 Nov 2019 00:13:06 GMT</pubDate><enclosure length="53804415" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525493/9b0944d05404a267f1680b8ce22bb18a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we have a question of the week from Ian…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3363</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525493/6d3e1475a69e9ee175585892e9a1620d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we have a question of the week from Ian Straehley, inspired by the USMLE Step 2 CK, as well as an interview with Dr. Robert Hirschtick of Northwestern University on what it means to be a doctor, how you should think as a physician, and his many popular pieces published in journals like JAMA. "Copy-and-Paste": doi.org/10.1001/jama.295.20.2335 "Extremities": doi.org/10.1001/jama.300.10.1125 "The Quick Physical Exam": doi.org/10.1001/jama.2016.8182 Robiewon on YouTube: www.youtube.com/channel/UC2Ki7Zbo2VCGQAYinsJhU3w "You Did Not Teach Me What You Thought You Did": doi.org/10.1001/jama.2019.15849 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.21 Aiming for the Hard Targets & Harm From Screening and Overdiagnosis with Dr. H Gilbert Welch]]></title><description><![CDATA[We begin this week's episode by addressing a listener's feedback to our discussion of smoldering multiple myeloma. We then expand on our critique of 'going after the soft targets' (criticizing studies that fall apart with little resistance) by elucidating how to identify and go after hard targets and why it's so important that you do. Finally, we launch into an interview with Dr. H Gilbert Welch that explores his tremendous body of work on the preventable harm that comes from too generous a hand with novel diagnostic advances.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/221-aiming-for-the-hard-targets-and-8e2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/709890547</guid><pubDate>Fri, 08 Nov 2019 18:30:16 GMT</pubDate><enclosure length="128179834" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525494/ab82e3c47126bb5c3f036312ee65100f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this week's episode by addressing a list…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>8011</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525494/a48f08589a12b5fa5625c0f3e04e23a0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this week's episode by addressing a listener's feedback to our discussion of smoldering multiple myeloma. We then expand on our critique of 'going after the soft targets' (criticizing studies that fall apart with little resistance) by elucidating how to identify and go after hard targets and why it's so important that you do. Finally, we launch into an interview with Dr. H Gilbert Welch that explores his tremendous body of work on the preventable harm that comes from too generous a hand with novel diagnostic advances. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.20 "Courageous Skeptics", Lenalidomide, QOTW, and a Political Conversation with Dr. Andy Saultz]]></title><description><![CDATA[We begin this week's episode with a thoughtful discussion of the internet's "courageous skeptics". Then, after lamenting the way in which the recent study "Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma" was conducted, we end with an interview with Dr. Andy Saultz on his ongoing campaign for Oregon state representative. We break up the interview with a couple Hem/Onc boards questions of the week from Dr. Emerson Chen. <br/><br/>Lenalidomide in Smoldering Multiple Myeloma: <a href="http://doi.org/10.1200/JCO.19.01740" class="linkified" target="_blank">doi.org/10.1200/JCO.19.01740</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/220-courageous-skeptics-lenalidomide-f66</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/706623421</guid><pubDate>Fri, 01 Nov 2019 23:55:27 GMT</pubDate><enclosure length="149506619" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525495/338cc1104fd1634ac0ef6b95e0564f11.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this week's episode with a thoughtful di…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9344</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525495/b63c5882f91c24259df136cb4b17f5f2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this week's episode with a thoughtful discussion of the internet's "courageous skeptics". Then, after lamenting the way in which the recent study "Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma" was conducted, we end with an interview with Dr. Andy Saultz on his ongoing campaign for Oregon state representative. We break up the interview with a couple Hem/Onc boards questions of the week from Dr. Emerson Chen. Lenalidomide in Smoldering Multiple Myeloma: doi.org/10.1200/JCO.19.01740 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.19 Remembering Dr. Bernard Fisher & Self-Diagnosis with Dr. Mark Lewis]]></title><description><![CDATA[This week we give a short monologue on the late Dr. Bernard Fisher's legacy in the field of oncology, and then dive into a far-ranging interview with Dr. Mark Lewis of Intermountain Healthcare on his career, his family, and diagnosing himself with MEN1 syndrome. <br/><br/>Dr. Fisher's obituary in the New York Times: <a href="https://www.nytimes.com/2019/10/19/science/dr-bernard-fisher-dead.html" class="linkified" target="_blank">https://www.nytimes.com/2019/10/19/science/dr-bernard-fisher-dead.html</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/219-remembering-dr-bernard-fisher-17b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/701709199</guid><pubDate>Fri, 25 Oct 2019 19:20:31 GMT</pubDate><enclosure length="127954971" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525496/34fec8358d15a8dbfdfe4a0e4c2f2054.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we give a short monologue on the late D…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7997</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525496/1e40876ac1744ea92dd806d2c839fc26.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we give a short monologue on the late Dr. Bernard Fisher's legacy in the field of oncology, and then dive into a far-ranging interview with Dr. Mark Lewis of Intermountain Healthcare on his career, his family, and diagnosing himself with MEN1 syndrome. Dr. Fisher's obituary in the New York Times: https://www.nytimes.com/2019/10/19/science/dr-bernard-fisher-dead.html Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.18 Questions of the Week, Talking About Toxicity, ASCO Guidelines Authors' COI with Dr. Eitan Amir]]></title><description><![CDATA[This week we begin with a critique of the recent perspective article in the New England Journal of Medicine, titled "Talking about Toxicity — 'What We’ve Got Here Is a Failure to Communicate'". After that we interview Dr. Eitan Amir on his paper on undisclosed conflicts of interest among authors of ASCO guidelines. Interspersed between segments of the interview, we invite guest Dr. Sven Olson on to offer a correction to a recent Hem/Onc boards question of the week on Lynch Syndrome (original question posed in episode 2.11) and we invite Ian Straehley on for a question of the week inspired by the USMLE Step 2 CK.<br/><br/>Talking about toxicity: <a href="http://doi.org/10.1056/NEJMp1908310" class="linkified" target="_blank">doi.org/10.1056/NEJMp1908310</a> <br/>COI among authors of ASCO guidelines: <a href="http://doi.org/10.1002/cncr.32408" class="linkified" target="_blank">doi.org/10.1002/cncr.32408</a><br/>Transparency in medicine: <a href="http://doi.org/10.1002/cncr.32407" class="linkified" target="_blank">doi.org/10.1002/cncr.32407</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/218-questions-of-the-week-talking-fc2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/698477455</guid><pubDate>Fri, 18 Oct 2019 22:49:36 GMT</pubDate><enclosure length="74342093" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525497/9ffdbbed84ec4f73487938219ac4ef3a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we begin with a critique of the recent …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4646</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525497/ee7720e3d4c272fb9b80324e01e885ce.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we begin with a critique of the recent perspective article in the New England Journal of Medicine, titled "Talking about Toxicity — 'What We’ve Got Here Is a Failure to Communicate'". After that we interview Dr. Eitan Amir on his paper on undisclosed conflicts of interest among authors of ASCO guidelines. Interspersed between segments of the interview, we invite guest Dr. Sven Olson on to offer a correction to a recent Hem/Onc boards question of the week on Lynch Syndrome (original question posed in episode 2.11) and we invite Ian Straehley on for a question of the week inspired by the USMLE Step 2 CK. Talking about toxicity: doi.org/10.1056/NEJMp1908310  COI among authors of ASCO guidelines: doi.org/10.1002/cncr.32408 Transparency in medicine: doi.org/10.1002/cncr.32407 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.17 Questions of the Week, BEACON, & Use of Subacuate Rehab with Dr. Jonathan Yeh]]></title><description><![CDATA[We start this week's episode with a quick breakdown of why the recent BEACON trial is "the worst trial" host VP has ever read. After that, we have two questions of the week: one from medical student Audrey Tran, and one inspired by the Hem/Onc boards from Dr. Sven Olson. We end with an interview with Dr. Jonathan Yeh of Johns Hopkins University School of Medicine on his recent paper: "Has There Been a Shift in Use of Subacute Rehabilitation Instead of Hospice Referral Since Immunotherapy Has Become Available?". <br/><br/>BEACON: <a href="http://doi.org/10.1056/NEJMoa1908075" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1908075</a><br/>Subacute Rehabilitation: <a href="http://doi.org/10.1200/JOP.19.00044" class="linkified" target="_blank">doi.org/10.1200/JOP.19.00044</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/217-questions-of-the-week-beacon-34e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/692892001</guid><pubDate>Tue, 08 Oct 2019 19:23:37 GMT</pubDate><enclosure length="78618651" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525498/98837a3ebb1f2138704f273b8eb7d674.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode with a quick breakdo…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4914</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525498/d6a93fe7340dddf0347b52eefb606e85.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode with a quick breakdown of why the recent BEACON trial is "the worst trial" host VP has ever read. After that, we have two questions of the week: one from medical student Audrey Tran, and one inspired by the Hem/Onc boards from Dr. Sven Olson. We end with an interview with Dr. Jonathan Yeh of Johns Hopkins University School of Medicine on his recent paper: "Has There Been a Shift in Use of Subacute Rehabilitation Instead of Hospice Referral Since Immunotherapy Has Become Available?". BEACON: doi.org/10.1056/NEJMoa1908075 Subacute Rehabilitation: doi.org/10.1200/JOP.19.00044 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.16 FLAURA & What Truly Matters in the Career of an Academic Physician with Dr. Vinay Prasad]]></title><description><![CDATA[This week we break down the limitations of the recent FLAURA trial and then we're back in the Plenary Session Mobile Command Unit! We have a special guest host, Dr. Christopher Booth of Queen's University in Kingston, Ontario, Canada. He and Dr. Bishal Gyawali, also of Queen's University, conduct a reverse interview with our usual host, Dr. Vinay Prasad of Oregon Health & Science University, on his career, the formation of Plenary Session, and what truly matters in the career of an academic physician.<br/><br/>FLAURA: <a href="http://doi.org/10.1056/NEJMoa1713137" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1713137</a><br/>Price of an Anticancer Drug: <a href="http://doi.org/10.1001/jamainternmed.2017.3601" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2017.3601</a><br/>Simply Measurable or Clinically Meaningful? <a href="http://doi.org/10.1200/jco.2011.38.7571" class="linkified" target="_blank">doi.org/10.1200/jco.2011.38.7571</a><br/>The Emperor Has No Clothes: <a href="http://doi.org/10.1200/JCO.2008.19.5594" class="linkified" target="_blank">doi.org/10.1200/JCO.2008.19.5594</a><br/>Making Room in Oncology: <a href="http://www.medscape.com/viewarticle/917628" class="linkified" target="_blank">www.medscape.com/viewarticle/917628</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/216-flaura-and-what-truly-matters-a35</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/690209113</guid><pubDate>Wed, 02 Oct 2019 22:27:49 GMT</pubDate><enclosure length="94028806" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525499/91b28117ebc735d3ff133eda49da725d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we break down the limitations of the re…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5877</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525499/8a4bd33cdf91940243ca563e74fe137d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we break down the limitations of the recent FLAURA trial and then we're back in the Plenary Session Mobile Command Unit! We have a special guest host, Dr. Christopher Booth of Queen's University in Kingston, Ontario, Canada. He and Dr. Bishal Gyawali, also of Queen's University, conduct a reverse interview with our usual host, Dr. Vinay Prasad of Oregon Health &amp; Science University, on his career, the formation of Plenary Session, and what truly matters in the career of an academic physician. FLAURA: doi.org/10.1056/NEJMoa1713137 Price of an Anticancer Drug: doi.org/10.1001/jamainternmed.2017.3601 Simply Measurable or Clinically Meaningful? doi.org/10.1200/jco.2011.38.7571 The Emperor Has No Clothes: doi.org/10.1200/JCO.2008.19.5594 Making Room in Oncology: www.medscape.com/viewarticle/917628 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.15 Bonus! The Value of Progression-Free Survival as a Treatment Endpoint with Dr. Michael Raphael]]></title><description><![CDATA[This BONUS episode is an interview with Dr. Michael Raphael of Sunnybrook Health Sciences Centre in Toronto, Ontario on his new paper out today in JAMA Oncology: "The value of progression-free survival as a treatment endpoint among patients with advanced cancer: a systematic review and qualitative assessment of the literature".<br/><br/>Value of PFS: <a href="https://jamanetwork.com/journals/jamaoncology/article-abstract/2751879" class="linkified" target="_blank">https://jamanetwork.com/journals/jamaoncology/article-abstract/2751879</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/215-bonus-the-value-of-progression-e18</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/686744092</guid><pubDate>Thu, 26 Sep 2019 15:04:05 GMT</pubDate><enclosure length="34033693" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525500/07a179913944fa0de34b11e1127b3974.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is an interview with Dr. Micha…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2127</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525500/7e56b56c80601b33a9cc0133ddad13b5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is an interview with Dr. Michael Raphael of Sunnybrook Health Sciences Centre in Toronto, Ontario on his new paper out today in JAMA Oncology: "The value of progression-free survival as a treatment endpoint among patients with advanced cancer: a systematic review and qualitative assessment of the literature". Value of PFS: https://jamanetwork.com/journals/jamaoncology/article-abstract/2751879 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.14 Questions of the Week & Qualifications of a Fellowship Applicant with Dr. Jeremy Cetnar]]></title><description><![CDATA[This week we sit down with Dr. Jeremy Cetnar, director of the Oregon Health & Science University Hematology & Oncology Fellowship Program. In this far-ranging interview, we discuss what he is looking for when reviewing applications to the fellowship program. We also have two questions of the week: one from Dr. Derrick Tao, inspired by the MKSAP; and one from Dr. Sven Olson on hematology and oncology. <br/><br/>Tweetorials: <a href="http://doi.org/10.1056/NEJMp1906790" class="linkified" target="_blank">http://doi.org/10.1056/NEJMp1906790</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/214-questions-of-the-week-and-qualifications-65f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/686291224</guid><pubDate>Tue, 24 Sep 2019 22:24:47 GMT</pubDate><enclosure length="97060684" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525501/2b66f63391eb7b2fd2a8b859abea253e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we sit down with Dr. Jeremy Cetnar, dir…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6066</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525501/71763ea8346905b6ff1813209b267089.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we sit down with Dr. Jeremy Cetnar, director of the Oregon Health &amp; Science University Hematology &amp; Oncology Fellowship Program. In this far-ranging interview, we discuss what he is looking for when reviewing applications to the fellowship program. We also have two questions of the week: one from Dr. Derrick Tao, inspired by the MKSAP; and one from Dr. Sven Olson on hematology and oncology. Tweetorials: http://doi.org/10.1056/NEJMp1906790 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci]]></title><description><![CDATA[On this week's BONUS episode, we sit down with Dr. Huseyin Naci, Assistant Professor of Health Policy at the London School of Economics, to discuss his new paper that came out Wednesday (producer's edit: not "yesterday" as said in the podcast - apologies for the delay!) in the British Medical Journal. The paper's titled "Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis."<br/><br/>RCTS Supporting Approvals: <a href="http://doi.org/10.1136/bmj.l5221" class="linkified" target="_blank">doi.org/10.1136/bmj.l5221</a><br/><br/>Back us on Patreon! <a href="http://patreon.com/plenarysession" class="linkified" target="_blank">patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/213-bonus-rcts-supporting-approvals-f1d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/684363333</guid><pubDate>Fri, 20 Sep 2019 22:50:18 GMT</pubDate><enclosure length="37961673" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525502/0ce752fdf421b9e9b15ca73c8da4d948.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>On this week's BONUS episode, we sit down with Dr…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2373</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525502/86b42276178196b5e3c7a4b0c7555b24.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>On this week's BONUS episode, we sit down with Dr. Huseyin Naci, Assistant Professor of Health Policy at the London School of Economics, to discuss his new paper that came out Wednesday (producer's edit: not "yesterday" as said in the podcast - apologies for the delay!) in the British Medical Journal. The paper's titled "Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis." RCTS Supporting Approvals: doi.org/10.1136/bmj.l5221 Back us on Patreon! patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.12 Questions of the Week, Ethics of RCTs, & Transmission and Medical Overuse with Dr. Dan Morgan]]></title><description><![CDATA[We begin this week's episode by revisiting last week's topic on the ethics of randomized controlled trials (RCTs) to address some of the controversy stirred up by our episode. We transition from there to an interview with Dr. Dan Morgan of the University of Maryland School of Medicine on hospital transmission and medical overuse. We have two questions of the week, as well -- one from Ian Straehley, inspired by the USMLE Step 2 CK; and one from Audrey Tran, inspired by the life of a medical student.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/212-questions-of-the-week-ethics-ae8</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/682479398</guid><pubDate>Tue, 17 Sep 2019 18:01:40 GMT</pubDate><enclosure length="93869148" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525503/d72fc7c3a27dce352c92bede21b9be4b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this week's episode by revisiting last w…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5867</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525503/783e0ccad4be435820bd60352706dae1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this week's episode by revisiting last week's topic on the ethics of randomized controlled trials (RCTs) to address some of the controversy stirred up by our episode. We transition from there to an interview with Dr. Dan Morgan of the University of Maryland School of Medicine on hospital transmission and medical overuse. We have two questions of the week, as well -- one from Ian Straehley, inspired by the USMLE Step 2 CK; and one from Audrey Tran, inspired by the life of a medical student. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.11 Questions of the Week, When RCTs are Necessary, & AYA Oncology with Dr. Adam Duvall]]></title><description><![CDATA[After a hiatus from our segment on reviewing recent trials, we return to discuss the need for randomized controlled trials (RCTs). In the wake of the 2019 World Conference on Lung Cancer, we focus on whether a phase III trial of selpercatinib (LOXO-292) in RET rearranged lung cancer is feasible, practical, and ethical. We also have two questions of the week in this episode -- one from Dr. Derrick Tao, inspired by the MKSAP; and one from Dr. Sven Olson on hematology and oncology -- as well as an interview with Dr. Adam Duvall of OHSU on his career in the field of adolescent and young adult (AYA) oncology. <br/><br/>Back us on Patreon! <a href="http://patreon.com/plenarysession" class="linkified" target="_blank">patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/211-questions-of-the-week-when-rcts-ef7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/680137832</guid><pubDate>Thu, 12 Sep 2019 16:44:22 GMT</pubDate><enclosure length="97415949" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525504/907ee33248d878513f6f478ec5ee1420.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>After a hiatus from our segment on reviewing rece…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6088</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525504/49a987e9b6b09bb2b496920f10a3dd64.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>After a hiatus from our segment on reviewing recent trials, we return to discuss the need for randomized controlled trials (RCTs). In the wake of the 2019 World Conference on Lung Cancer, we focus on whether a phase III trial of selpercatinib (LOXO-292) in RET rearranged lung cancer is feasible, practical, and ethical. We also have two questions of the week in this episode -- one from Dr. Derrick Tao, inspired by the MKSAP; and one from Dr. Sven Olson on hematology and oncology -- as well as an interview with Dr. Adam Duvall of OHSU on his career in the field of adolescent and young adult (AYA) oncology. Back us on Patreon! patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.10 Questions of the Week: the USMLE Step 2 CK, the MKSAP, & Hematology/Oncology]]></title><description><![CDATA[We have three questions for you this week: one from Ian Straehley, inspired by the USMLE Step 2 CK; one from Dr. Derrick Tao, inspired by the MKSAP; and one from Dr. Sven Olson on hematology and oncology.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/210-questions-of-the-week-the-usmle-0b1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/676821411</guid><pubDate>Thu, 05 Sep 2019 19:33:23 GMT</pubDate><enclosure length="22513902" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525505/6975c62ad6dde63eb7e89973b87daf95.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have three questions for you this week: one fr…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1407</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525505/0a0cb90ba3fc707e5e41a2a0ee052660.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have three questions for you this week: one from Ian Straehley, inspired by the USMLE Step 2 CK; one from Dr. Derrick Tao, inspired by the MKSAP; and one from Dr. Sven Olson on hematology and oncology. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.09 Questions of the Week & Informed Consent in Clinical Trials with Dr. Lynn Jansen]]></title><description><![CDATA[We start this week with two Questions of the Week: the first is from Ian Straehley on the USMLE Step 2 CK, and the second is from Dr. Sven Olson on hematology/oncology. We end with an interview with Dr. Lynn Jansen of OHSU on the therapeutic misconception, optimism bias, and a deep discussion of the ethics of consenting patients for enrollment in early-phase clinical research trials.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/209-questions-of-the-week-and-informed-659</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/672277634</guid><pubDate>Wed, 28 Aug 2019 17:13:37 GMT</pubDate><enclosure length="77096861" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525506/625cbf8c51e1586ad0535b2cb7a2809e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week with two Questions of the Week…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4819</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525506/2aa314e004390061f0dbeefbdcda03b8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week with two Questions of the Week: the first is from Ian Straehley on the USMLE Step 2 CK, and the second is from Dr. Sven Olson on hematology/oncology. We end with an interview with Dr. Lynn Jansen of OHSU on the therapeutic misconception, optimism bias, and a deep discussion of the ethics of consenting patients for enrollment in early-phase clinical research trials. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.08 Questions of the Week: the MKSAP, the USMLE Step 2 CK, & From a Med Student]]></title><description><![CDATA[We have three questions for you this week: one from Dr. Derrick Tao, inspired by the MKSAP; one from Ian Straehley, inspired by the USMLE Step 2 CK; and one from Audrey Tran, inspired by her journey through medical school. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/208-questions-of-the-week-the-mksap-8ed</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/669663884</guid><pubDate>Thu, 22 Aug 2019 21:42:08 GMT</pubDate><enclosure length="35903639" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525507/177dbc00413b1065f9a0f63efd255366.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We have three questions for you this week: one fr…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2244</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525507/bc917bf3694a9cdb811505b25a30d9d5.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We have three questions for you this week: one from Dr. Derrick Tao, inspired by the MKSAP; one from Ian Straehley, inspired by the USMLE Step 2 CK; and one from Audrey Tran, inspired by her journey through medical school. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu]]></title><description><![CDATA[We start this week's episode with a Question of the Week from medical student Audrey Tran on translational research and medical student training. Afterwards, we have an in-depth interview with Dr. Adam Cifu of the University of Chicago on his recent publication: "Physical Examination Pet Peeves". <br/><br/>Pet Peeves: <a href="http://doi.org/10.4300/JGME-D-18-01063.1" class="linkified" target="_blank">doi.org/10.4300/JGME-D-18-01063.1</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/207-translational-research-and-physical-d37</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/666773909</guid><pubDate>Fri, 16 Aug 2019 17:16:58 GMT</pubDate><enclosure length="74105527" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525508/c4461b1567f7887ed883fd5226667c3c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We start this week's episode with a Question of t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4632</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525508/343256e8623bbddca5b680b3c2c70a02.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We start this week's episode with a Question of the Week from medical student Audrey Tran on translational research and medical student training. Afterwards, we have an in-depth interview with Dr. Adam Cifu of the University of Chicago on his recent publication: "Physical Examination Pet Peeves". Pet Peeves: doi.org/10.4300/JGME-D-18-01063.1 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.06 Heart Failure, Choosing a Specialty, & the Bayesian Approach with Dr. Frank Harrell]]></title><description><![CDATA[We're back with more questions of the week! Our first question, from Ian Straehley, is inspired by the USMLE Step 2 CK; our second question, from Audrey Tran, is on deciding on a medical specialty. We end the episode with an interview with Dr. Frank Harrell of Vanderbilt University on the Bayesian approach to statistical thinking.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/206-heart-failure-choosing-a-specialty-c0b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/662171717</guid><pubDate>Tue, 06 Aug 2019 23:31:55 GMT</pubDate><enclosure length="78844558" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525509/605179f8d259bde02dd1b099611aa0da.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're back with more questions of the week! Our f…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6570</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525509/a01b42c27b007e81646ea461b8428319.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're back with more questions of the week! Our first question, from Ian Straehley, is inspired by the USMLE Step 2 CK; our second question, from Audrey Tran, is on deciding on a medical specialty. We end the episode with an interview with Dr. Frank Harrell of Vanderbilt University on the Bayesian approach to statistical thinking. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.05 Reup! Cancer Screening 101 with Dr. Adam Obley]]></title><description><![CDATA[In this REUP episode, we replay a section of our interview with Dr. Adam Obley of OHSU: a primer on cancer screening. This audio was first aired on episode 2.03.<br/><br/>Not So Silver Lining: <a href="http://doi.org/10.1001/archinternmed.2011.73" class="linkified" target="_blank">doi.org/10.1001/archinternmed.2011.73</a><br/>Mammography Screening: Truth, Lies and Controversy: <a href="http://www.crcpress.com/Mammography-Screening-Truth-Lies-and-Controversy/Gotzsche/p/book/9781846195853" class="linkified" target="_blank">www.crcpress.com/Mammography-Screening-Truth-Lies-and-Controversy/Gotzsche/p/book/9781846195853</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/205-reup-cancer-screening-101-with-587</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/658711331</guid><pubDate>Wed, 31 Jul 2019 15:26:18 GMT</pubDate><enclosure length="69852790" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525510/e78e913ea4921f4910c29f2497d211d9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this REUP episode, we replay a section of our …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4366</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525510/b083604e6b0c54bd98298c0fe352907e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this REUP episode, we replay a section of our interview with Dr. Adam Obley of OHSU: a primer on cancer screening. This audio was first aired on episode 2.03. Not So Silver Lining: doi.org/10.1001/archinternmed.2011.73 Mammography Screening: Truth, Lies and Controversy: www.crcpress.com/Mammography-Screening-Truth-Lies-and-Controversy/Gotzsche/p/book/9781846195853 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.04 Reup! Tumor-Treating Fields for Glioblastoma with Dr. Michael Hayes]]></title><description><![CDATA[In this REUP episode, we replay a section of our interview with Dr. Michael Hayes of Kaiser Permanente. This audio was first aired on episode 2.01. The interview is on the relationship between conflict of interest and editorial stance on tumor-treating fields for glioblastoma multiforme.<br/><br/>TTF: <a href="http://doi.org/10.1016/j.jcpo.2019.100189" class="linkified" target="_blank">doi.org/10.1016/j.jcpo.2019.100189</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/204-reup-tumor-treating-fields-for-8c5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/658674767</guid><pubDate>Tue, 30 Jul 2019 19:33:00 GMT</pubDate><enclosure length="34539419" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525511/62f260b2aeced28f6e6b0b0ebca38f13.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this REUP episode, we replay a section of our …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2159</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525511/4d15d52688dc07d32977b405f661108d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this REUP episode, we replay a section of our interview with Dr. Michael Hayes of Kaiser Permanente. This audio was first aired on episode 2.01. The interview is on the relationship between conflict of interest and editorial stance on tumor-treating fields for glioblastoma multiforme. TTF: doi.org/10.1016/j.jcpo.2019.100189 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.03 Dr. Charles Moertel and the Modern Oncologist & Cancer Screening 101 with Dr. Adam Obley]]></title><description><![CDATA[This week we launch a new segment on Plenary Session: Question of the Week! We invite Dr. Sven Olson on to ask a sample hematology/oncology boards question and we invite Audrey Tran on to ask a question from a medical student. Before that, we talk about the legacy of Dr. Charles Moertel and how modern oncologists, in contrast, will be remembered. We end the episode with an interview with Dr. Adam Obley of OHSU -- his fourth appearance on the podcast! -- on cancer screening.<br/><br/>Dr. Moertel's obituary: <a href="https://www.nytimes.com/1994/06/29/obituaries/charles-moertel-66-studied-treatment-and-cost-of-cancer.html" class="linkified" target="_blank">https://www.nytimes.com/1994/06/29/obituaries/charles-moertel-66-studied-treatment-and-cost-of-cancer.html</a><br/>Faith Lost, a Doctor Turns Bitter: <a href="https://www.latimes.com/archives/la-xpm-1993-09-12-mn-34516-story.html" class="linkified" target="_blank">https://www.latimes.com/archives/la-xpm-1993-09-12-mn-34516-story.html</a><br/>Not So Silver Lining: <a href="http://doi.org/10.1001/archinternmed.2011.73" class="linkified" target="_blank">doi.org/10.1001/archinternmed.2011.73</a><br/>Mammography Screening: Truth, Lies and Controversy: <a href="https://www.crcpress.com/Mammography-Screening-Truth-Lies-and-Controversy/Gotzsche/p/book/9781846195853" class="linkified" target="_blank">https://www.crcpress.com/Mammography-Screening-Truth-Lies-and-Controversy/Gotzsche/p/book/9781846195853</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/203-dr-charles-moertel-and-the-modern-761</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/655463654</guid><pubDate>Tue, 23 Jul 2019 22:37:45 GMT</pubDate><enclosure length="120601812" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525512/7a80340133c7fbce63ee45990b9ae4da.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we launch a new segment on Plenary Sess…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7538</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525512/3596c5f466dd8de532f5fecb76c11ff0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we launch a new segment on Plenary Session: Question of the Week! We invite Dr. Sven Olson on to ask a sample hematology/oncology boards question and we invite Audrey Tran on to ask a question from a medical student. Before that, we talk about the legacy of Dr. Charles Moertel and how modern oncologists, in contrast, will be remembered. We end the episode with an interview with Dr. Adam Obley of OHSU -- his fourth appearance on the podcast! -- on cancer screening. Dr. Moertel's obituary: https://www.nytimes.com/1994/06/29/obituaries/charles-moertel-66-studied-treatment-and-cost-of-cancer.html Faith Lost, a Doctor Turns Bitter: https://www.latimes.com/archives/la-xpm-1993-09-12-mn-34516-story.html Not So Silver Lining: doi.org/10.1001/archinternmed.2011.73 Mammography Screening: Truth, Lies and Controversy: https://www.crcpress.com/Mammography-Screening-Truth-Lies-and-Controversy/Gotzsche/p/book/9781846195853 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.02 BONUS! Improving Access to Prescription Drugs through Policy Change with Dr. Stacie Dusetzina]]></title><description><![CDATA[This BONUS episode is a recording of a lecture that Dr. Stacie Dusetzina of Vanderbilt University gave for grand rounds at OHSU on June 19, 2019. The lecture is on the cost of prescription drugs and out-of-pocket spending.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/202-bonus-improving-access-to-prescription-fb9</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/652586261</guid><pubDate>Wed, 17 Jul 2019 19:13:46 GMT</pubDate><enclosure length="42911559" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525513/ae2ab96a15224a6ee83a2f579e0fe442.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is a recording of a lecture th…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2682</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525513/935559ee56c1ff476237edb7b7277ed9.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is a recording of a lecture that Dr. Stacie Dusetzina of Vanderbilt University gave for grand rounds at OHSU on June 19, 2019. The lecture is on the cost of prescription drugs and out-of-pocket spending. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter]]></title><description><![CDATA[Welcome to season 2! We're starting this season off with a little bit of everything: a critique of the FDA's accelerated approval of selinexor for penta-refractory multiple myeloma; an interview with Dr. John Reneau of Ohio State University on ECHELON-2 (brentuximab vedotin in t-cell lymphomas); an interview with Dr. Michael Hayes of Kaiser Permanente on parachutes in medicine plus the relationship between conflict of interest and editorial stance on tumor-treating fields for glioblastoma multiforme; and an interview with Dr. Stacie Dusetzina - a leading researcher in health care policy and the cost of cancer drugs, and an avid Twitter user - of Vanderbilt University on #MedTwitter.<br/><br/>ECHELON-2: <a href="http://doi.org/10.1016/S0140-6736(18)32984-2" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(18)32984-2</a><br/>Facing Our Mistakes: <a href="http://doi.org/10.1056/NEJM198401123100211" class="linkified" target="_blank">doi.org/10.1056/NEJM198401123100211</a><br/>Parachutes: <a href="http://doi.org/10.9778/cmajo.20170088" class="linkified" target="_blank">doi.org/10.9778/cmajo.20170088</a><br/>TTF: <a href="http://doi.org/10.1016/j.jcpo.2019.100189" class="linkified" target="_blank">doi.org/10.1016/j.jcpo.2019.100189</a><br/>Impact of Disclosing Financial Ties: <a href="http://doi.org/10.1001/archinternmed.2010.39" class="linkified" target="_blank">doi.org/10.1001/archinternmed.2010.39</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/201-selinexor-echelon-2-parachutes-196</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/650306192</guid><pubDate>Fri, 12 Jul 2019 21:50:27 GMT</pubDate><enclosure length="152140176" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525514/11bc594410b776835ccea71a5179abf1.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Welcome to season 2! We're starting this season o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9509</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525514/cfcffbccd2cbfaa8995a42ebe34d0db7.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Welcome to season 2! We're starting this season off with a little bit of everything: a critique of the FDA's accelerated approval of selinexor for penta-refractory multiple myeloma; an interview with Dr. John Reneau of Ohio State University on ECHELON-2 (brentuximab vedotin in t-cell lymphomas); an interview with Dr. Michael Hayes of Kaiser Permanente on parachutes in medicine plus the relationship between conflict of interest and editorial stance on tumor-treating fields for glioblastoma multiforme; and an interview with Dr. Stacie Dusetzina - a leading researcher in health care policy and the cost of cancer drugs, and an avid Twitter user - of Vanderbilt University on #MedTwitter. ECHELON-2: doi.org/10.1016/S0140-6736(18)32984-2 Facing Our Mistakes: doi.org/10.1056/NEJM198401123100211 Parachutes: doi.org/10.9778/cmajo.20170088 TTF: doi.org/10.1016/j.jcpo.2019.100189 Impact of Disclosing Financial Ties: doi.org/10.1001/archinternmed.2010.39 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma]]></title><description><![CDATA[We begin this week's episode by breaking down the recent phase III trial on voxeletor in sickle cell disease with Dr. Sven Olson of OHSU. Next, we feature guest Dr. David Steensma of the Dana-Farber Cancer Institute in a far-reaching interview on being well-read, running a small lab, humanizing cancer, learning from our past use of erythropoiesis-stimulating agents, understanding the headache of contract research organizations, defining cancer, and more!<br/><br/>Voxeletor in Sickle Cell: <a href="http://doi.org/10.1056/NEJMoa1903212" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903212</a><br/>Don't Mention It: <a href="http://doi.org/10.1200/JCO.2008.17.7238" class="linkified" target="_blank">doi.org/10.1200/JCO.2008.17.7238</a><br/>The Raven: <a href="http://doi.org/10.1200/JCO.2017.76.3458" class="linkified" target="_blank">doi.org/10.1200/JCO.2017.76.3458</a><br/>Erythropoietin Use in Cancer: <a href="http://doi.org/10.1200/JCO.2005.05.036" class="linkified" target="_blank">doi.org/10.1200/JCO.2005.05.036</a><br/>Contract Research Organizations: <a href="http://doi.org/10.1002/cncr.29994" class="linkified" target="_blank">doi.org/10.1002/cncr.29994</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/168-voxeletor-with-dr-olson-and-humanizing-18b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/646727481</guid><pubDate>Fri, 05 Jul 2019 18:01:16 GMT</pubDate><enclosure length="120484366" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525515/0506bab852a1e149bbc2456ffddf8b2c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this week's episode by breaking down the…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7530</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525515/6084021127450f52b19ac97a09af4d96.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this week's episode by breaking down the recent phase III trial on voxeletor in sickle cell disease with Dr. Sven Olson of OHSU. Next, we feature guest Dr. David Steensma of the Dana-Farber Cancer Institute in a far-reaching interview on being well-read, running a small lab, humanizing cancer, learning from our past use of erythropoiesis-stimulating agents, understanding the headache of contract research organizations, defining cancer, and more! Voxeletor in Sickle Cell: doi.org/10.1056/NEJMoa1903212 Don't Mention It: doi.org/10.1200/JCO.2008.17.7238 The Raven: doi.org/10.1200/JCO.2017.76.3458 Erythropoietin Use in Cancer: doi.org/10.1200/JCO.2005.05.036 Contract Research Organizations: doi.org/10.1002/cncr.29994 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina]]></title><description><![CDATA[This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs. <br/><br/>MONALEESA-7: <a href="http://doi.org/10.1056/NEJMoa1903765" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903765</a><br/>Free drug samples are a marketing tool: <a href="http://doi.org/10.2105/AJPH.2007.114249" class="linkified" target="_blank">doi.org/10.2105/AJPH.2007.114249</a> <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/167-monaleesa-7-and-the-cost-of-cancer-f8b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/643132245</guid><pubDate>Thu, 27 Jun 2019 22:53:42 GMT</pubDate><enclosure length="134396555" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525516/f564c5b1a57a041d9d5d11cf88d7a563.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we begin the episode by discussing MONA…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>8400</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525516/2b675409c5b4a9dd51e01ff87a8a18b0.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs. MONALEESA-7: doi.org/10.1056/NEJMoa1903765 Free drug samples are a marketing tool: doi.org/10.2105/AJPH.2007.114249 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell]]></title><description><![CDATA[This week we open with a critical take on our current system of disseminating scientific research, specifically focusing on the prevalence of -- and dependence on -- medical writers. In the second half of the episode, we interview Dr. Allen Pannell of the Haslam College of Business at the University of Tennessee on using a Frequentist approach vs a Bayesian approach in the context of a single clinical trial. <br/><br/>Frequentist vs Bayesian: <a href="http://doi.org/10.1136/bmjopen-2018-024256" class="linkified" target="_blank">doi.org/10.1136/bmjopen-2018-024256</a><br/>Dr. Pannell's breast cancer support group: <a href="https://www.breastconnect.org/" class="linkified" target="_blank">https://www.breastconnect.org/</a><br/>Dr. Pannell's research project: <a href="http://tinyurl.com/peerErPrHer2" class="linkified" target="_blank">http://tinyurl.com/peerErPrHer2</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/166-employing-medical-writers-and-608</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/639710985</guid><pubDate>Thu, 20 Jun 2019 19:19:46 GMT</pubDate><enclosure length="61413776" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525517/384ba6ef9d8c57e8ad3ee25aab5f3278.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we open with a critical take on our cur…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3838</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525517/a801ed80f42f96f2f49835c293c5d79b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we open with a critical take on our current system of disseminating scientific research, specifically focusing on the prevalence of -- and dependence on -- medical writers. In the second half of the episode, we interview Dr. Allen Pannell of the Haslam College of Business at the University of Tennessee on using a Frequentist approach vs a Bayesian approach in the context of a single clinical trial. Frequentist vs Bayesian: doi.org/10.1136/bmjopen-2018-024256 Dr. Pannell's breast cancer support group: https://www.breastconnect.org/ Dr. Pannell's research project: http://tinyurl.com/peerErPrHer2 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.65 BONUS! Focusing and Building Your Presence on Twitter]]></title><description><![CDATA[In this BONUS episode we give advice on how to use Twitter effectively: how to focus your content, how to build your Twitter following, and how to conceptualize of the platform as an information network. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/165-bonus-focusing-and-building-your-ee5</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/635792325</guid><pubDate>Wed, 12 Jun 2019 23:24:49 GMT</pubDate><enclosure length="38380046" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525518/a7b95edbd5bbe8fb0b8eef3540fe2e58.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this BONUS episode we give advice on how to us…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2399</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525518/0f3c9947ebfe2f0039028f3c005f4b07.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this BONUS episode we give advice on how to use Twitter effectively: how to focus your content, how to build your Twitter following, and how to conceptualize of the platform as an information network. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.64 Effectiveness of Cancer Screening with Dr. Joaquín Chapa and POLO with Dr. Emerson Chen]]></title><description><![CDATA[This week we discuss the recent paper "Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice?" with its author, Dr. Joaquín Chapa of OHSU. We then revisit the POLO trial with Dr. Emerson Chen of OHSU, who disagrees with last episode's analysis.<br/><br/>Effectiveness of Screening: <a href="http://doi.org/10.1016/j.mayocp.2019.02.016" class="linkified" target="_blank">doi.org/10.1016/j.mayocp.2019.02.016</a><br/>POLO: <a href="http://doi.org/10.1056/NEJMoa1903387" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903387</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/164-effectiveness-of-cancer-screening-b35</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/632768007</guid><pubDate>Thu, 06 Jun 2019 18:31:06 GMT</pubDate><enclosure length="64875732" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525519/8b93544c924cd15ae6f3935c333ea73a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss the recent paper "Interpreti…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4055</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525519/9c8ef1d1c7e6e23f4c1576a4cfbb5b81.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss the recent paper "Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice?" with its author, Dr. Joaquín Chapa of OHSU. We then revisit the POLO trial with Dr. Emerson Chen of OHSU, who disagrees with last episode's analysis. Effectiveness of Screening: doi.org/10.1016/j.mayocp.2019.02.016 POLO: doi.org/10.1056/NEJMoa1903387 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.63 POLO, TITAN, & from ASCO: FDA Approval, Surrogate Endpoints, and Patient Experience]]></title><description><![CDATA[This week we cover some of the highlights from this year's ASCO annual meeting. We discuss the POLO study "Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer" and the TITAN study "Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer", both recently published in NEJM. We end with a presentation titled "Expedited Program Use and Patient Experience in Trials", which was given in a shortened version at ASCO.<br/><br/>POLO: <a href="http://doi.org/10.1056/NEJMoa1903387" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903387</a><br/>TITAN: <a href="http://doi.org/10.1056/NEJMoa1903307" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1903307</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/163-polo-titan-and-from-asco-fda-74f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/631686687</guid><pubDate>Tue, 04 Jun 2019 17:27:54 GMT</pubDate><enclosure length="79936473" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525520/d3ec6a203887bd67d2f35ee438a3bdd3.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we cover some of the highlights from th…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4996</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525520/304e7f65364892cd1aefce7a915a52ad.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we cover some of the highlights from this year's ASCO annual meeting. We discuss the POLO study "Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer" and the TITAN study "Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer", both recently published in NEJM. We end with a presentation titled "Expedited Program Use and Patient Experience in Trials", which was given in a shortened version at ASCO. POLO: doi.org/10.1056/NEJMoa1903387 TITAN: doi.org/10.1056/NEJMoa1903307 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.62 Rates of Cancer Screening, BILCAP Outcry, Waterfall Plots and Response Rate, & Dr. Jeff Sharman]]></title><description><![CDATA[We begin this episode by responding to listener feedback from episode 1.61's discussion of clinic appointment time and rates of cancer screening. We also tackle listeners' outcry over our take-down of BILCAP (spoiler alert: BILCAP is still a null trial) and how outcry like this highlights the need to train clinicians to think probabilistically. From there, we move on to discussing the recent paper by Myung Sun Kim in JAMA Network Open on waterfall plots and how they are a visual distortion of response rate. We end the episode with an interview with Dr. Jeff Sharman of Willamette Valley Cancer Institute in Eugene, Oregon on community oncology, enrolling patients in clinical trials, expertise of academia, and using real-world evidence.<br/><br/>Waterfall plots: <a href="http://doi.org/10.1001/jamanetworkopen.2019.3981" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2019.3981</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/162-rates-of-cancer-screening-bilcap-c47</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/625528017</guid><pubDate>Thu, 23 May 2019 20:47:49 GMT</pubDate><enclosure length="87868920" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525521/5b4b6a689f830f361e5fb398031bc8ad.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this episode by responding to listener f…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5492</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525521/759a15160cc9635cb2c6543108baec12.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this episode by responding to listener feedback from episode 1.61's discussion of clinic appointment time and rates of cancer screening. We also tackle listeners' outcry over our take-down of BILCAP (spoiler alert: BILCAP is still a null trial) and how outcry like this highlights the need to train clinicians to think probabilistically. From there, we move on to discussing the recent paper by Myung Sun Kim in JAMA Network Open on waterfall plots and how they are a visual distortion of response rate. We end the episode with an interview with Dr. Jeff Sharman of Willamette Valley Cancer Institute in Eugene, Oregon on community oncology, enrolling patients in clinical trials, expertise of academia, and using real-world evidence. Waterfall plots: doi.org/10.1001/jamanetworkopen.2019.3981 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.61 Postpublication Metrics of RCTs, PCP Appointment Time, Bortezomib, & Dr. Christopher Booth]]></title><description><![CDATA[This week we cover three papers -- "Postpublication Metrics of Randomized Clinical Trials With and Without Null Findings" by Murray et al. in JAMA, "Association of Primary Care Clinic Appointment Time With Clinician Ordering and Patient Completion of Breast and Colorectal Cancer Screening" by Hsiang et al. in JAMA Network Open, and "Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers" by Drilon et al. in Molecular Case Studies. We end with an interview with Dr. Christopher Booth of Queens University in Kingston, Ontario, conducted in the Plenary Session Mobile Command Unit. <br/><br/>Postpublication Metrics: <a href="http://doi.org/10.1001/jama.2019.2994" class="linkified" target="_blank">doi.org/10.1001/jama.2019.2994</a><br/>PCP Appointment Time: <a href="http://doi.org/10.1001/jamanetworkopen.2019.3403" class="linkified" target="_blank">doi.org/10.1001/jamanetworkopen.2019.3403</a><br/>Exceptional Responders: <a href="http://doi.org/10.1101/mcs.a003665" class="linkified" target="_blank">doi.org/10.1101/mcs.a003665</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/161-postpublication-metrics-of-rcts-04a</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/621255423</guid><pubDate>Wed, 15 May 2019 23:13:06 GMT</pubDate><enclosure length="148415741" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525522/e8e61652a56174d20ec75f2492582a30.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we cover three papers -- "Postpublicati…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>9276</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525522/aed9efa17cac1bd0a50f2a1932e37988.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we cover three papers -- "Postpublication Metrics of Randomized Clinical Trials With and Without Null Findings" by Murray et al. in JAMA, "Association of Primary Care Clinic Appointment Time With Clinician Ordering and Patient Completion of Breast and Colorectal Cancer Screening" by Hsiang et al. in JAMA Network Open, and "Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers" by Drilon et al. in Molecular Case Studies. We end with an interview with Dr. Christopher Booth of Queens University in Kingston, Ontario, conducted in the Plenary Session Mobile Command Unit. Postpublication Metrics: doi.org/10.1001/jama.2019.2994 PCP Appointment Time: doi.org/10.1001/jamanetworkopen.2019.3403 Exceptional Responders: doi.org/10.1101/mcs.a003665 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.60 I-PREDICT, Flawed Phase I Trials, & the Cost of Drugs with Dr. Daniel Hartung]]></title><description><![CDATA[We revisit I-PREDICT, discuss the "Imputability of Adverse Events to Anticancer Drugs" (a letter published recently in the New England Journal of Medicine), and interview Dr. Daniel Hartung of Oregon State University's College of Pharmacy on his vast knowledge of the cost of drugs, specifically addressing Acthar gel and multiple sclerosis drugs.<br/><br/>Imputability of Adverse Events: <a href="http://doi.org/10.1056/NEJMc1900053" class="linkified" target="_blank">doi.org/10.1056/NEJMc1900053</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/160-i-predict-flawed-phase-i-trials-baf</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/618313563</guid><pubDate>Thu, 09 May 2019 23:05:32 GMT</pubDate><enclosure length="76922569" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525523/bdf4bb5ac468efeaaca4ff9cc735e93e.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We revisit I-PREDICT, discuss the "Imputability o…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4808</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525523/065112fe8d53bff01d1f3ec0aa4e599b.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We revisit I-PREDICT, discuss the "Imputability of Adverse Events to Anticancer Drugs" (a letter published recently in the New England Journal of Medicine), and interview Dr. Daniel Hartung of Oregon State University's College of Pharmacy on his vast knowledge of the cost of drugs, specifically addressing Acthar gel and multiple sclerosis drugs. Imputability of Adverse Events: doi.org/10.1056/NEJMc1900053 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.59 BONUS! Should Evidence Come with an Expiration Date? with Palmer Greene]]></title><description><![CDATA[In this BONUS episode, we interview Palmer Greene, a fourth-year medical student at the University of Chicago Pritzker School of Medicine, on his recent paper: "Should Evidence Come with an Expiration Date?", published in the Journal of General Internal Medicine.<br/><br/>Expiration Date?: <a href="http://doi.org/10.1007/s11606-019-05032-4" class="linkified" target="_blank">doi.org/10.1007/s11606-019-05032-4</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/159-bonus-should-evidence-come-with-716</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/617722272</guid><pubDate>Wed, 08 May 2019 22:07:37 GMT</pubDate><enclosure length="18174644" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525524/386cceb514263a4116f969b6db529af9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this BONUS episode, we interview Palmer Greene…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1136</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525524/7f2c35ae91f4d8568ace8d15b61f2514.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this BONUS episode, we interview Palmer Greene, a fourth-year medical student at the University of Chicago Pritzker School of Medicine, on his recent paper: "Should Evidence Come with an Expiration Date?", published in the Journal of General Internal Medicine. Expiration Date?: doi.org/10.1007/s11606-019-05032-4 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal]]></title><description><![CDATA[This week we discuss three paired papers on precision oncology published in Nature Medicine and then, later in the episode, go in-depth on the implications of these negative studies with Dr. Talal Hilal of the Mayo Clinic. We also discuss the use of magic mouthwash for oral mucositis with Plenary Session fan, Dr. Arjun Gupta of Johns Hopkins University. <br/><br/>WINTHER: <a href="http://doi.org/10.1038/s41591-019-0424-4" class="linkified" target="_blank">doi.org/10.1038/s41591-019-0424-4</a><br/>TARGET: <a href="http://doi.org/10.1038/s41591-019-0380-z" class="linkified" target="_blank">doi.org/10.1038/s41591-019-0380-z</a><br/>I-PREDICT: <a href="http://doi.org/10.1038/s41591-019-0407-5" class="linkified" target="_blank">doi.org/10.1038/s41591-019-0407-5</a><br/>Magic mouthwash: <a href="http://doi.org/10.1001/jamainternmed.2018.6223" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2018.6223</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/158-magic-mouthwash-with-dr-arjun-d04</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/617055480</guid><pubDate>Tue, 07 May 2019 16:12:12 GMT</pubDate><enclosure length="90364136" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525525/eca562f634abb95f9f6b3c2aa87ff66a.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss three paired papers on preci…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5648</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525525/59eb26996899181dfa605a40a637cff2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss three paired papers on precision oncology published in Nature Medicine and then, later in the episode, go in-depth on the implications of these negative studies with Dr. Talal Hilal of the Mayo Clinic. We also discuss the use of magic mouthwash for oral mucositis with Plenary Session fan, Dr. Arjun Gupta of Johns Hopkins University. WINTHER: doi.org/10.1038/s41591-019-0424-4 TARGET: doi.org/10.1038/s41591-019-0380-z I-PREDICT: doi.org/10.1038/s41591-019-0407-5 Magic mouthwash: doi.org/10.1001/jamainternmed.2018.6223 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal]]></title><description><![CDATA[In this BONUS episode, we interview Dr. Talal Hilal of the Mayo Clinic on his paper that was published today in JAMA Oncology, titled "Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration". <br/><br/>Control Arm Quality: <a href="http://doi.org/10.1001/jamaoncol.2019.0167" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2019.0167</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/157-bonus-control-arm-quality-in-6e7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/614708781</guid><pubDate>Thu, 02 May 2019 16:58:55 GMT</pubDate><enclosure length="32213057" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525526/30a6ae24d9ead755c87bbc95f0be7773.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this BONUS episode, we interview Dr. Talal Hil…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2013</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525526/30c23c92256807ab1c8c3329b4f0b136.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this BONUS episode, we interview Dr. Talal Hilal of the Mayo Clinic on his paper that was published today in JAMA Oncology, titled "Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration". Control Arm Quality: doi.org/10.1001/jamaoncol.2019.0167 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.56 BONUS! Real World Data & the Search for Meaningful Cancer Care with Dr. Christopher Booth]]></title><description><![CDATA[This BONUS episode is the recording of a Grand Rounds lecture that Dr. Christopher Booth of Queen's University in Kingston, Canada gave this morning (May 1, 2019) at OHSU. The title is "Achieving the Achievable: Real World Data and the Search for Meaningful Cancer Care".<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/156-bonus-real-world-data-and-the-320</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/614368485</guid><pubDate>Wed, 01 May 2019 23:01:25 GMT</pubDate><enclosure length="46759290" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525527/65cdcd815aa017d68c821f11be759e87.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a Grand Ro…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2922</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525527/11b2f9f7fb29d177bc1bfc3767a151cb.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a Grand Rounds lecture that Dr. Christopher Booth of Queen's University in Kingston, Canada gave this morning (May 1, 2019) at OHSU. The title is "Achieving the Achievable: Real World Data and the Search for Meaningful Cancer Care". Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.55 Role of a Professional Society & More with Dr. Cliff Hudis of ASCO]]></title><description><![CDATA[This week we sit down with Dr. Cliff Hudis, the CEO of the American Society of Clinical Oncology, to discuss the role of a professional society, the evolution of oncology, building a career, and more. <br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/155-role-of-a-professional-society-d87</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/613349472</guid><pubDate>Mon, 29 Apr 2019 22:20:46 GMT</pubDate><enclosure length="95638365" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525528/840d571d088526b5c765a7be5562b2e9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we sit down with Dr. Cliff Hudis, the C…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5977</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525528/df9f8ffd19d59eaddf7146260a653828.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we sit down with Dr. Cliff Hudis, the CEO of the American Society of Clinical Oncology, to discuss the role of a professional society, the evolution of oncology, building a career, and more. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.54 Association of Patient Characteristics and Tumor Genomics with Clinical Outcomes & SABR-COMET]]></title><description><![CDATA[In this week's episode, we break down two recently published papers. The first is "Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database" by Singal et al., published in JAMA. The second is "Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial" by Palma et al., published in The Lancet.<br/><br/>Characteristics and genomics: <a href="http://doi.org/10.1001/jama.2019.3241" class="linkified" target="_blank">doi.org/10.1001/jama.2019.3241</a><br/>SABR-COMET: <a href="http://doi.org/10.1016/S0140-6736(18)32487-5" class="linkified" target="_blank">doi.org/10.1016/S0140-6736(18)32487-5</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/154-association-of-patient-characteristics-89d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/607940790</guid><pubDate>Thu, 18 Apr 2019 17:00:50 GMT</pubDate><enclosure length="32540739" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525529/9ebdf323edef3828ecdde1044a997b69.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this week's episode, we break down two recentl…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2034</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525529/8e235a70b70efa694b3352de8debc258.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this week's episode, we break down two recently published papers. The first is "Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database" by Singal et al., published in JAMA. The second is "Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial" by Palma et al., published in The Lancet. Characteristics and genomics: doi.org/10.1001/jama.2019.3241 SABR-COMET: doi.org/10.1016/S0140-6736(18)32487-5 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.53 CALGB 50303, REMoDL-B, & REMS, Orphan Drug Act, and Role of the FDA with Dr. Ameet Sarpatwari]]></title><description><![CDATA[We begin this episode with a discussion of two recent clinical trials in lymphoma: CALGB 50303 and REMoDL-B, respectively published in the Journal of Clinical Oncology and The Lancet Oncology. We include a primer on the history of lymphoma and the development of R-CHOP. We follow that with an in-depth interview with Dr. Ameet Sarpatwari of the Harvard Medical School on Risk Evaluation and Mitigation Strategies (REMS), the Orphan Drug Act, and, broadly, the purpose of the US FDA. <br/><br/>CALGB 50303: <a href="http://doi.org/10.1200/JCO.18.01994" class="linkified" target="_blank">doi.org/10.1200/JCO.18.01994</a><br/>REMoDL-B: <a href="http://doi.org/10.1016/S1470-2045(18)30935-5" class="linkified" target="_blank">doi.org/10.1016/S1470-2045(18)30935-5</a><br/>Dr. Sarpatwari's online course: <a href="https://www.edx.org/course/the-fda-and-prescription-drugs-current-controversies-in-context" class="linkified" target="_blank">https://www.edx.org/course/the-fda-and-prescription-drugs-current-controversies-in-context</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/153-calgb-50303-remodl-b-and-rems-aa6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/604478778</guid><pubDate>Thu, 11 Apr 2019 17:05:15 GMT</pubDate><enclosure length="102201996" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525530/656ebfc340838ad9db5c4b7d75310eeb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this episode with a discussion of two re…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6388</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525530/8f63458e37d3160e4bff36d5356b9ab1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this episode with a discussion of two recent clinical trials in lymphoma: CALGB 50303 and REMoDL-B, respectively published in the Journal of Clinical Oncology and The Lancet Oncology. We include a primer on the history of lymphoma and the development of R-CHOP. We follow that with an in-depth interview with Dr. Ameet Sarpatwari of the Harvard Medical School on Risk Evaluation and Mitigation Strategies (REMS), the Orphan Drug Act, and, broadly, the purpose of the US FDA. CALGB 50303: doi.org/10.1200/JCO.18.01994 REMoDL-B: doi.org/10.1016/S1470-2045(18)30935-5 Dr. Sarpatwari's online course: https://www.edx.org/course/the-fda-and-prescription-drugs-current-controversies-in-context Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.52 BILCAP & DOACs for Thromboprophylaxis in Patients with Cancer with Dr. Sven Olson]]></title><description><![CDATA[In this week's episode we critique the statistics of the recent trial "Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study" that was published in The Lancet Oncology. Then, with Dr. Sven Olson of OHSU, we break down the two papers published in NEJM on thromboprophylaxis with direct oral anticoagulants (DOACs) for patients with cancer: "Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer" and "Apixaban to Prevent Venous Thromboembolism in Patients with Cancer". <br/><br/>BILCAP: <a href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30915-X" class="linkified" target="_blank">www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30915-X</a><br/>Rivaroxaban: <a href="http://doi.org/10.1056/NEJMoa1814630" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1814630</a><br/>Apixaban: <a href="http://doi.org/10.1056/NEJMoa1814468" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1814468</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/152-bilcap-and-doacs-for-thromboprophylaxis-212</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/600933861</guid><pubDate>Thu, 04 Apr 2019 16:25:09 GMT</pubDate><enclosure length="57228334" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525531/1070bdfa81c48777fd21bfc7589ea006.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this week's episode we critique the statistics…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3577</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525531/0d8d07b39564e7950f88ac0cfa54b16f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this week's episode we critique the statistics of the recent trial "Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study" that was published in The Lancet Oncology. Then, with Dr. Sven Olson of OHSU, we break down the two papers published in NEJM on thromboprophylaxis with direct oral anticoagulants (DOACs) for patients with cancer: "Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer" and "Apixaban to Prevent Venous Thromboembolism in Patients with Cancer". BILCAP: www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30915-X Rivaroxaban: doi.org/10.1056/NEJMoa1814630 Apixaban: doi.org/10.1056/NEJMoa1814468 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.51 BONUS! Study Time Reduction Using Surrogate End Points with Dr. Emerson Chen]]></title><description><![CDATA[In this BONUS episode, we sit down for a quick interview with Dr. Emerson Chen of OHSU on his recent paper in JAMA Internal Medicine on how using surrogate end points as opposed to overall survival for FDA approval for oncology drugs only results in a reduced drug development time of approximately 11 months.<br/><br/>Study Time Reduction: <a href="http://doi.org/10.1001/jamainternmed.2018.8351" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2018.8351</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/151-bonus-study-time-reduction-using-c1f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/599923893</guid><pubDate>Tue, 02 Apr 2019 19:27:20 GMT</pubDate><enclosure length="24762936" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525532/61030a0581c76f656860bcb88c620edf.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this BONUS episode, we sit down for a quick in…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>1548</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525532/1e57bfb73f0cc15e65b72d55e700dc5f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this BONUS episode, we sit down for a quick interview with Dr. Emerson Chen of OHSU on his recent paper in JAMA Internal Medicine on how using surrogate end points as opposed to overall survival for FDA approval for oncology drugs only results in a reduced drug development time of approximately 11 months. Study Time Reduction: doi.org/10.1001/jamainternmed.2018.8351 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.50 Replacing RCTs, Physicians on Twitter, Open-Access, & Orthopedics with Dr. Kathryn Schabel]]></title><description><![CDATA[This week we tackle the recent paper published in the Journal of Clinical Oncology titled "Comparison of Population-Based Observational Studies With Randomized Trials in Oncology" as well as a couple papers lamenting physicians' use of Twitter and the open-access model for journal publishing. We end the episode with an in-depth interview with Dr. Kathryn Schabel of OHSU on orthopedic surgery and how she practices. <br/><br/>Observational Studies vs RCTs: <a href="http://doi.org/10.1200/JCO.18.01074" class="linkified" target="_blank">doi.org/10.1200/JCO.18.01074</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/150-replacing-rcts-physicians-on-c1e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/597986325</guid><pubDate>Fri, 29 Mar 2019 19:04:35 GMT</pubDate><enclosure length="111698029" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525533/5d82f95f675900382cdc0df2ce1b41b9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we tackle the recent paper published in…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6981</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525533/2f546d61b3f29709fcda80becece38a6.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we tackle the recent paper published in the Journal of Clinical Oncology titled "Comparison of Population-Based Observational Studies With Randomized Trials in Oncology" as well as a couple papers lamenting physicians' use of Twitter and the open-access model for journal publishing. We end the episode with an in-depth interview with Dr. Kathryn Schabel of OHSU on orthopedic surgery and how she practices. Observational Studies vs RCTs: doi.org/10.1200/JCO.18.01074 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.49 Student Questions, Boeing 737 Max, Pancreatic Surveillance, Leukemia Drugs with Dr. Elihu Estey]]></title><description><![CDATA[We begin this episode by answering questions from a med student who is a Plenary Session fan. We transition from there to a discussion of the recent news stories on the FAA's handling of the Boeing 737 Max controversy and how this reflects on other USA regulatory agencies like the FDA. After a critique of the recent paper "Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance" published in the Journal of Clinical Oncology, we end with an interview with Dr. Elihu Estey of the University of Washington on his 40 years of experience as an oncologist, the "Renaissance" of drugs for leukemia, and advice for trainees on how to approach career goals. <br/><br/>Pancreatic Surveillance: <a href="http://doi.org/10.1200/JCO.18.01512" class="linkified" target="_blank">doi.org/10.1200/JCO.18.01512</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/149-student-questions-boeing-737-b40</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/594220992</guid><pubDate>Fri, 22 Mar 2019 18:25:37 GMT</pubDate><enclosure length="110354708" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525534/2a6929bc7266e07246758908a04ac7ae.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this episode by answering questions from…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6897</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525534/d1d0287c08b5e34821da00f767dd9786.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this episode by answering questions from a med student who is a Plenary Session fan. We transition from there to a discussion of the recent news stories on the FAA's handling of the Boeing 737 Max controversy and how this reflects on other USA regulatory agencies like the FDA. After a critique of the recent paper "Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance" published in the Journal of Clinical Oncology, we end with an interview with Dr. Elihu Estey of the University of Washington on his 40 years of experience as an oncologist, the "Renaissance" of drugs for leukemia, and advice for trainees on how to approach career goals. Pancreatic Surveillance: doi.org/10.1200/JCO.18.01512 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.48 Falsified Data in Meta-Analyses and the Expert Halo Effect with Dr. Stephanie Halvorson]]></title><description><![CDATA[This week we dive deep into an article in JAMA IM on falsified data in meta-analyses. We also discuss the recent JAMA viewpoint "Reducing the Expert Halo Effect on Pharmacy and Therapeutics Committees" with its author, Dr. Stephanie Halvorson of OHSU.<br/><br/>Falsified data: <a href="http://doi.org/10.1001/jamainternmed.2014.7774" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2014.7774</a><br/>Expert Halo Effect: <a href="http://doi.org/10.1001/jama.2018.20789" class="linkified" target="_blank">doi.org/10.1001/jama.2018.20789</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/148-falsified-data-in-meta-analyses-c0f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/589686753</guid><pubDate>Wed, 13 Mar 2019 23:04:07 GMT</pubDate><enclosure length="57871155" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525535/4d85811c481271314738e00f772c68a8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we dive deep into an article in JAMA IM…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3617</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525535/1c9f42f312c69a0ed0b7ddb1a1563338.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we dive deep into an article in JAMA IM on falsified data in meta-analyses. We also discuss the recent JAMA viewpoint "Reducing the Expert Halo Effect on Pharmacy and Therapeutics Committees" with its author, Dr. Stephanie Halvorson of OHSU. Falsified data: doi.org/10.1001/jamainternmed.2014.7774 Expert Halo Effect: doi.org/10.1001/jama.2018.20789 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.47 BONUS! Medical Reversal: Class Lecture]]></title><description><![CDATA[This BONUS episode is a lecture on medical reversal that was pre-recorded for a class at Harvard Medical School. The recording was played for students in February of 2019 and followed by a Q&A. The slides referenced are available to Patreon supporters.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/147-bonus-medical-reversal-class-d25</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/588625644</guid><pubDate>Mon, 11 Mar 2019 23:06:57 GMT</pubDate><enclosure length="54402512" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525536/38e084468bc9945f168d8383757bac2c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is a lecture on medical revers…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3400</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525536/2afe0aac79ba5c8fc7eef779baee6648.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is a lecture on medical reversal that was pre-recorded for a class at Harvard Medical School. The recording was played for students in February of 2019 and followed by a Q&amp;A. The slides referenced are available to Patreon supporters. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.46 BONUS! Personal Finances with Dr. Tom Beer]]></title><description><![CDATA[In this bonus episode, we bring back Dr. Tom Beer of OHSU from episode 1.33 to discuss how to manage your personal finances. The interview is aimed at young physicians, but there is something for all audiences as we cover a broad range of topics: paying off loans, optimizing retirement savings, buying a home, and investing.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/146-bonus-personal-finances-with-f2c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/586961895</guid><pubDate>Fri, 08 Mar 2019 17:10:06 GMT</pubDate><enclosure length="73639919" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525537/58828470542904a89e9aa14d69e3e66f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this bonus episode, we bring back Dr. Tom Beer…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4602</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525537/ce4b3131695fffedede3ad889f35eaf2.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this bonus episode, we bring back Dr. Tom Beer of OHSU from episode 1.33 to discuss how to manage your personal finances. The interview is aimed at young physicians, but there is something for all audiences as we cover a broad range of topics: paying off loans, optimizing retirement savings, buying a home, and investing. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.45 Real-World Data, Gottlieb, & Using the EHR for Meaningful Improvement with Dr. Deborah Cohen]]></title><description><![CDATA[This week's episode begins with praise for the recent article by Booth CM, Karim S, and Mackillop WJ on real-world data published in Nature Reviews Clinical Oncology. Next, we tackle the resignation of Scott Gottlieb as FDA commissioner and how we can measure the success of the FDA. Finally, we have an interview with Dr. Deborah Cohen of OHSU on effective communication between the clinician and the patient and how we can use data from the Electronic Health Record to make meaningful improvements in care.<br/><br/>Real-world data: <a href="http://doi.org/10.1038/s41571-019-0167-7" class="linkified" target="_blank">doi.org/10.1038/s41571-019-0167-7</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/145-real-world-data-gottlieb-and-000</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/586047648</guid><pubDate>Wed, 06 Mar 2019 22:10:32 GMT</pubDate><enclosure length="56693346" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525538/8ed38998e2e15c17d64291cf035c99b5.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's episode begins with praise for the re…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3543</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525538/e5b73a89e03edd7f858e423bac284837.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's episode begins with praise for the recent article by Booth CM, Karim S, and Mackillop WJ on real-world data published in Nature Reviews Clinical Oncology. Next, we tackle the resignation of Scott Gottlieb as FDA commissioner and how we can measure the success of the FDA. Finally, we have an interview with Dr. Deborah Cohen of OHSU on effective communication between the clinician and the patient and how we can use data from the Electronic Health Record to make meaningful improvements in care. Real-world data: doi.org/10.1038/s41571-019-0167-7 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.44 BONUS! Screen Time and Children's Performance]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given as part of the medical school class Appraising Medical Literature, taught at OHSU. This clip from the class critiques the recent JAMA Pediatrics paper "Association Between Screen Time and Children’s Performance on a Developmental Screening Test". <br/><br/>Screen Time: <a href="http://doi.org/10.1001/jamapediatrics.2018.5056" class="linkified" target="_blank">doi.org/10.1001/jamapediatrics.2018.5056</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/144-bonus-screen-time-and-childrens-632</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/583582638</guid><pubDate>Fri, 01 Mar 2019 23:25:53 GMT</pubDate><enclosure length="45021418" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525539/d761e7ed04167af99ff7c28bf8164ae6.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2814</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525539/81d7faa1dd1a83eeb4d91aeba3afef26.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given as part of the medical school class Appraising Medical Literature, taught at OHSU. This clip from the class critiques the recent JAMA Pediatrics paper "Association Between Screen Time and Children’s Performance on a Developmental Screening Test". Screen Time: doi.org/10.1001/jamapediatrics.2018.5056 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.43 Andexanet Alfa with Dr. Tom Deloughery & National Medicaid Policy with Dr. John McConnell]]></title><description><![CDATA[In this episode we discuss the controversy over the recent article in NEJM, "Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors", with Dr. Tom Deloughery of OHSU. We end with an interview with Dr. John McConnell, also of OHSU, on health economics and Medicaid.<br/><br/>Andexanet Alfa: <a href="http://doi.org/10.1056/NEJMoa1814051" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1814051</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/143-andexanet-alfa-with-dr-tom-deloughery-0af</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/579777057</guid><pubDate>Fri, 22 Feb 2019 23:17:58 GMT</pubDate><enclosure length="97850626" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525540/3227c8f6486452eb470af44087677e48.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we discuss the controversy over t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6116</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525540/9988d73012b6c068eed69f12545723dc.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we discuss the controversy over the recent article in NEJM, "Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors", with Dr. Tom Deloughery of OHSU. We end with an interview with Dr. John McConnell, also of OHSU, on health economics and Medicaid. Andexanet Alfa: doi.org/10.1056/NEJMoa1814051 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández]]></title><description><![CDATA[In the first half of this episode, Dr. Sven Olson of OHSU joins us to help critique the recent NEJM paper, "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura". In the second half, we interview Dr. Inmaculada Hernández of the University of Pittsburgh on her work on the economic principles behind runaway drug prices.<br/><br/>Caplacizumab: <a href="http://doi.org/10.1056/NEJMoa1806311" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1806311</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/142-caplacizumab-for-ttp-with-dr-17e</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/574830231</guid><pubDate>Wed, 13 Feb 2019 18:47:02 GMT</pubDate><enclosure length="73682136" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525541/e7b2e0738fd81902ddc904a3589da46f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In the first half of this episode, Dr. Sven Olson…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4605</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525541/a27fc259192ff80fc016da71ee83f10d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In the first half of this episode, Dr. Sven Olson of OHSU joins us to help critique the recent NEJM paper, "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura". In the second half, we interview Dr. Inmaculada Hernández of the University of Pittsburgh on her work on the economic principles behind runaway drug prices. Caplacizumab: doi.org/10.1056/NEJMoa1806311 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.41 Geneva Oath and Financial Relationships Among Guideline Authors with Dr. Joshua Niforatos]]></title><description><![CDATA[We feature two interviews this week: the first is a hallway conversation with [soon-to-be] Dr. Antonious Hazim of OHSU on the Declaration of Geneva and the second is a discussion with [soon-to-be] Dr. Joshua Niforatos on his recent paper in The American Journal of Emergency Medicine, titled "Financial relationships with industry among guideline authors for the management of acute ischemic stroke".<br/><br/>Financial relationships: <a href="http://doi.org/10.1016/j.ajem.2019.01.037" class="linkified" target="_blank">doi.org/10.1016/j.ajem.2019.01.037</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/141-geneva-oath-and-financial-relationships-412</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/572415348</guid><pubDate>Sat, 09 Feb 2019 00:35:06 GMT</pubDate><enclosure length="54942518" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525542/e8f761c5dee04f580d9e114ea50065d2.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We feature two interviews this week: the first is…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3434</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525542/d833e70c8a79cf983948942802b5096a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We feature two interviews this week: the first is a hallway conversation with [soon-to-be] Dr. Antonious Hazim of OHSU on the Declaration of Geneva and the second is a discussion with [soon-to-be] Dr. Joshua Niforatos on his recent paper in The American Journal of Emergency Medicine, titled "Financial relationships with industry among guideline authors for the management of acute ischemic stroke". Financial relationships: doi.org/10.1016/j.ajem.2019.01.037 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.40 The World of Hematology with Dr. Thomas Deloughery]]></title><description><![CDATA[This episode features an interview with hematologist Dr. Thomas Deloughery of OHSU. We cover a broad range of topics including 23andMe, wilderness medicine, academia, and Twitter. We'll be back next week with our regular introductory monologue!<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/140-the-world-of-hematology-with-72b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/570825141</guid><pubDate>Wed, 06 Feb 2019 00:46:38 GMT</pubDate><enclosure length="62418554" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525543/950d7e8d6306a0f788c0237e1d7c5413.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This episode features an interview with hematolog…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3901</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525543/6b45a9edc641f7025c9d4e70b53dda78.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This episode features an interview with hematologist Dr. Thomas Deloughery of OHSU. We cover a broad range of topics including 23andMe, wilderness medicine, academia, and Twitter. We'll be back next week with our regular introductory monologue! Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.39 Looking Back On a Tenure in Medicine with Dr. Alex Denes]]></title><description><![CDATA[In this episode we interview Dr. Alex Denes of OHSU on his decades-long career in medicine: what practices have changed and what have stayed the same. No monologue this week - we'll be back next week with more insights!<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/139-looking-back-on-a-tenure-in-medicine-d7f</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/568750326</guid><pubDate>Sat, 02 Feb 2019 00:34:26 GMT</pubDate><enclosure length="61635716" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525544/422044d6336c6be444f54e61d4071a13.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we interview Dr. Alex Denes of OH…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3852</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525544/170319b521115a1a6928a1b657dbc47d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we interview Dr. Alex Denes of OHSU on his decades-long career in medicine: what practices have changed and what have stayed the same. No monologue this week - we'll be back next week with more insights! Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.38 Lartruvo, New Directions for Cancer Trials, Gene Expression Profiling, & Dr. Miriam Knoll]]></title><description><![CDATA[In this episode we tackle Eli Lilly's drug Lartruvo (olaratumab) and the under-powered phase II trial that led to its FDA accelerated approval; a viewpoint in JAMA on new directions for cancer trials; and gene expression profiling for carcinoma of unknown primary. We end with an interview with Dr. Miriam Knoll of Hackensack Meridian Health on employment after residency or fellowship, residency training, and the medical specialty pipeline.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/138-lartruvo-new-directions-for-cancer-82d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/564708801</guid><pubDate>Sat, 26 Jan 2019 00:47:17 GMT</pubDate><enclosure length="93841978" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525545/0eb0361445cff26afa98d147a40f79bd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we tackle Eli Lilly's drug Lartru…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5865</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525545/9ecf69e1e113a6c01facc450eea9e432.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we tackle Eli Lilly's drug Lartruvo (olaratumab) and the under-powered phase II trial that led to its FDA accelerated approval; a viewpoint in JAMA on new directions for cancer trials; and gene expression profiling for carcinoma of unknown primary. We end with an interview with Dr. Miriam Knoll of Hackensack Meridian Health on employment after residency or fellowship, residency training, and the medical specialty pipeline. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.37 BONUS! Medical Reversal for a General Audience]]></title><description><![CDATA[This BONUS episode is the recording of a talk given at the Salem City Club on January 11, 2019. It's the talk on medical reversal that has been featured in previous episodes, but this time the format and content have been updated for a broader, more general audience.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/137-bonus-medical-reversal-for-a-443</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/560672889</guid><pubDate>Fri, 18 Jan 2019 16:34:06 GMT</pubDate><enclosure length="41808986" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525546/efd77735f314203c5bd19f20540bf038.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a talk giv…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2613</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525546/8b5a449701b3308bf07d5168e2679ec4.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a talk given at the Salem City Club on January 11, 2019. It's the talk on medical reversal that has been featured in previous episodes, but this time the format and content have been updated for a broader, more general audience. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.36 Generic Price Competition & Military Surgical Advances with Dr. Martin Schreiber]]></title><description><![CDATA[This week we dive into the recent paper by Drs. Cole and Dusetzina titled "Generic Price Competition For Specialty Drugs: Too Little, Too Late?". We also have an interview with Dr. Martin Schreiber of OHSU on his experiences as a trauma surgeon, both stateside and on the battlefield.<br/><br/>Generic Price Competition: <a href="https://doi.org/10.1377/hlthaff.2017.1684" class="linkified" target="_blank">https://doi.org/10.1377/hlthaff.2017.1684</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/136-generic-price-competition-and-54c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/559557144</guid><pubDate>Tue, 15 Jan 2019 20:06:15 GMT</pubDate><enclosure length="73241606" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525547/4a769e92db43b4b434444d68481f665b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we dive into the recent paper by Drs. C…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4578</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525547/33289f04f3a8b46ff87f3c7d49114fca.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we dive into the recent paper by Drs. Cole and Dusetzina titled "Generic Price Competition For Specialty Drugs: Too Little, Too Late?". We also have an interview with Dr. Martin Schreiber of OHSU on his experiences as a trauma surgeon, both stateside and on the battlefield. Generic Price Competition: https://doi.org/10.1377/hlthaff.2017.1684 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.35 BONUS! Conflict of Interest in Oncology]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given to the Bioethics Study Group at OHSU on January 9, 2019 on conflict of interest, specifically in the field of oncology. Backers of our Patreon will be sent accompanying slides.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/135-bonus-conflict-of-interest-in-9de</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/557094123</guid><pubDate>Thu, 10 Jan 2019 23:03:09 GMT</pubDate><enclosure length="44020408" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525548/1f6888fc57e7d32544c057f49abbac4f.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2751</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525548/f9a919759bf261c0d8083d2c4d724f6d.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given to the Bioethics Study Group at OHSU on January 9, 2019 on conflict of interest, specifically in the field of oncology. Backers of our Patreon will be sent accompanying slides. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.34 Endpoints in ECOG-ACRIN 2511, Update to KEYNOTE-024, & Mentorship with Dr. Joseph Shatzel]]></title><description><![CDATA[In this episode, we discuss two recent papers published in the Journal of Clinical Oncology: ECOG-ACRIN 2511 and the update adding overall-survival and crossover results to KEYNOTE-024. We end with an interview with Dr. Joseph Shatzel of OHSU on mentorship.<br/><br/>ECOG-ACRIN 2511: <a href="http://doi.org/10.1200/JCO.18.00264" class="linkified" target="_blank">http://doi.org/10.1200/JCO.18.00264</a><br/>KEYNOTE-024 update: <a href="http://doi.org/10.1200/JCO.18.00149" class="linkified" target="_blank">http://doi.org/10.1200/JCO.18.00149</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/134-endpoints-in-ecog-acrin-2511-1f2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/556929147</guid><pubDate>Thu, 10 Jan 2019 16:53:24 GMT</pubDate><enclosure length="67961528" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525549/7273ba428483a63a68c1dc482e4cef4b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode, we discuss two recent papers pub…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4248</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525549/ae9dff8926ea3aa2344f21ffdb17dc67.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode, we discuss two recent papers published in the Journal of Clinical Oncology: ECOG-ACRIN 2511 and the update adding overall-survival and crossover results to KEYNOTE-024. We end with an interview with Dr. Joseph Shatzel of OHSU on mentorship. ECOG-ACRIN 2511: http://doi.org/10.1200/JCO.18.00264 KEYNOTE-024 update: http://doi.org/10.1200/JCO.18.00149 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.33 Guarantee-Time Bias & Trials, Philanthropy, and Cancer Research with Dr. Tom Beer]]></title><description><![CDATA[In this episode we discuss guarantee-time bias in the context of the recent JAMA Oncology paper titled "Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer". We also have an interview with Dr. Tom Beer, the Deputy Director of the OHSU Knight Cancer Institute, on clinical trials, leadership, philanthropy, and future directions in cancer research.<br/><br/>Profiling preexisting antibodies: <a href="http://doi.org/10.1001/jamaoncol.2018.5860" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2018.5860</a><br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/133-guarantee-time-bias-and-trials-089</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/554236458</guid><pubDate>Sat, 05 Jan 2019 00:07:08 GMT</pubDate><enclosure length="88504640" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525550/3b7a53b8b4d280b5fb6a8916cdad1696.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we discuss guarantee-time bias in…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5532</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525550/d456d3a3e72f15c439e8ce4231765bca.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we discuss guarantee-time bias in the context of the recent JAMA Oncology paper titled "Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer". We also have an interview with Dr. Tom Beer, the Deputy Director of the OHSU Knight Cancer Institute, on clinical trials, leadership, philanthropy, and future directions in cancer research. Profiling preexisting antibodies: doi.org/10.1001/jamaoncol.2018.5860 Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.32.1 Radiation Oncology with Dr. Brian Kavanagh]]></title><description><![CDATA[Episode 1.32 ran a little long, so this is episode 1.32.1 - we broke out the interview with Dr. Brian Kavanagh, the Chairman of Radiation Oncology at the University of Colorado, to make the interview more accessible.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/1321-radiation-oncology-with-dr-brian-d92</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/554154900</guid><pubDate>Fri, 04 Jan 2019 20:51:15 GMT</pubDate><enclosure length="68223172" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525551/ef251fdf1927a11d9e0806779219d1ad.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Episode 1.32 ran a little long, so this is episod…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4264</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525551/0644a764cfe7d0a48e7c4a44e28ffa58.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Episode 1.32 ran a little long, so this is episode 1.32.1 - we broke out the interview with Dr. Brian Kavanagh, the Chairman of Radiation Oncology at the University of Colorado, to make the interview more accessible. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.32 Rating Metrics, Conflict of Interest in the News, & Radiation Oncology with Dr. Brian Kavanagh]]></title><description><![CDATA[This week we discuss various academic indices including the h-index and the new Altmetric score, and we go over the recent NY Times article on conflict of interest. We end with an interview with Dr. Brian Kavanagh, the Chairman of Radiation Oncology at the University of Colorado.<br/><br/>NY Times: <a href="https://www.nytimes.com/2018/12/31/upshot/congratulations-on-the-promotion-but-did-science-get-a-demotion.html" class="linkified" target="_blank">https://www.nytimes.com/2018/12/31/upshot/congratulations-on-the-promotion-but-did-science-get-a-demotion.html</a><br/><br/>Back us on Patreon! <a href="http://patreon.com/plenarysession" class="linkified" target="_blank">patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/132-rating-metrics-conflict-of-interest-873</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/553288953</guid><pubDate>Thu, 03 Jan 2019 00:19:16 GMT</pubDate><enclosure length="114804303" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525552/3ee4820b79194825c9c8e472193c4fbb.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week we discuss various academic indices inc…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>7175</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525552/160b25c0571369b721bdb7995cfb7faa.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week we discuss various academic indices including the h-index and the new Altmetric score, and we go over the recent NY Times article on conflict of interest. We end with an interview with Dr. Brian Kavanagh, the Chairman of Radiation Oncology at the University of Colorado. NY Times: https://www.nytimes.com/2018/12/31/upshot/congratulations-on-the-promotion-but-did-science-get-a-demotion.html Back us on Patreon! patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.31 Ketogenic Diet, COMET-1 and COMET-2, the Health Insurance Marketplace with Dr. Jane Zhu]]></title><description><![CDATA[We begin this episode with a discussion of Dr. Mukherjee's ongoing study combining a ketogenic diet with PI3 kinase inhibition. We continue with a take on a recent reanalysis of COMET-1 and COMET-2, two failed randomized controlled trials of cabozantinib versus prednisone or mitoxantrone-prednisone in metastatic castration-resistant prostate cancer. We end with an interview on instabilities in the health insurance marketplace with Dr. Jane Zhu of OHSU, an expert in the Affordable Care Act.<br/><br/>Keto diet + PI3 kinase: <a href="https://www.nytimes.com/2018/12/05/magazine/its-time-to-study-whether-eating-particular-diets-can-help-heal-us.html" class="linkified" target="_blank">https://www.nytimes.com/2018/12/05/magazine/its-time-to-study-whether-eating-particular-diets-can-help-heal-us.html</a><br/>COMET-1: <a href="http://doi.org/10.1200/jco.2015.65.5597" class="linkified" target="_blank">http://doi.org/10.1200/jco.2015.65.5597</a><br/>COMET-2: <a href="https://doi.org/10.1016/j.eururo.2018.11.033" class="linkified" target="_blank">https://doi.org/10.1016/j.eururo.2018.11.033</a><br/><br/>Back us on Patreon! <a href="https://www.patreon.com/plenarysession" class="linkified" target="_blank">https://www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/131-ketogenic-diet-comet-1-and-comet-e1b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/550419051</guid><pubDate>Thu, 27 Dec 2018 00:45:11 GMT</pubDate><enclosure length="91252236" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525553/4e2aea1aafe133044dfe2f0561e23be9.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this episode with a discussion of Dr. Mu…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5703</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525553/9c44879c2b550f34c0952c8473699107.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this episode with a discussion of Dr. Mukherjee's ongoing study combining a ketogenic diet with PI3 kinase inhibition. We continue with a take on a recent reanalysis of COMET-1 and COMET-2, two failed randomized controlled trials of cabozantinib versus prednisone or mitoxantrone-prednisone in metastatic castration-resistant prostate cancer. We end with an interview on instabilities in the health insurance marketplace with Dr. Jane Zhu of OHSU, an expert in the Affordable Care Act. Keto diet + PI3 kinase: https://www.nytimes.com/2018/12/05/magazine/its-time-to-study-whether-eating-particular-diets-can-help-heal-us.html COMET-1: http://doi.org/10.1200/jco.2015.65.5597 COMET-2: https://doi.org/10.1016/j.eururo.2018.11.033 Back us on Patreon! https://www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.30 BONUS! Clinical Trial Endpoints, Drug Approval, Incentives in Oncology]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given to the National Breast Cancer Coalition on December 11, 2018. It's on clinical trial endpoints, FDA drug approval, and incentives in oncology. Backers of our Patreon will be sent accompanying slides.<br/><br/>Back us on Patreon! <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/130-bonus-clinical-trial-endpoints-8ea</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/547322364</guid><pubDate>Wed, 19 Dec 2018 17:02:05 GMT</pubDate><enclosure length="67297392" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525555/a2a77f0869a3ecedee5571a3e4062a17.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4206</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525555/b8b8e7d61ee65f57288dd1741bb6ac16.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given to the National Breast Cancer Coalition on December 11, 2018. It's on clinical trial endpoints, FDA drug approval, and incentives in oncology. Backers of our Patreon will be sent accompanying slides. Back us on Patreon! www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.29 RCT of Parachutes and Frameworks for Internal Medicine with Dr. Andre Mansoor]]></title><description><![CDATA[We begin this episode with a critique of the recent paper in the BMJ, "Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial" and we end it with an interview with Dr. Andre Mansoor, discussing his new book: "Frameworks for Internal Medicine."<br/><br/>Parachutes: <a href="https://www.bmj.com/content/363/bmj.k5094" class="linkified" target="_blank">https://www.bmj.com/content/363/bmj.k5094</a><br/><br/>Back us on Patreon! <a href="https://www.patreon.com/plenarysession" class="linkified" target="_blank">https://www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/129-rct-of-parachutes-and-frameworks-0d7</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/546501291</guid><pubDate>Tue, 18 Dec 2018 00:51:24 GMT</pubDate><enclosure length="74674789" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525556/f803742465306e2d210ef7315a9ef493.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this episode with a critique of the rece…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4667</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525556/fd6b5cd4dfd754bd0646e884e71a4ad3.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this episode with a critique of the recent paper in the BMJ, "Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial" and we end it with an interview with Dr. Andre Mansoor, discussing his new book: "Frameworks for Internal Medicine." Parachutes: https://www.bmj.com/content/363/bmj.k5094 Back us on Patreon! https://www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi Nabhan]]></title><description><![CDATA[In this episode we critique two recent FDA drug approvals (venetoclax in combination with azacitidine or decitabine or low-dose cytarabine; glasdegib in combination with low-dose cytarabine -- both for acute myeloid leukemia)and we interview Dr. Chadi Nabhan, the Chief Medical Officer of Cardinal Health, on career transitions. The interview was taped on location at the 2018 annual conference of the American Society of Hematology in San Diego. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/128-questionable-fda-drug-approvals-0b3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/544141716</guid><pubDate>Thu, 13 Dec 2018 00:32:17 GMT</pubDate><enclosure length="46620220" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525557/540ad23d484665e537e5c3e2a1bd4000.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we critique two recent FDA drug a…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3885</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525557/a7f6fbc338c30ce2dd9fa6518784e3e3.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we critique two recent FDA drug approvals (venetoclax in combination with azacitidine or decitabine or low-dose cytarabine; glasdegib in combination with low-dose cytarabine -- both for acute myeloid leukemia)and we interview Dr. Chadi Nabhan, the Chief Medical Officer of Cardinal Health, on career transitions. The interview was taped on location at the 2018 annual conference of the American Society of Hematology in San Diego. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.27 BONUS! Medical Reversal]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given to hospitalists at Kaiser Permanente on November 14, 2018. It's a slightly different version of the talk on medical reversals that we recorded for episode 1.16. Backers of our Patreon will be sent accompanying slides.<br/><br/>Back us on Patreon: <a href="https://www.patreon.com/plenarysession" class="linkified" target="_blank">https://www.patreon.com/plenarysession</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/127-bonus-medical-reversal-bee</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/540892713</guid><pubDate>Thu, 06 Dec 2018 22:56:29 GMT</pubDate><enclosure length="41599083" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525558/14a8a1132e2444de88c947677006d3ce.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3467</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525558/9e40f0eb39f79a29d650a8127d987f75.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given to hospitalists at Kaiser Permanente on November 14, 2018. It's a slightly different version of the talk on medical reversals that we recorded for episode 1.16. Backers of our Patreon will be sent accompanying slides. Back us on Patreon: https://www.patreon.com/plenarysession This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.26 Lesson From an ASH Abstract, Behind the Scenes of a Residency Program with Dr. Sima Desai]]></title><description><![CDATA[Having just returned from the 2018 American Society of Hematology (ASH) Annual Meeting, we begin this episode by discussing the abstract of a study that stretches its conclusions. We dedicate most of the episode to an interview with Dr. Sima Desai, the program director for OHSU's Internal Medicine Residency Program. She gives some great insight on the program's inner workings.<br/><br/>ASH abstract: <a href="https://ash.confex.com/ash/2018/webprogram/Paper117448.html" class="linkified" target="_blank">https://ash.confex.com/ash/2018/webprogram/Paper117448.html</a><br/><br/>We have also launched our Patreon page! Become a patron at <a href="http://www.patreon.com/plenarysession" class="linkified" target="_blank">www.patreon.com/plenarysession</a>. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/126-lesson-from-an-ash-abstract-behind-7e3</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/539876754</guid><pubDate>Tue, 04 Dec 2018 22:27:45 GMT</pubDate><enclosure length="71195279" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525559/bd680c1fd37f0b6c6382ce8def743973.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Having just returned from the 2018 American Socie…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4450</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525559/02739c2d8209f5f07baed1ff4d6d6e3c.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Having just returned from the 2018 American Society of Hematology (ASH) Annual Meeting, we begin this episode by discussing the abstract of a study that stretches its conclusions. We dedicate most of the episode to an interview with Dr. Sima Desai, the program director for OHSU's Internal Medicine Residency Program. She gives some great insight on the program's inner workings. ASH abstract: https://ash.confex.com/ash/2018/webprogram/Paper117448.html We have also launched our Patreon page! Become a patron at www.patreon.com/plenarysession. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.25 Welch's Legacy, Interpreting NGS, Uncertainty over Pregabalin, Beyond EBM with Dr. Sam Edwards]]></title><description><![CDATA[In this episode we discuss: Dr. Gilbert Welch's Wikipedia page and how we should keep his decades of work in perspective, a Twitter conversation between experts on differing interpretations of results from next-generation sequencing, the new paper in JAMA titled "Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications", and finally, along with Dr. Sam Edwards of OHSU, we criticize the recent perspective piece in NEJM titled "Beyond Evidence-Based Medicine".<br/><br/>Welch's Wikipedia: <a href="https://en.wikipedia.org/wiki/H._Gilbert_Welch" class="linkified" target="_blank">https://en.wikipedia.org/wiki/H._Gilbert_Welch</a><br/>Pregabalin: <a href="http://doi.org/10.1001/jamainternmed.2018.5705" class="linkified" target="_blank">doi.org/10.1001/jamainternmed.2018.5705</a><br/>Beyond EBM: <a href="http://doi.org/10.1056/NEJMp1806984" class="linkified" target="_blank">doi.org/10.1056/NEJMp1806984</a><br/><br/>We have also launched our Patreon page! Become a patron at <a href="https://www.patreon.com/plenarysession" class="linkified" target="_blank">https://www.patreon.com/plenarysession</a>. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/125-welchs-legacy-interpreting-ngs-f15</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/536440710</guid><pubDate>Tue, 27 Nov 2018 22:15:18 GMT</pubDate><enclosure length="77456737" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525560/39002ea708df4fc24069ca5367c7515b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we discuss: Dr. Gilbert Welch's W…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4841</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525560/72ceee7959148cb14e4b7edb3671dac4.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we discuss: Dr. Gilbert Welch's Wikipedia page and how we should keep his decades of work in perspective, a Twitter conversation between experts on differing interpretations of results from next-generation sequencing, the new paper in JAMA titled "Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications", and finally, along with Dr. Sam Edwards of OHSU, we criticize the recent perspective piece in NEJM titled "Beyond Evidence-Based Medicine". Welch's Wikipedia: https://en.wikipedia.org/wiki/H._Gilbert_Welch Pregabalin: doi.org/10.1001/jamainternmed.2018.5705 Beyond EBM: doi.org/10.1056/NEJMp1806984 We have also launched our Patreon page! Become a patron at https://www.patreon.com/plenarysession. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate]]></title><description><![CDATA[In this episode we discuss John Ioannidis' article on the uselessness of medical conferences, published in JAMA: "Are Medical Conferences Useful? And for Whom?", followed by an interview with return-guest Dr. Adam Obley on a few recent clinical trials: Vascepa, fish oil, vitamin D, and methotrexate.<br/><br/>Medical conferences: <a href="http://doi.org/10.1001/jama.2012.360" class="linkified" target="_blank">doi.org/10.1001/jama.2012.360</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/124-useless-medical-conferences-and-50d</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/532646028</guid><pubDate>Tue, 20 Nov 2018 00:28:15 GMT</pubDate><enclosure length="48293205" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525561/3b4e0eb403b13bf4e78a795af5d361ef.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we discuss John Ioannidis' articl…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3018</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525561/b76152421d0202a412e0f606485fdf1f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we discuss John Ioannidis' article on the uselessness of medical conferences, published in JAMA: "Are Medical Conferences Useful? And for Whom?", followed by an interview with return-guest Dr. Adam Obley on a few recent clinical trials: Vascepa, fish oil, vitamin D, and methotrexate. Medical conferences: doi.org/10.1001/jama.2012.360 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given as part of the Biomedical Engineering Seminar series at Oregon Health & Science University on November 9, 2018. The talk is on how to move technological devices to the clinic with fewer reversals. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/123-bonus-developing-technology-with-556</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/530536572</guid><pubDate>Thu, 15 Nov 2018 22:14:28 GMT</pubDate><enclosure length="57764161" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525562/904f263cfd6a51dd5f519865f8fc926b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3610</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525562/8460fb95f17e33c99087ced37c0f4116.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given as part of the Biomedical Engineering Seminar series at Oregon Health &amp; Science University on November 9, 2018. The talk is on how to move technological devices to the clinic with fewer reversals. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner]]></title><description><![CDATA[In this episode, we tackle the recent papers in the New England Journal of Medicine on "Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma" and "Immunotherapy Combinations in Multiple Myeloma", as well as a comment in The Lancet Oncology's editorial "9 Weeks That Matter for Patients With Gastric Cancer". We conclude with an interview with Dr. Erick Turner of OHSU on the FDA, regulatory capture, selective reporting, and transparency.<br/><br/>Elo-pom-dex: <a href="http://doi.org/10.1056/NEJMoa1805762" class="linkified" target="_blank">http://doi.org/10.1056/NEJMoa1805762</a><br/>Immunotherapy combinations: <a href="http://doi.org/10.1056/NEJMp1803602" class="linkified" target="_blank">http://doi.org/10.1056/NEJMp1803602</a><br/>9 weeks that matter: <a href="http://doi.org/10.1016/S1470-2045(18)30752-6" class="linkified" target="_blank">http://doi.org/10.1016/S1470-2045(18)30752-6</a><br/>Dr. Turner's seminal paper: <a href="https://doi.org/10.1056/NEJMsa065779" class="linkified" target="_blank">https://doi.org/10.1056/NEJMsa065779</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/122-elo-pom-dex-immunotherapy-combos-59c</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/529018596</guid><pubDate>Tue, 13 Nov 2018 01:12:43 GMT</pubDate><enclosure length="72963246" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525563/294af37cd95a120ebdb0fd7dc1b2ecca.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode, we tackle the recent papers in t…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4560</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525563/2ed63e17e6ed938f25e50e8b1bfd5804.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode, we tackle the recent papers in the New England Journal of Medicine on "Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma" and "Immunotherapy Combinations in Multiple Myeloma", as well as a comment in The Lancet Oncology's editorial "9 Weeks That Matter for Patients With Gastric Cancer". We conclude with an interview with Dr. Erick Turner of OHSU on the FDA, regulatory capture, selective reporting, and transparency. Elo-pom-dex: http://doi.org/10.1056/NEJMoa1805762 Immunotherapy combinations: http://doi.org/10.1056/NEJMp1803602 9 weeks that matter: http://doi.org/10.1016/S1470-2045(18)30752-6 Dr. Turner's seminal paper: https://doi.org/10.1056/NEJMsa065779 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees]]></title><description><![CDATA[In this episode we question the conclusions of the phase II trial "Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma", review the long-term overall survival results from PALOMA-3, discuss Dr. Gyawali et al.'s paper on the need for transparency in reporting harms from cancer drugs, and interview Dr. Talal Hilal from the Scottsdale Mayo Clinic on his advice for trainees.<br/><br/>Nab-paclitaxel and gemcitabine: <a href="http://doi.org/10.1001/jamaoncol.2018.3277" class="linkified" target="_blank">doi.org/10.1001/jamaoncol.2018.3277</a><br/>Palbociclib and fulvestrant: <a href="http://doi.org/10.1056/NEJMoa1810527" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1810527</a><br/>Reporting harms: <a href="http://doi.org/10.1136/bmj.k4383" class="linkified" target="_blank">doi.org/10.1136/bmj.k4383</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/121-nab-paclitaxel-in-cca-os-of-paloma-026</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/525701127</guid><pubDate>Tue, 06 Nov 2018 17:03:29 GMT</pubDate><enclosure length="69785503" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525564/abfa56a22581ac891dacd04431042843.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we question the conclusions of th…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4362</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525564/e8d98aebd048aaa4cdb8cca905129a56.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we question the conclusions of the phase II trial "Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma", review the long-term overall survival results from PALOMA-3, discuss Dr. Gyawali et al.'s paper on the need for transparency in reporting harms from cancer drugs, and interview Dr. Talal Hilal from the Scottsdale Mayo Clinic on his advice for trainees. Nab-paclitaxel and gemcitabine: doi.org/10.1001/jamaoncol.2018.3277 Palbociclib and fulvestrant: doi.org/10.1056/NEJMoa1810527 Reporting harms: doi.org/10.1136/bmj.k4383 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross]]></title><description><![CDATA[We begin this episode analyzing the unrepentant hype of precision oncology in a monologue that was originally one half of a debate titled: "Is Precision Oncology Generating Patient Benefit or Just Hype?" We conclude with an interview with Dr. Andrae Vandross on the mentor/mentee relationship. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/120-precision-oncology-some-benefit-b32</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/522337050</guid><pubDate>Tue, 30 Oct 2018 21:06:50 GMT</pubDate><enclosure length="93087562" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525565/c56da59b4c1fa4918ffa5eb78fac6603.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We begin this episode analyzing the unrepentant h…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5818</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525565/fb9cf79253cfd2874ebdf7833455a636.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We begin this episode analyzing the unrepentant hype of precision oncology in a monologue that was originally one half of a debate titled: "Is Precision Oncology Generating Patient Benefit or Just Hype?" We conclude with an interview with Dr. Andrae Vandross on the mentor/mentee relationship. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.19 BONUS! Introduction to Cancer Drug Policy]]></title><description><![CDATA[This BONUS episode is the recording of a lecture given as part of a Cancer Intersession course for med students at Oregon Health & Science University on October 25, 2018. The talk is an introduction to cancer drug policy. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/119-bonus-introduction-to-cancer-c40</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/520328607</guid><pubDate>Fri, 26 Oct 2018 17:41:50 GMT</pubDate><enclosure length="47667938" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525566/58a54898d304a87157b3c6876fa0fd63.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a lecture …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2979</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525566/8380e767933365d92085cb7bb6bcbf26.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a lecture given as part of a Cancer Intersession course for med students at Oregon Health &amp; Science University on October 25, 2018. The talk is an introduction to cancer drug policy. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan]]></title><description><![CDATA[In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations.<br/>IMpassion130: <a href="http://doi.org/10.1056/NEJMoa1809615" class="linkified" target="_blank">doi.org/10.1056/NEJMoa1809615</a><br/>Hot-spotting: <a href="https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters" class="linkified" target="_blank">https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/118-impassion130-and-hot-spotting-d09</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/518862447</guid><pubDate>Tue, 23 Oct 2018 21:17:24 GMT</pubDate><enclosure length="60021975" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525567/f8d8be4ce47d4be25a5d2f6cefc91c45.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we evaluate the IMpassion130 tria…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3751</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525567/17c390a5c722f5a2c4b84906f3c536f8.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations. IMpassion130: doi.org/10.1056/NEJMoa1809615 Hot-spotting: https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.17 BONUS! Interpretation of Cancer Clinical Trials]]></title><description><![CDATA[This BONUS episode is the recording of a two-part talk addressed to oncology fellows given at Oregon Health & Science University on October 5 and October 12, 2018. The talk is on how to interpret cancer clinical trials. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/117-bonus-interpretation-of-cancer-c9b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/518368779</guid><pubDate>Mon, 22 Oct 2018 22:03:50 GMT</pubDate><enclosure length="74922638" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525568/a817067b4b84189cf0031bf5e6fec73b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a two-part…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4683</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525568/ad7c26b2dc9564338959a9f4f7a13182.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a two-part talk addressed to oncology fellows given at Oregon Health &amp; Science University on October 5 and October 12, 2018. The talk is on how to interpret cancer clinical trials. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong]]></title><description><![CDATA[This BONUS episode is the recording of the Hospitalist Grand Rounds given at Oregon Health & Science University on October 11, 2018. The talk is on medical reversal. Before the talk we discuss the paper "Many Analysts, One Data Set: Making Transparent How Variations in Analytic Choices Affect Results" by Silberzahn et al., published in Advances in Methods and Practices in Psychological Science.<br/>Paper: <a href="http://doi.org/10.1177/2515245917747646" class="linkified" target="_blank">doi.org/10.1177/2515245917747646</a> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/116-bonus-crowdsourcing-data-analysis-8da</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/515898276</guid><pubDate>Wed, 17 Oct 2018 22:13:38 GMT</pubDate><enclosure length="53602139" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525569/b9e29c70012d17a1147e663564d2adbd.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of the Hospit…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3350</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525569/e3b2dc7904be0b3b49e15cbb924125ce.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of the Hospitalist Grand Rounds given at Oregon Health &amp; Science University on October 11, 2018. The talk is on medical reversal. Before the talk we discuss the paper "Many Analysts, One Data Set: Making Transparent How Variations in Analytic Choices Affect Results" by Silberzahn et al., published in Advances in Methods and Practices in Psychological Science. Paper: doi.org/10.1177/2515245917747646 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare]]></title><description><![CDATA[In this episode we review the recent paper in Nature Reviews Clinical Oncology by Booth, C.M. and Detsky, A.S. titled "Why patients receive treatments that are minimally effective?". We discuss the failure of CheckMate 331 to meet its primary endpoint despite having received accelerated FDA approval. Finally, we bring back Dr. Adam Obley (from episode 1.01) to talk about low-value healthcare, medical education, social media, and more! <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/115-minimally-effective-treatments-233</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/515313321</guid><pubDate>Tue, 16 Oct 2018 20:23:37 GMT</pubDate><enclosure length="75240705" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525570/78b0043f6138fff0474e9286296e5d0d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we review the recent paper in Nat…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4703</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525570/756d87d50b0ccf867a30042caa3ae24e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we review the recent paper in Nature Reviews Clinical Oncology by Booth, C.M. and Detsky, A.S. titled "Why patients receive treatments that are minimally effective?". We discuss the failure of CheckMate 331 to meet its primary endpoint despite having received accelerated FDA approval. Finally, we bring back Dr. Adam Obley (from episode 1.01) to talk about low-value healthcare, medical education, social media, and more! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing]]></title><description><![CDATA[This BONUS episode is the recording of the 22nd annual Pennington Lecture given at Oregon Health & Science University on September 21, 2018. The lecture is on seven myths of medicine and marketing. Before the lecture we read and discuss the editorial "Desperation Oncology" by Tito Fojo, published in Seminars in Oncology. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/114-bonus-immunotherapy-in-desperation-db2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/513438309</guid><pubDate>Fri, 12 Oct 2018 19:19:52 GMT</pubDate><enclosure length="54281306" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525571/a6f61aaf0b2a961f12a676a21958381d.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of the 22nd a…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3393</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525571/8adc70e6e0c84cb17835bdc4c5119761.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of the 22nd annual Pennington Lecture given at Oregon Health &amp; Science University on September 21, 2018. The lecture is on seven myths of medicine and marketing. Before the lecture we read and discuss the editorial "Desperation Oncology" by Tito Fojo, published in Seminars in Oncology. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu]]></title><description><![CDATA[Listen in for a breakdown of the good and the bad of KEYNOTE-189(trial published in NEJM), a discussion with Dr. Talal Hilal of the Mayo Clinic on the rise of minimal residual disease as a clinical endpoint, and an interview with Dr. Adam Cifu of the University of Chicago Pritzker School of Medicine on medical education, sham trials, and more. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/113-keynote-189-dr-talal-hilal-on-2a1</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/511543776</guid><pubDate>Mon, 08 Oct 2018 23:50:42 GMT</pubDate><enclosure length="93212532" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525572/72a31e372b733694ce521f2548ca1d28.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Listen in for a breakdown of the good and the bad…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>5826</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525572/afa13224a53440a0131dc73a3b9c7dd3.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Listen in for a breakdown of the good and the bad of KEYNOTE-189(trial published in NEJM), a discussion with Dr. Talal Hilal of the Mayo Clinic on the rise of minimal residual disease as a clinical endpoint, and an interview with Dr. Adam Cifu of the University of Chicago Pritzker School of Medicine on medical education, sham trials, and more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology]]></title><description><![CDATA[This BONUS episode is the recording of a Grand Rounds talk given at Oregon Health & Science University on September 19, 2018. The talk was inspired by the article by JPA Ioannidis titled "Evidence-based medicine has been hijacked: a report to David Sackett", published May 2016 in the Journal of Clinical Epidemiology. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/112-bonus-evidence-based-medicine-f33</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/509187966</guid><pubDate>Wed, 03 Oct 2018 23:57:08 GMT</pubDate><enclosure length="35522886" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525573/ef49ed64033d1fede26ea236116551b0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This BONUS episode is the recording of a Grand Ro…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2220</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525573/5c80535ffd19f5c5d8a46766fce04e2a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This BONUS episode is the recording of a Grand Rounds talk given at Oregon Health &amp; Science University on September 19, 2018. The talk was inspired by the article by JPA Ioannidis titled "Evidence-based medicine has been hijacked: a report to David Sackett", published May 2016 in the Journal of Clinical Epidemiology. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali]]></title><description><![CDATA[We discuss Dr. Califf's comment on the "social media peanut gallery of experts", Dr. Drazen's comment on "research parasites" and his retirement from NEJM, the recent paper in JAMA on long-term follow up for antibiotics as compared to appendectomies, and the paper in JAMA Internal Medicine on the relationship between health-related quality of life and progression-free survival. Finally, we interview Dr. Bishal Gyawali on a variety of topics, including cancer groundshot. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/111-peanut-gallery-research-parasites-ef2</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/508660509</guid><pubDate>Tue, 02 Oct 2018 22:55:34 GMT</pubDate><enclosure length="104299324" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525574/314f9698bb5bbd015e06ce7e1f3bef6c.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We discuss Dr. Califf's comment on the "social me…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>6519</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525574/188e506e7c45a3e7284546bf6ec8ee5e.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We discuss Dr. Califf's comment on the "social media peanut gallery of experts", Dr. Drazen's comment on "research parasites" and his retirement from NEJM, the recent paper in JAMA on long-term follow up for antibiotics as compared to appendectomies, and the paper in JAMA Internal Medicine on the relationship between health-related quality of life and progression-free survival. Finally, we interview Dr. Bishal Gyawali on a variety of topics, including cancer groundshot. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet]]></title><description><![CDATA[Today we tackle some cardiologists' opposition to criticizing clinical trials on Twitter, the PACIFIC trial on durvalumab in stage III non–small-cell lung cancer, and the recent paper in Heart: "Percutaneous Coronary Intervention for Stable Coronary Artery Disease" by R.K. Al-Lamee, A.N. Nowbar, and D.P. Francis. We end with an interview on academic medical publishing with Dr. Rebecca Cooney, North American Executive Editor of The Lancet. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/110-criticism-via-twitter-pacific-e27</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/505213416</guid><pubDate>Tue, 25 Sep 2018 23:30:47 GMT</pubDate><enclosure length="69758754" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525575/726189c3c8a85c4115866035488311d7.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Today we tackle some cardiologists' opposition to…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4360</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525575/39f1d326864542607a39867394e02441.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Today we tackle some cardiologists' opposition to criticizing clinical trials on Twitter, the PACIFIC trial on durvalumab in stage III non–small-cell lung cancer, and the recent paper in Heart: "Percutaneous Coronary Intervention for Stable Coronary Artery Disease" by R.K. Al-Lamee, A.N. Nowbar, and D.P. Francis. We end with an interview on academic medical publishing with Dr. Rebecca Cooney, North American Executive Editor of The Lancet. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints]]></title><description><![CDATA[Special episode! We discuss the recent correspondence in NEJM on response rate in phase I clinical trials, the JACOB trial published in The Lancet Oncology on pertuzumab for HER2-positive gastric cancer, and we give an evaluation of MI, stroke, and metastasis as hard endpoints. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/109-response-rate-in-phase-i-trials-552</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/502749735</guid><pubDate>Thu, 20 Sep 2018 19:47:47 GMT</pubDate><enclosure length="32341794" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525576/d4feca83c7e617f55c8c51ae78160ab6.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Special episode! We discuss the recent correspond…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2021</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525576/2f04dc1829aef58b35fab2eb6bd0ca48.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Special episode! We discuss the recent correspondence in NEJM on response rate in phase I clinical trials, the JACOB trial published in The Lancet Oncology on pertuzumab for HER2-positive gastric cancer, and we give an evaluation of MI, stroke, and metastasis as hard endpoints. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds]]></title><description><![CDATA[In this episode we discuss hyperprolific authors and the recent comment in Nature by JPA Ioannidis, R Klavans, & KW Boyack; NCCN guidelines with fourth-year medical student Jeffrey Wagner; and point-of-care ultrasounds with Dr. Renee Dversdal of OHSU. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/108-hyperprolific-authors-nccn-with-fd4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/500064129</guid><pubDate>Fri, 14 Sep 2018 23:53:37 GMT</pubDate><enclosure length="60040054" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525577/7ce2dfc34a759b0513aafd285ef8a9ba.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we discuss hyperprolific authors …</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3752</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525577/8edfb14aa31199a4de935dd5c4ed6ebc.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we discuss hyperprolific authors and the recent comment in Nature by JPA Ioannidis, R Klavans, &amp; KW Boyack; NCCN guidelines with fourth-year medical student Jeffrey Wagner; and point-of-care ultrasounds with Dr. Renee Dversdal of OHSU. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola]]></title><description><![CDATA[In this episode we discuss the USA FDA's recent approval of sunitinib as the adjuvant treatment for patients with resected renal cell carcinoma who are at high risk of relapse. We also interview cardiologist Dr. John Mandrola on new directions forward for evidence-based medicine. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/107-adjuvant-sunitinib-in-rcc-future-e92</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/498553899</guid><pubDate>Tue, 11 Sep 2018 20:38:27 GMT</pubDate><enclosure length="60217164" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525578/acf3c8130e577e1d2dbfb2b2c557ec78.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we discuss the USA FDA's recent a…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3764</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525578/8c002af54a01412d38f9e2826629a882.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we discuss the USA FDA's recent approval of sunitinib as the adjuvant treatment for patients with resected renal cell carcinoma who are at high risk of relapse. We also interview cardiologist Dr. John Mandrola on new directions forward for evidence-based medicine. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority]]></title><description><![CDATA[In this episode we break down the RELEVANCE trial published in the New England Journal of Medicine; discuss big data in observational studies with Jenny Gill, MS; and interview Dr. Catherine Livingston of OHSU, an expert in healthcare policy, on her work with the Oregon Health Authority and state Medicaid. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/106-relevance-jenny-gill-and-dr-catherine-baa</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/496751190</guid><pubDate>Fri, 07 Sep 2018 20:12:20 GMT</pubDate><enclosure length="78790046" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525610/08868e24672abae434d89b99ce9fac11.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we break down the RELEVANCE trial…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>4924</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525610/ff18e75169cb9429a1cf5aacede0cb5a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we break down the RELEVANCE trial published in the New England Journal of Medicine; discuss big data in observational studies with Jenny Gill, MS; and interview Dr. Catherine Livingston of OHSU, an expert in healthcare policy, on her work with the Oregon Health Authority and state Medicaid. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity]]></title><description><![CDATA[In this episode we cover the cost and efficacy of cancer drugs; review ECHELON-1; interview Dr. Derrick Tao of OHSU about his recent Lancet Oncology paper on poor control arms; and discuss evidence-based medicine with EBM expert and internist at OHSU, Dr. Martha Gerrity. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/105-cost-and-efficacy-of-cancer-drugs-47b</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/495716910</guid><pubDate>Wed, 05 Sep 2018 21:43:47 GMT</pubDate><enclosure length="58494754" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525611/1d19b9a1f34953de94f084d49c1171b0.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In this episode we cover the cost and efficacy of…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3656</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525611/d50af6025804fb342a959d443454855a.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In this episode we cover the cost and efficacy of cancer drugs; review ECHELON-1; interview Dr. Derrick Tao of OHSU about his recent Lancet Oncology paper on poor control arms; and discuss evidence-based medicine with EBM expert and internist at OHSU, Dr. Martha Gerrity. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser]]></title><description><![CDATA[This week's episode is on nutritional epidemiology by JPA Ioannidis; lenvatinib for hepatocellular carcinoma; nivolumab and ipilimumab for melanoma; and #medtwitter with Dr. Avi O Glasser from OHSU. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/104-nutritional-epi-lenvatinib-nivo-1c6</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/492881187</guid><pubDate>Thu, 30 Aug 2018 17:12:54 GMT</pubDate><enclosure length="54607801" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525612/cb4a42c79a914343ec6fe69f4bf9af5b.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>This week's episode is on nutritional epidemiolog…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3413</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525612/993df68e1daf66dccd6bed99ac49e9c1.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>This week's episode is on nutritional epidemiology by JPA Ioannidis; lenvatinib for hepatocellular carcinoma; nivolumab and ipilimumab for melanoma; and #medtwitter with Dr. Avi O Glasser from OHSU. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross]]></title><description><![CDATA[We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/103-rwe-right-to-try-talazoparib-2de</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/488803968</guid><pubDate>Tue, 21 Aug 2018 23:07:59 GMT</pubDate><enclosure length="63390318" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525613/7361507021505a0ad4cec2deff404498.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>We're moving to our new format. We begin with a m…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>3962</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525613/f506f8eaf3f6830f697ac2e048c84989.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar]]></title><description><![CDATA[In episode 2, we discuss the fellowship program and then take a deep dive into hype surrounding cancer drugs. Our guest is Jeremy Cetnar, MD from Oregon Health & Science University. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/102-hemonc-fellowship-and-hype-in-4e4</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/486589152</guid><pubDate>Thu, 16 Aug 2018 23:48:00 GMT</pubDate><enclosure length="33864768" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525614/4fe858ac98e9927f07df880a26482818.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>In episode 2, we discuss the fellowship program a…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2117</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525614/d0663ef1832bbe461dfece071eb2630f.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>In episode 2, we discuss the fellowship program and then take a deep dive into hype surrounding cancer drugs. Our guest is Jeremy Cetnar, MD from Oregon Health &amp; Science University. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item><item><title><![CDATA[1.01: Introduction and Dr. Adam Obley]]></title><description><![CDATA[Join us for an introduction to who we are and what our podcast is about, then stick around for a hard-hitting discussion of evidence-based medicine, randomized controlled trials, sham controls, and broad next-generation sequencing in cancer. Our guest is Adam Obley, an Assistant Professor of Medicine at Oregon Health & Science University. <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.drvinayprasad.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.drvinayprasad.com/subscribe</a>]]></description><link>https://www.drvinayprasad.com/p/101-introduction-and-dr-adam-obley-619</link><guid isPermaLink="false">tag:soundcloud,2010:tracks/485652588</guid><pubDate>Tue, 14 Aug 2018 23:22:58 GMT</pubDate><enclosure length="34148146" type="audio/mpeg" url="https://api.substack.com/feed/podcast/224525615/2e3b6866d75aabbd3bae6a5f4e8932c8.mp3"/><itunes:author>Vinay Prasad MD MPH</itunes:author><itunes:subtitle>Join us for an introduction to who we are and wha…</itunes:subtitle><itunes:explicit>Yes</itunes:explicit><itunes:duration>2846</itunes:duration><itunes:image href="https://substackcdn.com/feed/podcast/231792/post/224525615/0fc2ddaa4f0299051f509ae0f43ec335.jpg"/><dc:creator>plenarysessionpodcast@gmail.com (Vinay Prasad, MD MPH)</dc:creator><itunes:summary>Join us for an introduction to who we are and what our podcast is about, then stick around for a hard-hitting discussion of evidence-based medicine, randomized controlled trials, sham controls, and broad next-generation sequencing in cancer. Our guest is Adam Obley, an Assistant Professor of Medicine at Oregon Health &amp; Science University. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe</itunes:summary><itunes:keywords>medicine,oncology,health,policy</itunes:keywords></item></channel></rss>